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Abstract 
Lyme borreliosis is the most common tick-borne, human infection across the Northern 
hemisphere. The agent responsible, Borrelia burgdorferi sensu lato (s.l.) covers a family of 
Spirochaetes with unique characteristics which are shared by both Gram-negative and Gram-
positive bacteria. The outer membrane (OM) is rich in lipoproteins but contains a relatively 
low density of integral membrane proteins (OMPs), of these OMPs very few have been 
identified and even fewer are well characterised.  The OmpA-like transmembrane domain 
defined by the Pfam family PF01389 is a 8-stranded membrane spanning β-barrel and is well 
conserved among Gram-negative bacteria but to date remains unknown in Spirochaetes. 
Building from previous computational work which had sought to identify possible OMPs from 
B. burgdorferi s.l. four OmpA-like proteins, BAPKO_0422 (Borrelia afzelii), BB_0562, 
BB_0406 (B. burgdorferi) and BG0408 (Borrelia garinii) have been identified and structurally 
characterised. The four proteins are encoded by chromosomal genes and highly conserved 
between Borrelia species and may be of diagnostic or therapeutic value. Structural 
characterisation by both circular dichroism and small angle X-ray scattering suggests these four 
proteins adopt a compact globular structure rich in β-strand (~40%) with Ab initio molecular 
envelopes resembling a cylindrical peanut shape with dimensions of ~25x45 Å consistent with 
an 8-stranded β-barrel. The present work demonstrates that BAPKO_0422 can bind human 
factor H (hfH) and some evidence for a further interaction between the BAPKO_0422 protein 
and heparin. The interaction with hfH may contribute to the spirochaete’s immune evasion 
mechanisms by the inhibition of the complement response. 
 
The zoonotic life-cycle of Borrelia and challenges by the host’s immune system causes an ever 
changing environment which often leads to fluctuations of O2 exposure. Although B. 
burgdorferi s.l. have a distinct lack of metabolic systems including peroxidases and catalase 
enzymes the Spirochaetes genome does encode a single superoxide dismutase gene (sodA - 
bb_0157). Previously assigned as a Fe-SOD there has been some debate whether this protein 
requires iron or manganese as a co-factor. The present work demonstrates that the B. 
burgdorferi enzyme SodA requires manganese for activity and does not display cambialistic 
behaviour. Structural and proteomic characterisation suggests the B. burgdorferi SodA enzyme 
shares significant sequence similarity to a superoxide dismutase from Thermus thermophilus.   
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Chapter 1: Introduction 
1.1 Lyme Disease 
1.1.1 A brief history of Lyme disease 
Lyme borreliosis or Lyme disease is the most common arthropod-borne, human infection 
reported throughout the northern hemisphere (CDC, 2013). Since the beginning of the 
twentieth century, symptoms associated with the disorder were well documented; however the 
etiological agent remained unidentified. During the 1970’s, unusual clusters of oligoarthritis, 
mainly identified in juveniles from rural communities were reported around the town of Lyme, 
situated in southeastern Connecticut, USA (Steere et al., 1977). The annual epidemics which 
peaked during the summer months from as early as 1972, ran somewhat undetected and were 
largely misdiagnosed as juvenile rheumatoid arthritis (Steere et al., 1972). Following the 
assistance from nearby Yale University, which was initially requested by a group of shrewd 
parents, the observation that a number of patients had presented with a distinctive, expanding 
skin lesion, provided the key in identifying the agent responsible for what is now described as 
a global health concern. The now familiar bulls eye rash or erythema migrans had previously 
been described in Northern Europe, following a bite from the sheep tick, Ixodes scapularis, 
which was already believed to be caused by an unknown infectious agent (Hellerström, 1930). 
This link propelled an intensive investigation, leading to the isolation of a novel spirochaete 
from the North American deer tick Ixodes scapularis, so named Borrelia burgdorferi after its 
co-discoverer Willy Burgdorfer (Burgdorfer et al., 1982). 
 
From the initial isolation and identification of the spirochaete, no less than 20 closely related 
species were identified with this number continuing to grow and have become known as 
B.burgdorferi sensu lato (s.l.). Within B. burgdorferi s.l. at least three genospecies are 
pathogenic to humans, B. afzelii and B. garinii in Europe and B.burgdorferi sensu stricto, 
predominantly within the United States however the number of pathogenic strains is growing. 
 
Borrelia are highly specialised pathogens with the ability to tightly regulate gene expression in 
response to their environment, allowing them to achieve a complex lifecycle between 
invertebrate vectors and vertebrate hosts (Fraser et al., 1997).  The transmission of 
B.burgdorferi requires the efficient migration, from the tick’s gut to the salivary glands, during 
the invertebrate’s blood meal, which stages the penetration of the pathogen into the vertebrate’s 
tissues (Ribeiro et al., 1987).  Subsequent colonisation of uninfected ticks from the host 
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completes the complex enzootic cycle and highlights the pathogens requirement to significantly 
adapt to the often changing environment (Fisher et al., 2005). 
 
Over the past few years Lyme disease has become a hot topic, especially within the US, with 
the 2012 presidential candidate Mitt Romney including the disease within his campaign 
strategy (The New Yorker, 2012). The two medical societies, The Infectious Diseases Society 
of America (IDSA) and The International Lyme and Associated Diseases Society (ILADS) are 
at arms following the development of conflicting clinical and patient recommendations. This 
conflict has rapidly escalated with the IDSA accusing ILADS as being involved in an ‘axis of 
evil’ by their association and recommendation of misguided physicians and controversial 
treatment strategies. In retaliation ILADS believe that the IDSA are ignoring crucial scientific 
information and that they have conflicts of interest with commercial value when publishing 
guidelines. The pair appear to have formed a stance with the IDSA against and the ILADS for 
the belief of chronic infections which require long antibiotic treatment periods with both sides 
publishing research in support and against pro-longed therapies. Some researchers have 
attempted to bring clarity to their work in the form of independent review articles the most 
recent by Borchers, 2014 and Sanchez, 2015. Patients unfortunately are stuck in the middle and 
are often attracted to treatments which sound promising but have little scientific significance 
when current diagnostic testing and standard treatments fail. 
 
1.1.2 Symptoms 
Early symptoms of localised infection are often seen within three to 30 days from transmission 
and often take the form of erythema migrans (EM), more commonly known as the ‘bull’s eye 
rash’ as shown in figure 1.1 (Murray and Shapiro, 2010, Tibbles et al., 2007, DePietropaolo et 
al., 2006).  Up to 80 per cent of patients infected, present with the characteristic rash, which is 
commonly defined as a circular or oval-shaped skin lesion, which may expand outwards and 
range in size between 5 to 70cm (Tibbles et al., 2007). Adults most commonly present with 
EM on the legs, buttocks or groin area and less frequently on the arms and trunk. Presentations 
of EM upon the head are mostly seen in children at a rate of 20-40% of cases (Berglund et al., 
1995 and Altpeter et al., 2013). Interestingly the typical bull’s eye effect with a central clearing 
is only seen in 19% of American cases compared to 80% of European patients (Tibbles and 
Edlow, 2007).  
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EM was previously considered exclusive to Lyme disease. However the USA has recorded 
patients presenting with EM who have been diagnosed with an illness similar to that of Lyme 
borreliosis known as southern tick-associated rash illness (STARI) which is transmitted by the 
lone star tick (A. americanum) by an unknown agent (Tibbles and Edlow, 2007). Fortunately 
for most patients presenting with an EM rash antibiotic therapy is often successful and further 
complications are rare. However, for those patients where an EM is not present, not seen or 
they are misdiagnosed, disseminated infection can lead to dangerous complications (Borchers 
et al., 2014). A full summary of symptoms and their associated disease stages can be reviewed 
in table 1.1. 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Examples of the early manifestation of Lyme disease, Erythema migrans. A. The classical bull’s 
eye rash on the arm of an adult patient (Ogden et al., 2008). B. A faint annular EM on a paediatric patient (Glatz 
et al., 2014). 
 
 
Presentation of Lyme borreliosis following infection can be clearly grouped into three specific 
stages – early localised infection, early disseminated infection and late persistent infection, also 
described as primary, secondary and tertiary (Borchers et al., 2014). There is also a further 
stage which has been coined as post-Lyme syndrome, whether this is indeed still an active 
infection or a resulting immune disorder is still up for debate (Wormser et al., 2006, Murray 
and Shapiro, 2010, Borchers et al., 2014).   
 
Following infection, systemic symptoms may become apparent. These include vague 
symptoms such as headache, fatigue, a stiff neck, fever, nausea, myalgias and dysesthesia 
(Tibbles and Edlow, 2007). A more obvious symptom is the presence of a further EM lesion 
A B 
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away from the original site of transmission. Borrelial lymphocytoma, lymphocytoma cutis or 
lymphadenosis benigna cutis is observed in around 4.5% of European cases of early 
disseminated Lyme borreliosis and most often in children (Altpeter et al., 2013, Berglund et 
al., 1995, Huppertz et al., 1999, Christova and Komitova, 2004, Dhôte et al., 2001, Lipsker et 
al., 2001). It appears as a bluish-red nodular swelling (figure 1.2) and is often seen on the 
earlobe of infected children or upon the nipple of an infected adult and can be painful to the 
touch (Maraspin et al., 2002, Strle at al., 1992, Colli et al., 2004). It can be seen from weeks to 
months following infection and sometimes during the EM period. Although lymphocytoma is 
not exclusive to Borrelia infection the frequency of its presentation is highest in Lyme endemic 
areas (Borchers et al., 2014). 
 
 
 
Figure 1.2. An example of early disseminated Lyme disease, Borrelia lymphocytoma. An example of 
Borrrelia lymphocytoma on the ear of an Austrian paediatric patient. (Glatz et al., 2014) 
 
 
When EM is not present or is no longer present, Lyme neuroborreliosis (LNB) is often the 
presenting complaint of disseminated infection and can develop anytime between days to 3 
months following exposure (Hubálek, 2009). Studies suggest that 10-15% of patients who are 
not treated for EM will develop neurological symptoms (Steere et al., 1978, Asbrink et al., 
1986) with the highest rates seen in children and within the over 50 age group (Berglund et al., 
1995, Huppertz et al., 1999, Hansen & Lebech., 1992, Henningsson et al., 2010). Presentation 
of neuroborreliosis appears to have a male to female ratio of 1.5:1 in Europe (Hansen & 
Lebech., 1992, Oschmann et al., 1998, Bremell & Hagberg., 2011, Henningsson et al., 2010 
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and Beglund et al., 2002). Neurological manifestations vary but most common examples are, 
cranial neuropathies such as facial nerve palsy, lymphocytic meningitis, cranial neuritis, 
radiculoneurtitis and encephalitis (Greco et al., 2012, Reik et al., 1979, Dhôte et al., 2000, 
Hansen & Lebech., 1992, Oschmann et al., 1998, Henningsson et al., 2010). A breakdown of 
American cases reported to the CDC showed 9% of LNB patients presented with Bell’s palsy, 
4% showed radiculoneuritis, 1% developed meningitis and a further 1% encephalitis (CDC, 
2013). European datum suggests that 16-23% of infected patients present with some form of 
LNB. Of these 70-90% of these adult patients complained of severe radiculitic pain often at its 
peak during the night (Dhôte et al., 2000, Hansen & Lebech., 1992 and Oschmann et al., 1998) 
and cranial neuritis was seen to affect 40-50% of adult patients mainly as Bell’s palsy (Dhôte 
et al., 2000, Hansen & Lebech., 1992, Oschmann et al., 1998, Henningsson et al., 2010). CSF 
lymphocytic pleocytosis is also common in European patients with neuroborreliosis (Dhôte et 
al., 2000, Hansen & Lebech., 1992, Oschmann et al., 1998, Henningsson et al., 2010) and has 
become part of the diagnostic criteria for LNB. Other rare but observed conditions seen in 
European cases are, progressive encephalomyelitis, chronic meningoencephalitis, 
meningomyelitis and radiculomyelitis (Hansen & Lebech., 1992, Oschmann et al., 1998). 
 
Although cardiac involvement is rare, Lyme cardioborreliosis is observed in upto 1% of both 
American (CDC, 2013) and European cases reported, often associated with early disseminated 
disease. The condition can become apparent anywhere between a few days to three months 
following infection (Berglund et al., 1995, Lesnyak et al., 1998, Huppertz et al., 1999 and 
Christova et al., 2004). Statistically Lyme carditis is mostly seen in the 20 to 40 years age group 
with a ratio of 3:1, male to female. It presents most commonly as fluctuating disturbances in 
atrioventricular (AV) conduction (Steere et al., 1980, van der Linde., 1991 and Costello et al., 
2009) and the block is most commonly above the bundle of His, within the AV node (Steere et 
al., 1980 and van der Linde., 1991) although other areas within the AV conduction system can 
be affected. Based on recorded cases, half resulted in a total heart block with one third of these 
patients requiring a temporary pacemaker (Costello et al., 2009, McAlister et al., 1989 and 
Midttun et al., 1997). Other reported cardiac manifestations include, endocarditis, pericarditis, 
myocarditis, pericardial effusion and congestive heart failure (Berglund et al., 1995, Lesnyak 
et al., 1998, Huppertz et al., 1999, Borchers et al., 2014). 
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Clinical manifestations of Lyme borreliosis 
Stage Other names Manifestations 
 
Stage 1 
 
Early localised 
 
Erythema migrans (EM) 
Flu-like symptoms, headache, myalgia, 
arthralgia, local lymphadenopathy. 
Borrelia lymphocytoma – commonly of 
the earlobe or nipple 
 
Stage 2 
 
Early disseminated 
 
Multiple erythema migrans 
Sweats, myalgia, arthralgia 
Viral-like meningitis or encephalitis 
Cranial nerve palsy 
Mononeuritis multiplex 
Radiculopathies 
Cardiac conduction disturbances 
Arthritis 
Myocarditis 
Pericarditis 
Cardiomyopathy and heart failure 
 
Stage 3 
 
Late disseminated 
 
Oligoarthritis 
Acrodermatitis chronica atrophicans 
 
 
Stage 4 
 
Post Lyme syndrome or Chronic 
Lyme disease 
 
Fatigue 
Joint and muscle pain 
Sleep issues and depression 
Auto-immune responses 
Neuropathy 
 
Table 1.1. Stages and clinical manifestations of Lyme borreliosis. Table of disease progression with related 
symptoms. The table has been adapted from the British Journal of Hospital Medicine with an additional stage 
representing chronic symptoms often associated with Post Lyme Disease Syndrome or chronic Lyme disease. 
 
 
Later cutaneous manifestations of Lyme borreliosis are predominantly observed in women 
from middle age upwards and take form as acrodermatitis chronica atrophicans or ACA. This 
predisposition towards females remains unexplained but the condition appears as a bluish-red 
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discolouration of the skin normally on the upper side of the feet or hands (Asbrink et al., 1986). 
It has been reported that this condition often occurs on the same area in which the original EM 
was observed years earlier although only 20% of these patients gave a history of the original 
EM manifestation (Asbrink et al., 1986). ACA may spread to other extremities of the body and 
become symmetrical and is rarely seen to resolve quickly with symptoms often remaining for 
several years followed by atrophy of the skin (Asbrink & Hovmark., 1988). Development of a 
sensory polyneuropathy is also seen in 30-40% of patients following ACA (Kindstrand et al., 
1997, Asbrink & Hovmark., 1988 and Kristoferitscho et al., 1988). Development of ACA is 
fairly rare and occurs in 1-7% of European Lyme disease patients (Berglund et al., 1995, 
Altpeter et al., 2013 and Huppertz et al., 1999). However has not yet been reported in Chinese 
(Ai et al., 1988) or Russian cases (Lesnyak et al., 1998) and it is also particularly rare within 
the USA. 
 
Following infection, 60% of patients who present with EM but who do not receive appropriate 
treatment develop recurrent episodes of Lyme arthritis (LA) (Steere et al., 1987). However this 
condition is extremely rare in patients who do receive a suitable antibiotic therapy (Borchers 
et al., 2014). This presents problems for those patients who don’t recognise an EM or who do 
not present with the typical early symptoms that would be easily recognised by a primary care 
physician. Arthritic conditions can develop during the early infection stage anytime from days 
to a few months after infection but is also seen as a repeating late manifestation which can 
occur years later. Typical LA is described as brief but reoccurring monoarticular or asymmetric 
oligoarticular swelling and pain of the large joints or migratory polyarthritis of both the small 
and large joints (Steere et al., 1987, Huppertz et al., 1999, Gerber et al., 1998). The condition 
often resolves even in untreated patients however some cases have shown evidence of chronic 
synovitis and permanent joint destruction (Steere et al., 1987). 
  
A flurry of recent studies has suggested a possible link or correlation with LNB and the 
development of Alzheimer’s disease (AD) (Bu et al., 2014, Mawanda and Wallace, 2013, 
Halperin, 2011 and Miklossy, 2008). Past research has elucidated that infectious burden plays 
a role in cardiovascular disease and stroke with some evidence emerging that the overall burden 
of prior infection, including an infection with Borrelia increases the likelihood of developing 
AD (Bu et al., 2014). This topic still remains controversial with much further investigation 
required.  
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1.1.3. Diagnosis 
Diagnosis of Lyme borreliosis remains discordant. For patients that present with EM, alongside 
a history of potential tick exposure, diagnosis is relatively straightforward. However the 
absence of EM, for example during the later disease stages, renders the diagnosis reliant upon 
laboratory confirmation of infection.  Genetic studies following the completion of 
B.burgdorferi’s genome (Fraser et al., 1997) suggested an unusual absence of biosynthetic 
pathways (discussed in section 1.3.4 Genomic Complexity), highlighting the pathogens 
requirement to obtain nutrients from its environment (Fraser et al., 1997).  This distinct lack of 
metabolic systems, makes the spirochete difficult to culture under normal conditions and in 
vitro growth is only obtained through the use of highly enriched culture media (Barbour, 1984). 
 
Both direct and indirect methods have been used within the laboratory setting to assist 
diagnosis of Lyme borreliosis, direct methods include culture or detection of the pathogen 
specific proteins and indirect diagnosis involves detection of antibodies raised against the 
invading bacterium (Murray et al., 2010). The gold standard is the isolation of Borrelia spp. by 
culture followed by PCR-based approaches to confirm the Borrelia strain. In many cases 
culture is not carried out as the turn-around time is often 2-6 weeks often after a clinical 
treatment decision is made and the test often returns negative with an overall sensitivity of 40-
70% for a sample taken from an EM (Strle et al., 1996 & Smith et al., 2002) and a 3-17% 
sensitivity for CSF samples (Strle et al., 2006 and van Dam et al., 1993). This low sensitivity 
can be attributed to the difficulty in culturing the bacteria or the relatively low levels of Borrelia 
within the fluid taken.    
 
PCR based techniques based upon the principle of recognising Borrelia DNA can be useful 
especially if this DNA is found within synovium samples from patients presenting with Lyme 
Borreliosis. However this isn’t always an indication of active disease and again suffers from 
the same problems with a sensitivity of 75-80% from EM samples (Liveris et al., 2002 and 
O’Rourke et al 2013), 15-30% from the CSF (Lebech et al., 2002 and Nocton et al., 1996) and 
60-85% from synovial fluid samples (Nocton et al., 1994 and Jones et al., 2009). 
 
A single serological test can often yield a false positive result as many individuals are infected 
with spirochaete bacteria prior to exposure to Borrelia and spirochaetal oral infection is 
common. Within the UK a two-tiered testing method is recommended. This diagnostic method 
uses an enzyme linked immunosorbent assay (ELISA) followed by a confirmatory western 
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blot. The initial ELISA is a C6 antigen based assay which is combined for both IgG and IgM 
followed by a confirmatory western blot for IgG and IgM separately.  In order for a patient to 
be diagnosed with Lyme disease in absence of EM, both of the tests must be returned positive 
alongside Lyme disease symptoms. Again sensitivity is problematic as outlined in table 1.2, 
and many people presenting with EM in Europe never seroconvert. Antibodies against Borrelia 
are often slow to develop with IgM undetectable until after 1-2 weeks following infection and 
IgG often undetectable until 6 weeks has passed (Berglund et al., 1995, Aguero-Rosenfeld et 
al., 1993, Engstrom et al., 1995, Steere et al., 2008, Glatz et al., 2008, Aguero-Rosenfeld et al., 
1996 and Craft et al., 1984). Following the eventual generation, IgM and IgG antibodies may 
persist for many years (Engstrom et al., 1995 and Aguero-Rosenfeld et al., 1996) making it 
impossible to discriminate between previous and new cases of infection. Interestingly recent 
research has identified that the rate of seropositivity is connected to the duration of symptoms 
prior to seeking diagnosis and treatment (Berglund et al., 1995, Aguero-Rosenfeld et al., 1996, 
Tveitnes et al., 2009, Cerar et al., 2010). This may suggest that early antibiotic treatment plays 
some role in preventing development of seropositivity particularly in Europe (Glatz et al.,2006 
and Stanek and Kahl, 1999). 
 
 
 
Test Type 
% Reactivity for patients with: 
EM  
Acute phase 
EM 
Convalescent 
phase 
Neurological 
presentations 
Arthritic 
presentations 
Whole-cell ELISA 33-49 76-86 79 100 
IgM Western blot 43-44 75-84 80 16 
IgG Western blot 0-13 15-21 64-72 96-100 
Two-tier test method 29-40 29-78 87 97 
 
Table 1.2 – Diagnostic reactivities of B. burgdorferi antibody detection within US patients using various 
methods. Table adapted from a review by Aguero-Rosenfeld et al., 2005. The table demonstrates the huge range 
in reactivities observed for the current B. burgdorferi testing methods during different stages of clinical 
presentation and highlights the need to improve the current methods used.  
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1.1.4. Treatment and vaccination 
Treatment of Lyme borreliosis varies throughout affected countries, once diagnosed correctly, 
antibiotic therapy is often employed and can prevent development of other complications 
(Borchers et al., 2014). Effective antibiotics include β-lactams, tetracyclines and in some cases 
macrolides are useful (Borchers et al., 2014). The best procedure still remains unclear which 
leads to variation of treatment strategies across the globe. It is becoming more evident that not 
all individuals respond the same and not all Borrelia species react equally to the current 
antibiotics in use (Preac Mursic et al., 1996). Treatment guidance has been proposed from 
several organisations around the world and is mostly based upon available evidence from 
randomised controlled trials (RCTs). On the whole, recommendations are similar with the 
major differences lying within dosage and treatment lengths with ILADS advocating harsher 
and more aggressive treatment strategies. However, the justification for these extended 
treatments are based on relatively old studies possibly giving an unbalanced opinion by 
ignoring much newer research which often does not support the use of prolonged treatment 
strategies (Borchers et al., 2014). 
 
As the risk of acquiring Borrelia infection following a tick bite remains low even when the tick 
itself is infected, prophylaxis is not currently recommended under normal circumstances. 
However, a US randomised placebo-controlled trial of prophylaxis by means of a single dose 
of 200 mg of doxycycline within 72 hours of tick removal was effective at preventing the 
development of initial stage symptoms (Nadelman et al., 2001). Alike the American study a 
Russian trial found they could reduce the infection rate by a factor of 11 when administering 
200 mg of doxycycline for upto 5 days following a tick bite (Korenberg et al., 1996). 
 
The European National Neurological Society (EFNS) recommends an oral course of 
doxycycline or intravenous administration of ceftriaxone (Steere et al., 2004) over a period of 
2-4 weeks, for adult patients presenting with early dissemination stages of infection (Rosa et 
al., 2005).  Some studies have demonstrated the requirement of multiple, long term courses of 
antibiotics for those patients diagnosed with chronic Lyme. However, this is not always 
effective once the spirochaete has gained access to the central nervous system (Livengood et 
al., 2006).  Such extended antibiotic treatment is also considered unsuitable or ineffective for 
patients presenting with symptoms which have persisted for over six months following 
infection (Mygland et al., 2009). This condition is often described as post Lyme disease 
syndrome. Compilation of several large RCTs have not shown any evidence that the extension 
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of doxycycline treatment from 10 to 20 days improves average patients outcomes (Wormser et 
al., 2003, Stupica et al., 2012 and Kowalski et al., 2010). Many of these studies have noted that 
in a small number of cases of extended treatment some patients did benefit. However, such 
benefits need to outweigh the risks of aggressive therapy. Arthritic symptoms that persist for 
over three months following antibiotic treatment are often referred to as treatment resistant LA 
and are best tackled using a different strategy other than antibiotics especially when synovial 
fluid is not positive for borrelial DNA. These include, anti-inflammatory drugs, intra-articular 
corticosteroids or disease modifying anti-rheumatic drugs (Wormser et al., 2006). 
  
A commercially available vaccine was developed in 1998 (Steere et al., 1998). However, it was 
withdrawn three years later due to decreasing sales following controversy over possible side 
effects (Krupka et., 2011).  The outer surface protein A (OspA) vaccine was administered in 
three 30µg doses, following the final dose 99% of the participants tested positive for the OspA 
antibody.  The study proposed the vaccine was 76% effective against B. burgdorferi sensu lato 
(Steere et al., 1998, Nigrovic et al., 2006).  Further production of alternative vaccines has not 
yet been successful, primarily due to antigenic variation of outer surface proteins between 
different strains (Krupka et al., 2011). 
 
 
1.1.5. Post-Lyme disease syndrome (PLDS) 
Following antibiotic therapy, 3-27% of patients who presented with EM complain of remaining 
symptoms (Borchers et al., 2014). This proportion increases to 10-40% for those who were 
diagnosed with LNB (Borchers et al., 2014). Residual symptoms often include, headache, 
fatigue, irritability, arthralgias, myalgias, stiff neck, paresthesias (Berglund et al., 2002, Ljøstad 
& Mygland et al., 2009, Borg et al., 2005, Eikeland et al., 2012, Eikeland et al., 2011, Benke 
et al., 1995 and Vrethem et al., 2002) and issues with concentration and memory (Shadick et 
al., 1994, Ravdin et al., 1996 and Klempner et al., 2001). Neuropsychological studies of 
previous adult LNB patients up to 30 months following the resolution of infection have shown 
reduced verbal and visual memory, deficits in attention/executive function and reduced 
processing speed when compared to healthy controls (Eikeland et al., 2012 and Benke et al., 
1995) however this is not seen in paediatric patients.  
 
As discussed in a recent review article (Borchers et al., 2014) several studies have stated that 
further antibiotic therapy for these residual symptoms is ineffective (Mygland et al., 2009), not 
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useful (Wormser et al., 2006) or has not shown sustained benefit (British Infection Association, 
2011). The review makes an interesting point that all three of these statements are false as in 
two of the same studies a subset of the patients did indeed show a significant improvement 
which was sustained. The review calls into question our lack of understanding of the human 
microbiome in Lyme patients and suggests this may influence the symptom of PLDS. Evidence 
for PLDS remains unclear and the term seems to now describe any symptoms a patient may 
suffer following an adequate antibiotic treatment. There is no current standardised case 
definition for the syndrome and much further study is required in order to identify patients with 
active recurring borreliosis from those who are not suffering from an active infection but may 
be displaying post Lyme symptoms such as autoimmune disorders or after effects following 
neuroborreliosis. 
 
 
1.1.6. Incidence 
Lyme borreliosis or Lyme disease is the most common arthropod-borne, human infection 
reported throughout the northern hemisphere and is becoming increasingly more common. 
During 2001 within the UK there were a total of 268 cases of laboratory confirmed Lyme 
borreliosis, giving a mean annual rate of infection of 0.50 per 100,000 people (HPA, 2013). By 
2011 using the latest available HPA statistics, this number had increased to 959 or 1.73 per 
100,000 (HPA. 2013). Since 2001 the number of laboratory confirmed cases has steadily 
increased and this increase can be attributed to several factors. Proposed factors vary and 
include, changes in the population size of I. ricinus due to milder winters and climate change, 
increased recreational activity within UK ‘hotspots’ as shown in figure 1.3 and some links to 
migration from eastern European countries where there is high prevalence of Lyme borreliosis, 
in these cases the infection may have not been acquired within the UK (HPA, 2013). Other 
proposed factors taken from the UK governments guidance for Lyme borreliosis include, 
increased awareness of the disease, greater access to diagnostic facilities and more sensitive 
diagnostic methods (HPA, 2013). Many cases of UK Lyme borreliosis are never laboratory 
confirmed, with the HPA estimating an additional 1000-3000 cases per year and Lyme disease 
charities suggesting that this number could be even higher at around 15000. 
 
Within the USA Lyme disease has been classed as a nationally notifiable disease since 1991 
and alike the UK, cases have rose at a steady pace since 1992 where there were 9908 laboratory 
confirmed cases which peaked at 30,000 by 2009 (Kuehn, 2013). Under reporting still remains 
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problematic (Naleway et al., 2002, Coyle et al., 1996) and the CDC estimates that actual cases 
are likely closer to 300,000 a year (Kuehn., 2013). Using the ten-fold prediction of confirmed 
to actual cases the CDC has proposed the UK may indeed be encountering more cases than the 
HPA are predicting and likely in line with estimates made by UK Lyme disease charities. In 
contrast studies suggest some over-diagnosis may be taking place; Lyme borreliosis symptoms 
are vague, particularly those associated with post-Lyme disease. 
 
 
 
Figure 1.3 - Distribution of Lyme disease in England. A distribution map of Lyme disease cases within England 
and Wales between 1986 and 1998. During this time the New Forest presented as a ‘hot spot’ current data suggests 
these spots have increased to include Thetford forest, Exmoor and the Scottish highlands (Adapted from Smith et 
al., 2000). 
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1.1.7. Risk of infection 
Age distribution of infection across the globe appears bimodal with spikes between the ages of 
5 to 9 years and in the over 50’s (Hubálek. 2009, Zeman et al 2013 & Huppertz et al., 1999). 
Within the UK such rates are similar with the 45-64 age group most at risk of infection (HPA, 
2013). All risk groups globally have a fairly evenly spread male to female ratio. It appears that 
males constitute more in American cases especially within paediatric cases at around 61% 
(Borchers et al.,2015). However, this is counteracted by the slight predisposition towards 
females in Europe (Hubálek. 2009 & Zeman et al 2013). 
 
American statistics show that African-American cases are significantly underrepresented (Fix 
et al., 2000) previous studies have suggested that this may be simply due to demographics with 
fewer African-Americans living within the endemic rural areas, however a study using data 
from Maryland observed that fewer infected African-Americans presented with an EM and in 
some cases this resulted in arthritic late manifestations of the disease (Fix et al., 2000). 
 
The obvious risk factor for Borrelia infection is spending recreational time outdoors. However 
there must be a balance between healthy outdoor activity and the prevention of infection. The 
most effective way to prevent infection is to avoid tick habitats in endemic areas, such as tall 
grass and woodland. This however, would rule out some of our much loved British parks and 
reserves. More sensible precautions include wearing suitable clothing, such as long trousers 
and socks when walking through long grass, using DEET repellents, the inspection of the body 
for ticks following exposure and prompt removal of ticks once found. A second risk factor is 
previous diagnosis of Lyme disease (Bennet et al., 2002, Salazar et al., 1993., Nowakowski et 
al., 2003), this is likely due to this groups environmental and behavioural risk factor that led to 
the primary infection being repeated. This risk of secondary infection with Lyme disease also 
suggests that previous infection may not protect from reinfection, possibly due to variations in 
circulating strains. Studies on mice demonstrated that immunity could be induced. However, it 
was strain specific (Barthold, 1996) and current data for Human’s propose that this immunity 
may last ≥6 years (Khatchikian, 2014). 
 
Following a tick bite from within an area where Lyme borreliosis is endemic only 3-12% of 
individuals in Europe (Maiwald et al., 1998, Huegli et al., 2011, Fryland et al., 2010, Nahimana 
et al., 2004 and Korenberg et al., 1996) and 1-3% in the USA become infected (Sood et al., 
1997, Shapiro et al., 1992 and Costello et al., 1989), however upto half of European subjects 
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seroconvert with no clinical symptoms or classed as asymptomatic where as in the USA 
asymptomatic seroconversion is fairly rare (Nadelman et al., 2001 & Steere et al., 2003). 
Interestingly a study of a group of highly exposed Swiss orienteers remained asymptomatic 
following seroconversion (Fahrer et al., 1991). A recent review article highlighted how 
remarkable the study was and made the point that over 30% of European patients that present 
with EM never develop seropositivity (Borchers et al., 2014). Seroconversion in both Europe 
and the USA remains unclear and much further study is needed. 
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1.2 Ticks 
1.2.1 Ecology, reservoirs and the tick lifecycle 
There appears to be distinctive differences between tick vectors across the northern hemisphere 
and is further discussed in figure 1.4. The hard tick I. ricinus is considered the main vector of 
Lyme disease across Europe with Ixodes persulcatus as the most commonly identified vector 
in Asia (Gray, 1998). The USA demonstrates a split population with I. scapularis most 
commonly found as the spirochetes vehicle in upper midwestern and northeasten areas and 
Ixodes pacificus as the responsible vector in western USA (Gray, 1998). 
 
 
 
Figure 1.4 - Distribution of hard tick vectors of Lyme Borrelia across the world. Within the USA two hard 
tick vectors Ixodes scapularis and Ixodes pacificus dominate northeastern and western areas respectively. Ixodes 
ricinus is most prominent in Europe and Ixodes persulcatus in Asia. The Baltic states between these areas have a 
circulation of two Borrelia vectors, with a mix of I. ricinus and I. persulcatus which are both implicated in Lyme 
Borreliosis. Figure from Stanek et al., 2011. 
 
 
Females Ixodes ticks are predominantly responsible for disease transmission although adult 
males may ingest host fluids following attachment they rarely withdraw a significant amount 
of blood (Piesman & Gern, 2005). As a consequence their involvement in disease transmission 
is considered insignificant although further research is required to confirm this (Piesman & 
Gern, 2005). The females of all four tick species share a similar four-stage lifecycle where 
feeding occurs only once during each active stage – egg, larva, nymph and adult, shown in 
figure 1.5.  Post-feeding, the ticks release from the host and return to the soil. If the 
Page | 40  
 
environmental conditions are favourable, normally a minimum of 80% humidity, the ticks 
begin a several month development period before moving into the next stage of the lifecycle 
(Piesman and Gern, 2005). For adult females this stage results in the laying of around 2000 
eggs (Piesman and Gern, 2005).  The full length of the tick lifecycle often varies between 2 
and 6 years and is largely determined by host availability and the current climate (Piesman and 
Gern, 2005). Although the Ixodes genus is considered as the primary vector for pathogenic 
Borrelia transmission, other ticks have been demonstrated to harbour and transmit the bacteria 
some of which include Amblyomma americanum mainly located in Georgia and Florida (Clark 
et al., 2013) and Dermacentor reticulatus in Spain (Lledó et al., 2014). Much further study is 
needed to elucidate other competent vectors to gain a better picture of the tick bacteria 
symbiosis.   
 
Within Europe three species of the Ixodes family have been proposed to behave as vectors for 
B. burgdorferi s.l. these include, the previously discussed Ixodes ricinus alongside Ixodes 
hexagonus and Ixodes urinae (Piesman & Gern, 2005). Although these three species share the 
same three-stage lifecycle, their ecologies somewhat differ. This vector biology is particularly 
important and can explain much of a diseases epidemiology. For example, Ixodes ricinus is a 
non-nidicolous tick which occupies open spaces, in contrast Ixodes hexagonous and Ixodes 
urinae are nidicolous and are often found in caves and burrows often close to their hosts 
highlighting a close tick to host relationship (Zeman & Benes, 2013). As non-niducolous ticks 
occupy an open environment they must actively seek a host and this is often achieved by 
waiting on the blade edges of long grass. The questing nature of non-nidicolous ticks is 
responsible for the increased contact they have with humans in comparison to their nidicolous 
counterparts Ixodes hexagonous and Ixodes urinae (Zeman & Benes, 2013).  
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Figure 1.5 - Tick-Borellia burgdorferi sl lifecycle. The red crosses indicate non-reservoir hosts. The red dots 
represent B. afzelii, the blue B. garinii and the green indicates B. burgdorferi. The size of the dots indicate the 
scale of involvement of each genospecies in each particular organism. Figure from Stanek et al., 2011. 
 
 
Ticks favour areas with good vegetation cover and a humidity between 80-85% or more simply 
a mild damp climate (Piesman & Gern, 2005). Current UK hotspots for infection with Borrelia 
include, the New Forest, Thetford, Exmoor, Salisbury Plain, Scottish highlands and islands, 
the lake district, parts of Sussex, Surrey, Wiltshire, Berkshire and the Yorkshire moors (HPA, 
2013). A study of the distribution of B. burgdorferi s.l. in I. ricinus across central England 
demonstrated that habitat type significantly influenced the probability of a ticks likelihood of 
infection (Bettridge et al., 2013). Their findings suggested that ticks found in deciduous 
woodland were twenty times more likely to be infected with B. burgdorferi s.l. than ticks found 
within moorland. The same study also identified small pockets of central England where B. 
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burgdorferi s.l. infection of I. ricinus appeared absent or extremely low, these included North 
Wales, Lancashire, Eastern Cumbria and Northumberland (Bettridge et al., 2013). However, 
the study did highlight that although B. burgdorferi infection levels were low or absent within 
these areas it could not be ruled out that these spots may only be temporarily void of infected 
ticks due to annual fluctuations. In contrast this lack of infection within these areas could be 
attributed to habitat type which in effect could influence tick questing. 
 
  
Figure 1.6 - Ixodes ricinus ticks at various stages of the lifecycle. A. B. C. D. The blue bar represents 1.5cm. 
Figure adapted from a photograph taken from Phillippe Parola Collection (Extract from the 16th Consensus 
Conference on Anti-infective therapeutics 2006).  
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1.2.2 Tick morphology 
Ixodes ticks have a relatively large body of around 2-30mm and have 4 pairs of legs as a nymph 
and adult. The gnathosoma or the mouthparts comprise of the hypostome, palps and chelicerae 
which are clearly visible in all stages with backwardly pointing teeth on the hypostome shown 
in figure 1.7. Ticks are believed to quest for a host at the tip of a blade of grass by waving their 
front legs in the direction of an approaching host in order to aboard should the animal brush 
past (Cook, 2015). The setae within the Haller’s organ and the tip of the front legs can detect 
host stimuli such as vibrations, carbon dioxide, humidity and temperature allowing preparation 
to claim a new host. 
  
Figure 1.7 - The anatomy of an Ixodes ricinus tick. Credit to Peter York – National History Museum London. 
The Ixodes mouthparts or gnathosoma are composed of the hypostome, palps and chelicerae. The Haller’s organ 
is located at the tip of the front legs and is essential for the detection of host stimuli. 
 
 
1.2.3 Feeding of ticks and the transmission of Borrelia 
As a general rule feeding occurs for around 3 days for larvae, 5 for nymphs and 7 days for adult 
females. (Stanek et al., 2011). After locating a host the tick begins to attach using numerous 
projections on the hypostome, these hook type appenditures anchor the tick following 
penetration of the skin by the hypostome (Cook, 2015). Adult ticks can become particularly 
engorged during a blood meal with their weight increasing considerably compared to their 
native size (Ribeiro et al, 2006)   Spirochaetes including Borrelia can reside in the midgut of 
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unfed ticks and begin to replicate and disseminate to the salivary glands during a blood meal. 
(Ribeiro, 1987).  
In order for a tick to successfully obtain a blood meal and for Borrelia to infect a new animal 
a number of host defences must be confronted. A humans first line of defence is the skin which 
the tick penetrates via the hypostome giving access to the host blood supply. Tick saliva 
provides the first contact and contains a mixture of factors which alleviate host pain, ensure a 
continual blood supply to the area of penetration and prevent coagulation (Tyson et al., 2007, 
Chmelar et al., 2012 and Ribeiro, 1987). 
Animal models suggest that infection with Borrelia rarely occurs within 24 hours of tick 
attachment with effective transmission peaking between 48-72 hours (Dattwyler et al., 2005, 
Kalish et al., 2001, Steere and Angelis, 2006, Lakos and Solymosi, 2009). Some experimental 
data have demonstrated that Bb-infected I. scapularis nymphs can transfer a significant number 
of spirochaetes as early as 24 hours following attachment although further studies are required 
(Weber et al., 1990). It is likely that the time period required for effective transmission is both 
strain and host species specific (Dattwyler et al., 2005, Kalish et al., 2001). Transmission speed 
of I. ricinus within Europe doesn’t appear to follow the same trend. Data suggest that the host 
can become infected with B. afzelii as early as 17 hours following attachment however the 
current evidence is limited and based upon the gerbil model (Klempner et al., 2001, Krupp et 
al., 2003). The study also noted that B. afzelii was more rapidly transmitted by I. ricinus than 
the transfer of B. burgdorferi which highlights the difficulty in giving accurate guidance about 
the relationship between attachment time and risk. 
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1.3 Borrelia  
1.3.1 Spirochaetes and Borrelia 
Spirochaetes are small, coiled bacteria which are often responsible for complex diseases. The 
family covers Borrelia, Leptospira, Serpulina and Treponema. Certain strains of Leptospiridia 
are the causative agent of Weil’s disease a rare systemic infection which can lead to renal 
failure and liver damage (Inoue et al., 2010). Treponema pallidum is the bacteria responsible 
for syphilis and other family members have been associated with periodontitis and endocarditis 
(Golden et al., 2003). Of the currently known Borrelia strains almost one third can cause Lyme 
disease (Hengge et al., 2003), a further proportion are responsible for relapsing fever and the 
remaining strains are uncharacterised in terms of their ability to colonise a human host. 
 
 
1.3.2 The genus Borrelia 
The genus Borrelia was principally identified in 1834 and so named Spirillium giganteum 
which was later changed to Borrelia in 1907 (Wright, 2009).  There are over thirty species of 
Borrelia described within scientific literature, with some newer species identified over recent 
years (Margos et al., 2011 and Rudenko et al., 2010).  B. burgdorferi sensu stricto, B. afzelii 
and B. garinii are collectively known as B. burgdorferi sensu lato and are the main species 
responsible for Lyme borreliosis within humans, (Rizzoli et al., 2011) while B. duttonii, B. 
hermsii and B. reurrentis are most commonly associated with relapsing fever (Schwan et al., 
2003). A recent phylogenomic study has proposed that the genus Borrelia should be divided 
into two genera. This recommendation was that all relapsing fever Borrelia should belong to 
the genus Borrelia and the creation of a new genus, Borreliella gen. nov. which would contain 
all Lyme disease causing Borrelia (Adeolu and Gupta, 2014). The three species that will be 
discussed throughout the research project include, B. afzelii, B. garinii and B. burgdorferi s.s. 
and from here on denoted as B. burgdorferi s.l. Any reference to the term Borrelia accounts as 
a generalisation to both relapsing fever and Lyme disease causing spirochaetes. 
 
 
 
 
 
 
 
Page | 46  
 
1.3.3 Relapsing Fever Borreliae 
As previously discussed spirochaetes from the genus Borrelia are also responsible for the 
bacterial infection termed relapsing fever. This infection most commonly manifests as 
recurring episodes of flu-like symptoms such as fever, headaches, muscle and joint pain and 
nausea (Dworkin et al., 2008). Relapsing fever is often separated into two branches consisting 
of tick-borne relapsing fever (TBRF) and louse-borne relapsing fever (LBRF). 
 
Figure 1.8 - Phylogenetic tree generated from groEL gene sequences from B. burgdorferi sl strains. The 
phylogenetic tree was taken from Lee et al., 2003. The tree was constructed using the maximum-likelihood 
method. The groEL gene was selected as amino acid sequences within this frame are highly conserved across 
Borrelia species. 
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Alike Borrelia strains associated with Lyme disease, the number of Borrelia species associated 
with relapsing fever has almost doubled since the 1980s. Over 17 strains are now associated 
with relapsing fever with a number of others awaiting further characterisation and isolation 
(Cutler, 2006). Within ticks, relapsing fever is mainly transmitted by the Ornithodoros genus 
using a similar mechanism as what is seen with the transmission of Lyme disease by Ixodes 
ticks. However relapsing fever Borreliae have also been demonstrated to be transmitted by 
louse, potentially harnessing the spirochaete with epidemic potential (Cutler, 2006). 
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Genospecies Distribution Human disease manifestations 
B. afzelii Europe Lyme disease 
B. americana North America Lyme disease 
B. andersonii North America Lyme disease 
B. bavariensis Europe, Asia Lyme disease 
B. bissettii Europe, North America Lyme disease 
B. burgdorferi Europe, North America Lyme disease 
B. californiensis North America Lyme disease 
B. carolinensis North America Lyme disease 
B. crocidurae Africa Relapsing fever 
B. duttonii Africa Relapsing fever 
B. finlandensis  Europe Lyme disease 
B. garinii Europe, Asia Lyme disease 
B. hermsi North America, Canada Relapsing fever 
B. hispanica Africa Relapsing fever 
B. japonica Japan Lyme disease 
B. kurtenbachii North America Proposed to be involved in Lyme disease 
B. lonestari North America Southern tick-associated rash illness (STARI) 
B. lusitaniae Europe Lyme disease 
B. miyamotoi* North America, Japan, Europe Unknown 
B. parkeri North America, Canada Relapsing Fever 
B. recurrentis Africa Relapsing Fever 
B. sinica China Lyme disease 
B. spielmanii Europe Lyme disease 
B. tanuki Japan Prevalence in humans unconfirmed 
B. turdi Japan Prevalence in humans unconfirmed 
B. turicatae North America, Canada Relapsing Fever 
B. valaisiana Europe, Asia Lyme disease 
B. yangtze China Prevalence in humans unconfirmed 
 
Table 1.3. A summary of known Borrelia strains and their global distribution. Table compiled using literature 
data, searching for strains isolated from human hosts. *B. miyamotoi – The human disease manifests itself as a 
‘Lyme disease-like’ syndrome without the characteristic EM rash. The strain is genetically related to relapsing 
fever spirochaetes with the first human infection reported in Russia in 2011, the spirochaete has now been 
identified across both North America, Asia and Europe.  
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1.3.4 Genomic complexity 
The genome of B. burgdorferi can be considered as one of the most complex arrangements 
seen within all bacteria (Casjens et al., 2000, Casjens et al., 2012, Fraser et al., 1997) and is 
made up of a ~950kb linear chromosome and a variety of both circular and linear plasmids 
which range in size from 9 to 62kb (Brisson et al., 2012). In total Borrelia are known to carry 
the largest number of plasmids ever described in bacteria (Reyes-Lamothe et al., 2012). The 
linear chromosome is highly conserved across many Borrelia species (Casjens et al., 1995, 
Fraser et al., 1997, Glöckner et al., 2004, Glöckner et al., 2006, Schutzer et al., 2010). However, 
extensive variation is observed among the plasmid elements, an example is the highly variable 
OspC protein which is encoded on the 26kb plasmid. In general all of the plasmids are 
maintained at a low copy number, (Beaurepaire and Chaconas, 2005), with the exception of a 
small circular plasmid isolated from the Ip90 strain which seems to have a higher copy number 
(Dunn et al., 1994). Within the Borrelia family such plasmids are often referred to as essential 
genetic elements, (Stewart et al., 2005) or mini chromosomes (Barbour and Zückert, 1997) as 
some contain genes which are significant regulators of the tick-vertebrate lifecycle (Norris et 
al., 2010). The linear counterparts have covalently closed telomeres (Barbour and Garon, 1987) 
and replication is dependent upon ResT, an essential telomere resolvase (Kobryn and 
Chaconas, 2002).  
 
The majority of housekeeping genes are found upon the linear chromosome and although some 
plasmids are essential for propagation of the enzootic cycle they are not required for in vitro 
culturing (Stewart et al., 2005). One particular single copy plasmid, Cp26 is the only known 
essential plasmid for in vitro growth. This plasmid encodes the ResT enzyme essential for the 
replication of Borrelia’s linear DNA (Kobryn and Chaconas, 2002). Curiously the same 
plasmid also encodes the outer surface protein C (OspC) which is crucial for successful 
transmission from the tick to the vertebrate host (Grimm et al., 2004, Pal et al., 2004, Stewart 
et al., 2006, Tilly et al., 1997). 
 
Although members of the genus Borrelia are considered to possess the most complex genomes 
of all known bacteria, their genome is often defined as vastly redundant, due to its particularly 
large number of paralogous genes, specifically among the cp32 family of plasmids, where large 
stretches of fundamentally identical genes can be located and are interrupted by variable genes 
encoding lipoproteins (Casjens et al., 2011). The first B.burgdorferi strain sequenced was B31-
MI and was found to be composed of a single linear chromosome alongside 12 linear and 9 
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circular plasmids, which contribute approximately 47% to the total genome as shown in figure 
1.9. This unusual makeup of Borrelia makes genetic manipulation difficult, plasmid loss during 
experiments is one of the main challenges during in vitro experiments (Brisson et al., 2012). 
Many of Borrelia’s proteins remain with unknown function which is further complicated by 
the fact that around 30% of Borrelia’s open reading frames share no sequence similarity to 
previously annotated genes (Casjens et al., 2000). 
 
 
 
 
 
 
 
 
 
 
Figure 1.9 Genetic arrangement of B. burgdorferi B31 strain. The B. burgdorferi strain B31 is comprised of a 
single linear chromosome, 12 linear plasmids and 9 circular plasmids. All of the linear components contain 
covalently closed telomeres and require the ResT enzyme for replication of the linear DNA. Figure created using 
genomic data from Casjens et al., 2000. 
 
A further oddity of B.burgdorferi is its absence of many metabolic pathways.  The bacteria is 
an auxotroph for all nucleotides, amino acids and fatty acids, it also lacks genes encoding 
essential enzymes for oxidative phosphorylation and the tricarboxylic acid cycle and instead 
acquires energy via the fermentation of sugar to lactic acid (Fraser et al., 1997).  The lack of 
such pathways and metabolic enzymes is possibly explained by reductive evolution, as the 
organism moved towards a lifecycle parasitizing required nutrients from its hosts.  Curiously 
much research suggests B.burgdorferi does not require iron (Posey & Gherardini, 2000 & 
Troxell et al., 2012), normally essential for many metabolic activities of bacteria (Messenger 
& Barclay, 1983).  To date no genes have been identified within the spirochaetes genomes that 
are known to encode iron-requiring proteins such as Borrelia’s single superoxide dismutase 
(SOD), which is now thought to utilise manganese as its cofactor (Troxell et al., 2012). 
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1.3.5 Morphology and Ultrastructure 
In terms of morphology, Borrelia burgdorferi s.l. can be described as coiled, highly motile 
spirochaetes with a length of 20-30µm (Krupka et al., 2008). The species was originally 
classified as Gram-negative due to the identification of both an outer and cytoplasmic 
membrane. However, the group showed distinctive differences from their counterparts 
resulting in the creation of a new phylum (Paster et al., 1991). Borrelia harness a unique mode 
of motility by means of their endoflagella or axial filaments, which enable successful survival 
in viscous environments such as intestinal tracts, mucosal tissues and possibly biofilm 
(Guttenplan & Kearns, 2013). In contrast to bacteria with an extracellular flagella, a 
spirochaetes endolflagella is attached to both termini of the cytoplasmic membrane as shown 
in figure 1.10. This endoflagella spans the entire cell essentially weaving from one side of the 
protoplasmic cylinder to the other. Within B. burgdorferi s.l.the number of these can be 
anywhere between 7 and 11 (Hovind-Hougen, 1984 and Motaleb et al., 2000) and are the 
principle component responsible for the bacteria’s unusual shape (Motaleb et al., 2000).   
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Figure 1.10. The ultrastructure of the spirochaete Borrelia. Figure taken from Rosa et al., 2005. The bacterium 
is enveloped by both an outer and a cytoplasmic membrane. Between these two structures and within the 
periplasmic space exists a layer of peptidoglycan. Multiple flagella span the periplasmic space and are attached at 
the cytoplasmic membrane at each termini. These flagella weave around the protoplasmic cylinder and are 
responsible for the spirochaete’s unusual shape (Rosa et al., 2005). 
 
 
1.3.6 Alternative morphological states 
It has been known for a number of years that B. burgdorferi s.l is capable of initialising drastic 
changes in its morphology (Barbour & Hayes, 1986, Miklossy et al., 2008, Garon et al., 1991) 
however the reasons why this occurs and whether this is of clinical importance remains unclear. 
Many Borrelia strains including B. burgdorferi s.l. have the capacity to produce extracellular 
vesicles or blebs when grown in vitro (Barbour & Hayes, 1986, Garon et al., 1991) and there 
is some evidence that these can occur during infection (Dorward et al., 1991). Cryoelectron 
tomography studies have revealed that these outer membrane vesicles are often released close 
to areas of cell division (Kudryashev et al., 2009) and exposure to stress appears to be enough 
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to initiate their production and release from the membrane. These blebs are known to contain, 
plasmid DNA, OspA and OspB proteins alongside a significant number of other cytosolic and 
inner membrane molecules including the Borrelia protein enolase which is responsible for 
plasminogen binding and activation (Toledo et al., 2011). Curiously the vesicles must also 
carry some of these adhesion proteins as exposed components upon the outer membrane as the 
vesicles have been demonstrated to bind to human endothelial cells (Shobery & Thomas, 1993). 
 
Cyst formation has also been described for Borrelia and involves a huge shift in the structure 
of the cells shape and changes to membrane integrity (Alban et al., 2000). Research suggests 
(Alban et al., 2000) that cyst formation occurs in response to starvation and can be induced in 
vitro by the cultivation of Borrelia in serum free BSKII media (Alban et al., 2000). Many 
atypical forms of Borrelia have been described and include cystic, loops, rings and end knob 
forms (Miklossy et al., 2008).  Although the process is particularly slow it is thought to still be 
an active process and requires some level of continuous protein synthesis (Bergström & 
Zückert, 2010). The development into a cystic form also appears to be a reversible action with 
studies suggesting upto 53% of cells can then revert back to the active coiled morphology 
(Bergström & Zückert, 2010). The implications of cyst formation in vivo still remains unclear 
and needs much further research in order to understand the complex cycle this unique 
bacterium participates in. 
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1.4 The Borrelia outer membrane 
1.4.1 Introduction to the outer membrane and its diagnostic and therapeutic importance 
The components of the outer membrane of all bacteria play a major role in the survival of the 
micro-organism. These components are particularly important when the external environment 
of the micro-organism is frequently changing, for example when the bacteria switch host. This 
outer membrane must function appropriately and maintain control of influx and efflux whilst 
remaining stable. Proteins and cell membrane components play a crucial role in ensuring the 
system is not breached allowing the bacteria to adapt to the ever changing environment. Within 
E. coli approximately 50% of the mass of a bacterium’s outer membrane consists of protein 
whether this be in the form of lipoproteins or integral membrane proteins (Koebnik et al., 2000) 
highlighting the importance of these exterior membrane features. 
 
The membranes found with B. burgdorferi are often described as unique and consist of a variety 
of glycolipids, a huge array of surface exposed lipoproteins and a smaller number of integral 
membrane proteins (Kudryashev et al., 2009), yet lack highly inflammatory 
lipopolysaccharides (LPS) often found within Gram-negative bacteria (Takayama et al., 1987). 
Two of these glycolipid components contain cholesterol and include ACGal (cholesteryl 6-O-
acyl-β-D-galactopyranoside) and CGal (cholesteryl-β-D-galactopyranoside), whilst the third. 
MGalD (mono-α-galactosyl-diacylglycerol) does not (Ben-Menachem et al., 2003 and 
Schroder et al., 2003). Curiously the B burgdorferi genome is not known to encode any 
pathways for cholesterol biosynthesis which is further supported by the fact that B. burgdorferi 
cannot be grown in vitro unless the media is supplemented with cholesterol (Coleman et al., 
2015). As B. burgdorferi cannot produce its own supply of these biomolecules and yet cannot 
sustain life without them it has been presumed that the spirochaete must acquire cholesterol 
from the tissue and fluids from the infected host. This assumption has been further supported 
by recent evidence for a novel mechanism in vitro where by B. burgdorferi can acquire 
cholesterol by contact with the plasma membrane of eukaryotic cells (Crowley et al., 2013). A 
further oddity of the spirochaetes relationship with cholesterol is that cholesterol glycolipids 
can amalgamate to form lipid rafts within the outer membrane of B. burgdorferi which although 
are often seen within eukaryotic cells they are poorly understood and recognised within 
prokaryotes. Within eukoryotic membranes these lipid rafts have been associated with vesicle 
formation (Huttner and Zimmerberg, 2001), cytosis (Chen and Rand, 1997), membrane 
elasticity (Salaün et al., 2004) and the lateral sorting of proteins and receptor clustering (Epand 
2008). 
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Borrelia’s outer surface provides the platform between itself and the infected host, highlighting 
that proteins associated on the outer membrane must hold some responsibility for Borrelia’s 
capacity to disseminate throughout the host tissues. Alongside their roles in dissemination these 
surface molecules must also provide mechanisms for the spirochaete to remain hidden from 
the immune response.  The arrangement of such proteins within the outer membrane appears 
to vary in line with the spirochaetes enzootic cycle, its host and importantly in accordance to 
its environment (Fraser et al., 1997, Babb et al., 2001). There are several protein families which 
have been identified to be associated with Borrelia’s outer membrane and include a significant 
number of lipoproteins (~100) such as, outer surface proteins (osp’s), decorin binding proteins 
and complement regulator acquiring proteins (CRASPs) (Skare et al., 1997, Cassatt et al., 
1998) and a smaller number of integral membrane spanning proteins.  The wide array of 
lipoproteins is likely to be one of Borrelia’s tools providing on-going immune evasion 
strategies allowing successful dissemination throughout the host. A full list of key Borrelia 
surface proteins are summarised in table 1.4. 
 
Over the past decade several reviews have highlighted the importance of identifying and 
characterising bacterial outer surface proteins with the hope of identifying new drug and 
vaccine targets. This has been particularly noted for Borrelia where many proteins remain 
annotated as hypothetical and hold no known function (Kenedy et al., 2012). As B. burgdorferi 
is considered an extracellular pathogen, much research has focused on the production of a 
vaccine allowing humoral immunity to protect any given individual from active disease. During 
1998 the outer surface protein A (OspA) based vaccine was licensed and approved for human 
use. Although this vaccine was commercially available for several years it is no longer in use. 
The withdrawal of the OspA based vaccine has directed much research towards the 
identification of Borrelia antigens that fulfil the three requirements of a good vaccine 
candidate, these include, 
i. The antigen is surface exposed. 
ii. The antigen is conserved among several strains. 
iii. The antigen is produced both during tick transmission and mammalian infection. 
 
Alongside the importance of identifying new antigens, proteins situated on the outer membrane 
are at the direct interface between the host and the invading pathogen, they often have crucial 
cellular roles with some moonlighting as important virulence factors with examples 
summarised in table 1.4. 
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Protein 
 
Alternative 
names 
 
 
Type 
 
Known functions 
 
Expression 
 
Reference 
OspA BBA15 Lipoprotein Adhesion to tick gut 
Spirochaete-spirochaete 
aggregation 
Degradation of the 
ECM 
Adhesion to host cells 
Activation of host 
immune cells 
Vector/Host Pal et al., 2004, Pat 
et al., 2000, Fuchs 
et al., 1994, 
Pulzova et al., 
2011. 
OspB  Lipoprotein Adhesion to tick gut Vector Fikrig et al., 2004 
OspC  Lipoprotein Adhesion to tick 
salivary glands 
Establishment of early 
host infection 
Degradation of the 
ECM 
Vector/Host Ramamoorthi et al., 
2005, Pal et al., 
2004, Lagal et al., 
2006. 
 
OspD  Lipoprotein  Vector Li et al., 2007. 
OspF  Lipoprotein   Lam et al., 1994. 
VlsE  Lipoprotein   Eicken et al., 2002 
P66 Oms66, 
BBO603 
OM 
spanning 
Channel forming porin Host Skare et al., 1997 
BBK32  Lipoprotein ECM adhesion Vector/Host Fikrig et al., 2000 
CRASP-1 BBA68 Lipoprotein Complement system 
evasion 
ECM degradation 
Adhesion to host cells 
Adhesion to the ECM 
Host Bykowski et al., 
2008, Haupt et al., 
2007, Hallstrom et 
al., 2010, Gilmore 
et al., 2008. 
CRASP-2 BBH06 Lipoprotein Complement system 
evasion 
 
Host Kraiczy et al., 2001, 
Brissette et al., 
2009.  
CRASP-3 ErpP Lipoprotein Complement system 
evasion 
ECM degradation 
Host Schwab et al., 2013, 
Haupt et al., 2007, 
Siegel et al., 2010, 
Brissette et al., 
2009. 
CRASP-4 ErpC Lipoprotein Complement system 
evasion 
ECM degradation 
Host Schwab et al., 2013, 
Haupt et al., 2007, 
Brissette et al., 
2009. 
CRASP-5 ErpA Lipoprotein Complement system 
evasion 
ECM degradation 
Host Haupt et al., 2007, 
Siegel et al., 2010, 
Brissette et al., 
2009, Schwab et al., 
2013. 
DbpA BBA24 Lipoprotein Adhesion to ECM via 
decorin 
 Fischer et al., 2003 
DbpB BBA25 Lipoprotein Adhesion to ECM via 
decorin 
 Fischer et al., 2003 
RevA   Adhesion to the ECM 
via Fibronectin and 
laminin 
Host Brissette et al., 
2009 
RevB   Adhesion to the ECM 
via fibronectin 
Host Brissette et al., 
2009 
BmpA   Purine transport Host Verma et al., 2009 
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Adhesion to the ECM 
via laminin 
BmpB   Adhesion to the ECM 
via laminin 
Host Verma et al., 2009 
BmpC   Adhesion to the ECM 
via laminin 
Host Verma et al., 2009 
BmpD   Adhesion to the ECM 
via laminin 
Host Verma et al., 2009 
ErpX  Lipoprotein Adhesion to the ECM 
via laminin 
 
Host Brisette et al., 2009. 
 
Bgp BBO588  Adhesion to the ECM 
via glycosamino glycan 
and heparin 
Host Parveen et al., 
2006, Cluss et al., 
2004. 
 
BBB07   Adhesion to the 
endothelium via α3β1 
and integrins 
Host Behera et al., 2007 
BB0690   Persistence during tick 
starvation  
Vector Li et al., 2007 
BptA BBE16  Persistence within the 
tick 
Vector Revel et al., 2005 
BBE31   Tick gut/salivary glands 
migration vua TRE31 
Vector/Host Zhang et al., 2011 
BBA52   Tick gut/salivary glands 
migration 
Vector/Host Kumar et al., 2011 
BBE22 PncA 
Nicotinamidase 
 Tick gut/salivary glands 
migration 
Host Purser et al., 2003 
BBA64 P35  Tick gut/salivary glands 
migration 
Persistent host infection 
Vector/Host Gilmore et al., 
2007, Gilmore et 
al., 2008 
BBA65   Tick gut/salivary glands 
migration 
Vector/Host Gilmore et al., 2007 
BBA66   Tick gut/salivary glands 
migration 
Vector/Host Gilmore et al., 2007 
BBA73   Persistent host infection Host Hughes et al., 2008 
BBA03   Tick/host transmission Vector/Host Bestor et al., 2012 
BBO250   Cell division and 
envelope integrity 
Vector/Host Liang et al., 2010 
BBA07   Tick/host transmission Vector/Host Xu et al., 2010 
BBA74 Oms28  Tick environment 
adaption 
Vector/Host Mulay et al., 2009, 
Mulay et al., 2006 
FliG1   Motility in viscous 
media 
Vector/Host Li et al., 2010 
BesC BB0142 OMP Porin  Bunikis et al., 2008 
DipA BB0418 OMP Dicarboxylate-specific 
porin 
 Thein et al., 2012 
BamA BB0603 OMP Barrel assembly 
machinery 
Vector/Host Lenhart et al., 2010 
Table 1.4. A summary of B.burgdorferi surface proteins with known functions and corresponding ligands. 
Adapted from Pulzova and Bhide 2014. 
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1.4.2 Lipoproteins and Borrelia 
As the name suggests ‘lipoproteins’ may be described as any conjugated protein whereby the 
non-protein moiety consists of at least one lipid; this lipid may be cholesterol, phospholipid, 
triacylglycerol or a combination of the above. Bacterial lipoproteins cover a broad range of 
functions including cellular physiology (Sutcliffe et al., 1995) and replication (Alloing et al., 
1994) with many significantly contribute to bacterial virulence (Cassatt et al., 1998, Haake. 
2000, Schroder et al. 2003). Across both Gram-positive and Gram-negative bacteria 
lipoproteins have been implicated in adhesion, conjugation, nutrient uptake, sporulation and 
the extracytoplasmic folding of proteins (Alloing et al., 1994, Mathiopoulos et al., 1991, Perego 
et al., 1991, Sutcliffe et al., 1995). Within pathogenic bacteria these roles extend to key 
virulence factors including, colonisation, evasion of the host defences and immunomodulation 
(Cassatt et al., 1998, Haake. 2000, Schroder et al. 2003). 
 
Bacterial lipoproteins are initially translated as preprolipoproteins with a characteristic 
secretion signal peptide. This N-terminal signal peptide, of usually around 20 amino acids is 
present in the biosynthesis of both Gram-positive and Gram-negative bacterial lipoproteins 
(Inouye et al., 1977). Lipoprotein diacylglyceryl transferase (Lgt) is then responsible for the 
modification of a conserved sequence at the C-terminal of the signal peptide known as the 
lipobox, [LVI][ASTVI][GAS]C. Lgt catalyses the covalent attachment of a diacylglycerol 
moiety to the thiol group on the side chain of the cysteine residue resulting in the production 
of prolipoprotein (Babu et al., 2006). Following lipidation the signal sequence of the 
prolipoprotein is cleaved by lipoprotein signal peptidase which leaves the cysteine of the 
lipobox as the new amino-terminal residue (Tokunaga et al., 1982). 
 
Within Gram-negative bacteria and GC-rich Gram-positive bacteria the newly cleaved 
prolipoprotein undergoes an additional modification (Vidal-Ingigliardi et al., 2007). 
Lipoprotein N-acyl transferase (Lnt) catalyses the attachment of an amide-linked acyl group to 
the N-terminal cysteine residue. However, lipoproteins produced both and with and without 
this additional modification anchor tightly to the membrane following signal peptide-
dependent translocation across the cytoplasmic membrane (Vidal-Ingigliardi et al., 2007). The 
structure of the acyl chains are believed to be predominantly derived from membrane 
phospholidids for Borrelia these include phosphatidylcholine and phosphatidylglycerol. 
However, studies suggest that there may be variations in the structures of the acyl chains with 
one interesting case from B.burgdorferi (Bouchon et al., 1997) where the lipid component of 
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their lipoproteins contains an acetyl group in replacement for one of the ester linked fatty acids 
(Beermann et al., 2000). As many lipoproteins are surface exposed it has been questioned 
whether such acyl moieties play other roles alongside anchorage to the membrane (Kovacs-
Simon et al., 2011). 
 
As previously addressed bacterial lipoproteins represent a significant number of virulence 
factors, they are particularly important within the spirochaete genus and are the most abundant 
proteins that are expressed by all spirochaetes (Haake. 2000, Liang et al., 2002, Radolf et al., 
1994). B.burgdorferi is known to encode over 100 lipoproteins (Fraser et al., 1997) with 
approximately 8% of all genes likely to fall within this category (Casjens et al., 2000).  
 
 
1.4.3 Bacterial integral membrane proteins 
1.4.3.1 Introduction to beta-barrel proteins 
Outer membrane proteins (OMPs) make up a smaller part of the outer membrane of gram-
negative bacteria in comparison to those proteins which are anchored to the membrane by N-
terminal lipids. OMPs are found to span the outer membrane of all Gram-negative bacteria, 
chloroplasts and mitochondria (Schulz, 2000). To date all OMPs have been identified or 
characterised as β-barrels. These integral proteins come in various sizes and have been 
demonstrated to span the outer membrane from 8 to 22 times (Khalid et al., 2006) and follow 
a set assembly format which is further discussed in Schulz’s construction rules shown in table 
1.5. OMPs are assembled so that the proteins hydrophobic surface is exposed to the lipid bilayer 
core. In simple terms a beta barrel protein consists of a large beta-sheet that twists to form an 
enclosed assembly where the first strand is hydrogen bonded to the last. These proteins are 
often characterised by short membrane spanning strands of alternate hydrophobic residues up 
to ten amino acids in length, followed by loop regions which are often highly variable (Schulz, 
2000).  
 
OMPs across many Gram-negative bacteria fulfil multiple roles from structural integrity 
(Pautsch & Schulz, 1998) and adhesion (Vandeputte-Rutten et al., 2003, Yamashita et al., 2011, 
Prince et al., 2002) to roles as porins (Hong et al., 2006, Oomen et al., 2004, Koronakis et al., 
2000, Cowan et al., 1992) and enzymes (Snijder et al., 1999, Hwang et al., 2002). Considering 
that 2-3% of genes found within Gram-negative bacteria are predicted to encode barrel like 
OMPs only around ~25 of these structures have been solved to date leaving a huge gap in our 
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knowledge of this important protein family. Of the solved structures (shown in table 1.6) many 
appear as monomers, one from Escherichia coli or E. coli (OmpLA) has been demonstrated to 
form a homodimer (Snijder et al., 1999) and several porins from E. coli (tolC, OmpF, PhoE) 
have shown homo-trimer structures (Koronakis et al., 2000, Cowan et al., 1992). On the whole 
these proteins are characterised with long flexible loops extending at the extracellular side in 
contrast with the short tight turns extending from the periplasmic side of the membrane. The 
beta barrel structure can be described like inverted micelles where amino acid residues on the 
surface of the barrel which are facing the lipid bilayer are exclusively hydrophobic residues 
with an internal core of mostly polar amino acids. This is clearly the opposite of what is seen 
with most soluble proteins which harbour a hydrophobic core. 
 
 
I. The N and C termini are both located at the periplasmic side and the number of β-strands is even* 
II. The β-strands tilt is always 45o are comparable to the β-sheet twist. 
III. All of the β-strands are antiparallel and connected to their closest neighbour along the chain. 
IV. The shear number of an n-stranded barrel is positive and around n+2. 
V. The connection strands at the periplasmic ends are short turns of only a few residues and are 
designated T1, T2, etc. 
VI. The external barrel loops are normally long and named L1, L2, etc. 
VII. The β-barrel surface is in contact with the non-polar membrane interior and contains aliphatic side 
chains which form a non-polar ribbon. 
VIII. The aliphatic ribbon is lined by two girdles composed of aromatic side chains. 
IX. The sequence of all parts of the β-barrel is variable during evolution when compared to soluble 
proteins with the external loops showing exceptional sequence variability. 
 
Table 1.5. The principles of a β-barrel fold. A summary of the β-barrel construction rules adapted from Schulz, 
2000. *An exception to the even strand rule is seen in the 19-stranded voltage-dependent anion channel (VDAC) 
within mitochondria (Maurya & Mahalakshmi, 2013) and chloroplasts (Hayat & Elofsson, 2012). 
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Protein No. 
β-strands 
Oligomeric 
state 
Organism No. 
Amino 
acids 
PDB 
code 
Function Reference 
OmpA 8 Monomer E. coli 171 1QJP Structural, 
adhesion, 
invasion 
Pautsch & 
Schulz, 
1998 
OmpW 8 Monomer E. coli 197 2F1V Hydrophobic 
channel 
Hong et al., 
2006 
OmpX 8 Monomer E. coli 148 1QJ8 Toxin 
binding 
Vogt & 
Schulz, 
1999 
PagP* 8 Monomer E. coli 170 1MM4 Palmitoyl 
transferase 
Hwang et 
al., 2002 
NspA 8 Monomer N. meningitides 155 1P4T Adhesion Vandeputte-
Rutten et 
al., 2003 
Ail 8 Monomer Y. pestis 157 3QRC Adhesion Yamashita 
et al., 2011 
OmpT 10 Monomer E. coli 297 1I78 Protease Vandeputte-
Rutten et 
al., 2001 
OpcA 10 Monomer N. meningitides 253 1K24 Adhesion Prince et al., 
2002 
NalP 12 Monomer N. meningitides 308 1UYN Auto-
transporter 
Oomen et 
al., 2004 
OmpL
A 
12 Dimer E. coli 269 1QD6 Phospho-
lipase 
Snijder et 
al., 1999 
TolC 3X4 Trimer E. coli 428 1EK9 Export 
channel 
Koronakis 
et al., 2000 
FadL 14 Monomer E. coli  427 1T16 Fatty acid 
transporter 
Van den 
Berg et al., 
2004 
OmpF 16 Trimer E. coli 340 2OMF Porin Cowan et 
al., 1992 
PhoE 16 Trimer E. coli 330 1PHO Porin Cowan et 
al., 1992 
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Porin 16 Trimer Rh. capsulatus 301 2POR Porin Weiss & 
Schulz, 
1992 
Porin 16 Trimer Rh. blastica 289 1PRN Porin Kreusch et 
al., 1994 
OmpK
36 
16 Trimer K. pneumoniae 342 1OSM Porin Dutzler et 
al., 1999 
Omp32 16 Trimer C. acidovorans 340 1E54 Porin Zeth et al., 
2000 
MspA 8X2 Octamer M. smegmatis 184 1UUN Porin  Faller et al., 
2004 
LamB 18 Trimer E. coli 421 1MAL Maltose 
porin 
Schirmer et 
al., 1995 
Maltop
orin 
18 Trimer S. typhimurium 421 2MPR Maltose 
porin 
Meyer et al., 
1997 
ScrY 18 Trimer S. typhimurium 413 1A0S Sucrose 
porin 
Forst et al., 
1998 
BtuB 22 Monomer E. coli 594 1NQE Cobalamin 
transporter 
Chimento et 
al., 2003 
FhuA 22 Monomer E. coli  723 2FCP Iron 
transporter 
Ferguson et 
al., 1998 
FepA 22 Monomer E. coli  724 1FEP Iron 
transporter 
Buchanan et 
al., 1999 
FecA 22 Monomer E. coli  741 1KMO Iron 
transporter 
Ferguson et 
al., 2002 
Table 1.6. β-barrel outer membrane proteins with solved structures. A summary of outer membrane proteins 
with solved structures. *Structure solved by NMR. 
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1.4.3.2 Escherichia coli - OmpA 
Outer membrane protein A (OmpA) is one of the most studied and characterised proteins within 
the family. The ompA gene, originally annotated as tolG was first identified in E. coli in 1974 
and although the study did not identify the protein as a major OMP they did conclude that a 
mutation within the ompA gene gave rise to a phenotype which was tolerant to a L-type colicin 
known as Bacteriocidin JF246 (Foulds & Chai, 1978). Shortly after its identification the same 
pair demonstrated that the protein was indeed a major outer membrane protein with a later 
study adding that it must be comprised of two domains as C-terminal truncated mutants could 
still insert themselves into the membrane with an expected phenotype (Bremer et al., 1982). 
Following this early work, Morona et al. postulated that the protein may cross the membrane 
several times following interpretation of colicin resistance patterns developed from ompA 
mutants (Morona et al., 1984). Two years later an extremely elegant study based on Raman 
spectroscopy by Vogel & Jähnig concluded that the OmpA protein was composed of eight 
membrane spanning anti-parallel β-strands connected by four long outer loops which are 
exposed at the surface of the membrane with smaller or short turns on the periplasmic side 
(Vogel & Jähnig, 1986). Not until 1998 was Vogel & Jähnig’s prediction confirmed by the 
release of the first single crystal OmpA N-terminal structure (Pautsch & Schulz, 1998), their 
prediction was remarkably accurate and the crystal structure (figure 1.11) showed that the N-
terminal 171 amino acids form an eight stranded β-barrel often described as an inverted micelle 
with a hydrophobic girdle and a predominantly polar core. The C-terminal periplasmic domain 
is responsible for binding to peptidoglycan. The early exploration of integral OMPs led to the 
creation of a set of β-fold construction rules described in a review by Schulz (Schulz, 2000). 
These principles are summarised in table 1.5. 
 
The heat modifiable protein OmpA from E. coli was originally purified in 1977 and was 
demonstrated to have a molecular mass of 33 kDa. This value however was seen to differ 
according to experimental conditions. When the whole protein was subjected to 60oC heat 
treatment, OmpA was observed to migrate to 35-36 kDa (Beher et al., 1980, Freudl et al., 1986) 
in contrast when subjected to SDS-PAGE without heat treatment the protein is seen to resolve 
at around 28-31 kDa (Freudl et al., 1986). This difference in migration is likely due to the 
differences in conformation or denaturation of the heat treated sample compared to the native 
sample, this difference in unfolding allows a larger amount of SDS to bind to the protein 
resulting in the varying migration. 
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Figure 1.11. The crystal structure of the E. coli OmpA membrane spanning domain. A. The surface 
representation of OmpA. B. A cartoon of the secondary structure components of OmpA. Both figures were 
generated using PDB accession code 1BXW (Pautsch and Schulz, 1998) and images produced in Pymol 
(Schrödinger, 2010). 
 
 
OmpA from E. coli has been implicated in various cellular and pathogenic roles including 
structural integrity and cell shape (Prasadarao et al., 1996), a receptor of colicin (Foulds & 
Barrett, 1973) a receptor for several phages (Morona et al., 1984), roles in F-conjugation 
(Weiser & Gotschlich, 1991) and invasion of brain microvascular endothelial cells or BMEC’s 
(Shin et al., 2005). 
 
 
1.4.3.3 E. coli – OmpX 
OmpX from E. coli is an 18 kDa integral membrane protein which has been implicated in cell 
adhesion and invasion of host cells (Vogt & Schulz, 1998, de Kort et al., 1994) and the evasion 
of the host complement system (Vogt & Schulz, 1999). When comparing the X-ray crystal 
structure (figure 1.12) with its counterpart OmpA, it becomes apparent that there is a notable 
difference in the global dimensions and OmpA contains significantly longer extracellular 
loops. Curiously it has been suggested that a portion of the OmpX β-barrel protrudes out of the 
exterior with this exposed edge of β-sheet able to bind many proteins that have a surface 
exposed β-strand (Schulz, 2000). As OmpX is often highly expressed during E. coli stress 
A B 
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conditions, OmpX may be a useful defensive tool by binding attacking proteins (Schulz, 2000). 
Alike OmpA both barrels are packed with internal polar residues forming a hydrogen bonding 
network (Pautsch & Schulz, 1998, 2000, Vogt & Schulz, 1999)  and as they can be described 
as inversed micelles they are unlikely to form pores (Schulz, 2000). 
 
Alike OmpA, various OmpX homologs have been identified among Gram-negative bacteria, 
these include the attachment invasion locus (Ail) protein from Yersinia pestis (Yamashita, 
2011), the phoP activated gene C protein (PagC) (Nishio et al., 2005) and the resistance to 
complement killing protein (Rck) (Heffernan et al., 1992) proteins from Salmonella 
typhimurium, which are further discussed in section 1.4.3.5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.12. The crystal structure of E. coli OmpX. A. The surface representation of OmpX. B. A cartoon of 
the secondary structure components of OmpX. Both figures were generated using PDB accession code 1QJ8 (Vogt 
& Schulz, 1999) and images produced in Pymol (Schrödinger, 2010). 
 
 
1.4.3.4 E. coli – Omp W 
OmpW also from E. coli represents another well conserved integral membrane protein. The 21 
kDa β-barrel protein (figure 1.13) spans the outer membrane of E. coli and has been 
demonstrated to behave as a hydrophobic channel (Hong et al., 2006). Several homologs have 
been identified across Gram negative bacteria and implicated in environmental stress 
mechanisms. These roles include protection from oxidation (Gil et al., 2007), osmosis (Xu et 
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al., 2005) and temperature (Nandi et al., 2005). Proteomic studies have also identified some 
correlation between the upregulation of OmpW and bacterial antibiotic resistance and increased 
virulence (Goel and Jiang, 2009). More recent work has demonstrated that ompW-deletion 
mutants are more susceptible to phagocytosis and the protein is an efficient protective antigen 
(Wu et al., 2013). However, this may not be of clinical importance due to the association of 
increased OmpW expression with reactive arthritis (Singh et al., 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.13. The NMR determined structure of E. coli OmpW. A. The surface representation of OmpW. B. A 
cartoon of the secondary structure components of OmpA. Both figures were generated using PDB accession code 
2F1V (Hong et al., 2006) and images produced in Pymol (Schrödinger, 2010). 
 
 
1.4.3.5 OmpA-like proteins 
OmpA-like homologues can be found across many Gram-negative and positive bacteria and 
are designated as the OmpA-like superfamily. This family contains a whole host of proteins 
with varying levels of characterisation. The protein OmpA from E. coli is well studied yet 
others lack any functional annotation. Several examples of characterised OmpA-like proteins 
are further explained in table 1.7. As many bacteria possess a high number of these OmpA-like 
proteins which are surface exposed, within pathogenic strains they are often implicated in a 
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number of pathogenic roles in various organs but are most commonly associated with the 
urogenital and respiratory system (Krishnan and Prasadarao, 2012). Their involvement in 
disease is often attributed to roles including adhesion, evasion, invasion and host cell activation 
(Smith et al., 2007) and with their surface exposed position alongside a high copy number 
within the bacterial outer membrane they can be promising targets for vaccine development, 
with some examples shown in table 1.8. 
 
Species Designated 
protein name 
Organ affected Known pathogenic roles Reference 
Actinobacillus OmpA Respiratory tract Adherence Ojha et al., 2005 
Aggregatibacter OmpA Oral  Adherence Kajiya et al., 2011 
Chlamydia MOMP Urogenital Adherence Su et al., 1996 
Haemophillus P5 Respiratory tract 
and CNS 
Adherence and evasion Miyamoto & Bakaletz, 
1996 
Klebsiella OmpA Respiratory tract Adherence, 
proinflammatory and 
antimicrobial resistance 
Catalina et al., 2011 
Llobet et al., 2009 
Leptospira Loa22 Nephritis Toxicity Ristow et al., 2007 
Neisseria OmpA/Rmp Genitourinary Adherence, invasion and 
evasion 
Serino et al., 2007 
Salmonella OmpA Systemic Unknown Stocker et al., 1979 
Yersinia OmpA Systemic Intracellular survival Bartra et al., 2011 
Table 1.7. A summary of characterised OmpA homologues across various bacterial species. 
 
 
Bacteria Protein Evidence Reference 
E. coli OmpA Activates dendritic cells Jang et al., 2011 
Haemophilus influenzae OmpP1 Protective in animal models Bolduc et al., 2000 
Haemophilus influenzae OmpP2 Conserved across all species Galdiero et al., 2003 
Klebsiella pneumonia OmpA Activates macrophages and dendritic cells Catalina et al., 2011 
Leptospira LipL32 Reactivity with convalescent mouse sera and 
well conserved 
Grassmann et al., 
2012 
Neisseria meningitidis NspA Antibodies are protective Martin et al., 2000 
Richettsia OmpA Protective in mice Jiao et al., 2005 
Shigella flexneria OmpA Well conserved and evokes type I cell 
mediated immunity 
Pore & Chakrabarti, 
2013 
Table 1.8. A summary of proposed outer membrane protein vaccine targets. 
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1.4.3.5.1 Yersinia pestis – Ail 
The OmpA homolog, Ail is spread throughout several species of pathogenic Yersiniae and is 
of particular interest within the plague pathogen Y. pestis. It is a well-studied, multifunctional 
protein and a member of the OmpA-like family. Within pathogenic Yersiniae, Ail has five 
known functions, 
i. Complement inhibition/evasion (Kolodziejek et al., 2007) 
ii. Inhibition of the inflammatory response (Felek and Krukonis, 2009, Hinnebusch et 
al., 2011) 
iii. Adhesion and attachment to host tissues (Kolodziejek et al., 2010, Felek & 
Krukionis 2009) 
iv. Delivery of Yersinia outer proteins to host tissues (Felek & Krukonis, 2008, 
Yamashita et al., 2011) 
v. Prevention of the recruitment of polymorphonuclear leukocytes to the lymph nodes 
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Figure 1.14. The crystal structure of Y. pestis Ail. A. The surface representation of Ail. B. A cartoon of the 
secondary structure components of Ail. C. Surface representation of the electrostatic potential of Ail. The figure 
is generated looking through the barrel from the exterior of the membrane.  All figures were generated using PDB 
accession code 3QRA (Yamashita et al., 2011) and images produced in Pymol (Schrödinger, 2010). 
 
 
Structurally Ail is a relatively small, monomeric, 8-stranded β-barrel at 17 kDa. The crystal 
structure as shown in figure 1.14 is typical of the OmpA-like family with 8 antiparallel β-
strands and four extracellular loops. Alike OmpA and OmpX there appears to be no apparent 
channel throughout the transmembrane barrel (Yamashita et al., 2011) although the two regions 
A B 
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of positive charge around the extracellular surface may play a role in Ail’s ability to bind a 
number of substrates (Yamashita et al., 2011).    
 
 
1.4.3.5.2 Neisseria – NspA 
The 18 kDa, 8-stranded β-barrel, membrane protein NspA is remarkably well conserved among 
Neisseria gonorrhoeae and N. meningitides isolates (Martin et al., 1997, Plante et al., 1999, 
Moe et al., 1999) however, its function is poorly understood. The crystal structure was 
published during 2003 as shown in figure 1.15 (Vandeputte-Rutten et al., 2003) and indicated 
that one extracellular loop (L3) was particularly large and of possible therapeutic value due to 
its surface exposure in vivo. Searches based on sequence similarity indicate that NspA holds 
significant sequence similarity to the Opa family of Neisseria OMP proteins which are 
understood to behave as adhesins (Martin et al., 1997) highlighting a role in virulence. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.15. The crystal structure of Neisseria meningitidis NspA. A. The surface representation of NspA. B. 
A cartoon of the secondary structure components of NspA. Loop L3 is exposed in vivo and of possible therapeutic 
value (Vandeputte-Rutten et al., 2003). Both figures were generated using PDB accession code 1P4T (Vandeputte-
Rutten et al., 2003) and images produced in Pymol (Schrödinger, 2010). 
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1.4.3.6 OmpA-like proteins and the blood brain barrier 
The blood-brain barrier (BBB) is an essential component of the neural microenvironment and 
is formed by brain microvascular endothelial cells (BMECs), astrocytes and pericytes which 
create a physical yet functional barrier that regulates the passage of molecules to and from the 
brain (Kim, 2006). The barrier itself protects not only from normal fluctuations and changes 
within the host but also safeguards the brain from any microorganisms and toxins that have 
gained access to the circulatory system. Pathogens have been described to cross the BBB in 
three distinct ways, these include transcellular and paracellular movement across the barrier or 
gaining access by means of the ‘Trojan-horse’ mechanism as described in figure 1.16.  
 
Transcellular movement by bacteria across the BBB refers to the transfer of pathogens through 
the actual cell with no disruption to the tight junctions (Kim, 2006). In contrast to this, 
paracellular transfer is the crossing of pathogens between the barrier cells sometimes with some 
form of tight junction disruption (Kim, 2006). The third means of crossing involves the Trojan-
horse mechanism whereby the pathogen gains access to the neural microenvironment by 
migrating across the barrier inside of phagocytes, for example within an infected macrophage 
(Kim, 2006). 
 
Infections of the central nervous system remain an important health concern with bacterial 
meningitis within the top ten causes of infection-related deaths worldwide (World Health 
Organisation, 2004). For most meningitis causing pathogens the route of BBB transfer is most 
often transcellular with evidence to support this type of crossing seen within E. coli, 
Streptococcus agalactiae, S. pneumoniae, Neisseria meningitides and the fungal pathogen 
Cryptococcus neoformans. Several studies have suggested that the protozoan pathogen 
Trypanosoma spp (Masocha et al., 2007, Grab et al., 2004) and some strains from Borrelia spp 
(Grab et al., 2005, Sethi et al., 2006) may follow a paracellular route when crossing the blood-
brain barrier. However, this still remains poorly understood and they have also been shown 
able to cross a BMEC barrier via a transcellular mechanism (Grab et al., 2005, Sethi et al., 
2006). Both Listeria monocytogenes and Mycobacterium tuberculosis have been suggested to 
utilise the Trojan-horse mechanisms of transfer whereby they gain access to the neural 
environment via infected phagocytes. However, alike those pathogens implicated in 
paracellular transfer both L. monocytogenes and M. tuberculosis are able to use a transcellular 
route. 
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Within some infections there appears to be a relationship between the level of bacteraemia and 
the development of meningitis particularly during infection with E. coli, S. agalactiae and S. 
pneumoniae (Kim et al., 1992, Ferrieri et al., 1980, Kim, 1987, Dietzman et al., 1974, Bell et 
al., 1985, Sullivan et al., 1982, Marra & Brigham, 2001). Research suggests that a certain 
degree of bacteraemia must be reached before the BBB is breached (Kim et al., 1992, Ferrieri 
et al., 1980, Kim, 1987, Dietzman et al., 1974, Bell et al., 1985, Sullivan et al., 1982, Marra & 
Brigham, 2001). This is particularly interesting as Borrelia spp are able to cross the BBB but 
bacteraemia is not normally high during the spirochaetal infection (Eshoo et al., 2012). 
Although during E. coli infections a high level of bacteraemia is required for BBB invasion 
this state is not sufficient for the development of meningitis and the actual binding of HBMECs 
is a requirement for the bacterial in vivo crossing of the BBB (Kim, 2006).  
 
A key example of this blood brain barrier crossing involves the OmpA protein from certain 
pathogenic strains of E. coli. These strains have the ability to trigger septicaemia and meningitis 
in both humans and domestic animals (Smith et al., 2007). A key study indicated that purified 
OmpA protein from these strains can adhere to brain microvascular endothelial cells or BMECs 
(Shin et al., 2005). The same study highlighted that a pre-incubation of BMEC’s with the beta 
barrel region only, (i.e. the loops deleted), failed to reduce adhesion underlining the importance 
of OmpA within adherence and evasion (Prasadarao et al., 1996). Isogenic E. coli K1 mutants 
with gene deletions corresponding to the sequence encoding OmpA which is known to 
contribute to BMEC binding were significantly less able to cross the blood-brain barrier than 
the wildtype counterpart (Kim, 2001).  
 
Outside of the meningitic E. coli strains a similar pathway can be observed within Enterobacter 
sakazakii, a food-borne pathogen which can lead to sepsis and meningitis within paediatric 
patients (Chenu & Cox, 2009). The OmpA homolog within E. sakazakii is again crucial for 
adherence and the invasion of BMEC’s and human enterocytes (Kim et al., 2010, Wang & 
Kim, 2002).      
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Figure 1.16.  Mechanisms of microbial traversal of the blood-brain barrier. The blood brain barrier is a 
structural and functional barrier which regulates the passage of molecules both in and out of the protected 
environment. The barrier itself is formed by brain microvascular endothelial cells (BMECs), astrocytes and 
pericytes. The arrangement of BMECs allows the formation of tight junctions which restrict the passage of 
molecules into the neural environment (continued…).  
A. Transcellular 
B. Paracellular 
C. Trojan-horse mechanism 
Blood 
Brain 
Microorganism 
Endothelial cell 
Macrophage 
Page | 74  
 
The three major routes across the blood-brain barrier made by microbes. A. Transcellular – Whereby the pathogen 
crosses the barrier through barrier cells with no evidence of tight junction access or disruption.  B. Paracellular – 
Pathogens are observed to cross the barrier by disrupting the tight junctions or can be found between barrier cells. 
C. Trojan-horse mechanism – Pathogens gain access via infected phagocytes. 
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1.4.4 Known Borrrelia OMPs 
As previously noted very few B. burgdorferi integral membrane proteins have been identified 
and many of these remain poorly understood. Within all bacteria OMPs play a wide variety of 
important roles including nutrient acquisition via porins, antibiotic resistance by means of 
efflux pumps and adhesion (Schulz, 2002). As freeze fracture electron microscopy identified 
that the Borrelia outer membrane possesses 10 fold fewer integral OMPs in contrast to the E. 
coli outer membrane the identification of these important membrane components has been 
hindered. 
 
Very few porins are known within B. burgdorferi but include P13, Oms28, DipA, BesC and 
P66 within relapsing fever Borreliae. Both P13 and Oms28 remain poorly characterised but 
are speculated to hold porin like properties. BesC has been described as part of the efflux 
system (Bunikis et al., 2008) and DipA with dicarboxylate specificity (Thein et al., 2012).  
 
 
Figure 1.17. P66 homology modelling. The mature P66 amino acid sequence from B. burgdorferi was processed 
by the PRED-TMBB sever and the tertiary structure predicted. The protein is displayed as a ribbon model. Figure 
taken from Kenedy et al., 2014. 
 
DipA also known as Oms38 was originally identified in Borrelia strains responsible for 
relapsing fever and was extracted from OM fractions of B. duttonii, B. hermsii and B. 
recurrentis. These extractions were also demonstrated to hold pore forming activity in vitro 
(Thein et al., 2012). Further investigations found that DipA was well conserved among 
relapsing fever strains (Thein et al., 2012) and a homolog with similar characteristics was noted 
among Lyme disease Borreliae known as BB0418. Although the structure is yet to be solved 
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the DipA protein is believed to be an integral outer membrane porin and is fairly conserved 
across Borrelia strains. 
 
P66 however is the best characterised, non-selective porin, which also displays adhesion 
properties (Coburn & Cugini, 2003). P66 which is encoded by the open reading frame bb0603 
has a calculated molecular weight of 66kDa and is predicted to form a β-barrel comprised of a 
22 or 24 stranded transmembrane domain with modelling data shown in figure 1.17. Phase 
partitioning and circular dichroism studies support the hypothesis and suggest the protein is 
amphiphilic and consists of 48% β-strand (Kenedy et al., 2013). In vitro studies have 
demonstrated that not only can P66 form pores in artificial membranes with an extremely high 
channel conductance (Lugtenberg and van Alphen, 1983). It can also bind to β3-integrin and 
due to its surface exposed domains the protein is of particular interest for vaccination 
development (Kenedy et al., 2013). Unlike other known bacterial OMPs P66 does not display 
heat modification during heat shift assays and it has been postulated that this may be a unique 
property of spirochetal OMPs (Kenedy et al., 2013, Dyer et al., Appendix 4). 
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1.5 Protein expression throughout the enzootic lifecycle 
1.5.1 Major surface proteins of Borrelia expressed within the tick vector 
Following attachment to a rodent host, Borrelia can be identified within the tick midgut within 
24 hours of the blood meal (Schwan & Piesman, 2000). During this time the number of Borrelia 
within the tick midgut remains fairly stable (Dunham-Ems et al., 2009) until blood influx 
occurs which triggers essential environmental changes. This blood influx is characterised by 
an increased environmental temperature, a reduced pH and a rapid change in the number of 
Borrelia residing within the midgut upto one hundred thousand Borrelia cells per tick (Pulzova 
& Bhide, 2014). This ultimately leads to a swift modification to the Borrelia transcriptome and 
importantly the Borrelia outer membrane (Pulzova & Bhide, 2014). These global changes are 
actioned by the response regulator, Rrp2-RpoN-RpoS pathway which is responsible for the 
induction of more than 10% of Borrelia genes (Xu et al., 2010). The initial feeding induces 
expression of the outer membrane protein p66 (Cugini et al., 2003) and a family of proteins 
known for their ability to evade the complement response known as, complement regulator-
acquiring surface proteins or CRASPs (Pulzova & Bhide, 2014). These early changes to the 
Borrelia surface is likely to protect the bacteria from destruction during the primary stages of 
the blood meal (Pulzova & Bhide, 2014). 
 
During the later stages of the blood meal the protein BBO250 appears crucial for both correct 
cell division and cell envelope integrity (Liang et al., 2010). As the Borrelia count within the 
midgut begins to rise BBO250 is induced. Alongside BBO250 the outer surface protein A or 
OspA is abundantly expressed during the tick midgut stages (Schwan & Piesman, 2000). 
Although OspA has multiple functions (Pulzova & Bhide, 2014), during the tick midgut stage 
it is predominantly responsible for the mediation of attachment to the tick endothelium via the 
tick receptor for OspA (TROSPA) resulting in tick gut colonisation (Pulzova & Bhide, 2014). 
Other studies have also suggested that OspA may also act as its own receptor increasing 
adherence by bacterial aggregation (Pulzova & Bhide, 2014). 
 
The 28 kDa lipoprotein OspA is highly immunogenic and is anchored to the Borrelia outer 
membrane by a lipidated N-terminal cysteine (Huang et al., 1998). It forms a twenty one 
stranded antiparallel β-sheet with the C-terminus containing a single α-helix as shown in figure 
1.18. The monomeric protein is composed of two globular domains at each side of the β-sheet 
which is connected by the non-globular middle section (Bu et al., 1998). Both SAXS and NMR 
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studies suggest the protein exists in solution as a monomer (Bu et al., 1998, Huang et al., 2001) 
and therefore does not have a typical hydrophobic core.  
 
 
 
 
 
 
 
 
 
Figure 1.18. The crystal structure of B. burgdorferi OspA. A. The surface representation of OspA. B. A cartoon 
of the secondary structure components of OspA. Both figures were generated using PDB accession code 2G8C  
(Makabe et al., 2006) and images produced in Pymol (Schrödinger, 2010). 
 
Although both OspA and OspB are expressed upon Borrelia’s surface when residing within an 
unfed tick midgut, these proteins are downregulated upon the acquisition of a blood meal. 
During the feeding and following a rapid increase of the Borrelia cell density within the tick 
midgut, the migration of Borrelia to the salivary gland begins. This migration is coordinated 
by a number of interactions between Borrelia’s surface proteins and the ticks own components. 
The lipoprotein BBE31 has been demonstrated to interact with a tick gut receptor TRE31 and 
is required for Borrelia’s translocation into the haemolymph (Kumar et al., 2011) and 
Borrelia’s BBA52 surface protein has also been shown to assist the migration of the bacteria 
to the tick salivary glands (Kumar et al., 2011).  
 
 
 
 
 
 
 
 
Figure 1.19. The crystal structure of OspB. A. The surface representation of OspB. B. A cartoon of the 
secondary structure components of OspB. Both figures were generated using the PDB accession code 1RJL 
(Becker et al., 2005) and images produces in Pymol (Schrödinger, 2010). 
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A B 
Page | 79  
 
The most studied Borrelia protein within this stage is the outer surface protein C (OspC). 
Alongside BBA64 these proteins are not abundantly expressed by Borrelia residing in the gut 
of an unfed tick but are upregulated during a blood meal (Pulzova & Bhide, 2014). Studies 
have demonstrated that OspC is involved in salivary gland invasion and binds tightly to tick 
salivary gland tissue (Pal et al., 2004) and BBA64 is crucial for mammalian infection via tick 
bite transmission (Gilmore et al., 2007, Gilmore et al., 2008). Additionally OspC can bind the 
tick salivary gland protein, Salp15 enabling survival of antibody mediated killing during initial 
infection (Ramamoorthi et al., 2005). Structurally, OspC is a 23 kDa lipoprotein composed of 
four long anti-parallel α-helices and one short α-helix as shown in figure 1.20. Dimerisation of 
OspC produces an α-helical hydrophobic core (Kumaran et al., 2001) and the protein has been 
demonstrated to bind to a number of host ligands (Pal et al., 2004, Pulzova & Bhide, 2014) 
likely due to its strong negative electrostatic charge highlighting its importance in human 
disease. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.20. The crystal structure of OspC - A. Cartoon representation of the secondary structure components 
of OspC. B. The electrostatic potential of OspC viewed from the top of the molecule. Both figures were generated 
using PDB accession code 1GGQ with X-ray diffraction data from Kumaran et al., 2001 and images produced in 
Pymol (Schrödinger, 2010). 
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1.5.2 Borrelia proteins implicated in the early stage of host infection 
During tick feeding, OspA and OspB are downregulated and OspC is more abundantly 
expressed on the Borrelia outer membrane. This shift continues through transmission and early 
infection which is reflected by the absence of OspA and OspB antibodies during early 
mammalian disease (Schwan and Piesman 2000). The down regulation of OspA at this time is 
particularly important. As previously mentioned OspA is highly immunogenic, it is a potent 
stimulator or neutrophils and the production of cytokines (Morrison et al., 1997) and it’s down-
regulation during initial infection is significant. However, OspA antibodies are detectable 
during chronic infection indicating that the protein plays a larger role (Hsieh et al., 2007). 
During these early stages of infection the skin acts as the initial hurdle. As the spirochaete 
penetrates this barrier via the tick bite, the next obstacle is to avoid immune recognition. The 
spirochaetes exposed lipoproteins are targeted by the innate immune system, where interactions 
are formed between pattern-recognition receptors and Toll-like receptors on the surface of 
dermal fibroblast, keratinocytes and Langerhans cells (Ebnet et al., 1997). An EM rash is often 
devoid of neutrophils as the invading Borreliae acquire host proteins upon their surface 
essentially shielding the pathogen from the host immune response (Szczepanski & Benach, 
1991).  
 
 
1.5.3 Borrelia proteins responsible for dissemination and extracellular matrix adhesion 
For many pathogens the strategy to attach to host tissues is considered an essential component 
of colonisation and in general is mediated by numerous proteins expressed on a bacterial cell 
membrane known as adhesins. In vitro experiments have demonstrated that Borrelia can bind 
to a number of different host cells including endothelial cells, epithelial cells, lymphocytes, 
neuroglia and platelets (Comstock & Thomas, 1989, Szczepanski et al., 1990, Dorward et al., 
1997, Garcia-Monco et al., 1989, Thomas & Comstock, 1989). Although numerous Borrelia 
surface proteins have been demonstrated to mediate adhesion to various components of the 
extracellular matrix (Antonara et al., 2007) the mechanisms in which Borrelia penetrate the 
ECM and move to more distant tissues remains poorly understood. Following a short period of 
multiplication during localised infection lasting approximately 2 days, the spirochaetes begin 
to penetrate the walls of small arteries leading to dissemination and access to remote sites of 
connective tissue throughout the body where they are able to interact with the extracellular 
matrix. Several surface proteins from Borrelia have been identified to facilitate adhesion to the 
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ECM whether this be by adhesion to fibronectin, proteoglycans such as decorin or type I 
collagen.  
 
Proteoglycans are highly glycosylated proteins and are composed of a core protein which is 
covalently linked to one or more GAG chain. These chains are liner, long disaccharide repeats 
which are highly sulphated and can be classed by differences in their structure and their 
sensitivity to cleavage by lyases. Classes of GAGs are summarised in figure 1.21 but include 
heparin, heparan sulphate, dermatan sulphate and chondroitin-6-sulphate with various bacterial 
membrane proteins targeting each of these components. GAG binding specificity is also seen 
to differ throughout Borrelia strains and the targeting of different GAGs appears to result in 
the invasion of different host cell types. For example Borrelia strains which bind heparan 
sulphate appear to invade endothelial cells where those that target dermatan sulphate mainly 
attach to glial cells in vitro studies (Leong et al., 1998). Alongside this phenomenon, Borrelia 
strains that can adhere to both heparan sulphate and dermatan sulphate can invade both cell 
types (Leong et al., 1998, Pulzova & Bhide, 2014). This GAG specificity is explained by the 
fact that Borrelia produces multiple surface proteins which act as GAG-binding adhesins 
(Leong et al., 1998, Pulzova & Bhide, 2014, Parveen et al., 2006, Fischer et al., 2003) and this 
profile of expressed adhesins is likely to be characteristic for any given strain. 
   
One example of this is the glycosaminoglycan (GAG) binding protein Bgp (BB0588) which is 
secreted and found on the surface of the outer membrane (Parveen et al., 2006). The protein 
plays important roles in early infection by the means of binding heparin and agglutinating 
erythrocytes but also has roles in the inactivation of toxic metabolites within the host (Pulzova 
& Bhide, 2014). Bgp however is not constantly expressed during infection (Parveen et al., 
2006) which has led to researchers questioning its importance. However, as many Borrelia 
surface proteins have been identified to hold GAG-binding properties it is likely that constant 
expression of Bgp is simply not always required with an array of similar proteins also being 
available (Leong et al., 1998, Pulzova & Bhide, 2014, Parveen et al., 2006, Fischer et al., 2003) 
. 
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Figure 1.21. Glycosaminoglycan unit structure. The four common GAGs found within the ECM and their 
disaccharide structure. Chronodroitin sulphate is composed of the alternating sugars D-glucuronic acid and N-
Acetyl-D-Galatosamine. Dermatan sulphate is composed of the alternating sugars L-lduronic acid and N-Acetyl-
D-Galatosamine. Heparan sulphate is composed of D-Glucuronic acid and D-Glucosamine and the final GAG, 
heparin formed with the alternating sugars L-Iduronic acid and D-Glucosamine. 
 
The variable surface protein 2 (Vsp2) produced by B. turicatae the relapsing fever spirochaete 
has also been implicated in the GAG binding strategy and can bind to the ECM components, 
heparin and chondroitin sulphate (Magoun et al., 2000). Structural studies on the lipoprotein 
provided insight into this interaction which appears to be governed by ionic interactions from 
the basic amino acids on the protein and the sulphate and carboxylate groups of the GAGs 
(Lawson et al., 2006). It was also observed that heparin binding sites on Vsp2 corresponded to 
shallow pockets of positive charge on the outer protein surface which agreed well with previous 
studies (Capila & Linhardt, 2002). 
 
Other key proteins during the dissemination stages include the decorin binding proteins. These 
proteins are often implicated in the dissemination of Borrelia and the resulting arthritic 
symptoms (Fischer et al., 2003). Decorin binding protein A (DbpA – BBA24) and B (DpbB – 
BBA25) are the major players during this stage with distinct roles in cell binding (Fischer et 
al., 2003). A further method of adhesion lies within the binding to type I collagen, a protein 
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found within the connective tissue of the ECM. This binding has only been reported with the 
presence of decorin and results in the formation of protein fibres which enable the initial 
attachment leading to further invasion and the formation of micro-colonies of Borrelia within 
the ECM (Zambrano et al., 2004). Further mechanisms of adhesion include the porin P66 
previously discussed in section 1.4.4. The P66 protein enables the spirochete to adhere to host 
cells via an interaction between itself and the integrins αIIβ3 and αvβ3 (Skare et al., 1997). 
 
Throughout this stage the protein BBK32 is of particular interest and is localised on the cell 
surface of Borrelia during mammalian infection. The protein has the capacity to bind to 
fibronectin (Fischer et al., 2006) and interact with host GAGs show in figure 1.22 (Fischer et 
al., 2006). Studies suggest (Fischer et al., 2006) that not only does BBK32 promote binding to 
fibronectin but the protein is also involved in binding to purified heparin in vitro, dermatan 
sulphate and GAGs found on several cell lines including, 293 epithelial cells, C6 glial cells and 
EA-Hy926 endothelial cells (Fischer et al., 2006). 
 
As the ECM is a known protected niche for pathogens, our understanding of how B. burgdorferi 
s.l gains access and persists despite an on-going humoral response to the spirochaetes surface 
antigens is essential. During this time the Borrelial proteome appears essential in order to 
extend to chronic infection (Kung et al., 2013). 
 
 
1.5.4 Translocation of Borrelia across the vascular endothelium and the involvement of 
the blood brain barrier 
Penetration of the vascular endothelium by B. burgdorferi remains confusing in terms of 
whether the pathogen follows a paracellular or transcellular route although most researchers 
support the theory that the spirochaete uses a transcellular route (Comstock et al., 1993). 
Experimental evidence has demonstrated that B. burgdorferi can translocate a human umbilical 
vein endothelial cell monolayer (HUVECs) across the cytoplasm (Comstock et al., 1993) and 
B. burgdorferi have also been found within the intercellular junctions and beneath monolayers 
of endothelial cells (Szczepanski et al., 1990) suggesting that spirochaetes may be able to pass 
between cells. 
 
The actual penetration of the blood vessel wall consists of several processes including, 
dragging, tethering and adhesion interactions of the endothelium (Norman et al., 2008). These 
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interactions are mediated by the spirochaete cell surface binding to many host molecules 
including fibronectin, GAG’s and integrins (Norman et al., 2008). More particularly dragging 
interactions involve the Borrelia protein BBK32 as shown in figure 1.22 and further discussed 
below. 
 
 
 
Figure 1.22. Crystal structure of BBK32 in complex with Fibronectin - Cartoon ribbon representation of the 
BBK32 fibronectin complex. GREY – Crystal structure of B. burgdorferi B31 BBK32. BLUE – Fibronectin 
molecule type 2-3 (FN2-3). 
 
 
Despite the expression of numerous surface proteins which can initiate a strong immune 
response, B. burgdorferi s.l is able to cross the blood-brain barrier and invade the CNS causing 
neuroborreliosis also providing the pathogen with a new immune privileged site (Berndtson, 
2013). The mechanisms in which the pathogen crosses this barrier (Comstock et al., 1993, 
Szczepanski et al., 1990) and the damage that it causes (Berndston, 2013) which results in the 
neurological symptoms remain poorly understood. Viable Borrelia can be located within the 
CNS of Lyme borreliosis patients and viable spirochaetes have also have been observed 
intracellularly (Miklossy et al., 2008). Alike the ECM, Borrelia have been demonstrated to 
interact with many host cell surface molecules within both the blood-brain barrier and the CNS, 
these include decorin (Fischer et al., 2003), fibronectin (Fischer et al., 2006, Harris et al., 2014), 
GAGs (Magoun et al, 2000, Parveen et al., 2006, Leong et al., 1998) and integrins (Kenedy et 
al., 2013). These interactions with host molecules and Borrelia’s ability to traverse the blood-
brain barrier and invade the CNS appear to be facilitated by the numerous adhesion molecules 
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the spirochaete expresses upon its surface including, BBK32, Bgp, DbpA, DpbB and P66 
whose combined affect is essential for this invasion (Pulzova and Bhide, 2014). In terms of 
adhesion numerous proteins from Borrelia are thought to contribute but more particularly 
stationary adhesion is thought to involve the Borrelial protein BBB07 which interacts with 
RGD-independent integrins including α3β1 which is expressed at intercellular junctions 
(Behera et al., 2008). 
 
Some experimental data has demonstrated that B. burgdorferi OspA (ospA/BB_A15) alongside 
CD40 on the surface of brain-microvascular endothelial cells has a relationship which promotes 
tethering interactions and can be observed when the spirochaete crosses the blood-brain barrier 
(Pulzova et al., 2009).  Further evidence for OspA’s role in CNS invasion is supported by the 
fact that all Borrelia which adhere to neuronal cells are found to be OspA positive/OspC 
negative (Rupprecht et al., 2006) and the ospA gene has been described to be upregulated 
following the spirochaetes access to the cerebrospinal fluid (CSF) (Schutzer et al., 1997). This 
suggests that the OspA protein plays an important adhesion role during this time and is likely 
to be an essential factor to initiate Lyme Borreliosis (Schutzer et al., 1997). 
 
 
1.6 Immune evasion strategies 
Alike many other pathogens the spirochaete Borrelia employs numerous strategies in order to 
circumvent destruction by the hosts immune system. As recently reviewed by Berndston (2013) 
these strategies can be split into distinctive categories which include, 
1. Exploitation of tick salivary proteins in order to prevent the initial immune response 
2. The masking of Borrelia surface antigens to avert complement initiation. 
3. The seizure of localised host plasminogen activation. 
4. Continuous surface antigen variation. 
5. The bypassing and dodging of immune molecules by both chemotactic and by reaching 
immune-privileged sites. 
6. Horizontal gene transfer. 
7. Quorum sensing and possible engagement in ‘biofilm-like’ behaviour. 
8. Changes in the morphology of the spirochaete (formation of persister cells). 
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1.6.1 Tick salivary proteins 
Throughout out the early stages of infection a number of tick proteins play important roles in 
enabling the transmitted bacteria to survive the barrage of host responses. A number of tick 
salivary proteins have anti-inflammatory, anti-haemostatic and immunomodulatory effects, 
these include ISL929 and ISL1373 which are involved in the downregulation of 
polymorphonuclear PMN integrin expression and have been implicated in the inhibition of 
superoxide production within the vicinity of the bite (Guo et al., 2009).  
 
Salp20, another tick salivary protein has been shown to inhibit complement formation (Tyson 
et al., 2007). While a further interaction between Borrelia OspC and the tick salivary protein 
Salp15 ultimately blocks OspC-TLR2 interactions, effectively protecting the spirochaete from 
antibody mediated killing (Pulzova & Bhide, 2014). 
 
Tick salivary proteins are also known to inhibit both the initial activation and the further 
proliferation of CD4+ T-cells by means of binding to the CD4 receptor region (Anguita et al., 
2002). Furthermore these group of salivary proteins have also been demonstrated to inhibit 
numerous other immune cells including, dendritic cells (Hovius et al., 2008), natural killer cells 
(Kubes et al., 2002), macrophages (Gwakisa et al., 2001) and neutrophils (Montgomery et al., 
2004). The contribution of these tick salivary proteins give the invading pathogen, Borrelia a 
modest advantage and in effect buy the spirochaete a little time to establish an infection before 
clearance by the host immune system (Pulzova and Bhide, 2014). 
 
 
1.6.2 Hijacking plasminogen activation 
Much like a number of other pathogenic bacteria, B. burgdorferi can hijack the host’s 
plasminogen system in order to move beyond the initial site of infection (Brissette et al., 2009). 
In order to do so, the spirochaete must be able to cross the hosts physiological barriers such as 
the basement membrane and the extracellular matrix. This is often achieved by the recruitment 
of host proteases, normally the serine protease, plasmin. A number of pathogens express 
plasminogen receptors on their surface and the recruitment of host plasminogen provides the 
mechanism for invasion (Bhattacharya et al., 2012).  As the inactive plasminogen is converted 
to active plasmin by host plasminogen activators the bacteria can now be described to carry a 
proteolytic surface which assists the pathogen to degrade and rearrange the ECM (Bhattacharya 
et al., 2012).  
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Curiously, plasminogen receptors have a high abundance of lysine residues so it is no surprise 
that the A-T rich genomes of Borrelia which gives rise to a high proportion of lysine residues 
within Borrelia proteins (Fraser et al., 1997) can act as molecules that bind plasminogen, 
granting not all of these may be of physiological importance. For example several plasminogen 
binding proteins are known from Borrelia including, ErpA/C/P (Brissette et al., 2009), OspA 
(Fuchs et al., 1994), OspC (Lagal et al., 2006) and a 70kDa protein (Hu et al., 1997). However 
some of these proteins are downregulated during mammalian infection suggesting that not all 
of these plasminogen binding proteins are essential during this stage of infection. During 2012 
Önder et al identified that the B. burgdorferi outer surface protein C (OspC) contains a 
plasminogen receptor. Alike other pathogenic bacteria this surface receptor acts to recruit 
plasminogen which in turn is activated to plasmin allowing the digestion of fibrin and large 
glycoproteins essentially creating a path through the ECM (Önder et al., 2012). The 
relationship between OspC and invasiveness was further explored using mice. The study found 
that the invasiveness of B. burgdorferi using the mice model was dependent upon specific 
variations within the OspC protein (Lagal et al., 2006). 
 
A further player in Borrelia’s mechanism of hijacking host plasminogen is the cytosolic 
metalloenzyme, enolase (Toledo et al., 2011). Enolases also known as phosphopyruvate 
hydratases are responsible for the catalysis of 2-phospho-D-glycerate to phosphoenolpyruvate. 
Although enolases are often associated with the exterior of the cell, they are still considered 
cytosolic enzymes due to their lack of cell membrane anchoring and/or protein sorting 
machinery. These moonlighting cytosolic proteins are often identified as plasminogen 
receptors on the surface of both eukaryotic and prokaryotic cells (Pancholi, 2001, Pancholi & 
Fischetti, 1998, Bercic et al., 2008, LaFrentz et al., 2011, Mundodi et al., 2008, Pitarch et al., 
2004, Pitarch et al., 2006). 
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1.6.3 Evading the complement system 
The complement system is a complex component of innate immunity involving a highly 
regulated network of proteins and acts as the first line of defence against invading pathogens. 
(Sarma and Ward, 2011) During the late 19th century the German bacteriologist Hans Ernst 
August Buchner suggested that a ‘principle’ of blood serum was its ability to kill bacteria 
(Buchner et al., 1891). Shortly after, during 1896 a Belgian scientist working at the Pasteur 
Institute in Paris, Jules Bordet, demonstrated that the bactericidal effect of blood serum was 
comprised of two components, one which had the ability to retain function following heating 
and the second which lost such effect after heat treatment (Walport, 2001, Morgan, 1990). The 
actual term ‘complement’ was then coined by Paul Ehrlich during the late 1890’s as part of his 
larger proposals for the immune system, where he described the heat labile system to 
complement or aid the killing of bacteria by heat stable antibodies (Ehrlich, 1899).  
The complement system itself, is comprised of over thirty proteins, including soluble serum 
proteins and some which are associated with the membrane (Tegla et al., 2011). Activation of 
complement triggers a sequential cascade of enzymatic reactions which in turn provides the 
platform to permit the formation of the anaphylatoxins c3a and c5a (Hugli, 1986) and is 
summarised in figure 1.23.  These molecules have the ability to stimulate a range of 
physiological responses including opsonisation (Schifferli et al., 1986), chemotaxis of both 
macrophages and neutrophils (Arumugam et al., 2006, de Vries et al., 2003, Chenoweth & 
Hugli, 1978) modulation of the inflammatory response (Hugli, 1986), and finally cell apoptosis 
(Hugli, 1986). 
Activation of complement has been described to arise through three different pathways, so 
named the classical, the alternative and the lectin pathway (Sarma & Ward, 2011).  All three 
involve the sequential cleavage of various inactive zymogens until the formation of C3 where 
the three pathways converge as the activation products C3a, C3b and C5a are produced leading 
to the assembly of the membrane attack complex (Sarma & Ward, 2011).  
Initiation of the alternative pathway is triggered by the presence of carbohydrates, proteins and 
lipids on non-self surfaces (Lambris et al., 2008).  Low levels of C3b are continuously produced 
by C3 cleavage and available to bind to possible invading pathogens (Sarma & Ward, 2011).  
Such binding initiates Factor B recruitment to C3b followed by Factor C which cleaves Factor 
B producing the C3 convertase C3bBb (Sarma & Ward, 2011). The C3bBb molecule is 
stabilised by the presence of properdin within plasma which is released by activated neutrophils 
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(Kemper et al., 2010).  Properdin or Factor P protein is a positive regulator of complement 
activation and acts to stabilise the C3 convertase binding to C3b thereby preventing cleavage 
by Factors H and I (Kemper et al., 2010).  Recent data suggests that properdin has the ability 
to directly bind to both apoptotic and necrotic cells leading to complement activation (Kemper 
et al., 2010). 
Initiation of complement via the classical pathway occurs when immune complexes are formed 
by the binding of IgG or IgM to non-self antigens including pathogens (Sarma & Ward, 2011). 
Following the formation of the C1 complex composed of C1q, C1r and C1 molecules, the C1 
complex binds to the Fc region of the IgG or IgM immune complex (Sarma & Ward, 2011). 
This binding activates C1s which in turn cleaves C4 and C2 to form the CP C3 convertase 
(C4bC2a) (Sarma & Ward, 2011). 
In contrast, the lectin pathway can be initiated in response to invading yeast, bacteria, parasites 
and viruses and involves the binding of the mannose binding lectin (MBL) or the molecule 
Ficolin to carbohydrate motifs on the surface of the invading pathogen (Sarma & Ward, 2011). 
MBL and Ficolin are in constant circulation within the host serum normally in complex with 
MBL-associated proteins known as MASPs (Sarma & Ward, 2011). One of particular 
importance is MASP2 which once activated following the binding to a pathogen becomes 
activated and stimulates the cleavage of C4 to form C4a and C4b (Wallis, 2007). The release 
and attachment of C4b to the pathogen surface induces the binding of C2 which is then 
available to be cleaved by MASP2 to form C2b and C2a (Sarma & Ward, 2011). The cleavage 
of these pair of molecules allows the formation of LP C3 convertase (C4BC2a) where the three 
independent pathways converge (Sarma & Ward, 2011). 
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Figure 1.23. Complement activation pathways. The three different pathways of complement activation 
including the alternative, the classical and the lectin pathway. Molecules highlighted by boxes are factors known 
to inhibit or modulate the pathway. Adapted from Sarma and Ward, 2011. 
 
Many pathogens have developed elegant and effective ways to prevent destruction by the 
complement response and are known to target every aspect of the system from the early stages 
of complement activation via any pathway to the inhibition of end results such as opsonisation, 
phagocytosis and cell lysis (Lambris et al., 2008). Bacterial pathogens are particularly adept to 
such evasion which is achieved by the proteolytic removal of complement proteins or by simple 
complex interactions with complement mediators such as human factor H and factor H like 
protein 1 (Lambris et al., 2008). 
 
The Borrelia genospecies can be considered to vary with regards to their susceptibility to 
complement (Alitalo et al., 2001, Breitner-Ruddock et al., 1997, Pausa et al., 2003, Herzberger 
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et al., 2007). The group can also be further classified by their sensitivity or resistance to serum 
which is measured by determining the borreliacidal effect of the serum by means of the 
formation of the membrane attack complex upon the surface of the spirochaete as shown in 
figure 1.24.  B. garinii serotypes 5 and 6 are classed as serum sensitive, B. burgdorferi as 
moderately serum resistant and B. afzelii, B. spielmanii and B.bavariensis (B. garinii serotype 
4) as serum resistant (Alitalo et al., 2001, Breitner-Ruddock et al., 1997, Pausa et al., 2003 and 
Herzberger et al., 2007). 
 
 
Figure 1.24. Complement destruction of Borrelia spirochaetes. Assessment of serum sensitivity of Borrelia 
genospecies by scanning electron microscopy following incubation with 12.5% human serum for 1.5 hours. Left 
- serum-sensitive B. garinii A87S with arrows highlighting bleb formation caused by complement activation and 
the formation of the membrane attack complex (C5b-9) leading to membrane disruption and cell death. Right – 
Serum-resistant B. burgdorferi B31 with no noticeable blebs highlighting the failure of complement activation. 
Micrographs taken from de Taeye et al., 2013. 
 
 
In order for Borrelia to infect and establish an infection within the host the spirochaete must 
circumvent the host complement response both during and after transmission (de Taeye et al., 
2013). During the early stages of transmission the tick salivary protein TSLPI (Tick salivary 
lectin pathway inhibitor) plays a key role in preventing complement activation. The tick protein 
inhibits the binding of mannose-binding lectin to its ligand and blocks complement activation 
via the lectin pathway (de Taeye et al., 2013). The addition of this tick protein to a serum 
incubation of serum-sensitive Borrelia strains also reduced complement mediated killing 
emphasising the importance of this tick protein during the early stages of transmission (de 
Taeye et al., 2013). 
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Serum resistant Borrelia genospecies have evolved complex mechanisms of avoiding 
complement mediated destruction (de Taeye et al., 2013), however these mainly involve the 
procurement of host complement regulators on to their surfaces (Lambris et al., 2008). The 
main regulator for the activation of the alternative pathway is the plasma component factor H 
which is a large glycoprotein (150kDa) consisting of twenty complement control protein 
modules (CCPs) each spanning approximately sixty residues (Schmidt et al., 2008). This 
regulation is essential for the differentiation between self and non-self cells and often recruited 
by bacterial pathogens. This targeted recognition of microbial surfaces as opposed to activation 
on host surfaces is crucial and tight regulation is required to prevent uncontrolled complement 
activation. The ability of factor H to recognise host and non-host surfaces can be demonstrated 
by mutations in the carboxyl-terminus of the glycoprotein. Mutations within this region can 
cause unchecked alternative pathway activation upon the surfaces of host cells leading to often 
irreparable damage to erythrocytes, platelets and endothelial cells. This damage may result in 
serious systemic disease such as atypical haemolytic uremic syndrome (Jokiranta et al., 2007). 
 
 Much research has concentrated around the expression of complement regulator acquiring 
surface proteins (CRASPs) by Borrelia species with crystal structures deposited within the 
PDB for much of the protein family. CRASPs are lipoproteins and are abundantly expressed 
on the outer surface of Borrelia (Kraiczy et al., 2001, Hallström et al., 2010, de Taeye et al., 
2013). They act to prevent the complement cascade by binding to at least one member of the 
host factor H family of proteins (Kraiczy et al., 2001, Hallström et al., 2010, de Taeye et al., 
2013).  This acquisition of host factor H and factor H like proteins reduces the levels of 
complement activation by the alternative pathway, which results in the prevention of the 
formation of the membrane attack complex upon the spirochaetes surface (Kraiczy et al., 2001 
and Bykowski et al., 2008). The factor H family consists of complement factor H itself, factor 
H-like protein (FHL-1), a splice variant of factor H and five complement factor H-related 
proteins (CFHR 1-5) with roles which are poorly understood but may act as cofactors for factor 
H. In turn there are five known CRASPs (1-5) also known as Erp’s which are summarised in 
table 1.4 (Kraiczy et al., 2001, Hallström et al., 2010, de Taeye et al., 2013, Pulzova et al., 
2014). The five CRASPs have all been identified in serum resistant Borrelia strains across B. 
afzelii (BaCRASPs) and B. burgdorferi (BbCRASPs) with factor H binding partners 
summarised in table 1.9 (de Taeye et al., 2013). 
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 Factor H FHL-1 CFHR-1 CFHR-2 CFHR-3 CFHR-4 CFHR-5 
BbCRASP-1 Y Y - - - - - 
BbCRASP-2 Y Y - - - - - 
BbCRASP-3 Y - Y Y - - Y 
BbCRASP-4 Y - Y Y - - Y 
BbCRASP-5 Y - Y Y - - Y 
Table 1.9. B. burgdorferi CRASPs and factor H binding. A summary of the known interactions between B. 
burgdorferi CRASPs and Factor H or factor H like proteins. CRHR1-5 are known as complement factor H related 
proteins. Y indicated an interaction between the Borrelia protein and the complement regulator. 
 
 
1.6.4 Surface antigenic variation 
Antigenic variation remains a common mechanism of immune evasion for many bacteria with 
the most extensively studied organisms including, Neisseria meningitides and N. gonorrhoeae 
(Deitsch et al., 2009). Recombinational shuffling of B. burgdorferi’s genetic material (further 
discussed in section 1.3.4) allows surface epitopes to be continually refreshed (Zhang & Norris, 
1998). This progressive change to the pathogens outer surface frustrates the host’s humoral 
immune response and provides the spirochaete with an ever changing disguise. 
 
The outer surface lipoprotein VlsE (Variable major protein/Vmp-like sequence) from B. 
burgdorferi is known to undergo rapid antigenic variation and is believed to play a crucial role 
in evading the host’s immune response (Zhang & Norris, 1998). Structurally the 35-kDa protein 
contains six variable regions which form loop structures and occupy the membrane surface 
whilst covering the invariant regions of the protein (Eicken et al., 2002). Although the function 
of VlsE is poorly understood it is known that the protein is significant during mammalian 
infection and the loss of expression by the removal of the coding region from it’s plasmid Ip28-
1, results in reduced infectivity (Barbour, 1984 and Barbour et al., 1986). Further evidence 
supporting the importance of VlsE is that mutant Borrelia that lack the plasmid Ip28-1 are 
incapable of long term mammalian infection (Labandeira et al., 2003 Labandeira and Skare, 
2001, Purser and Norris, 2000). 
 
Antigenic variation is achieved by use of the vls locus which is comprised of the vlsE 
expression site followed by 11 to 15 silent vls cassettes (Zhang & Norris, 1998). By 
recombining segments of the silent cassettes with the vlsE region the resulting vlsE gene and 
the eventual outer surface protein is highly variable at specific surface exposed regions 
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protecting the invariant core (Liang et al., 2000, Zhang & Norris, 1998, Eicken et al., 2002). 
An important note is that this variation is only seen during mammalian infection and not during 
the colonisation of ticks or in vitro cultivation. In terms of speed, antigenic variation of vlsE 
seen in mice shows detectable sequence changes within 4 days and by 28 days every isolate 
can be considered unique with between 9-13 recombination events (Zhang and Norris, 1998). 
Similar systems have been identified in other pathogens associated with persistent infection 
and relapsing fever and include the protozoa Plasmodium spp, Trypanosoma spp (Barbour and 
Restrepo, 2000) and relapsing fever spirochaetes (Schwan and Hinnebusch, 1998). 
 
Expression studies have also demonstrated that B. burgdorferi keeps expression of VlsE under 
tight control and is seen to produce little when colonising the midgut of the tick and upregulates 
expression during mammalian infection (Indest et al., 2001) indicating that expression is most 
probably controlled in line with both exogenous and endogenous signals associated with the 
natural infectious cycle.
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Figure 1.25. Outer membrane protein regulation during tick and mammalian infection.  The profile of the Borrelia outer membrane is seen to drastically shift between 
hosts. Some proteins are specifically associated with expression during tick infection whereas others are notably involved during mammalian infection. Although OspA is in 
higher abundance during tick infection the protein has also been implicated in roles during mammalian infection and can be considered to be present during both environments.
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1.6.5 Oxidative stress and Borrelia superoxide dismutase 
B.burgdorferi’s ever changing environment often causes exposure to fluctuations in O2 and 
challenges by the host’s immune system contributes further to the oxidative stress placed upon 
the spirochete (Wang et al., 2013).  In order to survive the hostile environment B.burgdorferi 
can exploit a tick salivary gland protein, Salp25D when migrating from arthropods to mammals 
and although the spirochete lacks peroxidase or catalase enzymes its genome encodes a single 
superoxide dismutase gene, sodA (bb0153) which is essential for virulence (Esteve-Gassent et 
al., 2008). 
Superoxide dismutases (SODs) are a group of crucial enzymes which catalyse the 
disproportionation of superoxide to hydrogen peroxide and oxygen. Enzymatic activity 
requires a metal ion co-factor which can be used to distinguish between the different SOD 
isoforms which include Mn-SOD, Fe-SOD, Cu/Zn-SOD, Ni-SOD and cambialistic SODs 
which can effectively function with either manganese or iron as its co-factor (McCord & 
Fridovich, 1969, Yost & Fridovich, 1973, Keele & McCord, 1970, Youn et al., 1996, Martin 
et al., 1986). The different isoforms can be experimentally identified by their sensitivity to 
cyanide (Cu/Zn-SOD), sensitivity to hydrogen peroxide (Fe-SOD and Cu/Zn-SOD) or resistant 
to both cyanide and hydrogen peroxide treatments (Mn-SOD) (Asada et al., 1975, Benov & 
Fridovich, 1994). The family of Mn and Fe-SODs are particularly well conserved from bacteria 
to humans and Mn and Fe versions share significant homology and can bind either co-factor 
with similar affinities and binding geometries (Mizuno et al., 2004, Iranzo, 2011, Kang et al., 
2011, Yamakura et al., 2007). Although the binding affinities of both Fe and Mn-SODs for 
their co-factors are similar the binding of the incorrect metal ion renders the enzyme inactive 
possibly due to the disruption of redox potential over any physical changes to conformation 
(Vance and Miller, 1998, Jackson and Brunold, 2004). 
SodA from B. burgdorferi was originally characterized as a Fe-SOD based upon its resistance 
to cyanide yet enzymatic sensitivity to H2O2 (Whitehouse et al., 1997). Three years later a study 
demonstrated that this classification for Borrelia was unlikely, their reasoning included that; 
Borrelia have an extremely low intracellular iron concentration with evidence suggesting this 
could be as low as 10 atoms per cell, there is no growth requirement for iron and there is a 
distinct lack of cellular machinery for the uptake of iron (Posey and Gherardini., 2000).  Further 
studies failed to confirm Whitehouse’s findings that B.burgdorferi’s SOD was enzymatically 
sensitive to H2O2 but resistant to cyanide. However, instead suggested that the B.burgdorferi 
SOD was resistant to both treatments and was indeed a Mn-SOD (Troxell et al., 2012). The 
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group also suggested that the enzyme was unlikely to be cambialistic due to the low 
intracellular iron content and the lack of iron uptake proteins encoded within the genome. 
Within metalloprotein biology or evolutionary studies B. burgdorferi can be classed as a 
particularly interesting organism as it has evolved with no requirement for iron (Posey and 
Gherardini., 2000, Fraser et al., 1997). As previously described not only is the intracellular iron 
concentration extremely low the spirochaete can rapidly acquire remarkably high levels of 
manganese (Aguirre et al., 2013). Metalloproteomic studies have demonstrated that 
particularly high levels of manganese are crucial for SodA activation within B. burgdorferi. 
The study identified that the majority of the cells SodA enzyme associates with manganese 
with a smaller subset being held as inactive apoprotein (Aguirre et al., 2013). The study also 
demonstrated that although B. burgdorferi has evolved to a manganese rich and iron poor 
environment the opposite is seen for other microorganisms such as Saccharomyces cerevisiae 
and E. coli where the intracellular concentration of iron is high and the manganese co-factor 
concentration is low yet manganese is still captured by these SODs. In order to determine 
whether the B. burgdorferi SodA behaves in a similar manner the enzyme was expressed in the 
iron-rich mitochondria of S. cerevisiae and was found to be inactive suggesting the B. 
burgdorferi SodA is only active in the presence of a high manganese concentration. 
Recent modelling studies of B. burgdorferi SodA have highlighted strong homology to other 
known Mn-SODs and computer aided modelling of the proposed active site using the 
modelling software, Modeller (UCSF – Webb & Sali, 2014, Martin-Renom et al., 2000, Sali & 
Blundell, 1993, Fiser et al., 2000) has also highlighted some possibly unusual features within 
the hydrogen bonding near the enzymes active site which are not shared with other known 
bacterial SODs such as E. coli SodA (Lah et al., 1995). These differences are likely to have 
occurred due to B. burgdorferi adaption to a manganese rich and iron poor environment which 
is likely to give the pathogen a competitive edge when the infected host begins to starve the 
invader of iron (Posey and Gherardini, 2000, Correnti and Strong, 2012 and Johnson and 
Wessling-Resnick, 2011). The single B. burdorferi SOD gene has also been demonstrated to 
be essential for virulence highlighting the importance of characterisation of this normally well 
conserved enzyme. 
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Figure 1.26. Predicted active site of B. burgdorferi SodA. Homology models for B. burgdorferi SodA were 
generated using the above known Mn-SOD templates and generated using Modeller (UCSF – Webb & Sali, 2014, 
Martin-Renom et al., 2000, Sali & Blundell, 1993, Fiser et al., 2000). The figure shows the predated active site 
taken from Aguirre et al., 2013. The yellow represents residues from B. burgdorferi SodA and the green denotes 
residues from E. coli SodA. 
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1.7 Research Aims 
1.7.1 Borrelia OmpA-like proteins 
The B. burgdorferi s.l. genome is known to encode a large number of lipoproteins with upto 
8% of genes implicated. Much research has revolved around the identification and 
characterisation of lipoproteins with much progress made. However, many of these are often 
encoded on Borrelia’s vast number of plasmids which are often variable between genospecies 
(Fraser et al., 1997). This variability of plasmids between Borrelia strains has hindered the 
development of new vaccines and diagnostic methods. Freeze fracture electron microscopy has 
highlighted that Borrelia s.l. has an unusually low abundance of integral OMPs, possibly upto 
10-fold lower than what can be detected from an E. coli outer membrane (Lugtenberg and van 
Alphen, 1983, Radolf et al., 1994). This lower abundance alongside the limited antigenicity of 
known OMPs has possibly stalled the identification and characterisation of these integral 
proteins and in stark contrast to lipoproteins many of these hypothetical integral membrane 
proteins are encoded on the stable chromosome (Fraser et al., 1997). 
 
To date approximately ten OMPs have been identified in B. burgdorferi (Brooks et., 2005, 
Lenhart & Atkins., 2009, Antonara et al., 2007, Bunikis et al., 2008, Coburn & Cugini et al., 
2003, Cugini et al., 2003, Noppa et al., 2001, Skare et al., 1997, Wood et al., 2013 and Russell 
& Johnson., 2013) and it is likely that these ten proteins represent only a small subset of these 
Borrelia’s exposed integral proteins with many still not identified. Several studies have 
highlighted the importance of the identification and characterisation of these novel proteins 
(Tan et al., 2008, Wang et al., 2009, Jolley et al., 2001, Okamura et al., 2012) with the ultimate 
goal that some may offer suitable vaccine targets (Dunn et al., 2015) or aid current diagnostic 
tests. 
 
As the eight stranded membrane spanning beta barrel, OmpA from E. coli is highly conserved 
within Gram-negative bacteria it seemed appropriate to use this key protein as the basis of the 
initial search for novel OMPs in Borrelia. The OmpA protein has multiple cellular functions 
with involvement in, adhesion, structural integrity, immune evasion, biofilm formation and has 
also been associated with invasion of brain microvascular endothelial cells highlighting the 
importance of identifying homologs within other pathogenic bacteria.  
 
Previous work by Dr Adam Dyer (Identification and Structural Characterisation of Novel Outer 
Membrane Proteins in B. burgdorferi s.l. – Thesis 2013, University of Huddersfield) identified 
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BAPKO_0422 and a number of paralogous genes across B. burgdorferi, B. afzelii and B. garinii 
which were predicted to encode proteins believed to form 8-stranded outer-membrane β-
barrels. This identification was based upon a novel approach using hidden Markov models and 
fold prediction as traditional protein BLAST (Altschul et al., 1990) searching failed to identify 
any characterised proteins with any significant degree of sequence similarity. The identification 
of integral membrane proteins in this manner is often hindered due to the substantial sequence 
divergence of these proteins particularly within the sequences associated with the external loop 
regions which are highly variable. The research undertaken by Dyer, 2013 employed a unique 
approach to identify possible OmpA-like proteins based upon the creation of HMM profiles of 
known OmpA-like proteins and using this profile to search the Borrelia genome followed by 
further investigation using fold and signal sequence prediction. For full methodology and 
results please refer to the original text (Dyer, 2013, Dyer et al., Appendix 4). Following this 
bioinformatics study a number of proteins were identified as possible OmpA-like proteins and 
are summarised in table 1.10. 
 
Ordered locus 
name 
GenBank  
(UniProtKB)  
Accession codes 
No. of 
amino acids 
FFAS03 highest 
scoring template 
Signal sequence 
prediction 
(SignalP 4.1) 
BAPKO_0026 ABH01291.1 (Q0SPD7) 211 OmpW (2X27) N 
BB_0027 AAC66429.1 (O51058) 212 OmpW (2X27) Y 
BG0027 AAU06886.1 (Q662Y5) 212 OmpW (2X27) N 
BAPKO_0422 ABH01676.1 (Q0SNA2) 201 OmpA (2KOL) Y 
BB_0405 AAC66795.1 (O51366) 203 OmpW (2X27) Y 
BG0407 AAU07257.1 (Q661L4) 203 OmpW (2X27) Y 
BAPKO_0423 ABH01677.1 (Q0SNA1) 203 OmpA (2KOL) Y 
BB_0406 AAC66794.1 (O51367) 203 OmpA (2KOL) Y 
BG0408 AAU07258.1 (Q661L3) 203 OmpA (2KOL) Y 
BAPKO_0591 ABH01831.1 (G0IQB2) 181 NspA (1P4T) Y 
BB_0562 AAC66924.1 (O51510) 180 NspA (1P4T) N 
BG0572 AAU07409.1 (Q660W2) 179 NspA (1P4T) Y 
 
Table 1.10. Possible OmpA-like proteins identified by HMM/FFAS03/BLAST. Proteins were identified by 
searches from B. afzelii, B. burgdorferi and B. garinii translated open reading frames using hidden Markov models 
and signal sequence analysis (Dyer, 2013). 
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Following the initial identification a number of the possible 8-stranded beta barrel proteins 
were found within past literature and included BG0407 which had been noted as a human factor 
H binding protein (Bhide et al., 2009) and BB0405 which had previously been identified as a 
monomeric protein in outer membrane vesicles (Yang et al., 2011).  
 
The overall aims of the research was to clone a selection of these hypothetical proteins across 
all three Borrelia strains and produce recombinant protein in order to probe their structural and 
functional relationships and determine whether these proteins were indeed part of the OmpA-
like domain family. 
 
 
 
 
 
 
 
 
Summary of the research aims - Borrelia OmpA-like proteins: 
 Clone and produce recombinant OMPs from across B. burgdorferi, B. afzelii and 
B. garinii based upon the initial bioinformatic identification of possible OmpA-
like proteins. 
 Determine possible binding motifs within these proteins using bioinformatic 
techniques. 
 Identify possible binding ligands in vitro. 
 Explore possible conformations by means of homology modelling. 
 Characterise the unknown proteins using phase partitioning, circular dichroism, 
small angle X-ray scattering and X-ray crystallography. 
 Conclude whether these proteins are likely to belong to the OmpA-like domain 
family. 
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1.7.2 Superoxide dismutase A 
Alongside the investigation of possible Borrelia OMPs it was also planned to investigate 
another crucial protein, B. burgdorferi superoxide dismutase A. The small enzyme was selected 
for further investigation as it lacked full characterisation with regards to its enzymatic activity 
and its structure was yet to be solved although the protein is considered highly conserved 
among other bacteria. 
 
The complex lifecycle of B. burgdorferi often causes exposure of the pathogen to fluctuations 
in oxygen levels and the potential for the spirochaete to encounter reactive oxygen species 
(ROS) (Wang et al., 2013).  Previous studies have identified that B. burgdorferi’s superoxide 
dismutase A (SodA) (23.5kDa protein) is the key metalloenzyme responsible for degradation 
of ROS.  Early work suggested that the enzyme required the presence of iron to function 
(Whitehouese et al., 1997). However, it is now postulated that the required co-factor is 
manganese, as B. burgdorferi’s intracellular concentration of iron is minimal, at less than 10 
atoms per cell (Posey et al., 2000), there is a distinct lack of iron containing proteins and the 
spirochaete does not have the capacity to transport iron nor require it for growth (Radolf et al., 
2012). 
 
Much work has been published supporting that this enzyme is indeed a manganese SOD (Posey 
and Gherardini., 2000, Troxell et al., 2012, Radolf et al., 2012). However, no studies to date 
have identified whether this enzyme is cambialistic, whereby it could use both manganese and 
iron as its co-factor.  
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Summary of the research aims - B. burgdorferi superoxide dismutase A: 
 Produce recombinant superoxide dismutase A 
 Determine the metal co-factor required for enzymatic activity in vitro and 
determine whether the protein exhibits cambialistic behaviour. 
 Produce homology models. 
 Characterise the protein using circular dichroism, small angle X-ray scattering and 
X-ray crystallography. 
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Chapter 2: Materials and Methods 
2.1 Materials 
2.1.1 DNA and Oligonucleotides 
The BAPKO_0422-pET47 expression construct was kindly supplied by Dr Adam Dyer (The 
University of Huddersfield).  Borrelia genomic DNA used for the development of further 
constructs was supplied by Dr Gabi Margos (The University of Bath), from Borrelia DNA 
extracted from infected I.rinicus and also from Dr Volker Fingerle (German National 
Reference Centre for Borrelia) who provided purified genomic DNA from B. burgdorferi s.s 
B31, B. garinii PBi and B. afzelii PKo strains. The B. burgdorferi SodA construct was 
commercially codon optimized for expression within E. coli and synthetically produced by 
MWG Operon, Eberberg, Germany. 
 
The pET-47b(+) DNA was purchased from Novagen (Merck Serono Ltd, Middlesex, UK) and 
was used for targeted gene expression with the plasmid map shown in figure 2.1. The plasmid 
contains a T7 promoter and terminator along with the coding sequence for an N-terminal 
histidine tag followed by the recognition sequence for the highly specific (HRV) 3C protease.  
The presence of the 6-his-tag provided an ideal platform for immobilised metal affinity 
chromatography purification and the plasmid also conferred kanamycin resistance for 
selection. 
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Figure 2.1 - pET-47b(+) Plasmid map and cloning region – Overview of the vector map and the nucleotide 
sequence of the cloning region with restriction sites. (Taken from Novagen®) 
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Primers used throughout this project were designed and analysed using OligoExplorer 1.2 and 
OligoAnalyzer 1.2 (Genelink).  Primers were synthesised by Eurofins MWG Operon 
(Germany) and provided as lyophilised samples which were diluted to 100pmol/µl following 
manufacturer instructions using sterile nuclease free water (full oligonucleotide data sheets can 
be viewed within the appendix). Primers used to target genes bb_0562, bb_0406 and bg0408 
are summarised in table 2.1. Genes and proteins targeted are referred to using their Uniprot 
identifiers. 
 
Initial amplification primers were designed to target the gene of interest plus an additional ~10 
base pairs both up and downstream of the region. Restriction primers were then used to reduce 
this region back to its native sequence and to also add the required restriction site. Prior to 
selection of a restriction site the sequences were submitted to the web server NEBcutter v2.0 
in order to determine whether any restriction sites were naturally present within the nucleotide 
sequence, output data is shown in figure 2.2. Following the identification of any unsuitable 
restriction sites within the three genes, BamHI and NotI were selected as suitable restriction 
sites to add to the generated PCR products as shown in table 2.2. Neither of these two restriction 
sites were naturally present within the three genes nor present at any point with the vector apart 
from within the multiple cloning site. 
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Target Primer Name Sequence (5’-3’) Tm (oC) Length 
BB_0562 
 
BB_0562_F 
BB_0562_R 
TAT AATAATAAGACAAAATTTGGGAG 
GAATTTTTTCATAGCGCTTGGC 
53.8 
56.5 
26 
22 
BB_0406 
 
BB_0406_F 
BB_0406_R 
CTTTATAAAAATATATATATAGTGGAG 
TATGCGAGCTTAATTTTAATTACC 
52.8 
54.2 
27 
24 
BG_0408 
 
BG0408_F 
BG0408_R 
TTAAGTAAGCTTAATTTTA ATCACC 
TATAATAATAAGACAAAAT TTGGGAG 
53.1 
53.8 
27 
25 
 
Table 2.1 - Primers for initial amplification – Primer sequences, lengths and melting temperatures for 
oligonucleotides used to generate initial PCR products for expression construct development. Borrelia strains are 
denoted by BB, B. burgdorferi B31, BG, B. garinii PBi, BAPKO, B. afzelii PKo followed by the annotated gene 
number as recorded on NCBI (https://www.ncbi.nlm.nih.gov/) and the primer type of either F, forward or R, 
reverse. 
 
 
Target Primer Name Sequence (5’-3’) Tm (oC) Length 
BB_0562 
 
BB_0562_F_BamHI 
 
BB_0562_R_NotI 
AATTATGˇGATCCGAAAGATTCATATTTA 
AATAGAGGA 
ATAAGCˇGGCCGCGAATTTTTTCATAGCG 
CT 
62.8 
 
66.8 
37 
 
30 
BB_0406 
 
BB_0406_F_BamHI 
 
BB_0406_R_NotI 
AATTATGˇGATCCGTCTGACAATTATATG 
GTCAG 
ATAAGCˇGGCCGCTATGCGAGCTTAATTT 
TAATTACC 
64.5 
 
68.3 
33 
 
36 
BG_0408 
 
BG0408_F_BamHI 
 
BG0408_R_NotI 
AATTATGˇGATCCGTCTGACAATTATAT 
GGTCAG 
ATAAGCˇGGCCGCTTAAGTAAGCTTAAT 
TTTAATCACC 
64.5 
 
67.2 
33 
 
37 
 
Table 2.2 - Restriction site primers – Primers were designed to add appropriate restriction sites and to keep the 
amplified fragment in a correct reading frame for expression.  Between 4 to 6 bases were added to the ends of the 
oligonucleotides to improve restriction digestion efficiency. 
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Figure 2.2 – Restriction site analysis of Borrelia OMP genes to be cloned. Full graphical output highlighting 
the naturally present restriction sites in each of the three Borrelia OMP genes, generated using NEBcutter v2.0. 
From top to bottom, A - BB_0562, B - BB_0406 and C - BG0408. Red cut sites represent blunt ended cutting, 
blue cut sites indicate a 5’ extended cut, green a 3’ extended cut and black bars cuts one strand only. 
 
 
 
 
 
 
A 
B 
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2.1.2 Reagents, buffers and enzymes 
Required chemicals and reagents were purchased from Sigma-Aldrich (Gillingham, UK) and 
Fisher Scientific (Loughborough, UK), DNA purification kits from Qiagen and antibodies from 
Abcam. 
 
Chemical/Reagent Supplier Abbreviation 
Acrylamide (40% in solution) Fisher Bis-tris 
Agar Fisher - 
Ampicillin sodium salt Fisher Amp 
Ammonium persulfate Sigma APS 
Blue Dextran Sigma - 
Bovine serum albumin Sigma BSA 
Bradford reagent Invitrogen - 
Chloramphenicol Fisher Chl 
Complement human Factor H Cambridge Bioscience hFH 
Dithiothreitol Fisher DTT 
Ethylenediaminetetraacetic acid Fisher EDTA 
Glycerol Fisher - 
Guanidine Hydrochloride Fisher - 
Imidazole Fisher - 
Iron(II) chloride Fisher FeCl2 
Isopropyl β-D-1-thiogalactopyranoside Fisher IPTG 
Kanamycin sulphate Fisher Kan 
Lauryldimethylamine-oxide Sigma LDAO 
Lysozyme Sigma - 
Manganese(II) chloride Fisher MnCl2 
Nickel(II) sulphate Sigma - 
Protease inhibitor cocktail Sigma - 
Ribonuclease A Sigma - 
Sodium azide Fisher NaN3 
Sodium dodecyl sulphate Sigma SDS 
Sodium chloride Fisher NaCl 
Sodium phosphate monobasic Fisher - 
Sodium phosphate dibasic Fisher - 
Sucrose Sigma - 
Tetramethyethylenediamine Sigma TEMED 
Tris (hydroxymethyl)aminomethane-base Fisher Tris-Base 
Tris (hydroxymethyl)aminomethane-HCl Fisher Tris-HCl 
Triton X-100 Sigma - 
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Triton X-114 Sigma - 
Tryptone Fisher - 
Tween-20 Sigma - 
Urea Fisher - 
Yeast extract Fisher - 
1-oleoyl-rac-glycerol Sigma Monoolein 
3-[(-Chloamidopropyl)dimethylammonio]-1-
propanesulphonate 
Fisher CHAPS 
Table 2.3 - Chemicals and reagents – A list of chemicals and reagents used throughout the project and the 
supplier. 
 
 
Enzyme Reaction buffer Restriction site/ 
site of activity 
Supplier 
BamHI FastDigest FastDigest Buffer G^GATCC 
CCTAG^G 
Thermo 
DreamTaq DNA Polymerase DreamTaq Buffer 
 
___ Thermo 
EcoRI EcoRI Buffer G^AATTC 
CTTAA^G 
NEB 
NotI FastDigest FastDigest Buffer GC^GGCCGC 
CGCCGG^CG 
Thermo 
SalI NEBuffer 3 + BSA G^TCGAC 
CAGCT^G 
NEB 
Taq Polymerase Standard Taq Buffer 
 
___ NEB 
T4 DNA Ligase T4 DNA Ligase Buffer ___ 
 
Thermo 
HRV(3C) protease HRV(3C) reaction buffer Leu-Glu-Val-Leu-Phe-Gln-
↓-Gly-Pro 
 
Thermo 
Table 2.4 - Enzymes – Restriction and cloning enzymes used throughout the project. When commercial HRV(3C) 
wasn’t used the protease was expressed and purified in house using a H-3Cpro construct containing the protease 
gene with an N-terminal his-tag and MBP C-terminal tag. 
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Buffer/Media Composition 
Autoinduction media 1% w/v tryptone, 0.5% w/v yeast extract, 1x NPS, 1x 5052 
Coomassie blue stain 0.1% w/v Coomassie R250, 10% v/v glacial acetic acid, 40% v/v methanol 
Coomassie blue destain 10% v/v glacial acetic acid, 20% v/v methanol 
IEC denaturing binding buffer 8M urea, 20mM NaCl, 50mM Tris, pH8 
IEC denaturing elution buffer 8M urea, 1M NaCl, 50mM Tris, pH8 
IEC native binding buffer 20mM NaCl, 50mM Tris, pH8 
IEC native elution buffer 1M NaCl, 50mM Tris, pH8 
IEC refold buffer 1M urea, 20mM NaCl, 50mM Tris, pH8 
Inclusion body wash buffer 1 0.3 NaCl, 50mM Tris, 1mM EDTA, 10mM DTT, 5% v/v Triton X-100, 
pH8  
Inclusion body wash buffer 2 0.3 NaCl, 50mM Tris, 1% v/v Triton X-100, pH8 
Inclusion body wash buffer 3 0.3 NaCl, 50mM Tris, pH8 
IMAC denaturing binding buffer 8M urea, 0.3M NaCl, 50mM sodium phosphate, pH8 
IMAC denaturing wash buffer 8M urea, 0.3M NaCl, 50mM tris, 20mM imidazole , pH8 
IMAC denaturing elution buffer 8M urea, 0.3M NaCl, 50mM tris,  0.5M imidazole, pH8 
IMAC native binding buffer 0.3M NaCl, 50mM tris, pH8 
IMAC native wash buffer 0.3M NaCl, 50mM tris, 20mM imidazole , pH8 
IMAC native elution buffer 0.3M NaCl, 50mM tris, 0.5M imidazole , pH8 
IMAC refold buffer 1M urea, 0.3M NaCl, 50mM tris, pH8 
Lysis buffer 0.3M NaCl, 50mM Tris, 0.4µg/ ml lysozyme, 0.1% v/v Triton X-100, pH8 
MES running buffer 50mM MES, 50mM Tris base, 0.1% w/v SDS, 1mM EDTA, pH 7.3 
NPS x20 1 M Na2HPO4, 1 M KH2PO4, 0.5 M (NH4)2SO4 
TAE x10 400mM Tris base, 200mM acetic acid, 10mM EDTA 
TBE x10 1M Tris base, 1M Boric acid, 0.02M EDTA 
Transfer buffer 1.45% w/v Tris, 7.2% w/v glycine, 20% v/v methanol 
TBS x1 0.15M NaCl, 20mM Tris, pH 7.4 
TBS-TWEEN 0.15M NaCl, 20mM Tris, 0.05% v/v TWEEN-20,  pH 7.4 
SAXS buffer 1 0.3M NaCl, 50mM Tris, 0.06% w/v LDAO, pH8 
SAXS buffer 2 0.3M NaCl, 50mM Tris, 0.1% w/v LDAO, pH8 
Size exclusion buffer 0.3M NaCl, 50mM Tris, 0.1% w/v LDAO, pH8 
Super optimal broth (SOC) 2% w/v trptone, 0.5% w/v yeast extract, 10mM Nacl, 2.5mM KCl, 10mM 
MgCl2, 20mM glucose. 
Solubilisation buffer 8M urea, 0.3M NaCl, 50mM Tris, pH8 
Solubilisation buffer – low salt 8M urea, 20mM NaCl, 50mM Tris, pH8 
50x5052 25 % w/v α-lactose, 2.5 % w/v glucose, 10 % w/v glycerol 
 
Table 2.5 -Buffers and media - All buffers used were prepared fresh, filtered (0.45µm) and de-gassed if required 
for chromatography. 
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2.1.3 Detergents 
Detergents were purchased from Sigma Aldrich (Gillingham, UK). The detergents used 
throughout the project are summarised in table 2.6 and figure 2.3. 
 
 Synonyms CAS 
number 
Molecular 
weight 
Detergent 
type 
Critical micelle 
concentration 
Micelle 
size 
LDAO N,N-
Dimethyldodecylamin
e N-oxide, LDAO, 
DDAO, 
Lauryldimethylamine 
N-oxide 
1643-20-5 229.40 Zwitterionic ~1-2mM 17 kDa 
(Hermann, 
1962) 
SDS Sodium dodecyl 
sulphate 
151-21-3 288.38 Anionic ~8.2mM 18kDa 
Triton 
X-100 
4-(1,1,3,3-
Tetramethylbutyl)phe
nyl-polyethylene 
glycol, t-
Octylphenoxypolyeth
oxyethanol 
9002-93-1 625 Non-ionic ~0.2-0.9mM 81kDa 
(Biaselle 
& Millar, 
1975) 
Tween
-20 
Polyethylene glycol 
sorbitan monolaurate, 
Polyoxyethylenesorbit
an monolaurate 
9005-64-5 1228 Non-ionic ~0.06mM ----- 
 
Table 2.6 – Detergents and their properties. A summary of the detergents used throughout the project. All 
detergents were purchased from Sigma Aldrich (Gillingham, UK).  
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Figure 2.3 – Detergents and their chemical structures. The chemical organisation of the detergents used 
throughout the project. 
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2.1.4 Expression and maintenance E .coli strains 
All E. coli strains were purchased from New England Biolabs or Merck Millipore as competent 
cells. NEB Turbo cells were used for molecular biology and for plasmid maintenance with 
BL21 and Rosetta cells used for protein overexpression. E. coli cells used throughout the 
project are summarised in table 2.7. Rosetta DE3 cells were utilized for expression of 
recombinant proteins that required rare codons not commonly found within the expression host 
E. coli.  The additional tRNAs are supplied on a compatible chloramphenicol resistant plasmid 
and are driven by their native promoters. 
 
 
Strain Supplier Usage Genotype 
E. coli Rosetta (DE3) EMD 
Millipore 
Expression F- ompT hsdSB(RB- mB-) gal dcm λ(DE3 [lacI 
lacUV5-T7 gene 1 ind1 sam7 nin5]) pLysSRARE 
(CamR) 
 
E. coli BL21 (DE3) NEB Expression F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI 
lacUV5-T7 gene 1 ind1 sam7 nin5]) 
 
E. coli T7  NEB Expression fhuA2 lacZ::T7 gene1 [lon] ompT gal sulA11 
R(mcr-73::miniTn10--TetS)2 [dcm] R(zgb-
210::Tn10--TetS) endA1 Δ(mcrC-mrr)114::IS10 
 
E. coli Turbo NEB Maintenance F' proA+B+ lacIq ∆lacZM15 / fhuA2  ∆(lac-
proAB)  glnV galK16 galE15  R(zgb-
210::Tn10)TetS  endA1 thi-1 ∆(hsdS-mcrB)5   
 
Table 2.7 - E. coli strains used within the project with their genotypes – Both expression and maintenance 
strains were utilized within the project. Purchased cells were cultured for stock and subjected to 15% v/v glycerol 
(v/v) prior to flash freezing and storing at -80. 
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2.2 Methods 
All commercial kits, enzymes and specialist reagents were used as recommended by the 
manufacturer. 
 
2.2.1 Sequence analysis and BLAST searching 
The amino acid sequences for all proposed OMPs were subjected to Signal P analysis (Petersen 
et al., 2011) in order to deduce the presence of signal peptides. Default parameters for D-cutoff 
values were used and the organism group selected was always Gram-negative. Protein BLAST 
(Altschul et al., 1990) searches were used to search for sequence similarity both within the 
Borrelia genus and throughout all other bacteria groups. All BLAST (Altschul et al., 1990) 
searching was performed using the NCBI (https://www.ncbi.nlm.nih.gov/) online tool using 
default parameters and BLOSUM62 (Henikoff & Henikoff, 1992) as the scoring matrix. 
 
2.2.2 Molecular biology 
2.2.2.1 PCR amplification of gene targets and addition of restriction sites 
A PCR master mix was prepared for each set of amplification reactions. This contained all the 
required reagents with the exception of template DNA and primers.  The volumes shown in 
table 2.8 were multiplied for each required reaction plus three additional, one for a negative 
control, the second a positive (a housekeeping gene) and one extra to account for pipetting 
error. The genomic DNA supplied by Dr Volker Fingerle (German National Reference Centre 
for Borrelia) was used at a constant of 20ng per reaction. All reagents were kept on ice prior 
to amplification in a Techne TC-312 thermocycler.  The programmed cycle used was: 1 cycle 
of 2 minutes at 95oC followed by 35 cycles of, 1 min at 94oC, 30 to 60 seconds at a suitable 
annealing temperature and 1 min at 72oC.  The final extension step was at 72oC for 5 minutes. 
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Reagent  Volume 
MgCl2 4 µl 
X5 PCR buffer 10 µl 
dNTPs 1 µl 
Forward primer 1 µl 
Reverse primer 1 µl 
DNA template 2 µl 
Taq Polymerase 0.25 µl 
Sterile, nuclease free H2O 30.75 µl 
TOTAL VOLUME 50 µl 
 
Table 2.8 A typical PCR reaction - A 50 µl PCR reaction volume was used for all stages of PCR, the total 
reaction volume was multiplied to cover all required reactions plus additional for controls and a spare. 
 
Following agarose gel analysis and mini-prep of initial PCR products (Qiagen PCR purification 
kit), suitable restriction sites were added by PCR.  2µl of PCR product from the first 
amplification was added to a master mix as previously described, alongside 1µl of each 
restriction primer.  The programmed cycle was designed in line with the primer melting 
temperatures and the number of cycles varied from 28 to 35 in order to maximise final yield. 
 
 
2.2.2.2 Agarose gels 
PCR products at various stages of the experimental procedure were analysed by agarose gel 
electrophoresis.  For 1% w/v agarose mini gels, 0.4g of agarose was dissolved in 40 ml of 0.5% 
v/v TBE or TAE (table 2.5) containing 4µl of x10,000 SYBR safe DNA stain (Invitrogen) and 
heated in a microwave until dissolved.  The solution was poured into the casting tray and the 
comb positioned. Once solidified the casting ends and comb were removed and following 
loading alongside a 1kb DNA ladder (NEB), gels were run at 90kV, 200mA for one hour. All 
gels were visualised using a Syngene INGenius ultraviolet trans-illuminator. When smaller 
fragments required separation, the DNA ladder was substituted for one with smaller increments 
which ranged from 800bp upto a 1kb ladder all purchased from NEB. 
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2.2.2.3 DNA quantification 
DNA concentrations were determined using a Jenway Genova Nano, Micro-volume 
spectrophotometer using a sample size of 1.5µl and a corresponding blank, the concentration 
was deduced using equation 1 and sample purity was assessed using equation 2. 
 
Concentration (µg/ml) = (A260 – A320) x 50 x dilution factor 
Equation 1. Calculating DNA concentrations – Barbas et al., 2007. 
 
Sample purity = A260/A280 
Equation 2. Calculating the DNA purity ratio – Barbas et al., 2007. 
 
 
Following PCR reactions DNA was quantified using band intensity examination following 
agarose gel analysis, by comparing the intensity of the product alongside the intensity of a 
DNA ladder with a known concentration. However, the spectrophotometer reading was the 
preferred method and was used for calculating ligation reactions. 
 
 
2.2.2.4 Restriction digest and ligation of targets and vector 
All restriction digests were carried out following manufacturer recommendations.  PCR 
products were subject to mini-prep prior to digestion and restriction digests were carried out 
sequentially in the recommended buffer for each enzyme.  Extended restriction digests of both 
the PCR product and the pET47 vector were performed at 37oC, overnight with gentle agitation 
(50rpm).  The enzymes were then inhibited by heat treatment following manufacturer 
instructions. Following restriction digestion of both vector and the target gene, samples were 
subjected to mini-prep and the DNA concentrations obtained. Ligations reactions were carried 
out using molar ratios of 1:3, 1:5 and 1:10, vector to insert with the amount of vector not 
exceeding 50ng per reaction. In some cases the amount of vector was taken down to 5ng. 
Ligation reactions were carried out at 19oC and incubated for 2-4 hours. Following deactivation 
of the ligase following manufacturer instructions the ligated mixture was split into two samples. 
The first sample was subsequently used in transformations and the second was subjected to a 
further digestion using the SalI restriction enzyme, whereby the corresponding restriction site 
is lost should the vector have been successfully digested by both enzymes. The final digest was 
incubated at 37oC overnight, deactivated and used to transform E. coli cells. 
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2.2.2.5 Competency and transformation 
Where commercial, competent-ready cells were not used, cells were prepared using the calcium 
chloride method (Mandel & Higa, 1970).  Either expression or maintenance strain E. coli cells 
were streaked on to sterile LB plates and following overnight incubation a single colony was 
transferred to 5 ml of sterile LB and incubated overnight at 37oC. 1 ml of the overnight culture 
was subsequently transferred to 50 ml fresh LB and incubated as above until an optical density 
of 0.3 OD600 was achieved.  The culture was chilled on ice and centrifuged at 3300 x g for ten 
minutes to pellet the cells.  The medium was discarded and the cell pellet was re-suspended in 
10 ml of sterile, cold 0.1M CaCl2.  The suspension of cells was kept on ice for 30 minutes and 
the cells pelleted by centrifugation as above.  The final cell pellet was re-suspended in 1 ml of 
sterile, ice cold CaCl2 containing 15% v/v glycerol, aliquoted and stored ready for use at -80
oC.  
 
 
Transformation reaction Description 
Transformation 1 
 
Competent cells + unaltered ligation reaction 
Transformation 2 
 
Competent cells + digested ligation reaction 
Competency control 
 
Competent cells + unaltered vector 
Negative control 1 
 
Competent cells  with no DNA 
Negative control 2 Competent cells with vector digested with a single restriction enzyme (no 
ligation) 
Negative control 3 Competent cells with vector digested with both restriction enzymes (no 
ligation) 
 
Table 2.9 - Summary of transformations. Transformations were carried out alongside a series of controls to 
identify any putatively positive colonies contained the gene of interest. Transformation reactions were carried out 
in triplicate whereby the amount of plasmid DNA used was varied between 5-50ng. 
 
Transformations were carried out using 50µl of competent cells and various amounts of 
plasmid DNA in the region of 5-50ng, alongside appropriate controls described in table 2.9. 
Reactions were incubated on ice for 15 minutes then subjected to heat shock for 45 seconds at 
42oC before being returned to ice for 5 minutes.  450µl of LB or super optimal broth (SOC) 
(table 2.5) was added to the cells and they were allowed to recover at 37oC with gentle shaking 
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for one hour.  The entire volume of cells was then spread onto LB agar with appropriate 
antibiotic and incubated overnight at 37oC. 
 
 
2.2.2.6 Restriction analysis and extraction for storage 
Following successful transformations, several colonies were selected and individually cultured 
overnight in 5 ml of sterile lysogeny broth (LB) at 37oC with shaking.  Plasmid DNA was then 
extracted using a QIAprep spin miniprep kit (Qiagen) as per manufacturer guidelines and a 
sample of the DNA was subjected to restriction digest analysis. Restriction analysis was 
performed using the same two restriction enzymes, BamHI and NotI. Restriction digests were 
performed sequentially as previously described (section 2.2.2.4) in line with manufacturer’s 
instructions and the resulting digest analysed by agarose gel electrophoresis (section 2.2.2.2). 
Those transformations that showed two bands one at a similar size to the pET47 vector and one 
of a size representable of the gene insert were deemed successful. 
 
DNA from positive transformants was sent to Source Bioscience (Rochdale) for sanger 
sequencing using standard T7 promoter and terminator primers. The returned sequences were 
used for nucleotide BLAST (Altschul et al., 1990) searching and the reading frame checked 
prior to transformation into expression strains.    
 
 
2.2.3 Protein overexpression 
2.2.3.1 Recombinant protein expression by IPTG 
Constructs were used to transform suitable expression strains of E. coli, as previously described 
and stocks of transformed cells were stored at -80oC. Freezer stocks were cultured on to LB-
agar plates with suitable antibiotic as and when required and incubated overnight; a single 
colony from the plate was transferred into 10 ml of sterile LB containing appropriate antibiotics 
and incubated at 37oC overnight with shaking. 1 ml of this overnight culture was then 
transferred to either 50 ml or 500 ml of LB, again with appropriate antibiotics.  The OD600 was 
monitored until the culture reached 0.6 where a small sample was removed for SDS-PAGE 
analysis, before addition of IPTG to a final concentration of 1mM.  Cultures were incubated at 
37oC for 4 hours with vigorous shaking or at 15oC overnight.  A small sample of the culture 
was also taken post IPTG induction for further analysis.    
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2.2.3.2 Recombinant protein expression by auto-induction 
Auto-induction media was prepared as indicated in table 2.5. The tryptone and yeast extract, 
core media was prepared and autoclaved prior to addition of NPS, 5052 and appropriate 
antibiotic, all of which had been filter sterilised through a 0.45µM unit.  As with the IPTG 
controlled protocol, the auto-induction media was inoculated with 1 ml of overnight culture 
and incubated for 20-24 hours at 37oC with vigorous shaking at 200rpm. 
 
 
2.2.3.3 SDS-PAGE and Western blot analysis 
Samples were taken throughout protein production and purification and are further described 
in table 2.10. Any samples containing guanidine-HCl were desalted prior to SDS-PAGE 
analysis due to the unfavourable precipitation reaction between the denaturant and SDS. 
Protein from these samples was obtained by ethanol precipitation and resuspended in either 
8M urea or a simple salt buffer. Estimates of protein concentration were made prior to SDS-
PAGE analysis and this was achieved either by the deduction of the absorbance at 280 nm or 
by Bradford protein assay (Bradford, 1976). Following the determination of the protein 
concentration, samples for SDS-PAGE analysis were prepared using x4 LDS loading buffer 
(NuPAGE), DTT and deionised water. Sample volumes for analysis varied from 10 to 30 µl 
dependent upon the gel cast and contained DTT as a reducing agent when required. 
 
Sample Abbreviation Description 
 
Pre-induction --- A sample of the expression culture was taken 
prior to the addition of IPTG and was harvested 
as described in section 2.4. 
 
Post-induction --- A sample was taken following the full expression 
period. 
 
Total cell lysate Lysate A sample was retained following cell lysis. 
 
Soluble Sol A sample of the soluble fraction was acquired by 
centrifugation following cell lysis. 
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Inclusion body washes --- Samples of both the supernatant and pellet were 
retained from each wash during the inclusion 
body preparation procedure. 
 
Insoluble Insol The insoluble matter was subjected to its 
corresponding denaturant and a sample of the 
insoluble cellular proteins was obtained from the 
supernatant following centrifugation. 
. 
Immobilised metal affinity 
chromatography (IMAC) flow 
through 
FT A sample of IMAC flow through following 
loading of the protein sample. 
 
IMAC wash peaks 
 
 
--- Samples taken from any peaks in absorbance at 
280 nm during a low imidazole wash. 
IMAC eluate Eluate A sample of the IMAC eluate fractions were 
retained for analysis and positive fractions were 
pooled. 
 
Ion exchange chromatography 
(IEC) flow through 
FT A sample of IEC flow through following loading 
of the protein sample. 
 
IEC eluate Eluate A sample of the IEC eluate fractions were 
retained for analysis and positive fractions were 
pooled. 
 
Post dialysis  Samples taken following the concentrating and 
dialysis of fractions to determine protein 
condition. 
 
Prior to structural experiments 
Small angle X-ray scattering 
(SAXS), circular dichroism (CD) 
and crystallography 
 SDS-PAGE carried out prior to all experiments to 
determine protein condition 
 
Post SAXS  Samples analysed following SAXS experiments 
to determine protein condition 
 
Table 2.10 - A summary of the samples retained for SDS-PAGE analysis.  Samples for SDS-PAGE analysis 
were taken throughout all experimental stages in order to confirm, purity and degradation. Where required samples 
were reduced using DTT and boiled for 10 minutes at 70oC prior to loading. 
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2.2.3.4 Casting of gels and running conditions 
Where 4-12% bis/tris, pre-cast gels were not utilized (Invitrogen, Paisley, UK), 10% gels were 
cast using the PerfectBlue Dual Gel Twin S gel tank system (Peqlab, Salisbury Green, UK).  A 
10 ml resolving gel was cast using of 6.75 ml ultrapure water, 3.75 ml 1.5M Tris pH8.8, 3.75 
ml bis/tris acrylamide (40% v/v), 75 µL of SDS (20% w/v), 150 µl APS (10% w/v) and 15 µl 
TEMED (Final TEMED concentration 0.9% v/v).  The stacking gel was prepared with 3.13 ml 
ultrapure water, 1.25 ml Tris pH 6.8, 0.62 ml of bis/tris acrylamide (40% v/v), 25 µl of SDS 
(20% w/v), 50µl APS (10% w/v) and 5µl TEMED (Final TEMED concentration 0.9% v/v).  
Novex sharp pre-stained or un-stained protein standards were used at a volume of 7.5µl as a 
marker and gels were stained for an hour in coomassie blue R-250 before being subjected to 
de-stain. SDS-PAGE was run in MES SDS running buffer (as described in table 2.5) at 180 V, 
100mA for 40-50 minutes, or until the loading dye had reached the bottom of the gel. When 
improved resolution was required SDS-PAGE was run more slowly at 100mA and the tank 
system was either ice packed or water cooled if required.    
 
 
2.2.3.5 Western blot analysis 
All immunoblotting was undertaken using an XCell II blot module (Invitrogen) on ice.  
Following SDS-PAGE, gels were prepared for transfer by removal of the wells and foot.  PVDF 
transfer membrane was activated by methanol and wet transfer was achieved at 30 V for 90 
minutes using transfer buffer as described in table 2.5. The blotting module was arranged as 
shown in figure 2.4 where two sponges and two sheets of filter paper are soaked in transfer 
buffer and stacked with the gel and the membrane in the middle with filter paper and a sponge 
at each side. This stack was then positioned so that the gel was underneath the PVDF and 
closest to the cathode.  
 
Following blocking in 2% w/v milk powder made up in TBS (table 2.5), appropriate primary 
and secondary antibodies were used according to manufacturer instructions as described in 
table 2.11. Most primary antibodies were made up at a ratio of 1:1000 in TBS-Tween and the 
membrane incubated for 1 hour at 50 rpm/4oC. Following the primary incubation the 
membranes were washed with 5 ml of TBS-Tween for 5 mins with rapid shaking (150 
rpm/room temperature) three consecutive times prior to the addition of the secondary antibody 
at a ratio of 1:5000 made up in TBS-Tween. Secondary incubations were carried out for at least 
1 hour at 50 rpm/4oC, prior to washing with TBS-Tween three times as previously described.   
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Membranes were then visualised using a LI-COR Odyssey infrared imaging device (LI-COR 
Biosciences) at 680 nm.   
 
 
 
 
 
 
 
 
 
Figure 2.4 – Western blot module packing. Typical arrangement within the western blotting module. The gel is 
positioned underneath the PVDF membrane and closest to the cathode. 
 
 
 
Antibody Supplier Description Ratio 
(In TBS-Tween) 
Monoclonal  
mouse anti-his 
Invitrogen 
(MA1-21315) 
Primary antibody used to detect his-
tagged proteins 
1:1000 
Monoclonal mouse anti-
human factor H 
Abcam 
(ab118820) 
Primary antibody to detect human 
factor H 
1:1000 
Polyclonal goat anti-mouse 
AlexaFluor 680 
Invitrogen 
(A-21057) 
Secondary antibody used for 
fluorescent detection at 680nm. 
1:5000 
 
Table 2.11 - Antibodies used for western blotting – All antibodies were used subject to manufacturer guidance. 
Ratios were optimised for each particular western blot and antibody solutions were never re-used. 
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2.2.4 Protein extraction and preparation of OMP-A like proteins 
2.2.4.1 Cell harvesting and lysis 
E. coli expression cells were pelleted by low speed centrifugation (10,000 x g) at 4oC, the 
supernatant was discarded and the cells re-suspended in lysis buffer (table 2.5) at one twentieth 
of the original culture volume and kept on ice.  The suspension was separated into 15 ml falcon 
tubes and the cells disrupted by pulsed sonication on ice (40% amplitude, 5 seconds on, 10 
seconds off for a total of five minutes).  The disrupted suspension was centrifuged at 20,000 x 
g for 1 hour or until a firm pellet was formed.  The supernatant or soluble fraction was retained 
for analysis and the insoluble pellet kept for inclusion body preparation. 
 
 
2.2.4.2 Inclusion body preparation and solubilisation 
In order to obtain a high level of pure recombinant protein, the insoluble expression material 
was subjected to a DNase incubation and a multi-cycle, wash step. The insoluble material was 
resuspended in 0.3M NaCl, 50mM Tris base, pH7 and briefly pulsed sonicated at an amplitude 
of 40% for a total length of 30 seconds. DNase1 was added at 1 µg/ml and the solution 
incubated at 4oC for 4-16 hours. Following incubation, samples were centrifuged until all 
insoluble material was pelleted and weighed prior to re-suspension in wash buffer 1 (Table 2.5) 
at 10 ml per gram.  The suspension was briefly sonicated as previously described. Following 
this, the suspension was subjected to low speed centrifugation (~8000 x g) until a firm pellet 
was obtained.  This process was repeated twice with inclusion wash buffer 1, twice with wash 
buffer 2, and twice with wash buffer 3.  The inclusion body was then solubilized in denaturing 
buffer overnight at room temperature with shaking. 
 
 
2.2.5 Protein purification and refolding of OMP-A like proteins 
2.2.5.1 Immobilised Metal Affinity Chromatography (IMAC) 
Solubilized inclusion bodies were clarified by centrifugation (10,000 x g) or by filtration prior 
to all chromatographic steps.  IMAC was carried out using a 5 ml HisTrap HP Ni-NTA column 
(Qiagen and GE Healthcare) and assisted by an Akta Prime FPLC system (GE Healthcare).  
The column was equilibrated with ten column volumes of appropriate FPLC binding buffer 
(table 2.4), prior to protein sample loading.  The flow rate of protein samples was varied for 
optimal binding but was kept below 1 ml/min.  Following protein binding, equilibration buffer 
was fed through the column until a steady absorbance baseline was reached (280nm), followed 
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by 10 column volumes of FPLC wash buffer to remove any non-specifically bound proteins.  
The target protein was eluted by the competitive addition of imidazole to the column, in the 
form of an increasing gradient to 0.3M imidazole over a total volume of 50 ml. Flowthrough 
during protein loading and the eluate following wash steps was collected in 2 ml fractions and 
retained for SDS-PAGE analysis. The final eluate was collected in either 0.5 ml or 1 ml 
fractions and retained at 4oC for further use. 
 
 
2.2.5.2 Ion Exchange Chromatography 
Inclusion bodies were solubilised in low salt denaturing buffer (less than 20mM NaCl) and the 
cleared sample was loaded on to a 5 ml anion exchanger column (HiTrap Q – GE Healthcare), 
which had previously been equilibrated with 5 column volumes of IEC binding buffer (Table 
2.4).  The sample was then eluted by increasing NaCl concentration over a variety of gradients 
ranging from 40 to 100 ml at a flow rate of 1 to 3 ml/min. 
 
 
2.2.5.3 Bench top refolding 
Urea was removed from denatured protein samples by rapid dilution, protein samples were 
added to re-naturing buffer (at a volume 50 times larger than the original denatured protein 
volume and at an overall concentration of below 0.1 mg/ml) drop-wise, over several minutes.  
The diluted protein solution was left stirring overnight, prior to concentrating in a 10,000 
MWCO Amicon centrifugal device or where large volumes were generated by pumping onto 
a Ni-NTA column using a FPLC. 
 
 
2.2.5.4 On-column refolding 
On column-refolding was carried out by both IMAC and IEC, once the protein sample was 
bound to the target column the denaturing agent, in most cases urea, was removed by a shallow 
gradient from denaturing buffer to native buffer with appropriate detergent.  Refolding 
gradients were run between 50 to 200 ml at slow flow rates, below 0.8 ml/min.  
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2.2.5.5 Removal of the poly-histidine-tag 
The poly-histidine, purification tag of BAPKO_0422 was removed prior to some crystallisation 
trials and SAXS experiments.  The protease, HRV-3C was employed for cleavage of the 
recognition site LEVLFQ↓GP.  Protein samples were subjected to digests ranging from 1:100 
to 1:2 HRV-3C to protein and kept either at room temperature overnight or at 4oC for 48 hours 
with gentle agitation.  IMAC was performed using a Ni-NTA 5 ml column to remove the 
protease, polyhistidine tag and un-digested protein. 
 
 
2.2.5.6 Concentration and dialysis of protein samples 
Following both purification and tag removal, protein samples were adjusted to the desired 
concentration by the use of an Amicon centrifugal concentrator device 10,000 (MWCO). 
Following any concentrating procedure extensive dialysis was carried out using a Slide-A-
Lyzer 10k MWCO dialysis cassette (Thermo Scientific). Refrigerated protein dialysis was 
carried out over a minimum of three days with two buffer changes on day one. Dialysis was 
performed in a 500 ml beaker filled with 500 ml of the intended end buffer. Following dialysis, 
protein samples were used immediately for structural experiments or stored at -20oC in 10% 
v/v glycerol. 
 
 
2.2.5.7 UV absorbance spectrum of refolded protein and quantification 
Following protein purification and refolding, the UV absorbance spectrum was obtained for 
each sample.  Samples were blanked against their corresponding buffers and scanned from 220 
to 340 nm using a Spectrostar Nano UV spectrophotometer (BMG Labtech) in order to assess 
any DNA contamination (figure 2.5). Samples were diluted where required in order to achieve 
a reading between 0.1-1. Reading were taken using 300µL of protein solution in a disposable 
plastic UV cuvette (Eppendorf).  Protein concentrations were determined using theoretical 
extinction co-efficients, calculated using the online tool ProtParam by ExPASy and the Beer-
Lambert Law (Equation 3) alongside the reading at 280 nm minus the reading at 340 nm.  
 
A=εcl 
Equation 3 - The Beer-Lambert Law. Where A, absorbance; ε, molar extinction coefficient; c, concentration; 
l, pathlength. 
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Figure 2.5. UV spectral scans of mixed samples of protein and dsDNA. Samples of purified dsDNA (Herring 
sperm dsDNA) and protein (BSA) at different ratios and their corresponding UV spectrum. Figure adapted from 
application notes from Biotek.com. 
 
 
2.2.5.8 Size Exclusion Chromatography (SEC) 
SEC or gel filtration chromatography was used as a final polishing step and to remove any 
aggregation from the sample prior to structural experiments whilst allowing an estimation to 
be made of the size of the protein. Prior to all gel filtration runs the void volume of the column 
was determined using blue dextran and a calibration curve prepared using the known protein 
standards shown in table 2.12 and the calibration curve shown in figure 2.6. Protein standards 
were purchased from Sigma and reconstituted into 0.3M NaCl, 50mM tris base at pH8 prior to 
SEC. 
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Protein Standard Molecular weight (kDa) Elution volume (ml) 
Vitamin B12 1.35 17.55 
Ribonuclease A 13.7 13.43 
Ovalbumin 45 11.3 
Bovine serum albumin 66.5 10.19 
 
Table 2.12 - SEC calibration proteins – A summary of the proteins standards and their molecular weight used 
to construct a calibration curve. All proteins were prepared in SEC buffer (0.3M NaCl, 50mM tris, pH8). 
 
 
 
Figure 2.6 - Size exclusion calibration curve of known protein standards - Protein standards at 1 mg/ml were 
prepared in SEC buffer (components shown in table 2.4) filtered and 200µl injected into the top of the pre-
equilibrated column.  The flow rate was set at 1 ml/min and the absorbance monitored at 280nm. 
 
 
Protein samples were subjected to SEC to determine an approximation of the molecular weight 
and to attain a monodisperse sample for further experiments.  SEC was carried out using a 
Superdex 75 10/300 GL column (GE Healthcare) which was equilibrated with appropriate 
native buffers in most cases for OMPs this was 0.3M NaCl, 50mM tris base, 0.1% v/v LDAO 
at pH8.  Protein samples were concentrated to a volume of approximately 100µl with the 
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concentration not exceeding 10 mg/ml and injected onto the top of the column with a 1 ml 
disposable syringe. 
 
 
2.2.6 Characterisation of OMP-A like proteins 
2.2.6.1 Gel shift assays for Borrelia OMPs 
Gel shift assays were conducted according to published methods (Laemmli, 1970, Arora et al., 
2000, Tamm et al., 2004, Verhoeven et al., 2013). Samples of Borrelia OMPs were refolded 
into 0.3M NaCl, 50mM tris base, 0.1% v/v LDAO, pH8 and the assay undertaken using both 
native and SDS-PAGE. Two samples for each Borrelia OMP were prepared with one being 
subjected to a 10 minute incubation at 80oC and the second remaining at room temperature. 
Further gel shift assays were performed using varying concentrations of urea to assess whether 
protein migration during SDS-PAGE was affected by unfolding. Borrelia OMP proteins were 
prepared in 0.3M NaCl, 50mM tris base, 0.1% v/v LDAO with varying levels of urea from 8M 
to 1M and subjected to SDS-PAGE according to published methods. 
 
2.2.6.2 Phase partitioning of Borrelia OMPs 
Phase partitioning experiments were conducted according to previous published methods 
(Bordier, 1981). Proteins, haemoglobin, lysozyme and a voltage-dependent anion channel 
(VDAC) from Arabidopsis thaliana were selected as control proteins and were purchased from 
Sigma-Aldrich with the exception of the VDAC which was kindly supplied by Dr George 
Psakis and had been expressed, purified and refolded according to published methods (Mertins 
et al., 2012). 
 
The cloud point of a detergent in solution is the temperature at which it separates into two 
distinct phases and is normally observed when the detergent is close to or above it’s critical 
micelle concentration (CMC). As the micelles begin to aggregate two phases appear, one which 
normally appears cloudy caused by the micelle aggregation the second phase becomes depleted 
of detergent. This feature of detergents can be exploited in order to separate proteins which 
interact with detergents from those which do not. In order to do this a detergent with a low 
cloud point temperature is required with Triton X-114 most often being selected as it’s cloud 
point is approximately 23oC. However, this can be affected by the addition of salts or polymers. 
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For phase partitioning experiments all proteins solutions were prepared at 1 mg/ml in 10mM 
Tris-HCl pH7.4, 150mM NaCl, 1% v/v Triton X-114 0oC. A sucrose cushion consisting of 6% 
w/v sucrose, 10mM tris/HCl, pH 7.4, 150mM NaCl with 0.06% v/v Triton X-114 was prepared 
in an Eppendorf at a total volume of 200µl. On top of the sucrose cushion 50µl of ice cold 
protein solution was overlaid and incubated at 30oC for three minutes prior to centrifugation at 
300 x g for three minutes. The aqueous upper layer was removed (approximately 70µl) and 
supplemented with additional Triton X-114 to a concentration of 0.5% v/v. Following gentle 
agitation and a further three minute incubation at 0oC the aqueous phase was returned to the 
same sucrose cushion and incubated for 3 minutes at 30oC prior to centrifugation at 300 x g for 
three minutes in order to pellet the detergent phase further. Again the upper aqueous phase was 
removed and transferred to a fresh Eppendorf and was further supplemented with Triton X-114 
to a concentration of 2% v/v and incubated at 0oC for 3 minutes. Following the incubation the 
aqueous phase was incubated at 30oC for 3 minutes and subjected to a final round of 
centrifugation at 300 x g for 3 minutes. The aqueous phase following centrifugation was 
retained for analysis and the pellet discarded. The detergent phase from below the sucrose 
cushion was removed by aspirating 10µl from the very bottom of the Eppendorf and retained 
for SDS-PAGE analysis. 
 
This procedure was carried out for all three control proteins alongside the four proposed 
Borrelia OMPs. SDS-PAGE analysis of the resulting phases was performed as previously 
described in section 2.2.3.3. 
 
 
2.2.6.3 Affinity ligand binding assays for Borrelia OMPs 
Purified and re-folded OMPs (20-50µg) were subjected to non-reducing SDS-PAGE alongside 
human factor H (20µg) and bovine serum albumin (20µg) as positive and negative controls 
respectively.  The gel was immunoblotted, the membrane trimmed and then blocked in 5% w/v 
milk powder made up in TBS.  Following three, 5 minute washes with TBS-Tween (0.05% 
v/v) the membrane was incubated with human factor H, at concentrations between 5 to 88  
µg/ml made up in TBS and left at 4oC, overnight with gentle agitation.  The membrane was 
again washed as above with TBS-Tween, before incubation with the primary antibody for one 
hour (1:1000 mouse monoclonal anti-human factor H – Abcam).  Following further washing 
the membrane was subjected to the secondary antibody (1:5000 of goat anti-mouse polyclonal 
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alexafluor 680 – Abcam) incubated for one hour , washed and visualised on a LI-COR Odyssey 
infrared imaging device at 680nm. 
 
 
2.2.6.4 Immobilised heparin binding assays for Borrelia BAPKO_0422 
Purified and re-folded recombinant BAPKO_0422 was pumped onto a pre-equilibrated (x5 
column volumes of 0.1M NaCl, 50mM tris, 0.1% v/v LDAO at pH8) GE Healthcare HiTrap 
HP-5 ml Heparin column using an Akta Prime chromatography system. A total volume of 3 ml 
of BAPKO_0422 in solution (BAPKO_0422 at 0.5 mg/ml in 0.1M NaCl, 50mM tris base, 0.1% 
v/v LDAO, pH8) was loaded onto the column at a flow rate of 1 ml/min. The flow through was 
collected and retained for SDS-PAGE analysis. The column was further washed using 10 
column volumes of the equilibration buffer with all resulting flowthrough collected and 
retained. Following extensive washing the resulting protein was eluted by means of a 50 ml 
gradient from equilibration increasing upto 1M NaCl, 50mM tris base, 0.1% v/v LDAO at pH8, 
1 ml fractions were collected and used for SDS-PAGE analysis.  
 
 
2.2.7 Protein overexpression and preparation of superoxide dismutase A 
2.2.7.1 Bacterial Strains, Plasmids, Growth Conditions and Protein Expression 
In order to perform SOD activity assays, the expression and refolding methods which have 
previously been described in sections 2.2.2 and 2.2.3 were altered and are summarised below. 
The bb0153 gene was codon optimised for expression in E. coli, synthetically produced and 
sub-cloned into pET-47b(+)  (EMD Millipore).  The resulting construct was transformed into 
T7 Express Competent E. coli (New England BioLabs).  Transformed cells were grown in LB 
media at 37oC in an orbital incubator and expression induced for 4 hours by addition of 
isopropyl-β-D-thiogalactopyranoside (IPTG) to a working concentration of 1mM. Induced 
cells were harvested by centrifugation and lysed on ice by pulsed sonication in 0.3M NaCl, 
50mM Tris base, pH8. The soluble fraction was removed by centrifugation (20,000 x g for 
30mins at 4oC) and the pellet solubilised in 8M urea, 0.3M NaCl, 50mM Tris base, pH8 before 
clarification by centrifugation. 
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2.2.7.2 Production of apo-protein 
Existing metal ions were removed by utilising the properties of nitrilotriacetic acid (NTA) by 
the means of a stripped 5 ml Ni-NTA column (Qiagen).  The column was stripped of Ni2+ as 
advised within the user manual and the recombinant protein sample was passed twice through 
the column at a flow rate of 0.5 ml/min using an AKTA Prime FPLC system. 
 
 
2.2.7.3 Addition of metal co-factors   
Following the removal of bound metal ions by NTA the pH of the denatured protein solution 
was decreased to pH4 by slow addition of dilute hydrochloric acid.  MnCl2 and FeCl2 were 
added to samples of recombinant SodA to a final concentration of 1mM.  A third sample of the 
apo-protein was retained with no additions made.  Recombinant protein samples were 
incubated at 4oC overnight before the pH was increased back to pH8 by slow addition of dilute 
sodium hydroxide. 
 
 
2.2.7.4 On-column refolding and purification 
Samples were subjected to centrifugation at 16,000 x g for 30 minutes prior to purification 
using a Hi Trap Q HP column (Amersham Bioscience).  The column was equilibrated with 10 
column volumes of binding buffer (8M urea, 50mM Tris Base, 0.3M NaCl, pH8) and each 
recombinant protein sample loaded at 0.5 ml/min.  Following loading the protein was refolded 
into 1M urea, 50mM Tris base, 0.3M NaCl, 0.05% v/v LDAO, pH8, by a linear gradient over 
60 ml at a flow rate of 0.5 ml/min.  Refolded SodA was then subjected to 10 column volumes 
of wash buffer, 1M urea, 50mM tris base, 0.3M NaCl, 50mM imidazole, pH8 before being 
eluted by linear gradient of 50mM tris base, 0.3M NaCl, 0.3M imidazole, 0.05% v/v LDAO at 
pH8.  This process was repeated for each SodA sample, fractions containing the refolded 
protein were respectively pooled and subjected to SDS-PAGE analysis.  Mn-SodA, Fe-SodA 
and apo-SodA were concentrated and buffers exchanged (0.3M NaCl, 50mM Tris base, 0.05% 
v/v LDAO, pH8) using a 10NMWL Amicon Ultra-15 centrifugal filter unit (Merck Millipore), 
centrifuged at 16,000 x g for 20minutes at room temperature and their concentration 
ascertained by spectroscopy and Bradford analysis (Bradford, 1976). 
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2.2.7.5 Assaying SOD activity 
In solution superoxide dismutase activity was accessed using a SOD determination kit from 
Sigma. The assay was performed according to the manufacturer instructions with additional 
negative controls included to assess any possible interference from the utilized buffers.  
Although there are several methods in order to determine SOD activity both in solution or from 
a protein sample within a gel following electrophoresis separation the in solution Sigma-
Aldrich SOD determination kit was selected as it would allow a range of additional controls to 
be added. The assay kit measures SOD activity using WST-1 (2-(4-Iodophenyl)- 3-(4-
nitrophenyl)-5-(2,4-disulfophenyl)-2H tetrazolium monosodium salt) a highly water soluble 
tetrazolium salt that produces a water soluble formazan dye following reduction with a 
superoxide anion. The rate of this reduction by the superoxide anion can be described as 
linearly related to xanthine oxidase activity as shown in figure 2.7 which is inhibited by SOD 
allowing inhibition rates to be monitored by spectrophotometry via this colorimetric assay. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7. Reaction scheme for SOD activity determination. Indirect determination of SOD activity (SOD 
determination kit – Sigma 19160). The SOD assay kit assays SOD activity using a water soluble tetrazolium 
monosodium salt – WST-1. WST-1 produces a water soluble formazan dye upon reduction with superoxide 
anions. As the rate of reduction with O2 is linearly related to xanthine oxidase activity which is inhibited by SOD. 
Measuring the decrease in colour development at 440 nm allows the inhibition activity to be quantified. 
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xanthine 
uric acid 
O2 + H2O2 
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The kit was used to compare activity rates of recombinant Mn-SOD, Fe-SOD and apo-SOD 
and run in 96 well plates with a total well volume of 240 µl in quadruplets. Changes in 
absorption were measured at 440 nm using a BMG Labtech SPECTROstar Nano microplate-
reader. The assay was prepared according to manufacturer instructions (Sigma Aldrich – 19160 
SOD determination kit) and as presented in table 2.13. The enzyme working solution was added 
to each well last and using a multichannel pipette as this initiated the reaction. Following set 
up the microplate was mixed by shaking (80rpm) in a SPECTROstar microplate reader (BMG 
Labtech) and incubated at 37oC. The absorbance was measured at 450 nm every minute for a 
total of 20 minutes. 
 
Reaction SodA stock 
protein 
(µl) 
ddH2O 
(µl) 
WST 
working 
solution (µl) 
Enzyme 
working 
solution (µl) 
Dilution 
buffer 
(µl) 
SodA buffer 
(µl) 
Blank 1 - 20 200 20 - - 
Blank 2 - 13.02 200 20 - 6.98 
Blank 3 - 13.33 200 20 - 6.67 
Blank 4 - 12.77 200 20 - 7.23 
Blank 5 - 20 200 - 20 - 
Blank 6 6.98 13.02 200 - 20 - 
Blank 7 6.67 13.33 200 - 20 - 
Blank 8 7.23 12.77 200 - 20 - 
Mn-SodA 6.98 13.02 200 20 - - 
Fe-SodA 6.67 13.33 200 20 - - 
Apo-SodA 7.23 12.77 200 20 - - 
Table 2.13. Reaction volumes for assaying SOD activity. Reactions were set up according to manufacturer 
instructions (Sigma Aldrich – 19160 SOD determination kit). Blanks 2,3 and 4 were additional controls to ensure 
SodA buffers (0.3M NaCl, 50mM tris, pH8) did not interfere with the reaction. SodA stock protein volumes were 
calculated in order to achieve a well concentration of 100mg/ml for each reaction. The enzyme working solution 
was added last and using a multi-channel pipette as this initiated the reaction. 
 
 
 
 
 
 
 
 
 
 
Page | 135  
 
2.2.8 Structural Experiments of OMP-A like proteins and SodA 
2.2.8.1 Circular Dichroism - Sample preparation, data collection and analysis 
Circular dichroism experiments were carried out on a Jasco J-810 spectropolarimeter with the 
kind assistance of Dr Andrew Leech (University of York). Air and buffer blank background 
data was acquired and experimental measurements taken over a wavelength range of 185-260 
nm. Experimental data was obtained over five individual scans and averaged. A full summary 
of the experimental parameters are shown in table 2.14. Protein samples were prepared in 0.3M 
NaCl, 50mM tris base, 0.1% v/v LDAO at pH8 for OMPs and the same buffer but without the 
detergent LDAO for SodA. Protein samples were taken from high concentration protein stocks 
(~10mg/ml) and diluted using the same buffer to between 0.5 and 0.05mg/ml. 
 
Data acquired was analysed using DichroWeb (Whitmore and Wallace, 2004, Whitmore and 
Wallace, 2008). Algorithms used for deconvolution included CDSSTR (Compton & Johnson, 
1986, Manavalan & Johnson, 1987), CONTIN (Provencher & Glockner, 1981, Van Stokkum 
et al., 1990) and SELCON3 (Sreerema & Woody, 1993, Sreerema et al., 2000) alongside SP175 
(Lees et al., 2006) and SMP180 (Abdul-Gader et al., 2011) reference sets, further discussed in 
table 1. 
 
Experimental temperature 20oC 
Path length 0.2cm 
Protein concentration 0.1 mg/ml 
File format JASCO 1.30 
Wavelength range and step 185-260 nm in 0.5 nm increments 
Analysis algorithm CDSSTR (Compton & Johnson, 1986, Manavalan & Johnson, 1987) 
Reference sets SP175(short) (Lees et al., 2006) and SMP180 (Abdul-Gader et al., 2011) 
Initial wavelength 260 nm 
Final wavelength 185 nm 
Input units Mdeg/theta machine units 
Output units Mean residue ellipticity or delta epsilon  
Mean residue weight (Da)* 111.8 
 
Table 2.14. Parameters used during CD data collection and Dichroweb analysis 
*Mean residue weight in Daltons is the average molecular weight of all the amino acids within the protein 
sequence. The value is calculated by dividing the total molecular mass of the polypeptide by the number of 
residues. 
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2.2.8.2 Small Angle X-ray Scattering 
2.2.8.2.1 Sample preparation and data collection 
Purified protein samples for both in-house and synchrotron data collection were prepared in 
SAXS buffer (0.3M NaCl, 50mM tris base, 0.1% v/v LDAO - table 2.5) and subjected to 
extensive dialysis as previously described (section 2.2.5.6). Where LDAO was used extra care 
was taken in the preparation of blank samples. Blanks were obtained directly from the final 
dialysis buffer and stored at -20oC.   Control samples of Lysozyme were prepared at various 
concentrations ranging from 0.5-8mg/ml, both with and without LDAO and data collected for 
analysis as a control protein. In house scattering was collected on a BRUKER NANOSTAR 
all experiments were designed to obtain at least 300,000 counts per frame with the system under 
vacuum conditions. Sample volumes ranged from 60-100µl and held within a quartz glass 
capillary (diameter 1.5mm). Data for both the blank and the sample was collected in sets of 10 
frames with an exposure time of 2400 seconds per frame. 
 
 
2.2.8.2.2 Data analysis 
Following data collection all frames, both blank and sample were integrated by the chi axis 
using Bruker inbuilt software and an output file (.dat) generated. Integrated frames collected 
for both the blank and each sample were independently averaged using PRIMUS (Konarev et 
al., 2003) and then the averaged blank scattering deducted from the averaged sample scattering. 
This subtracted (.dat) file was then used as the starting point when working with the ATSAS 
(Svergun, 1992, Franke & Svergun, 2009, Volkov & Svergun, 2003, Kozin & Svergun, 2001, 
Svergun, 1999) suite of software. The devised pipeline for data analysis is shown in table 2.15. 
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Stage Program Summary Reference 
1 Primus Integrated scattering data is averaged and subtracted 
then visually checked for aggregation and 
consistency. Kratky and Guinier analyses are 
undertaken and an initial estimation of the radius of 
gyration may be made. 
Konarev et al., 2003 
2 GNOM An indirect transform of the data is carried out and 
the P(r) and Rg can be calculated. The resulting 
transformed data is saved as a .out file which can be 
used for ab initio modelling. 
Svergun, 1992 
3 DAMMIF Actions ab initio bead modelling. The program is run 
using the same data set twenty times to give multiple 
possible models. 
Franke & Svergun, 
2009 
4 DAMSEL All generated DAMMIF models are input into 
DAMSEL which superimposes all models and 
removes the least probable solutions. 
Volkov & Svergun, 
2003 
5 DAMSUP All models excluding DAMSELS outliers are taken 
by DAMSUP, the most probable solution is selected 
and all models are aligned to this. 
Volkov & Svergun, 
2003 
6 DAMAVER The aligned models are averaged by DAMAVER 
and a probability map is calculated. 
Volkov & Svergun, 
2003 
7 DAMFILT The final model is generated by DAMFILT which 
uses a given cut off value and removes regions of 
low occupancy. 
Volkov & Svergun, 
2003 
Table 2.15. SAXS data analysis pipeline. The ATSAS suite of programs was used to generate three dimensional 
models for each protein sample. The analysis process was tested with two control proteins further discussed in 
section 3.10.4 of the results chapter. 
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2.2.9 Crystallography of SOD and OMP targets  
2.2.9.1 Vapour diffusion crystallography 
Vapour diffusion crystallography (Benvenuti & Mangani, 2007, Drenth, 2007) was carried out 
using 24 well trays and set up in hanging drop format. Crystallisation screens utilized 
throughout the project are listed in table 2.16. All screens were formulated in house with the 
exception of the MembPASS screen which was purchased from Jena Bioscience. Well 
conditions were created using stock chemicals which were centrifuged and filtered using a 
0.45µm filter unit before being appropriately stored.  Proteins were concentrated between 10 
to 15 mg/ml as previously discussed and the drop was composed of 1 µl of concentrated protein 
and 1 µl of the mother liquor/well solution. Trays were incubated at 20oC and checked every 
day for the first week and once per week there after using a Leica stereozoom benchtop 
microscope. 
 
Crystallisation Screen Manufacturer 
Clear strategy screen 1 – CSS1 Molecular Dimensions 
Clear strategy screen 2 – CSS2 Molecular Dimensions 
Wizard Screen 1 Rigaku 
Wizard Screen 2 Rigaku 
Wizard Screen 3 Rigaku 
Wizard Screen 4 Rigaku 
MembPASS screen Jena Bioscience 
Table 2.16. Crystallisation screens used within the project. All screens with the exception of the MembPASS 
screen were created in house following the manufacturer’s formulations. 
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2.2.9.2 In meso phase crystallography 
In meso phase or lipidic cubic phase crystallography (LCP) was used in attempt to crystallise 
the OmpA-like proteins (Caffrey, M. and Cherezov, 2009). The basis of the method is the 
utilisation of a stable lipid cubic phase in order to provide a more natural environment for 
membrane protein crystallisation. Monoolein or MO (1-oleoyl-rac-glycerol) is the lipid of 
choice for this method although others can be used or combined with MO. In order to 
reconstitute the protein samples into the lipid environment a gas tight mixing device was 
created by the joining of two gas tight syringes using a coupling unit, which was constructed 
by the silver soldering of two syringe nuts together with a custom size needle positioned inside 
(as shown in figure 2.8).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8. Production of the LCP mixing device. A. Two Hamilton gas tight 200μl syringes with plastic 
ferrules removed. B. Two R nuts silver soldered together with a custom made 26 gauge needle through the middle 
held in place with a double plastic ferrule at each end. C. Final lipid/protein mixing device. 
 
 
C 
A 
B 
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LCP crystallography was set up as shown in figure 2.9 using 15-50 mg MO which was 
transferred to a plastic vial and the lipid melted by incubation at 37oC for 10 minutes. The 
molten lipid was then transferred to a 100µl Hamilton gas tight syringe with an attached syringe 
coupler, the weight of both the empty and filled syringe was recorded and the total amount of 
MO transferred calculated. Using a 25 µl gas tight Hamilton syringe with a flat tipped 26 gauge 
needle the concentrated protein was transferred to a second 100 µl Hamilton gas tight syringe. 
The amount of protein transferred was calculated in order to achieve a 40% w/v of protein 
solution within the final mixture for example; 30 mg of lipid was used with 20 µL of 
concentrated protein. The contents of both syringes were pushed up through the barrel to ensure 
no air bubbles were trapped and then the syringe containing protein was connected to the MO 
syringe via the coupling unit. The contents were mixed back and forth through both syringes, 
for approximately 5 minutes or until a homogenous cubic phase was achieved. 
 
Following mixing the protein/lipid paste was transferred across to a single syringe and the 
coupling unit replaced with a single 26 gauge needle. The loaded syringe was attached to a 
Hamilton dispensing unit and 0.5 µl of mixture was ejected into each well of a 96 well LCP 
screening plate (Swissci). Each well was overlaid with 0.5 µl of precipitant solution and the 
plate sealed with UPV film for storage at 20oC. Plates were checked every day for the first 
week and once per week there after using a Leica stereozoom benchtop microscope. 
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Figure 2.9. Protein preparation and set up of lipidic cubic phase crystallisation. A summary of the basic steps 
to reconstitute a protein sample into a lipid environment. A. The empty gas tight syringe was weighed and 30 mg 
of molten MO was added down the barrel. B. The plunger was replaced and the lipid pushed into the barrel. The 
loaded syringe and coupling unit was weighed to deduce the amount of MO used. C. To a second gas tight syringe 
the required amount of protein solution was added to the top of the syringe, in this case 20 µl at 10 mg/ml. D. The 
protein was moved up in the syringe in order to remove air bubbles. E. Both syringes were attached using the 
coupling unit and the contents passed between the two until a homogenous phase was achieved. F. Plate set up, 
flat 0.1mm deep 96 well plates were utilised. Each drop contained 0.5 µl of protein/lipid mix overlaid with 0.5 µl 
of any given precipitate. The plate was then sealed using UPV cover film and stored at 20oC. Figure adapted from 
methodology produced by the Cherezov Lab, University of Southern California. 
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2.2.10 In silico characterisation and homology modelling of OMPs 
Homology models for Borrelia OMPs were generated using Chimera (Pettersen et al., 2004) 
and Modeller (UCSF – Webb & Sali, 2014, Martin-Renom et al., 2000, Sali & Blundell, 1993, 
Fiser et al., 2000) alongside TMpred - ExPASy (Hofmann& Stoffel, 1993) in order to predict 
membrane spanning alignments. Although the modelling program PHYRE2 (Kelley, 2015) 
was the preferred method for homology modelling and was used for the Borrelia SodA project 
the program was unsuitable for OMP modelling. As the Borrelia OMPs held no significant 
level of sequence similarity to any known proteins templates were identified using a novel 
HMM approach (section 3.1). These templates shared very remote sequence similarity and a 
manual alignment of the templates was required which could not be achieved using PHYRE2 
(Kelley, 2015). For this reason Chimera (Pettersen et al., 2004) and Modeller (UCSF – Webb 
& Sali, 2014, Martin-Renom et al., 2000, Sali & Blundell, 1993, Fiser et al., 2000) offered a 
powerful alternative. 
 
 A wide selection of 8-stranded beta barrel proteins with known structures (table 2.17) were 
aligned and used for predictions. The sequence alignment used for generation of homology 
models for Borrelia OMPs is shown in figure 2.10. 
 
 
 
 
Protein Organism PDB code Reference 
PagP E. coli 3GP6 Cuesta-Seijo et al., 2010 
PagP E. coli 1THQ Ahn et al., 2004 
PagL P. aeruginosa 2ERV Rutten et al., 2006 
NspA N. meningitides 1P4T Vandeputte-Rutten et al., 2003 
OmpA transmembrane domain E. coli 1BXW Pautsch and Schulz, 1998 
OmpA transmembrane domain E. coli 1QJP Pautsch and Schulz, 2000 
OmpW E. coli 2F1T Hong et al., 2006 
Oprg P. aeruginosa 2X27 Touw et al., 2010 
Major outer membrane protein T. thermophilus 3DZM Brosig et al., 2009 
OmpX E. coli 1QJ8 Vogt and Schulz, 1999 
Ail Y. pestis 3QRA Yamashita et al., 2011 
 
Table 2.17. Bacterial OMPs used as templates for homology modelling. Protein sequences were manually 
aligned using Chimera (Pettersen et al., 2004) and Modeller (UCSF – Webb & Sali, 2014, Martin-Renom et al., 
2000, Sali & Blundell, 1993, Fiser et al., 2000) and TMpred to provide a template for homology modelling. 
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Figure 2.10. Sequence alignment for construction of homology models for Borrelia OMPs. The templates 
and alignment used for homology modelling of Borrelia OMPs using Chimera (Pettersen et al., 2004) and 
Modeller (UCSF – Webb & Sali, 2014, Martin-Renom et al., 2000, Sali & Blundell, 1993, Fiser et al., 2000). Pink 
residues are positive, blue are negative, red are non-polar and green any other. * Indicates a potential lipocalin 
domain TDY—I within BB_0406 and BG0408. 
 
 
 
 
 
 
 
 
 
* 
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Chapter 3: Results - Borrelia OMPA-like proteins 
3.1 Identification of possible OmpA-like proteins in B. burgdorferi s.l 
Previous work undertaken by Dr Adam Dyer identified a number of possible OmpA-like 
proteins within B. burgdorferi s.l.(Thesis, 2013, University of Huddersfield). As traditional 
protein BLAST (Altschul et al., 1990) searches of known Borrelia genomes using E. coli 
OmpA as a search term proved insensitive to detect homologues based on sequence similarity 
a Hidden Markov Model system was employed. The approach involved the selection of known 
OmpA-like proteins across a broad range of bacterial species and their sequences aligned. 
Generation of the multiple sequence alignments allowed the identification of the most 
conserved residues and also the regions that contain a higher rate of mutation, insertion or 
deletion. By recognising shared key residues within a protein family and building a HMM 
profile of multiple sequence alignments, the sensitivity of discovering more remote 
homologues was increased. From the large number of possible candidates identified any protein 
with a putative known function was removed alongside anything of a molecular weight much 
larger or smaller than that of known OmpA-like proteins. Following this exclusion a small 
number of proteins across B. burgdorferi, B. afzelii and B. garinii were identified as possible 
OmpA-like proteins and are summarised in table 1.10 within section 1.7.1. 
 
 
3.2 Amplification and cloning of B. burgdorferi s.l OMPA-like genes. 
3.2.1 Designing primers and signal sequence analysis 
Four primers were designed for each gene target, two for initial amplification and a second pair 
for the addition of BamHI and NotI restriction sites. It was decided that the signal sequence of 
each protein was to be removed in order to prevent translocation of recombinant proteins into 
the E. coli membrane and to force the formation of inclusion bodies. In order to achieve this, 
the three target sequences were sent to Signal P, their signal sequences were deduced with data 
shown in figure 3.1 and amplification primers were designed to bind after this sequence. 
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Figure 3.1. Results of SignalP analysis for Omp-A like proteins. All images were generated by SignalP 4.1 
(Petersen et al., 2011). The beginning of each proteins amino acid runs across the bottom with the red lines 
indicating a c-score which is used to assess the likelihood of a cleavage site at each amino acid position. The green 
or s-score, represents the probability of each residue being part of the single sequence and the blue line is the y-
score or a combination of the other two values in order to predict the site more accurately than using the c score 
alone. A) BAPKO_0422. – Signal sequence does not meet the threshold value set by Signal P for Gram-negative 
proteins. B) BB_0406 – Signal sequence present and exceeds the threshold value. C) BB_0562 – No signal 
sequence identified. D) BG0408 – Signal sequence present and exceeds the threshold value. 
 
 
 
 
 
 
 
 
A B 
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3.2.2 Amplification of the target genes 
Following identification of possible OmpA-like genes in B. afzelii, B. burgdorferi and B. 
garinii, targets were amplified using the primers described in tables 2.1 and 2.2. As DNA 
kindly supplied by Dr Volker Fingerle (German National Reference Centre for Borrelia) was 
of high quality for each Borrelia strain, nested PCR was not required and a standard method of 
PCR was employed.  
 
 
Initial denaturation The reaction mix was heated to 95oC for 5 minutes. 
 
Amplification cycles 
Denaturation The reaction mix was heated to 95oC for 30 seconds. 
Annealing The reaction temperature was lowered for 30 seconds 
BB_0562 – 52oC, BB_0406 – 52oC and BG0408 – 51oC. 
Extension The reaction mix was heated to 72oC for 1 minute. 
Final extension The reaction mix was heated to 72oC for 5 minutes 
 
Table 3.1. Experimentally determined PCR parameters. The PCR reactions contain three distinct stages 
including an initial denaturation, the amplification cycles and a final extension stage. The temperatures for each 
stage were experimentally determined to optimise the final product yield. 
 
 
Initial amplification was carried out at 4 and 5 oC below than the lowest melting temperature 
for each primer pair. This was deemed to be 49 oC and 50 oC for BB_0562 and 48 oC and 49oC 
for both BB_0406 and BG_0408. Unfortunately this failed to yield product and the annealing 
temperature was increased for all reactions to 51 and 52 oC (table 3.1). Product was obtained 
for all three targets following the increase of the annealing temperature with results shown in 
figure 3.3. It became apparent that the reactions were yielding two products of a similar size 
illustrated by the two bands shown on the agarose gel in figure 3.3, these products were both 
close to the expected size of the target genes at around 600-700bp. The 52 oC PCR reaction for 
BB_0562 and BB_0406 alongside the 51 oC reaction for BG_0408 were purified and subjected 
to restriction PCR. Restriction sites were added to all three genes successfully with a further 
round of PCR using 35 cycles and the appropriate primer combination. 
 
The restriction primers were designed to produce a product as similar as possible to the native 
gene minus the deduced signal sequence. In order to aid restriction digests non-native base 
pairs were added during restriction PCR. These six additional bases (AATTAT) were added to 
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the 5’ end of the primer and were followed by the required restriction site and then a 
complementary sequence for hybridisation to the amplified gene product as summarised in 
figure 3.2 In some cases a single base (G) was added following the restriction site in order to 
maintain the reading frame however the codon was always checked to ensure a stop codon was 
not misplaced.  The reverse primer also contained the complement to the native gene stop 
codon. 
 
 
 
Figure 3.2. Restriction PCR - An example of a forward overhang primer. The lower strand is the initial PCR 
product from the first round of amplification, the upper strand is the restriction PCR primer. The base pairs within 
the grey box represent the portion of the primer which is complementary to the PRC product and hybridises during 
the annealing stage. The remaining 5’ end of the primer outside if the grey box is non-complementary and 
overhangs the DNA template. This overhand consists of a single base (green) added in order to keep the forward 
reading frame, the restriction site for in this case BamHI (red) and finally six additional bases (blue) to assist 
subsequent restriction digests during the cloning process. 
 
 
Interestingly the restriction PCR provided a single product unlike the original amplification 
which gave two as previously discussed and shown in figure 3.4. It is likely that the initial 
amplification gave the same product although one was extended further past the gene possibly 
due non-specific binding of the primer during the initial amplification explaining the difference 
in length. This was later rectified during the PCR addition of the restriction sites. During this 
reaction only the product of the correct length could be used as a template for amplification, as 
the longer product would not have been a complimentary match to the designed primers.     
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Figure 3.3. Agarose electrophoresis of the initial amplification of OmpA-like proteins. PCR products 
generated from the primers listed in table 2.1 and 2.2 and ran on a 1% w/v agarose gel in 1X TAE buffer (table 
2.5). A) NEB 1kb ladder. B) BB_0562 at 51oC. C) BB_0562 at 52 oC. D) BB_0406 at 51 oC. E) BB_0406 at 52 
oC. F) BG_0406 at 51 oC. G) BG_0408 at 52oC. 
 
The annealing temperatures selected for restriction PCR covered only two temperatures for all 
three targets as product was attained upon the first attempt. Results from a gel electrophoresis 
for the restriction PCR are shown in figure 3.4 and show that strong amplification was achieved 
at 52oC for BB_0562 and BB_0406 and at 51oC for BG0408. 
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Figure 3.4. Agarose electrophoresis of the restriction PCR of OmpA-like proteins. PCR products generated 
from the primers discussed in tables 2.1 and 2.2 and ran on a 1% w/v agarose gel in 1X TAE buffer (table 2.5). 
A) NEB 1kb ladder. B) BB_0562 at 51oC. C) BB_0562 52oC. D) BB_0406 at 51oC. E) BB_0406 52oC. F) 
BG_0406 at 51 oC. G) BG_0408 at 51oC. 
  
 
 
3.2.3 Generation of gene constructs 
Following addition of the required restriction sites, the gene inserts and the pET47 vector were 
sequentially digested with appropriate restriction enzymes in order to liberate complimentary 
restriction sites for ligation (section 2.2.2). Following initial problems with inefficient digestion 
all digests were carried out overnight and all ligation reactions subjected to a final digest with 
the restriction enzyme SalI. During initial cloning experiments inefficient digestion of PCR 
products and the vector became problematic and led to the formation of false positive colonies 
following transformation. These false positives were caused by either uncut vector or vector 
cut with only one restriction enzyme which became re-circularised during ligation. These 
‘empty’ vectors did not contain the desired target genes yet were passing through the 
experimental procedure and obscuring the selection of true transformants. This issue was 
rectified by implementing a final restriction digest, where all ligation reactions were digested 
with SalI following the heat inactivation of T4 ligase. The SalI site was not present in any of 
A            B            C            D            E            F            G 
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2kb 
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0.5kb 
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the target gene inserts and the site is lost following the full digestion of pET47 with BamHI 
and NotI, making the site a desirable target for the destruction of any ‘empty’ vectors (section 
2.2.2). 
 
All ligation ratios (1:3, 1:5 and 1:10) appeared to provide positive clones although ligation 
reactions with a smaller amount of plasmid DNA (down to 5ng) were seen to be most successful 
at incorporating gene inserts into the pET47 vector most likely due to a higher efficiency of 
restriction due to the smaller amount of vector to digest (data not shown). Following the 
adaption of the protocol (section 2.2.2.4) to remove any re-circularised plasmid multiple clones 
were selected across all ligation ratios and were used to inoculate individual vials of 5 ml of 
LB supplemented with Kanamycin (50µg/ml) and incubated overnight at 37oC for 12 hours 
with vigorous shaking. Plasmids were extracted from each culture using a QIAprep Spin 
Miniprep kit (Qiagen, UK) and used for restriction analysis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. Agarose electrophoresis of the restriction analysis of OmpA-like constructs. Restriction analysis 
following an extended double digest with BamHI and NotI and ran on a 1% w/v agarose gel in 1X TAE buffer 
(table 2.5). A) NEB 1kb DNA ladder. B) Digested pET47-BB_0406. C) Digested pET47-BG_0408. D) Digested 
pET47- BB_0562. 
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Restriction analysis (section 2.2.2.6) was performed to identify the presence of a correct sized 
gene insert prior to sequencing. Constructs were digested with BamHI and NotI as previously 
described and the fragments analysed by gel electrophoresis. The gel analysis showed two 
bands for each construct following digestion, the first in the region of 5kb and the second at 
around ~600bp, gels are shown in figure 3.5. The analysis also showed two other bands for the 
BB_0406 construct. These additional bands are likely to be the result of star activity from 
BamHI during the extended digest in the NotI digest buffer as samples were not subjected to 
miniprep prior to the second digestion. 
 
 
3.2.4 Sequencing of the generated constructs 
Following confirmation that the constructs contained an insert at the expected size all vectors 
were sent to Source Bioscience (Rochdale, UK) for Sanger sequencing using T7 forward and 
reverse stock primers; sequences are shown in figure 3.6 with full sequencing data included in 
the appendix 1. Returned sequences were translated using EXPASY and the reading frame 
checked. Following translation the resulting peptide was run through Protein BLAST (Altschul 
et al., 1990) to ensure a match to the original gene. Sequence alignments for all three constructs 
can be seen in figure 3.7. It was noticed there were polymorphisms within the BB_0406 and 
BG0408 compared to the sequence from the NCBI database (https://www.ncbi.nlm.nih.gov/). 
Although these could have occurred during the cloning process it is most likely these 
polymorphisms are naturally found within the DNA provided for use as a template.  
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BB_0562 
Nucleotide sequence 
TATGGCACATCACCACCACCATCACTCCGCGGCTCTTGAAGTCCTCTTTCAGGGACCCGGGTACCAGGATCCGAA
AGATTCATATTTAAATAGAGGAATTGGCTTTGGAGCAAGCATTGGAAATCCAATTATTAACTTAATAATGTCATT
TCCTTTCATTGATTTTGAAATTGGCTATGGTGGTAGTAATGGAATAAATCTATCAGGCCCCAAACTTGAATCAAA
ATTTTATGATTTTAATTTATTAGCAATAGCAGCACTTGATTTCATTTTTACAATATCTTTGATAAAAAATTTAAA
TTTAGGAATTGGAATAGGAGGAAATATAAGCATATCGTCTCACACATCTAAATTAATAAATGTAGAATTAGGATT
TGGAATGAGAATTCCATTGGTTATTTTTTACGACATTACAGAAAATTTAGAAATAGGTATGAAAATAGCACCTTC
AATAGAATTCATCTCAAATACAAGGTCTCTTGCTCAACATAGAACCTATTCGGGCATAAAATCAAACTTTGCTGG
GGGAATATTTGCTAAGTACTATATCTTTTAACA 
Amino acid sequence 
MAHHHHHHSAALEVLFQGPGYQDPKDSYLNRGIGFGASIGNPIINLIMSFPFIDFEIGYGGSNGINLSGPKLESK
FYDFNLLAIAALDFIFTISLIKNLNLGIGIGGNISISSHTSKLINVELGFGMRIPLVIFYDITENLEIGMKIAPS
IEFISNTRSLAQHRTYSGIKSNFAGGIFAKYYIF 
 
BB_0406 
Nucleotide sequence 
TATGGCACATCACCACCACCATCACTCCGCGGCTCTTGAAGTCCTCTTTCAGGGACCCGGGTACCAGGATCCGTC
TGACAATTATATGGTCAGATGCAGCAAGGAAGAAGATTCAACCACCTGTATCGCAAAGCTTAAAGAAATAAAAGA
AAAGAAAGATTATGACTTATTTTCAATGGGCATTGGAATAGGAGATCCTATTGCAAATATTATGATTACAATTCC
TTATATAAATATTGATTTTGGATGTGGAGGTTTTATTGGCCTTAAGTCAAACAATTTTGAAAATTATCTAAATGG
TGGAATAGACGTTATTTTTAAAAAGCAAATTGGACAATATATGAAAATTGGCGGCGGCATTGGAATAGGTGCGGA
TTGGTCAAAAACATCCCTTATACCCCCTAATGAAGAAGAAGAAACTGATTATGAGAGAATAGGCGCTGTTATAAG
AATTCCTTTTATAATGGAATATAATTTTGCAAAAAATTTATCCATAGGATTCAAAATTTATCCTGCAGTAGGGCC
AACAATATTACTAACAAAACCCAGCATTTTATTTGAAGGAATTAAATTCAATTTTTTTGGATTTGGATTCATAAA
ATTTGCATTTAATTA 
Amino acid sequence 
MAHHHHHHSAALEVLFQGPGYQDPSDNYMVRCSKEEDSTTCIAKLKEIKEKKDYDLFSMGIGIGDPIANIMITIP
YINIDFGCGGFIGLKSNNFENYLNGGIDVIFKKQIGQYMKIGGGIGIGADWSKTSLIPPNEEEETDYERIGAVIR
IPFIMEYNFAKNLSIGFKIYPAVGPTILLTKPSILFEGIKFNFFGFGFIKFAFN 
 
BG_0408 
Nucleotide sequence 
TATGGCACATCACCACCACCATCACTCCGCGGCTCTTGAAGTCCTCTTTCAGGGACCCGGGTACCAGGATCCGTC
TGACAATTATATGGTCAGACGCAGCAAGGAAGAAGATTCAACAACCTGTATCGCAAAGCTTAAAGGCATAAAAGA
AAAAAAAAGTTATGACTTATTTTCAATGGGTATTGGAATAGGCAATCCTATTGCAAACATAATAATTACAATTCC
TTATATAAATATTGATTTTGGATATGGGGGTTTTATTGGTCCTAAGTCAAATAATTTTGAAAATTATCTAAACGG
CGGAATAGATATTGTTTTTAAAAAACAAATTGGACAATACATGAGAATCGGTGGCGGCATTGGAATAGGTGCAGA
TTGGTCAAAAACATCCCTCATACCTCCTGACGAAGAGAAAGAGACTGATTATGAGAGAATAGGCGCTGTTATAAG
AATTCCTTTTGTAATGGAATATAACTTTGCAAAAAATTTGTACATAGGATTCAAACTTTACCCTGCACTAGGGCC
AACAATATTGCTAACAAAGCCAAAAATTTTATTTGAAGGAATTAAATTCAATTTTTTTGGAT 
Amino acid sequence 
MAHHHHHHSAALEVLFQGPGYQDPSDNYMVRRSKEEDSTTCIAKLKGIKEKKSYDLFSMGIGIGNPIANIIITIP
YINIDFGYGGFIGPKSNNFENYLNGGIDIVFKKQIGQYMRIGGGIGIGADWSKTSLIPPDEEKETDYERIGAVIR
IPFVMEYNFAKNLYIGFKLYPALGPTILLTKPKILFEGIKFNFFGFGFIKFAFN 
 
Figure 3.6. Sequence data of OMP-pET47 constructs and resulting translations. DNA sequences and 
EXPASY translations following Sanger sequencing of the OMP-pET47 constructs using T7 promoter and 
terminator primers. Red shows the start codon, green the his-tag region, orange the HRV3C cleavage site and the 
gene of interest is shown in dark blue. 
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Figure 3.7. Protein BLAST results of translated OMP sequence data. Following translations of the OMP-
pET47 constructs the gene inserts were translated using EXPASY and used for protein BLAST (Altschul et al., 
1990) searching. The top sequence is the query or the gene insert with the actual NCBI 
(https://www.ncbi.nlm.nih.gov/) result underneath. Note that the query sequences are shorter due to the removal 
of the signal sequence. 
BB_0562 
BB_0406 
BG0408 
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3.3 Recombinant expression of BAPKO_0422, BB_0562, BB_0406 and BG0408 
3.3.1 Codon bias 
All four gene sequences (BAPKO_0422, BB_0562, BB_0406 and BG_0408) were analysed 
for rare codons using the Rare Coon Calculator (RaCC) from NIH MBI Laboratory for 
Structural Genomics and Proteomics. Unsurprisingly all of the genes contained a number of 
codons not frequently used with the expression system E. coli K12 and is further discussed in 
table 3.2. In order to achieve a high level of expression without premature termination, Rosetta 
(DE3) E. coli cells were selected for expression. The expression cells contained additional 
tRNAs for AGG, AGA, AUA, CUA, CCC, CGA, all of which were required for translation of 
the Borrelia proteins. These extra tRNAs were encoded on a chloramphenicol resistant plasmid 
and the strain gave high levels of overexpression.  
 
 
3.3.2 Autoinduction vs IPTG control 
Initial trials of autoinduction (section 2.2.3.2) failed to produce high levels of recombinant 
protein following 16 hours of incubation at 37oC at 200rpm when compared to induction with 
IPTG. This was rectified by increasing the incubation time to 20 hours. Protein yield was 
significantly higher following the extended incubation and much higher than expression under 
IPTG control likely due to the higher culture density achieved during autoinduction (Grabski 
et al., 2005). 
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 Rare 
Arg 
codons 
AGG, 
AGA, 
CGA 
 
Rare 
Leu 
codons 
CTA 
Rare 
Ile 
codons 
ATA 
Rare 
Pro 
codons 
CCC 
 
B. burgdorferi 
B31 
 
BB_0562 
Predicted 
outer 
membrane 
β-barrel 
 
gtg aaa aaa att ttt ATA ttg ttt atc atg att gca 
aac ATA tct aca aat ggt ttt aca aaa gat tca tat 
tta aat AGA gga att ggc ttt gga gca agc att gga 
aat cca att att aac tta ATA atg tca ttt cct ttc 
att gat ttt gaa att ggc tat ggt ggt agt aat gga 
ATA aat CTA tca ggc CCC aaa ctt gaa tca aaa ttt 
tat gat ttt aat tta tta gca ATA gca gca ctt gat 
ttc att ttt aca ATA tct ttg ATA aaa aat tta aat 
tta gga att gga ATA gga gga aat ATA agc ATA tcg 
tct cac aca tct aaa tta ATA aat gta gaa tta gga 
ttt gga atg AGA att cca ttg gtt att ttt tac gac 
att aca gaa aat tta gaa ATA ggt atg aaa ATA gca 
cct tca ATA gaa ttc atc tca aat aca AGG tct ctt 
gct caa cat AGA acc tat tcg ggc ATA aaa tca aac 
ttt gct ggg gga ATA ttt gct aag tac tat atc ttt 
taa 
 
 
 
4 
 
1 
 
16 
 
1 
 
B. burgdorferi 
B31 
 
BB_0406 
Predicted 
outer 
membrane 
β-barrel 
 
atg ATA aaa att ttt aaa aaa ATA tac att tta aca 
tta gta tta ggt atg gca cac ctt tct ttt gca tct 
gac aat tat atg gtc AGA tgc agc aag gaa gaa gat 
tca acc acc tgt atc gca aag ctt aaa gaa ATA aaa 
gaa aag aaa aat tat gac tta ttt tca atg ggc att 
gga ATA gga gat cct att gca aat att atg att aca 
att cct tat ATA aat att gat ttt gga tat gga ggt 
ttt att ggc ctt aag tca aac aat ttt gaa aat tat 
CTA aat ggt gga ATA gac gtt att ttt aaa aag caa 
att gga caa tat atg aaa att ggc ggc ggc att gga 
ATA ggt gcg gat tgg tca aaa aca tcc ctt ATA CCC 
cct aat gaa gaa gaa gaa act gat tat gag AGA ATA 
ggc gct gtt ATA AGA att cct ttt ATA atg gaa tat 
aat ttt gca aaa aat tta tcc ATA gga ttc aaa att 
tat cct gca gta ggg cca aca ATA tta CTA aca aaa 
cca agc att tta ttt gaa gga att aaa ttc aat ttt 
ttt gga ttt gga ttc ATA aaa ttt gca ttt aat taa 
 
 
 
3 
 
2 
 
14 
 
1 
 
B. garinii 
PBi 
 
BG_0408 
Predicted 
outer 
membrane 
β-barrel 
 
atg ATA aaa aat ttt aaa aaa atg cat att tta ATA 
tta gta tta ggt gta gca cac ctt tct ttt gca tct 
gac aat tat atg gtc AGA tgc agc aag gaa gaa gat 
tca acc acc tgt atc gca aag ctt aaa ggc ATA aaa 
gaa aaa aaa agt tat gac tta ttt tca atg ggt att 
gga ATA ggt aat cct att gca aac atc ATA att aca 
att cct tat gta aat att gat ttt gga tat ggg ggt 
ttt att ggc cct aag tca aat aat ttt gaa aat tat 
CTA aac ggc gga ATA gat att att ttt aaa aaa caa 
att gga caa tac atg AGA atc ggt ggc ggt att gga 
ATA ggt gca gat tgg tca aaa aca tcc ctt atg cct 
cct gac gaa gag gaa gag act gat tat gag AGA ATA 
ggc gct gtt ATA AGA att cct ttt gta atg gaa tat 
aac ttt gca aaa aat tta tac ATA gga ttc aaa gtt 
tac cct gca CTA ggg cca aca ATA ttg CTA aca aag 
cca aac att tta ttt gaa gga att aaa ttc aat ttt 
ttt gga ttt gga ttc ATA aaa ttt gca ttt aat taa 
 
 
 
4 
 
3 
 
16 
 
2 
 
Table 3.2. Rare codon analysis of Borrelia burgdorferi s.l. OmpA-like proteins. Prior to transformation of 
OMP-pET47 vectors for expression codon usage was calculated in order to select an appropriate expression strain 
of E. coli. Rare codons were identified using the Rare Coon Calculator (RaCC) from NIH MBI Laboratory for 
Structural Genomics and Proteomics 
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3.3.3 Western blot confirmation of expression 
Following expression western blot analysis was used to confirm the presence of the 
recombinant protein by the means of immunoblotting for the polyhistidine tag (section 2.2.3.5). 
Western analysis demonstrated that expression of all four proteins was achieved and these 
recombinant proteins were of an expected size (20-23 kDa) as shown in figure 3.8. Prior to 
blotting protein samples were separated by reducing SDS-PAGE in order to reduce any 
oligomers however in some cases BB_0406 and BG_0408 appeared on blots with three/four 
bands possibly representing forms of dimer tetramer and octamers (data not shown) or 
oligomerisation from incomplete folding. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8. Western blot confirmation of B. burgdorferi s.l.Omp-A like proteins. Western blot analysis of cell 
lysates following IPTG controlled expression of B. burgdorferi s.l.OmpA-like proteins. A) Novex protein 
standard. B) Untagged lysozyme. C) BAPKO_0422, ~23kDa. D) BB_0406, ~23kDa. E) BG0408, ~23kDa. F) 
Novex protein standard. G) BB_0562, ~20kDa. 
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3.4 Refolding and purification of B. burgdorferi s.l.OmpA-like proteins 
3.4.1 Preparation of inclusion bodies 
One of very few positives of working with insoluble proteins was the ease in which a protein 
sample can be purified to a fairly high grade without employing any chromatography. 
Following lysis the samples were centrifuged and the supernatant or soluble fraction was 
discarded. The insoluble pellets containing the cell debris and inclusion bodies were prepared 
using a multistep wash procedure described in section 2.2.4.2. By the end of the wash stages 
the material was solubilised in denaturant (8M urea, 0.3M NaCl, 50mM tris, pH8) and the 
protein was approximately 80% pure for all four protein samples (BAPKO_0422, BB_0562, 
BB_0406, BG0408), example data shown for BAPKO_0422 in figure 3.9. Some level of target 
protein was lost during the pellet washing steps as observed by SDS-PAGE analysis of the 
wash supernatants shown in figure 3.9 however this loss was acceptable in order to improve 
the sample purity prior to refolding. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9. SDS-PAGE analysis of BAPKO_0422 following inclusion body preparation. Inclusion body 
pellets were subjected to extensive washing prior to solubilisation in denaturant. At each wash step a sample of 
the supernatant was retained for analysis where minimal BAPKO_0422 protein is lost. SDS-PAGE performed 
using pre-cast bis/tris 4-12% gels (Novex) and MES buffer (50mM MES, 50mM Tris base, 0.1% w/v SDS, 1mM 
EDTA, pH 7.3). A) Novex Protein Standard. B) BAPKO_0422 IPTG controlled insoluble fraction. C) 
BAPKO_0422 autoinduction insoluble fraction. D) BAPKO_0422 IPTG controlled following pellet washing. E) 
BAPKO_0422 autoinduction following pellet washing. F-I) Supernatants from the pellet washing. 
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3.4.2 IMAC purification of OmpA-like proteins 
Early purification of BAPKO_0422 proved troublesome, several buffers and a range of pHs 
were trialled (section 2.2.5.1). However, the protein failed to bind to the Ni-NTA column, 
resulting in extremely poor yields and the majority of the protein remaining in the column flow 
through. Attempts were made to purify both under denaturing conditions in hope that the tag 
would be further exposed and also attempts were made to purify by Ni-NTA following 
refolding by rapid dilution. However, the binding yield remained low for BAPKO_0422 
showed in figure 3.10. Further attempts were made to resolve the binding problem and involved 
the addition of glycerol (5% v/v) to the equilibration buffer and to the sample in hope of 
disrupting any hydrophobic interactions (Bane et al., 2007) that could be responsible, binding 
did improve slightly but the yield remained lower than expected. This poor binding to Ni-NTA 
columns was curious as the other his-tagged proteins including BB_0562, BB_0406 and 
BG_0408 were not exhibiting the same behaviour.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10. Low binding IMAC chromatogram for BAPKO_0422. Ni-NTA affinity chromatography of 
BAPKO_0422 showing poor yield. Approximately 35 ml of solubilised BAPKO_0422 (8M Urea, 0.3M NaCl, 
50mM tris base, pH8) was pumped onto the pre-equilibrated His-trap column (GE Healthcare) and washed with 
10 column volumes of 8M urea, 0.3M NaCl, 50mM tris, 20mM imidazole, pH8 prior to elution by a gradient 
increase of the imidazole concentration within the eluent (0.3M NaCl, 50mM tris, 0.3M imidazole, 0.1% v/v 
LDAO, pH8). The first peak at ~20-50 ml is the loading peak, the second peak at ~104 ml is the elution peak 
BAPKO_0422 confirmed by SDS-PAGE analysis) followed by third increase in absorbance due to the low grade 
imidazole used for elution. 
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Following a UV scan of the BAPKO_0422 protein sample in order to determine its 
concentration following pellet washing it was noted that the absorbance at 260 nm was 
particularly high possibly indicating DNA contamination. This was not originally suspected 
due to the expression cells undergoing extensive sonication during the lysis procedure. These 
suspicions that BAPKO_0422 samples were heavily contaminated with DNA were confirmed 
by ion exchange chromatography and the resulting fractions subjected to a UV scan data shown 
in figure 3.11. However after treatment of refolded BAPKO_0422 with DNase the binding of 
the protein to the nickel column increased over 10 fold, shown in figure 3.12. After discovery 
of the high DNA content of BAPKO_0422, all lysates for all of the OmpA-like proteins were 
subject to a DNase incubation following refolding by rapid dilution or IEC prior to IMAC on-
column refolding and no further purification problems were encountered.  
 
 
Figure 3.11. UV absorbance spectrum of BAPKO_0422 IEC fractions prior to refolding. BAPKO_0422 
solubilised in urea was subjected to IEC in order to separate protein from DNA, fractions analysed by UV 
spectroscopy. Fractions 1-5 show a clear protein profile and were pooled and used for IMAC purification and on-
column refolding. Fractions 6, 8 and 8 were indicative of high levels of DNA and discarded following SDS-PAGE 
analysis. Comparative spectral scans of DNA/Protein ratios can be seen in figure 2.4 of the methods section. 
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3.4.3 Refolding of BAPKO_0422 and BB_0562 
Refolding of BAPKO_0422 and BB_0562 was less problematic than BB_0406 and BG0408, 
neither protein contained cysteine residues and the protein appeared to refold readily by 
removal of the denaturant and addition of the detergent LDAO. For both proteins this was 
achieved by both rapid dilution and by on-column refolding through a gradient removal of urea 
(section 2.2.5). On-column refolding was the preferred method as it avoided the processing of 
large volumes of protein solution that rapid dilution often generates. However, both proved to 
provide similar yields. As with all refolding strategies protein yield is low when compared to 
expression of soluble targets however both BAPKO_0422 and BB_0562 often delivered a final 
yield of 20-40% which was dependent upon the length and speed of the refolding gradient 
during on-column refolding. Yields were calculated based upon total protein and volume of the 
urea solubilised inclusion body fraction when compared to the volume and protein 
concentration of the refolded eluate following concentration and centrifugation to remove large 
aggregates.  
 
 
3.4.4 Refolding of BB_0406 and BG_0408 
Both BB_0406 and BG_0408 contained 2 cysteine residues which in both sequences these 
cysteines were separated by 8 residues. Due to presence of these cysteine residues the refolding 
yield was much lower than previously seen with BAPKO_0422 and BB_0562. Adaptations 
were made to protocols and buffer contents which included refolding under reducing conditions 
by rapid dilution and on-column refolding with the addition of further stabilisers such as 
glycerol (1-5% v/v) and L-arginine (0.1-0.5M). Protein yield remained fairly low following 
extensive optimisation and the original methods were put back into place. However, expression 
culture volumes were trebled in order to produce enough final product for downstream 
experiments. SDS-PAGE analysis of both BB_0406 and BG_0408 indicated that the 
recombinant protein could form oligomers including dimers, tetramers and octamers. These 
remained visible but at smaller proportions following reducing SDS-PAGE as shown in figure 
3.13. These oligomers were confirmed by immunoblotting for the polyhistidine tag following 
separation by non-reducing SDS-PAGE. 
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Figure 3.12. IMAC chromatograms for B. burgdorferi s.l.OmpA-like proteins. All IMAC purifications were undertaken using an Akta Prime chromatography system. 
Proteins were introduced to the pre-equilibrated column in 8M urea, 0.3M NaCl, 50mM tris, pH8 or for the case of BB_0562 without the denaturant urea. Following protein 
binding the column was washed with 10 column volumes of wash buffer (8M urea, 0.3M NaCl, 50mM tris, 50mM imidazole pH8) in order to remove non-specifically bound 
proteins. Where protein folding was achieved on the column the denaturant urea was removed by gradient reduction. Proteins were finally eluted from the column by a gradient 
increase of imidazole within the eluent (0.3M NaCl, 50mM tris, 0.3M imidazole, 0.1% v/v LDAO, pH8). A) BAPKO_0422 on-column refold and purification. B) BB_0562 
extended purification following refolding by rapid dilution. C) BB_0406 on-column refold and purification. D) BG0406 on-column refold and purification.
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Figure 3.13. SDS-PAGE analysis of Omp-A like proteins following immobilised metal affinity chromatography. 
Samples were retained during the extraction and purification procedure and analysed by reducing SDS-PAGE. SDS-
PAGE performed using pre-cast bis/tris 4-12% gels (Novex) and MES buffer (50mM MES, 50mM Tris base, 0.1% w/v 
SDS, 1mM EDTA, pH 7.3).  A) Analysis of BAPKO_0422 samples. Lane 1 – Novex protein marker, 2 – Cell lysate, 3 – 
Soluble fraction, 4 – Insoluble fraction, 5 – Pooled eluate following Ni-NTA chromatography. B) Analysis of BB_0562 
samples. Lane 1 – Novex protein standard, 2-3 Soluble fraction, 4 – Insoluble fraction, 5 – Pooled eluate following Ni-
NTA chromatography. C) Analysis of BB_0406 samples. Lane 1 – Novex protein standard, 2-3 – Soluble fractions, 4 – 
Insoluble fraction, 5 – Pooled eluate following Ni-NTA chromatography. D) Analysis of BG0408 samples. Lane 1 – 
Novex protein marker, 2-3 Soluble fractions, 4 – Pellet wash fraction, 5 – Pooled eluate following Ni-NTA 
chromatography. 
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3.4.5 Gel filtration of the OmpA-like proteins 
All OMPA-like proteins were subjected to gel filtration following the construction of a calibration 
curve shown in section 2.2.5.8. The column was equilibrated with an appropriate buffer matching the 
protein’s buffering solution. Filtration was undertaken at a flow rate between 0.2 and 0.5 ml/min 
dependent upon the over column pressure detected for each sample. Protein samples were 
concentrated to 5 mg/ml and injected onto the top of the column. The UV absorption at 280 nm was 
monitored and fractions collected during the elution peak for SDS-PAGE analysis. Elution volumes 
were used to calculate the estimated molecular weight using the calibration curve previously 
described. Gel filtration chromatograms for OMPA-like proteins are shown in figure 3.14 with final 
elution volumes and molecular weight estimations shown within the figure caption. 
 
 
 
Figure 3.14. Size exclusion chromatography of B. burgdorferi s.l.OmpA-like proteins. Samples of all OmpA-like 
proteins were subjected to gel filtration in order to assess the refolded state, determine an approximate molecular weight 
and to remove any large aggregates prior to structural experiments. All gel filtration was performed under reducing 
conditions. The injection point for all samples is set at 0 ml whereby the protein sample was injected into the top of the 
superdex 75 10/300 GL column (GE Healthcare). All peak fractions were collected and analysed by SDS-PAGE. RED – 
BB_0562 at 2 mg/ml (~21kDa). BLUE – BAPKO_0422 at 5 mg/ml (~23kDa). GREEN – BB_0406 at 1.5 mg/ml 
(~22.5kDa). ORANGE – BG0408 at 2 mg/ml (22.5kDa). 
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For all four OMPA-like proteins samples were often found as polydisperse with some levels of 
aggregation and a proportion of monomer and oligomer. Monomeric fractions for each protein were 
pooled and concentrated. For the case of BB_0406 and BG_0408 a proportion of the protein was 
found to be dimeric, tetrameric and octameric although SEC was performed under reducing 
conditions (0.3M NaCl, 50mM Tris, 0.1% v/v LDAO, 1mM DTT, pH8). These oligomers did not 
appear as sharp peaks on the chromatogram shown in figure 3.14 but were found following SDS-
PAGE of the eluate fractions before the peak representing the monomeric species. These fractions 
were removed with only monomeric species carried forward for structural experiments. 
 
 
3.4.6 UV spectral analysis of B. burgdorferi OmpA-like proteins 
Following early issues with regards to the presence of DNA within BAPKO_0422 samples all 
proteins samples were assessed by UV spectroscopy (section 2.2.5.7) following refolding and 
purification steps as shown in figure 3.15. All four OmpA-like protein samples contained minimal 
DNA contamination following the end stage of gel filtration. 
 
 
Figure 3.15. UV spectral analysis of B. burgdorferi OmpA-like proteins. Final UV spectrum for refolded and purified 
B. burgdorferi OmpA-like proteins. Scans were carried out on a UV Spectrostar Nano (BMG Labtech) with readings 
taken at 5 nm intervals from 220 to 340nm. 
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3.5 Gel shift assays for B. burgdorferi OmpA-like proteins 
The formation of E. coli’s OmpA secondary structure and a number of other bacterial OMPs can be 
easily monitored by gel shift assays (section 2.2.6.1). These experiments exploit the characteristic 
that such proteins display a shift in molecular mass during SDS-PAGE. E. coli OmpA is seen to run 
at approximately 30kDa when the protein is fully folded but this value shifts upto 35kDa when the 
protein is either partially or fully unfolded. Although this phenomenon is seen for many β-barrel 
membrane proteins it was not observed for any of the four B. burgdorferi OMPs studied within this 
research (An example gel shift assay for BB_0562 is shown in figure 3.16). Although this differs 
from what is considered ‘the norm’ for this protein family it is not unheard of that some bacterial 
OMPs do not exhibit a gel shift and include B. burgdorferi P66 (Kenedy et al., 2014). As previously 
discussed the Borrelia porin P66 also does not display any difference in molecular weight when 
folded as opposed to its unfolded state. This lack of size shift for these OMPs could be a general 
characteristic of B. burgdorferi OMPs (Kenedy et al., 2014, Dyer et al., Appendix 4). 
 
 
 
 
 
 
 
 
 
Figure 3.16. Gel shift assay for BB_0562. Samples of purified and refolded BB_0562 were denatured using varying 
concentrations of urea and analysed by SDS-PAGE. No shift in molecular weight was seen when comparing folded and 
unfolded samples. This behaviour was observed for all four B. burgdorferi OmpA-like proteins. 
 
 
3.6 Phase partitioning of B. burgdorferi OmpA-like proteins 
Phase partitioning experiments (section 2.2.6.2) were conducted in line with published methods 
(Bordier, 1981) for all four Borrelia OmpA-like proteins with data shown in figure 3.16. The low 
cloud point of Triton X-114 was exploited in order to separate amphiphilic membrane proteins from 
soluble proteins at a reasonably physiological temperature (~23oC).  Haemoglobin (Sigma) was 
selected as an aqueous negative control with Arabidopsis thaliana voltage-dependent anion channel 
1 (AtVDAC1) selected as a positive control. Phase partitioning experiments demonstrated that all 
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four of the proposed Borrelia β-barrels appeared within the detergent rich phase indicating that they 
are all amphiphilic and highly likely to be integral membrane components. 
BB_0406 and BG_0408 appeared in the detergent phase as monomeric, dimeric, tetrameric and a 
small proportion of octameric protein was present although unclear in figure 3.17 (blots E and F). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.17. Phase partitioning of Borrelia outer membrane proteins. SDS-PAGE analysis following the Triton X-
114 phase partitioning of possible Borrelia membrane proteins and controls. Lane 1 – aqueous phase, lane 2 – detergent 
phase. A) Negative control – Haemoglobin. B) Positive control – AtVDAC1, C) BAPKO_0422, D) BB_0562, E) 
BB_0406, F) BG0408. 
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3.7 Affinity ligand binding immunoblots (ALBI): Assaying for human factor H (hfH) binding 
Initial hfH binding assays (section 2.2.6.3) were carried out for only for BAPKO_0422 and required 
much optimisation. The limiting factor of the experiment was the cost of purchasing natural hfH, 
initially it was hoped that the assay could be carried out with a hFh incubation concentration close to 
that found in human plasma, somewhere between 200-500 μg/ml, however this would have cost in 
the region of £1000 per incubation. In order to reduce the cost and to prevent a considerable reduction 
to the incubation concentration the assay was carried out using a minimal amount of PVDF membrane 
and the volume of the hFh for incubation decreased to 2.5 ml, giving a final incubation concentration 
of 77 μg/ml, approximately a third of what is found in human plasma. Initial practice assays carried 
out at this concentration and below produced a very weak positive signal and which was in some 
cases masked by poor non-specific binding due to issues with blocking. These problems were 
originally thought to be due to the low concentrations of hfH within the incubation. However, 
following optimisation it was noted that the chosen vessel to perform the assay had a slight curvature 
to the bottom resulting in an unequal wash of hfH over the PVDF membrane. By increasing the 
incubation volume from 2.5 ml to 3 ml these problems were resolved. Full assay optimisation can be 
seen in figure 3.18. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.18. Optimisation of the hfH-BAPKO_0422 binding assay. Affinity ligand binding immunoblots of initial 
hfH-BAPKO_0422 assays. A) Initial experimental assay using 20µg of hfH as a positive control in lane 1 and 50µg of 
BAPKO_0422 in lane 2. B) Repeated assay with a weak positive signal. Lane 1 containing 0.3µg of hfH and 50µg of 
BAPKO_0422 in lane 2. C) Repeated assay with an increased amount of hfH used within the incubation, Lane 1 – 0.2µg 
of hfH, Lane 2 - 50µg of BAPKO_0422. D) Improved assay by increasing the incubation volume from 2.5 ml to 3 ml. 
Lane 1 – 0.2µg of hfH as a positive control, Lane 2 - 50µg of BAPKO_0422. 
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The second concern with the first hfH assays was the amount of hfH used as a positive control on the 
blot. Originally the amount of hfH used as the positive control was calculated based upon the average 
amount of protein required for effective transfer from an SDS-PAGE to a membrane, which is 
normally in the region of 20-30µg (Abcam, UK). However, this was far too high so further 
optimisation was required. An optimisation assay was carried out whereby various concentrations of 
hfH were subjected to native PAGE and subsequently transferred to PVDF which was blocked and 
probed with a primary anti-factor H (mouse anti-human - abcam) antibody followed by a secondary 
detection antibody (Alexa Fluor 680 goat anti-mouse), with data shown in figure 3.19. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.19. Optimisation of human fH as an ALBI positive control. Natural hfH run as a native PAGE and transferred 
to PVDF by wet transfer. Membranes were blocked with 5% w/v non-fat milk powder for 1hr, washed and probed with 
a primary anti-his followed by the secondary antibody. Lanes – (1) 0.5µg of hfH. (2) 0.1µg of hfH. (3) 0.25µg of hfH (4) 
0.35µg hfH. (5) 0.3µg of hfH. (6) 0.25 µg of hfH. (7) 0.2µg of hfH. 
 
 
Preceding the determination of an appropriate amount of hfH to use as a positive control several 
independent assays were undertaken for BAPKO_0422, all of which gave a positive result for hfH 
binding. Importantly a negative control blot was also carried out alongside every experimental assay. 
In this case the negative control followed the same process as of the experimental but the hfH 
incubation solution was substituted for TBS ensuring that neither antibody could give a false positive 
result. Extra proteins both natural and recombinant were also included on early blots as additional 
negative controls, these included BSA and the Borrelia protein SodA which was produced using the 
same expression system and carries the same N-terminal His-tag and HRV-3C recognition sequence.   
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Following extensive optimisation the final hfH-BAPKO_0422 binding assay was conducted with 
appropriate controls with full data shown in figure 3.20A. The ALBI assays resulted in a positive 
result for a hfH-BAPKO_0422 interaction. Following the positive assessment the assay was carried 
out for the remaining OMPs. BB_0562, BB_0406 and BG0408 with full data shown in figure 3.20A-
D. All three of these protein appeared negative for hfH binding with the positive control strip of 
BAPKO_0422 again giving a positive result (Figure 3.21). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.20. Assessing the interaction between hfH and BAPKO_0422. Affinity ligand binding immunoblots of hfH 
and BAPKO_0422 with control blots. Blot A. Experimental ALBI assay with a hfH incubation step. Lane 1 – 0.3µg of 
hfH. Lane 2 - 50µg of concentrated BAPKO_0422 showing a both monomeric and dimeric species. Lane 3 - 50µg of 
recombinant B. burgdorferi SodA. Blot B. Negative control ALBI assay carried out alongside blot A whereby the hfH 
incubation was substituted for a TBS incubation. Lane 1 - 0.3µg of hfH. Lane 2 - 50µg of BAPKO_0422. Lane 3 - 50µg 
of recombinant B. burgdorferi SodA. Blot C. Repeated negative control ALBI assay where the hfH incubation step was 
substituted with TBS. Lane 1 – 0.2µg of hfH. Lane 2 - 50µg of diluted BAPKO_0422. 
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Figure 3.21. Final hfH ALBI assays for Borrelia OMPs. Affinity ligand binding blots were used to assess any possible 
interaction between hfH and the four possible OMP proteins. For BB_0562, BB_0406 and BG_0408 no interaction was 
observed. Blot A. Experimental ALBI assay for BAPKO_0422 with a hfH incubation step. Lane 1 – 0.2µg of hfH. Lane 
2 - 50µg of diluted BAPKO_0422 showing a single monomeric species. Blot B. Experimental blot, Lane 1 – 0.2µg of 
hfH. Lane 2 - 50µg of BB_0562. Lane 3 - 50µg of BB_0406. Lane 4 - 50µg of BG0408. Blot C. Negative control blot. 
Lane 1 – 0.2µg of hfH. Lane 2 – 20µg of B. burgdorferi SodA. 
 
 
3.8 BAPKO_0422 - Heparin binding assays 
As previously discussed in section 3.4.2 recombinant BAPKO_0422 was seen to display a remarkable 
affinity for DNA which resulted in many problems during downstream chromatography experiments. 
BAPKO_0422 could only be purified by Ni-IMAC once the contaminating DNA was removed from 
the sample. These issues were not seen for the other three Borrelia OMPA-like proteins and raised 
the question whether BAPKO_0422 may interact with other negatively charged molecules such as 
the highly sulphated glycosaminoglycan, heparin. Although many proteins are known to interact with 
heparin or heparan sulphate, BAPKO_0422’s possible outer surface location could suggest an 
important interaction. 
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The ability of BAPKO_0422 to bind to heparin was assessed as previously discussed in section 
2.2.6.4. Recombinant BAPKO_0422 was fed onto a GE Healthcare Heparin column using an Akta 
Prime chromatography system and the resulting flowthrough and eluate was analysed using SDS-
PAGE analysis with the full data shown in figure 3.22. Following the introduction of 5 ml of 
BAPKO_0422 at a concentration of 0.5 mg/ml to the heparin column no substantial level of protein 
was seen in either the low NaCl wash (50mM NaCl) or within the flowthrough nor detected by SDS-
PAGE. 
 
 
 
Figure 3.22. BAPKO_0422 heparin binding assay. Recombinant BAPKO_0422 was applied to a heparin column and 
quantitatively retained and eluted using 1M NaCl. No significant peak was observed during the loading or during the low 
NaCl wash (50mM NaCl) and the majority released from the column during elution. 
 
 
The ability of BAPKO_0422 to bind heparin in vitro requires much further investigation in order to 
determine if this interaction is physiologically important in vivo during B. burgdorferi infection. The 
preliminary results require further confirmatory experiments including, Heparin competitive binding 
assays (Dawes & Pepper, 1987) and in vivo studies including knock out models (Snäll et al., 2016). 
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3.9. Circular dichroism experiments for Borrelia OMPs 
3.9.1. Introduction to circular dichroism 
Circular dichroism or CD is a common spectroscopic technique used for rapid assessment of a 
samples secondary structure. In technical terms CD can be defined as the disproportionate absorption 
of left and right-handed circularly polarised light (L-CPL and R-CPL) which occurs when the sample 
molecule contains at least one chiral chromophore. 
 
A beam of light can be described to have both time dependent electric and magnetic fields. Should 
this beam become linearly polarised by the use of filters or prisms the beam is observed to oscillate 
within a single plane. All types of polarised light are described as the sum of two independent linearly 
polarised states, for example vertical and horizontal polarised light. When these vertical and 
horizontal polarised states are both in phase and of equal amplitude the resulting wave can be 
described as linearly polarised at 45 degrees but should vertical and horizontal waves become out of 
phase the resulting wave is no longer linearly polarised (Greenfield, 2006). In the case of CD should 
the two polarised states become out of phase by a quarter of a wave the resulting wave can represented 
as a helix or alternatively known as circularly polarised light (CPL) which can be either right or left 
handed and are non-superimposable mirror images (Greenfield, 2006). This generated sinusoidal 
wave can be explained by two vectors of equal length which rotate in a circular pattern, one clockwise 
(ER) and the other counter-clockwise (EL) and are 90 degrees out of phase (Greenfield, 2006). 
Asymmetric molecules which contain at least one chiral chromophores may absorb left and right 
handed circularly polarised light disproportionately. This results in a rotation in the plane of light and 
the addition of the ER and EL vectors results in a wave which now traces an elliptical shape, known 
as elliptically polarized light. 
 
The CD of a sample is normally described as the difference in absorption of ER and EL known as ΔE 
shown in equation 4 or alternatively measured in degrees ellipticity which can be defined as the 
tangent of the ratio of the minor to major elliptical axis or molar ellipticity whereby the CD is 
corrected for sample concentration. CD units are often further converted to mean residue ellipticity a 
normalised unit which is particularly useful when using methods for estimating the secondary 
structure of proteins and is simply the molar ellipticity divided by the number of residues or amino 
acids within the molecule (Greenfield, 2006). 
 
For polypeptides and proteins CD is a useful tool for the rapid determination of the folded state and 
for estimating the total amounts of secondary structure. As the amide groups of the polypeptide 
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backbone are chromophores and their optical transitions can be further split to multiple transmissions 
due to exciton interactions (Sreerama and Woody, 2000) typical structural elements of proteins give 
rise to specific CD spectra. These indicative spectra are explained by the differential absorption of 
the amide chromophores or peptide bonds when present in particular chiral environments created by 
protein folding (Kelly et al., 2005). An example of this phenomenon is seen with α-helical proteins 
which have defined negative bands at both 222 and 208 nm and a positive band at 193 nm (Holwarth 
& Doty, 1966) in contrast proteins containing high levels of antiparallel β-sheets have clear negative 
bands at 218 nm and a positive band at 195 nm (Greenfield & Fasman, 1969). 
 
Circular dichroism = ΔA(λ) = A(λ)LCPL - A(λ)RCPL 
Equation 4. Calculation of CD. Where λ is the wavelength 
 
 
3.9.2 Circular dichroism of Borrelia OMPs 
CD data for all four proposed OMPs from Borrelia burgdorferi, afzelii and garinii were collected as 
previously described in section 2.2.8.1 using a JASCO J-810 spectropolarimeter (University of York). 
The resulting spectra are shown in figure 3.24. Recombinant OMPs were refolded, purified and 
centrifuged prior to data collection. Data were collected in quintuplicate across several concentrations 
for each protein sample in an effort to obtain the best spectra across the largest range of wavelength 
(full data are included within the appendix section 2). CD spectropolarimeters maintain a constant 
current by raising the voltage as the level of light falls. When scanning at lower wavelengths the 
absorbance increase causes the H[T] voltage to rise. This rise in voltage changes the ratio of signal to 
noise and at above 500 V data often becomes noisy and unreliable. This H[T] value is also known as 
the photomultiplier tube (PMT) voltage or dynode voltage with the cut-off value differing for each 
machine set up. Data collected preceding 600V H[T] were discarded due to reliability. All spectra 
were subjected to background subtraction using an appropriate blank with the resulting file used for 
deconvolution using the Dichroweb server (Whitmore & Wallace, 2007, Whitmore & Wallace, 2004, 
Lobley et al., 2002).  
 
Early assessment of BAPKO_0422 by circular dichroism produced a spectrum which appeared 
shifted towards the far UV and although the characteristic beta-sheet curve was present as shown in 
figure 3.23 the positioning of the curve did not agree with data for other predominantly beta sheet 
proteins. It was hypothesised that it was likely that the sample contained a mixed species of folded 
and partially folded protein and the data were discarded. A second sample of BAPKO_0422 was 
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subjected to CD which gave rise to a more accurate curve as shown in figure 3.24. This data did not 
appear to hold the same shift towards far UV and was used for deconvolution using the dichroweb 
server. It was later found that the shift towards the far UV was caused by technical problems with the 
spectropolarimeter whereby changes in wavelength were not correctly recorded by the software. 
 
 
 
 
 
 
 
 
 
 
Figure 3.23. Circular dichroism spectra of BAPKO_0422 – A. CD spectra of BAPKO_0422 showing a shift of the 
curve to far UV due to issues with the JASCO spectropolarimeter. Spectra obtained for 0.1mg/ml BAPKO_0422 in 0.3M 
NaCl, 50mM tris base, 0.1% v/v LDAO, pH8. B. CD spectra of BAPKO_0422 following the resolution of the problem. 
The H[T] value was reached at 195.5 nm and deconvolution calculated the secondary structure as 40% β-sheet, 4% helix, 
20% turn and 35% unordered. Spectra obtained for 0.075mg/ml BAPKO_0422 in 0.3M NaCl, 50mM tris base, 0.1% v/v 
LDAO, pH8. 
 
 
 
The H[T] value was reached at 195.5 nm and the data from 260 nm and down to this point was used 
for the estimation of the secondary structure. The sum of secondary structure was calculated to be 
40% β-sheet, 4% helix, 20% turn and 35% unordered. Using the CDSSTR algorithm (Compton & 
Johnson, 1986, Manavalan & Johnson, 1987) and both SP175 (Lees et al., 2006)  and SMP180 
(Abdul-Gader et al., 2011) data sets which were chosen as these data sets contain the largest number 
of reference proteins. The full contents of each data set can be found within appendix 2.  
 
Following the initial analysis of BAPKO_0422 further samples were produced alongside BB_0562, 
BB_0406 and BG0408 for CD analysis. During these experiments the limiting value of H[T] was 
reached at longer wavelength than what was observed for the previous BAPKO_0422 experiments. 
Initially deconvolution was not going to be undertaken as data were needed down to 195 nm. 
However, the H[T] value was reached at around 200 nm leaving the data from 200 nm to 195 nm 
unreliable. Deconvolution was tested for BAPKO_0422 as the secondary structure had already been 
A B 
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estimated from the earlier data set. Both deconvolution data sets agreed well even with the inclusion 
of the 5 nm of unreliable data. Therefore deconvolution was undertaken for the remaining OMPs 
down to 195 nm which in some cases extended slightly past the acceptable H[T] value. 
 
Figure 3.24. Circular dichroism spectra of Borrelia OMPs. The CD spectra for four proposed Borrelia OMPs. CD 
measurements were made on a JASCO J-810 with the measurements made from 260 nm to 185 nm at 0.5 nm 
increments. The spectra show all data including that once the H[T] reached 600V. Spectra for all proteins was obtained 
in 0.3M NaCl, 50mM tris base, 0.1% v/v LDAO, pH8. BAPKO_0422 – Sample concentration of 0.25 mg/ml With H[T] 
reaching 600 V at 200 nm. BB_0562 – Sample concentration of 0.25 mg/ml with H[T] reaching 600V at 205 nm. 
BB_0406 – Sample concentration of 0.2 mg/ml with H[T] reaching 600V at 199 nm. BG0408 – Sample concentration 
of 0.125 mg/ml with H[T] reaching 600V at 200 nm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page | 177  
 
Parameter BAPKO_0422 BB_0562 BB_0406 BG0408 
Experimental temperature 20oC 20oC 20oC 20oC 
Path length 0.2cm 0.2cm 0.2cm 0.2cm 
Protein concentration 0.25 mg/ml 0.25 mg/ml 0.2 mg/ml 0.2 mg/ml 
File format JASCO 1.30 JASCO 1.30 JASCO 1.30 JASCO 1.30 
Wavelength range 260-185nm 260-185nm 260-185nm 260-185nm 
Wavelength increments 0.5nm 0.5nm 0.5nm 0.5nm 
Analysis algorithm CDSSTR CDSSTR CDSSTR CDSSTR 
Reference set SP175/SMP180 SP175/SMP180 SP175/SMP180 SP175/SMP180 
Initial wavelength 260nm 260nm 260nm 260nm 
Final wavelength 185nm 185nm 185nm 185nm 
Input units Mdeg Mdeg Mdeg Mdeg 
Output units Mean residue 
ellipticity  
Mean residue 
ellipticity 
Mean residue 
ellipticity 
Mean residue 
ellipticity 
Mean residue weight (Da)* 111.9 110.2 112.8 112.8 
 
Table 3.3. Parameters selected for circular dichroism experiments for Borrelia OmpA-like proteins. *The mean 
residue weight was calculated as the average molecular weight of all the amino acids within the protein sequence. The 
value is calculated by dividing the total molecular mass of the polypeptide by the number of residues within the sequence. 
 
All four of the proposed Borrelia OMPs showed a spectrum typical of proteins containing large 
amounts of beta sheet with the distinctive minima close to 218 nm and maxima around 195 nm 
(Greenfield and Fasman, 1969) although in some cases this maxima was missed by noise due to the 
H[T] threshold being met. 
 
Deconvolution for all four Borrelia OMPs was consistent when using two independent data sets and 
all four proteins appear to share a similar proportion of secondary structure. The deconvolution data 
is shown in table 3.14 and the experimental and reconstructed fit can be seen in figure 3.25. 
Deconvolution for each sample using both SP175 (Lees et al., 2006)  and SMP180 (Abdul-Gader et 
al., 2011)  reference sets were averaged to give a final estimation of the secondary structure as 
summarised in table 3.4. Overall the four proteins appear to share a similar level of secondary 
structure and the CD experiments support that the four Borrelia proteins contain a high level of β-
sheet (~42%) indicating that they could indeed be integral β-barrel membrane proteins. 
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Figure 3.25. Deconvolution analysis of Borrelia OMPs. Plots were generated using the Dichroweb server using the 
CDSSTR algorithm (Compton & Johnson, 1986, Manavalan & Johnson, 1987) and SP175 (Lees et al., 2006) and SMP180 
(Abdul-Gader et al., 2011) as reference sets. (Continued…) 
SP175 SMP180 
1 
2 
3 
4 
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The left plots were produced using SP175 (Lees et al., 2006)  and the right side plots were generated using SMP180 
(Abdul-Gader et al., 2011) as the reference set. The green line represents the experimental data, the blue line is the 
reconstructed data using the CDSSTR (Compton & Johnson, 1986, Manavalan & Johnson, 1987) algorithm and the pink 
lines indicate the difference between the two. Areas where the pink line is at it’s longest suggest a poor fit between the 
experimental and reconstructed data (Whitmore and Wallace, 2004). From top to bottom – 1. BAPKO_0422, 2. BB_0562, 
3. BB_0406, 4. BG0408. 
 
Sample Reference 
set 
Helix Strand Turns Unordered Total 
BAPKO_0422 sample 1 SP175 0.04 0.42 0.12 0.4 0.98 
BAPKO_0422 sample 1 SMP180 0.03 0.43 0.11 0.41 0.98 
BAPKO_0422 sample 2 SP175 0.05 0.39 0.14 0.39 0.97 
BAPKO_0422 sample 2 SMP180 0.03 0.47 0.11 0.38 0.99 
BAPKO_0422 sample 3 SP175 0.05 0.40 0.13 0.41 0.99 
BAPKO_0422 sample 3 SMP180 0.05 0.41 0.12 0.41 0.99 
BB_0562 sample 1 SP175 0.06 0.41 0.12 0.40 0.99 
BB_0562 sample 1 SMP180 0.03 0.44 0.11 0.40 0.98 
BB_0562 sample 2 SP175 0.04 0.40 0.12 0.41 0.97 
BB_0562 sample 2 SMP180 0.04 0.43 0.12 0.40 0.99 
BB_0562 sample 3 SP175 0.04 0.40 0.12 0.42 0.98 
BB_0562 sample 3 SMP180 0.04 0.42 0.12 0.40 0.98 
BB_0406 sample 1 SP175 0.04 0.42 0.13 0.40 0.99 
BB_0406 sample 1 SMP180 0.04 0.44 0.12 0.40 1 
BB_0406 sample 2 SP175 0.03 0.43 0.12 0.40 0.98 
BB_0406 sample 2 SMP180 0.03 0.44 0.12 0.39 0.98 
BB_0406 sample 3 SP175 0.04 0.42 0.13 0.40 0.99 
BB_0406 sample 3 SMP180 0.04 0.44 0.12 0.40 1 
BG0408 sample 1 SP175 0.04 0.44 0.12 0.39 0.99 
BG0408 sample 1 SMP180 0.03 0.44 0.14 0.38 0.99 
BG0408 sample 2 SP175 0.06 0.41 0.13 0.40 1 
BG0408 sample 2 SMP180 0.06 0.40 0.12 0.42 1 
BG0408 sample 3 SP175 0.04 0.41 0.11 0.42 0.98 
BG0408 sample 3 SMP180 0.04 0.40 0.11 0.43 0.98 
 
Table 3.4. Deconvolution data for Borrelia OMPs. Deconvolution was carried out using the Dichroweb server based 
upon the CDSSTR algorithm (Compton & Johnson, 1986, Manavalan & Johnson, 1987) using both SP175 (Lees et al., 
2006) and SMP180 (Abdul-Gader et al., 2011) as data sets. Three different concentrations for each recombinant OMP 
were used. 
 
 
Following analysis of the Borrelia CD data, spectra for structurally characterised 8-stranded β-barrels 
were generated using Dichrocalc. Theoretical CD data were generated using pdb files for E. coli 
OmpA (1BXW - Pautsch and Schulz, 1998), OmpW (2FIV - Hong et al., 2006) and OmpX (1QJ8 - 
Vogt & Schulz, 1999) alongside Y. pestis Ail (3QRA - Yamashita et al., 2011) and N. meningitidis 
NspA (1P4T - Vandeputte-Rutten et al., 2003) in order to compare the experimental Borrelia OMP 
data with data for structurally characterised membrane proteins as shown in figure 3.26. The predicted 
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CD spectra followed the same distinct shape as what was seen for the Borrelia proteins with a the 
minima being around 218 nm and the maximum reaching around 195 nm giving further support that 
the Borrelia proteins follow a similar CD profile to that of known 8-stranded β-barrel proteins. 
 
 
Figure 3.26. Predicted CD spectra of structurally solved 8-stranded β-barrels. CD spectra were generated using 
pdb files and the online server Dichrocalc. 
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3.10. Small angle X-ray scattering of B. burgdorferi s.l.OmpA-like proteins 
3.10.1 Introduction to small angle X-ray scattering 
Small-angle scattering of X-rays (SAXS) and neutrons (SANS) are well-established techniques 
commonly used to elucidate structural information from a wide variety of samples, including 
nanoparticles, emulsions, metal alloys, synthetic polymers and importantly biological 
macromolecules in solution (Svergun, 2007). First applications of the techniques began in the late 
1930’s following the early studies of metallic alloys by Guinier (Guinier, 1939). This small angle 
scattering of X-rays close to the primary beam provides a unique scattering profile and when this 
profile is acquired from a monodisperse solution of non-interacting particles the data carries important 
information about size and shape. By the 1960’s the method was becoming increasingly important 
for the study of biological macromolecules in solution as it bypassed the requirement of crystalline 
material yet yielded low resolution structural information of around 1-2 nm and provided insight of 
the overall shape and internal structure (Svergun, 2007). By the 1980’s this interest decreased as 
progress in other structural tools furthered. The challenging problem with the small angle scattering 
of biological molecules was how one may take a one-dimensional scattering pattern and then extract 
three-dimensional structural information; the experiments were therefore limited to simple 
measurements such as volume and calculation of the radius of gyration. A breakthrough during the 
1990’s however changed these limitations, data analysis methods vastly improved and alongside 
further advances in instrumentation ab initio shape determination using rigid body refinement became 
possible. 
 
 
3.10.2. SAXS experimental set-up 
X-rays are part of the electro-magnetic spectrum alike that of visible light. However, the wavelength 
is much shorter. As an alternating electric field causes an alternating magnetic field the waves 
propagate at right angles from each other. The interactions of these X-rays with matter, results in both 
absorption and scattering, a fraction may pass straight through the sample, some may be absorbed 
leading to other energy releases and a further portion will be scattered into alternative directions of 
propagation (Svergun, 2007). For structural experiments hard X-rays with wavelengths (λ) of 0.10-
0.15 nm and energies of around 10keV are used.  
 
A typical biological SAXS experiment utilizes a monochromatic and collimated X-ray beam which 
illuminates macromolecules in solution and their scattering is recorded by a detector. The detector is 
shielded from the intense incident beam by the beam stop and acts to prevent masking of the weak 
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scattering from the sample.  As the macromolecules are in solution and not crystalline they are 
arranged in no particular orientation. Scattering is therefore normally presented as a radially averaged 
one dimensional curve following suitable background subtraction. This curve is often described by 
the intensity (I) as a function of the magnitude of q of the scattering vector as shown in equation 5. 
This curve reveals several important parameters including information regarding size, overall shape 
and oligomeric state of the molecule (Jacques and Trewhella, 2010). 
 
Statistically the quality of the obtained scattering data for a given particle improves with increasing 
intensity. However, every detector will have a designated saturation value. Within an experimental 
set-up, once this saturation point is met any further counts may be lost in overflows. The detector 
saturation value for any detector often constitutes as the maximum exposure time for any given 
sample. Repeating short frames or exposures is often the chosen method to improve data quality rather 
than increasing the exposure times, although this varies for each detector type and experimental set-
up. 
 
Contrast is equally important in SAXS experiments, should the contrast between the target particle 
and the solvent is zero, scattering is negligible and increasing exposure times or repeating frames will 
not improve visibility. Most experiments are designed so that the concentrations of the target 
molecules are far higher than the constituents of the solvent. However, contrast is particularly 
important when working with solvents containing detergents and particle samples at low 
concentrations. 
 
For accurate modelling using small angle scattering data the sample must be monodisperse, as the 
scattering generated from proteins is directly related to the square of their scattering length (Svergun 
et al., book) and aggregates can easily contribute disproportionately to the signal. Aggregation is 
easily identified by evaluation of the scattering profile at low q-values and manifests itself as a short 
upturn or increase in scattering. For monodisperse systems the background reduced intensity is 
directly proportional to the scattering from one molecule which has been averaged over all 
orientations (Svergun, 2007). The extent of the target signal can be described as directly relative to 
the number of particles within the sample that are illuminated by the X-ray beam (Petoukhov and 
Svergun, 2007).   
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Equation 5. SAXS pattern representation as scattered intensity as a function of the magnitude of the scattering 
vector. Where θ is the angle between the X-ray bean and the detector and λ is the wavelength of the X-rays. 
 
In general most small angle scattering experiments are carried out between 1-10 mg/ml. However, a 
range of concentrations are often used in order to determine the presence of interparticle interactions 
where in contrast to aggregation they are identified by a sharp downturn a low q. 
 
 
3.10.3. Data analysis and Ab initio methods 
Detected scattering profiles are normally subject to a radial integration, producing a scattered 
intensity curve. Following appropriate solvent reduction  these scattering curves can be used to 
determine a number of parameters including, the radius of gyration (Rg), molecular mass (MM), the 
maximum diameter of the particle (Dmax), the extrapolated intensity at zero scattering angle I(0) and 
the overall shape or a low resolution molecular envelope. 
 
Prior to modelling the scattering data is subjected to a Fourier transform normally using the program 
GNOM (Svergun, 1992), this transform takes the one-dimensional scattering curves and can calculate 
the particle distance distribution function p(r) and prepares output files for modelling. Following the 
transform the output files can be used to determine a low resolution shape to the randomly orientated 
particles within the solution. Popular modelling programs include, DAMMIN (Svergun, 1999), 
DAMMIF (Franke & Svergun, 2009) and GASBOR (Svergun et al., 2001). Both DAMMIN 
(Svergun, 1999) and DAMMIF (Franke & Svergun, 2009) begin by creating a search volume which 
represents the particle in question, this search volume, which is often a sphere has a radius of gyration 
larger than what is expected of the particle and is filled with dummy atoms. The program assigns each 
dummy atom as either the solute (protein) or the solvent and from taking an arbitrary start model the 
program uses simulated annealing in attempt to produce a compact, interconnected model which 
would generate a scattering pattern in close agreement to that of the experimental data. These initial 
modelling programs are normally carried out 10-20 times, each with an independent arbitrary initial 
model. This method results in the generation of a wide selection of models which all match the 
experimental scattering data. 
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Following the creation of the initial models, DAMAVER (Volkov & Svergun, 2003) is used to align, 
average and refine the envelopes. The DAMAVER (Volkov & Svergun, 2003) package is combined 
of a series of programs including, damsel, damsup, damaver and damfilt which are summarised in 
table 3.5.  Following the averaging and refinement of the models by the DAMAVER (Volkov & 
Svergun, 2003) suite the final fit of the experimental data is often somewhere between the 
DAMAVER (Volkov & Svergun, 2003) and DAMFILT (Volkov & Svergun, 2003) envelope. 
 
 
Program Function Reference 
PRIMUS An interface for performing manipulations of the scattering data including, 
subtraction, averaging, merging, extrapolation to zero concentration. 
Generation and evaluation of Guiner, Porod and Kratky plots. 
Konarev et al., 
2003 
GNOM An indirect transform program which takes one dimensional scattering curves 
and evaluates the P(r) and prepares .out files for modelling. 
Svergun, 1992 
DAMMIN A tool for ab-initio modelling of SAXS data based on bead modelling and 
simulated annealing. 
Svergun, 1999 
DAMMIF An improved ab-initio modelling program based upon the foundations of 
DAMMIN but implementing a new algorithm to speed up reconstruction by a 
factor of 25-40. 
Franke & 
Svergun, 2009 
SUPCOMB A program used to superimpose one 3D structure onto another and calculates 
a normal spatial discrepancy (NSD) which can be used to determine the best 
alignments between models. 
Kozin & 
Svergun, 2001 
DAMSEL The program takes all generated models in PDB format and superimposes all 
possible pairs using SUPCOMB then generates an output table which 
determines which models are outliers and selects a reference model. Models 
are considered as outliers if the NSD exceeds two standard deviations away 
from the calculated mean. 
Volkov & 
Svergun, 2003 
DAMSUP A program that aligns a set of models excluding the outliers to a selected 
reference model and calculates standard deviation from the NSD. 
Volkov & 
Svergun, 2003 
DAMAVER The program averages models that have been aligned by DAMSUP and 
computes a probability map. 
Volkov & 
Svergun, 2003 
DAMFILT Can take the DAMAVER file and filter the model by removal of low 
occupancy regions or loosely connected atoms, this model doesn’t always 
reflect the true size of the experimental data. 
Volkov & 
Svergun, 2003 
Table 3.5. Programs used for SAXS data analysis. A summary of the popular programmes used for the manipulation 
and analysis of scattering data. 
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3.10.4. Methodology control protein – Lysozyme 
3.10.4.1 Background subtraction of lysozyme 
Other than poor sample preparation the most common source of error during SAXS experiments is 
inappropriate background subtraction (Jacques and Trewhella, 2009). Ab initio modelling methods 
are particularly sensitive to such errors and can often deliver unexpected reconstructions when given 
poor data to build from. With this in mind lysozyme and ribonuclease A were employed as control 
proteins, they were selected due to their availability and known crystal structure. The control 
experiments were used to ensure correct background subtractions were being made and to investigate 
any possible changes to the constructed envelopes upon the addition of the detergent LDAO. Buffer 
blank samples of 0.3M NaCl, 50mM tris base, pH8 both with and without 0.1% v/v LDAO were 
subjected to 10 exposure frames each lasting 2400 seconds. The scattering profiles were 
independently recorded and integrated using the inbuilt Bruker software package. Lysozyme 
purchased from Sigma was reconstituted in the same buffer as described above, made up at 7 mg/ml 
both with and without 0.1% v/v LDAO. Lysozyme samples were exposed to X-rays in the same 
manner as the above buffer blanks and the scattering integrated by chi. Background subtraction of 
lysozyme with and without detergent was calculated using Primus (Konarev et al., 2003), by the 
subtraction of the scattering of the corresponding buffer blank which are shown in figure 3.27.  
 
 
 
 
 
 
 
 
 
Figure 3.27 – Small angle scattering curves produced by 7 mg/ml lysozyme with and without 0.1% v/v LDAO. 
Recorded scattering data displayed as log of intensity over the scattering vector (Ǻ). A) Raw scattering intensity plot of 
lysozyme and blank without LDAO. Red line is the scattering recorded for the blank sample (0.3M NaCl, 50mM tris base, 
pH8). Blue line shows the raw scattering recorded for lysozyme at 7 mg/ml in 0.3M NaCl, 50mM tris base, pH8. Purple 
line represents the adjusted scattering of lysozyme following buffer blank background subtraction. B) Raw scattering 
intensity plot of lysozyme and blank with the detergent LDAO. Red line is the scattering recorded for the blank sample 
(0.3M NaCl, 50mM tris base, 0.1% v/v LDAO, pH8). Blue line shows the raw scattering recorded for lysozyme at 7 
mg/ml in 0.3M NaCl, 50mM tris base, 0.1% v/v LDAO, pH8. Purple line represents the adjusted scattering of lysozyme 
following buffer blank background subtraction. 
 
A B 
Q Q 
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3.10.4.2. Calculating the radius of gyration (Rg) of lysozyme 
Following the collection of small angle scattering data it is possible to perform many types of analysis 
but within many SAXS experiments the initial calculation of a particles radius of gyration is 
particularly useful. The radius of gyration provides information regarding to the mass distribution or 
the overall spread of the molecule and can be defined as the root mean square distance of the 
collection of atoms from their shared centre of gravity. As this parameter is based upon the spread of 
a particles constituents, molecules which have the same volume but hold different shapes will have 
different radius of gyration values (Jacques and Trewhella, 2009). For most spherical molecules the 
radius of gyration can be calculated by a Guinier approximation which is described in equation 6. 
The approximation is based upon the slope of a Guinier plot at low q and allows for the estimation of 
two parameters, which include the radius of gyration and the extrapolated intensity at zero scattering 
angle, I(0). 
 
From the Guinier plot important information about the state of the protein within the solution can be 
extracted. Firstly any upturn at low q2 that cannot be explained by the beam stop is often a sign of 
aggregation. If this upturn is so large as to affect the overall slope the data must be discarded and no 
further analysis made, as the influence of this type of aggregation can greatly affect the scattering 
pattern and is extremely difficult to remove. Downturns within this region are normally indicative of 
interparticle interference which can often be alleviated by reducing the protein concentration.  
 
 
 
 
Equation 6. Calculating the radius of gyration of a spherical object by Guinier analysis. Where m = the slope of the 
line. 
 
In practical terms the Guinier approximation is often applied using a function in Primus (Konarev et 
al., 2003) known as AutoRg or alternatively is manually fitted by the user who selects the linear region 
within the slope of the Guinier plot. The AutoRg function within Primus (Konarev et al., 2003) 
calculates the radius of gyration by selecting a data range which is suitable for the application of the 
Guinier approximation. It begins by searching the initial portion of the input data and discards 
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anything that presents an upward or downward trend. Data is selected after these regions within the 
range where the scattering intensity begins to decay by an order of magnitude. The program them 
draws a cubic parabola within the chosen range in log scale of intensity and searches for curvature 
which could suggest a non-monodisperse system. This range is continuously refined until a suitable 
data range has been selected for Guinier analysis. Following the removal of any upturns and 
downturns and assessment of the monodispersity of the sample the program begins to select possible 
Guinier intervals which are normally between 5 to 15 data points. For each interval the program 
scores the linear fit whilst working within the limits of sminRg> 1 and smaxRg< 1.3. Once the best 
intervals are found the radius of gyration is calculated and an assessment made on the accuracy of the 
calculation based upon the quality of the intervals used. The AutoRg function can also give an idea 
of the overall quality of the data it does this by scoring several criteria which include, 
 
a. How many consistent intervals were found 
b. Where the sRg conditions weakened by selection 
c. How many initial points were discarded 
d. Was there indication of effects like aggregation or interparticle interference 
e. How accurate was the calculated radius of gyration.  
 
In most cases assessment of the radius of gyration using the auto function is a speedy and highly 
reliable tool. However, there are some circumstances where the program may fail, these may include 
experiments where the molecule is very large or not globular and the default SRg limits of 1-1.3 are 
not suitable. In some cases the upper SRg limit can be increased to 1.5 and on some occasions even 
higher. AutoRg may also struggle with scattering data containing upturns due to the beamstop, in 
these cases it often calculates a reasonable radius of gyration but assesses the quality as low.  
 
Alternatively Primus (Konarev et al., 2003) offers the function to display the scattering data as a 
Guinier plot whereby the user can manually select the linear region within given SRg limits allowing 
the calculation of the radius of gyration. The Guinier analysis for the control protein lysozyme is 
shown in figure 3.28. When manually selecting the Guinier region the goal is to remove any nonlinear 
points beginning in the low-q region in order to select a Guinier region within the desired SRg limits. 
Working within the sRg limits is normally crucial to ensure the estimated radius of gyration and I(0) 
are within 10% of the true value. As a Guinier analysis is an approximation of the SAXS curve the 
determined parameters are prone to normal estimation errors. Also any curvature in the residuals 
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shown in figure 3.28 is representative of non-linear behaviour and the possibility of a non-
monodisperse system. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.28. Manual Guinier plots of the control protein lysozyme generated using Primus. The scattering data is 
plotted as In[I(q)] vs q2. The blue data points represent the scattering data, the red line shows the Guinier fit and the green 
data shows the corresponding residuals. A) Guinier plot analysis of the scattering data from lysozyme without detergent. 
B) Guinier analysis of lysozyme in 0.1% v/v LDAO. 
 
 
For the first control protein lysozyme both AutoRg and manual Guinier analysis was applied to both 
of the data sets and the calculated radius of gyration values are summarised in table 3.6. Interestingly 
the radius of gyration is reasonably consistent regardless of the method of calculation but most 
importantly it does not substantially change with the addition of LDAO which is a major concern 
when using detergents in SAXS experiments. The calculated radius of gyration of lysozyme which is 
most accurately calculated using GNOM (Svergun, 1992) was deemed to be 16.09 Angstrom which 
correlates particularly well with literature data of 16.2 at 20oC under the conditions tested (Arai & 
Hirai 1999). 
 
 
 
Parameter Calculated Rg lysozyme without LDAO Rg lysozyme in LDAO 
Primus Auto Rg 15.22 +-0.08  (sRg 0.52-1.256) 16.34 +-0.31 (sRg 0.674-1.302) 
Manual Guinier Rg 15.90 +-0.104 (sRg 0.519-1.56) 16.3 +-0.101 (sRg 0.655-1.490) 
Reciprocal space Rg 16.09 16.08 
Real space Rg 16.10  16.09 
 
Table 3.6. A summary of the calculated Rg for lysozyme with and without the detergent LDAO. On the whole the 
calculated Rg for lysozyme appears to correspond well regardless of the method used to determine the parameter. The 
value calculated using AutoRg appears to diverge a from other methods possibly due to issues with the selection of the 
Guinier region. 
A B 
q2 q2 
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3.10.4.3. Kratky analysis of lysozyme 
A Kratky analysis of scattering data can give a wealth of information about the ‘unfolded-ness’ of a 
sample and is often used to identify disordered states from globular particles, examples are shown in 
figure 3.29A. As globular macromolecules follow Porod’s law they display a bell-shaped curve. In 
contrast any extended molecules or unfolded proteins lack a defined maxima and often plateau or 
increase within the high q range (Putnam et al., 2007). The Kratky plot or I(q)*q2 versus q was 
produced for the lysozyme scattering data using sasplot within the Primus (Konarev et al., 2003) 
software and is shown in figure 3.29B. The Kratky appears as a Gaussian-like bell shaped curve with 
a well-defined maximum, this suggests that the protein is folded under the current conditions tested 
and is likely to be a globular protein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.29. Kratky plot analysis. A) Schematic representation of possible Kratky plots adapted from literature issued 
by Standford Synchrotron Radiation Lightsource. B) Kratky plot of lysozyme. I(q)*q2 plot of the lysozyme scattering 
data in buffers with and without LDAO. Blue – Lysozyme in 0.3M NaCl, 50mM tris base, pH8. Red – Lysozyme in 
0.3M NaCl, 50mM tris base, 0.1% v/v LDAO, pH8. The Kratky plot of a Gaussian-like bell shape is indicative of a 
folded molecule. 
 
 
 
 
 
 
 
 
 
 
 
A B 
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3.10.4.4. GNOM analysis and evaluation of the pair-distance distribution function - P(r) 
After the initial analysis of the integrated SAXS data, GNOM (Svergun, 1992) from the ATSAS 
(Svergun, 1992, Franke & Svergun, 2009, Volkov & Svergun, 2003, Kozin & Svergun, 2001, 
Svergun, 1999) software package is often utilised as an indirect transform program which takes one-
dimensional scattering curves and calculates a distance distribution function or P(r) it also prepares 
files for ab initio modelling. The P(r) function is a description applied to the paired set of all distances 
between points within an object. Within SAXS experiments this can be applied to describe the paired 
set of distances between all of the atoms within the macromolecular structure and is extremely useful 
in understanding conformational changes within a macromolecule as a small change made, for 
example by the binding of a ligand will result in a detectable change in the P(r) distribution. These 
small changes can cause alterations in the mass distribution of the macromolecule around its centre 
of gravity and it’s radius of gyration and as this can be obtained from the P(r) function, comparisons 
of the radius of gyration of two different samples can expose possible conformational changes within 
the macromolecule. 
 
GNOM (Svergun, 1992) was used to action a Fourier transform of the lysozyme background 
subtracted scattering data, a suitable Rmax of 47 was chosen, this selection was based upon the 
smallest value possible that gave the data or curve a smooth return to zero. It was observed that any 
further decrease to the Rmax produced a curve which plummeted to zero and any increase beyond 47 
produced a stretched tail. In general terms the Rmax should be larger than the expected particle size 
and defines the bounds for the possible particle size. Globular macromolecules should display a P(r) 
function with a single peak while stretched or unfolded proteins have long tails at large r or in some 
cases display multiple peaks alike what is observed for multidomain proteins. Examples of possible 
P(r) functions are discussed further in figure 3.30. 
 
The radius of gyration calculated using a Guinier approximation relies upon a small portion of the 
data from a SAXS experiment, in contrast the same parameter calculated from the P(r) distribution 
uses all of the experimental curve in real space and is often considered as the most accurate 
interpretation. Both lysozyme data sets with and without detergent were independently processed by 
GNOM (Svergun, 1992) and are shown in figure 3.31. 
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Figure 3.30. Examples of possible P(r) distribution plots. The relationship between relative P(r) and actual molecular 
shape. Adapted from SAS studies of biological macromolecules in solution by Svergun & Koch. (2003). 
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Figure 3.31. P(r) distribution plots for lysozyme with and without LDAO. Plots for both data sets were generated 
using GNOM (Svergun, 1992) using the full data set and an Rmax of 47. A) P(r) of lysozyme at 7 mg/ml in 0.3M NaCl, 
50mM tris base, pH8. B) P(r) of lysozyme at 7 mg/ml in 0.3M NaCl, 50mM tris base, 0.1% v/v LDAO, pH8.  
 
 
3.10.4.5. Generating the lysozyme molecular envelopes 
Output files (.out) from GNOM (Svergun, 1992) were sent to DAMMIF (Franke & Svergun, 2009), 
an ab initio modelling program which was performed twenty times for each lysozyme data set, the 
models generated are shown in figures 3.32 and 3.33. DAMMIF (Franke & Svergun, 2009) is an 
improved version of a previous program, DAMMIN (Svergun, 1999). Both programs use a bead 
modelling method for rapid shape determination of small angle scattering data. The method uses a 
collection of densely packed beads to represent a particle within a search volume; each bead can be 
part of the macromolecule or part of the solvent. Using an arbitrary starting model the programs use 
simulated annealing to develop a compact model which yields a theoretical scattering pattern which 
in turn can be compared to the experimental data.  
 
 
 
 
 
 
 
 
 
A B 
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Figure 3.32. Molecular envelopes for lysozyme without LDAO. Data collected from a lysozyme sample at 7 mg/ml in 
0.3M NaCl, 50mM tris base, pH8. Molecular envelopes were generated by DAMMIF (Franke & Svergun, 2009) and the 
program repeated to produce twenty independent models. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.33. Molecular envelopes of lysozyme in 0.1% LDAO. Data collected from a lysozyme sample at 7 mg/ml in 
0.3M NaCl, 50mM tris base, 0.1% v/v LDAO, pH8. Molecular envelopes were generated by DAMMIF (Franke & 
Svergun, 2009) and the program repeated to produce twenty independent models. 
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3.10.4.6. Evaluation and refinement of the lysozyme models 
Assessment of the generated models was made using DAMAVER (Volkov & Svergun, 2003) and is 
summarised in table 3.7. DAMAVER (Volkov & Svergun, 2003) is a suite of programs used to align 
ab initio models allowing selection of the most probable solution from which, an averaged model is 
built. The group of programs begins with DAMSEL (Volkov & Svergun, 2003) which uses the 
SUPCOMB (Kozin & Svergun, 2001) method to superimpose the low resolution 3D structures and 
then begins to determine the most probable solution and eliminate outliers.  
 
DAMSUP (Volkov & Svergun, 2003) then takes all the models excluding the outliers and aligns the 
envelopes with the model that was selected as most probable. DAMAVER (Volkov & Svergun, 2003) 
then averages these aligned models and computes a probability map which is then filtered by 
DAMFILT (Volkov & Svergun, 2003) at a given cut off volume. Following removal of outliers and 
the superimposition of all models upon the reference envelope DAMAVER (Volkov & Svergun, 
2003) produced an averaged probability map which was filtered by the removal of low occupancy 
regions by DAMFILT (Volkov & Svergun, 2003). Both DAMFILT (Volkov & Svergun, 2003) and 
DAMAVER (Volkov & Svergun, 2003) models were used to produce the final envelope with a 
cartoon of the lysozyme crystal structure (1LYZ – Diamond, 1974) docked into the bead model. PDB 
coordinates for lysozyme were manually docked into the molecular envelope using Pymol 
(Schrödinger, 2010). The final refined envelopes are shown in figure 3.34 and 3.35.  
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Solution DAMSEL NSD 
average (Standard 
deviation of NSD = 
0.020) 
Include/Discard? DAMSUP NSD 
superimposition value 
Indicative fit 
(Chi squared) 
Lysozyme (No LDAO)  
A 0.539 Reference 0.000 1.960 
B 0.593 Include 0.572 1.962 
C 0.566 Include 0.571 1.961 
D 0.560 Include 0.535 1.960 
E 0.552 Include 0.457 1.959 
F 0.571 Include 0.530 1.961 
G 0.610 Discard ----- 1.961 
H 0.544 Include 0.524 1.963 
I 0.617 Discard ----- 1.960 
J 0.560 Include 0.521 1.960 
K 0.553 Include 0.542 1.959 
L 0.557 Include 0.502 1.958 
M 0.571 Include 0.554 1.961 
N 0.565 Include 0.548 1.962 
O 0.566 Include 0.554 1.962 
P 0.566 Include 0.554 1.959 
Q 0.565 Include 0.495 1.959 
R 0.562 Include 0.554 1.959 
S 0.555 Include 0.491 1.960 
T 0.552 Include 0.530 1.958 
Lysozyme (0.1% v/v LDAO)  
A 0.551 Include 0.546 1.578 
B 0.576 Include 0.538 1.588 
C 0.553 Include 0.505 1.575 
D 0.548 Include 0.532 1.578 
E 0.542 Include 0.517 1.575 
F 0.558 Include 0.525 1.577 
G 0.522 Reference 0.000 1.577 
H 0.533 Include 0.472 1.576 
I 0.545 Include 0.515 1.578 
J 0.528 Include 0.506 1.576 
K 0.532 Include 0.516 1.576 
L 0.546 Include 0.521 1.581 
M 0.536 Include 0.513 1.581 
N 0.538 Include 0.526 1.572 
O 0.562 Include 0.537 1.576 
P 0.535 Include 0.493 1.575 
Q 0.532 Include 0.516 1.576 
R 0.610 Discard ----- 1.576 
S 0.539 Include 0.509 1.582 
T 0.539 Include 0.504 1.581 
 
Table 3.7. A summary of the evaluation and refinement of lysozyme models by DAMSEL and DAMSUP. DAMSEL 
(Volkov & Svergun, 2003) determined the mean NSD as 0.556 and 0.546 for models generated with and without LDAO 
respectively. Envelopes G and I generated for lysozyme without LDAO and envelope R with LDAO were calculated as 
outliers and the data discarded. Data for envelope A and G again with and without LDAO were identified as the most 
probably solutions in each case and this data used as the reference sets for superimposition. DAMSUP (Volkov & 
Svergun, 2003) NSD values were calculated relative to the reference set. The chi squared value represents the indicative 
fit calculated by DAMMIF (Volkov & Svergun, 2003) for each generated model. 
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Figure 3.34. Refined and filtered molecular envelopes for lysozyme without LDAO. Final molecular envelopes for 
lysozyme at 7 mg/ml in 0.3M NaCl, 50mM tris base, pH8. The green represents the DAMFILT (Volkov & Svergun, 
2003), filtered envelope, the grey as the computed probability map generated by DAMAVER (Volkov & Svergun, 2003) 
and the pink ribbon cartoon is the known crystal structure of lysozyme (1LYZ) taken from the protein data bank. 1-2. 
Front and rear view. 3-4. Side view. 5-6. End on views of the molecule. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.35. Refined and filtered molecular envelopes for lysozyme in 0.1% v/v LDAO. Final molecular envelopes 
for lysozyme at 7 mg/ml in 0.3M NaCl, 50mM tris base, 0.1% v/v LDAO, pH8. The green represents the DAMFILT 
(Volkov & Svergun, 2003), filtered envelope, the grey as the computed probability map generated by DAMAVER 
(Volkov & Svergun, 2003) and the pink ribbon cartoon is the known crystal structure of lysozyme (1LYZ) taken from 
the protein data bank. 1-2. Front and rear view. 3-4. Side view. 5-6. End on views of the molecule. 
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3.10.4.7. Effects of LDAO upon the lysozyme molecular envelope 
In order to deduce the effects of LDAO scattering upon the lysozyme models a final envelope for 
lysozyme in LDAO and without detergent was created. These DAMFILT (Volkov & Svergun, 2003) 
envelopes are shown in figure 3.36. The envelopes were overlaid alongside the mesh structure from 
published X-ray diffraction experiments. The envelopes correlate well and no major changes to the 
model can be identified when LDAO was added to the sample.  
 
The data analysis of the control protein lysozyme was deemed suitable, the Rg of 16Ǻ was not seen 
to change between the two data sets with and without the detergent LDAO and is very close to 
literature values which are summarised in table 3.8. Most importantly it was determined that the 
scattering caused by the detergent LDAO could be compensated for by the acquisition of good quality 
data used for background subtraction. The control experiments identified the need for extra care when 
preparing blanks with a dialysis matched blank being the most desired option. 
 
 
Molecule Radius of gyration (Å) 
 
Lysozyme in 0.3M NaCl, 50mM tris base, pH8 
 
16.085 
Lysozyme in 0.1% v/v LDAO, 0.3M NaCl, 50mM tris base, pH8 16.095 
 
Lysozyme literature data 
Arai & Hirai 1999 
16.3 
 
 
Table 3.8. A summary of the radius of gyration of lysozyme. Calculated Rg of lysozyme both with and without 0.1% 
v/v LDAO alongside the literature data. The calculated Rg with and without detergent are extremely close and both are 
relative to published literature values. 
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Figure 3.36. Assessment of the final molecular envelope of lysozyme by overlaying the models. Overlaid models of 
lysozyme generated in Pymol (Schrödinger, 2010) and showing the molecular envelope of lysozyme with LDAO (orange) 
and without (green), plus a surface representation of the lysozyme crystal structure (purple) taken from the protein data 
bank (1LYZ). 1-2. Front and rear view. 3-4. End on views. 5-6. Side view of the overlaid envelopes. 
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3.10.5. Methodology control protein – Ribonuclease A 
3.10.5.1. Background subtraction of Ribonuclease A 
Scattering experiments were carried out for bovine pancreatic ribonuclease A as a second control in 
order to monitor the effects of LDAO upon the determined molecular envelope. Ribonuclease A was 
purchased from Sigma Aldrich and reconstituted at 5 mg/ml in 0.3M NaCl, 50mM tris base at pH8 
both with and without 0.1% v/v LDAO. The sample was subsequently centrifuged at 15,000 x g for 
30 minutes before scattering data was collected at the B21 beamline, Diamond Light Source, Oxford. 
A total of 18 frames per sample were collected each lasting 3 seconds with the corresponding buffer 
blank sample collected both prior and after each sample. Following data integration the scattering 
generated for the blank buffer was subtracted from the scattering produced for the control sample, 
ribonuclease A. Subtractions were carried out as previously described for the lysozyme control using 
Primus (Konarev et al., 2003) and the resulting curves are shown in figure 3.37.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.37. Small angle scattering curves produced by 5 mg/ml ribonuclease A with and without 0.1% LDAO. 
Recorded scattering data is displayed as log of intensity over the scattering vector q (Ǻ). A) Raw scattering intensity plot 
of ribonuclease A and blank without LDAO in the samples. The red line is the scattering recorded for the blank sample 
(0.3M NaCl, 50mM tris base, pH8). The blue line shows the raw scattering recorded for ribonuclease at 5 mg/ml in 0.3M 
NaCl, 50mM tris base, pH8. The purple line represents the adjusted scattering of ribonuclease A following buffer blank 
background subtraction. B) Raw scattering intensity plot of ribonuclease A and blank with the detergent LDAO. The red 
line is the scattering recorded for the blank sample (0.3M NaCl, 50mM tris base, 0.1% v/v LDAO, pH8). The blue line 
shows the raw scattering recorded for ribonuclease A at 5 mg/ml in 0.3M NaCl, 50mM tris base, 0.1% v/v LDAO, pH8 
and the purple line represents the adjusted scattering of ribonuclease A following buffer blank background subtraction. 
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3.10.5.2. Calculating the radius of gyration (Rg) of ribonuclease A 
The radius of gyration was calculated both manually using a Guinier approximation and by using the 
AutoRg function within the Primus software (Konarev et al., 2003). Guinier plots for ribonuclease A, 
both with and without detergent are shown in figure 3.38 and the calculated radius of gyration was a 
larger than the literature data of 14.3Å (Wang et al., 2008). From the Guinier analysis the sample was 
found to be of satisfactory quality and the linear region was easily determined. The radius of gyration 
for ribonuclease A both with and without LDAO was exactly the same and was determined to be 16Å 
by AutoRg and 16.4Å using a manual fitting, with full details of sRg limits used summarised in table 
3.9. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.38. Manual Guinier plots of the control protein ribonuclease A generated using Primus. The scattering 
data is plotted as In[I(q)] vs q2. The blue data points represent the scattering data, the red line shows the Guinier fit and 
the green data shows the corresponding residuals. A) Guinier plot analysis of the scattering data from ribonuclease A 
without detergent. B) Guinier analysis of ribonuclease A in 0.1% v/v LDAO. 
 
 
 
Parameter Calculated Rg ribonuclease A without LDAO Rg ribonuclease A in LDAO 
Primus Auto Rg 16.02 +-0.07  (sRg 0.657-1.305) 16.04 +-0.05 (sRg 0.502-1.305) 
Manual Guinier Rg 16.4 +-2.95 (sRg 0.196-1.3) 16.4 +-1.1 (sRg 0.192-1.28) 
Reciprocal space Rg 15.71 15.68 
Real space Rg 15.71  15.68 
Table 3.9. A summary of the radius of gyration for ribonuclease A with and without the detergent LDAO. The 
radius of gyration of ribonuclease A both with and without detergent was calculated by Guinier approximation and in real 
and reciprocal space. The values are in fair agreement but importantly there was no significant difference observed 
between the sample with LDAO. 
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3.10.5.3. Kratky analysis of ribonuclease A 
A Kratky plot or I(q)*q2 versus s was produced for both sets of ribonuclease A scattering data using 
sasplot within the Primus software (Konarev et al., 2003) which are shown in figure 3.39. The Kratky 
plot appears as a Gaussian-like bell shaped curve with a well-defined maximum point and the data 
returning towards zero which suggests a compact folded protein.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.39. Kratky plots for ribonuclease A with and without 0.1% LDAO. I(q)*q2 plot of the ribonuclease A 
scattering data in buffers with and without LDAO.  
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3.10.5.4. GNOM analysis and evaluation of the pair-distance distribution function P(r) of 
ribonuclease A 
Following the initial analysis using Primus (Konarev et al., 2003) the full scattering curve was input 
into GNOM (Svergun, 1992) which actioned a Fourier transform of the ribonuclease A background 
subtracted scattering data. A suitable Rmax of 45 was chosen, this selection was based upon the 
smallest value possible that gave a smooth return to zero. Both ribonuclease A data sets were 
independently processed by GNOM (Svergun, 1992) and the P(r) functions are shown in figure 3.40. 
Both ribonuclease A data sets with and without detergent produced similar P(r) functions and were 
indicative of a compact protein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.40. P(r) distribution plots for ribonuclease A with and without LDAO. Plots for both data sets were 
generated using GNOM (Svergun, 1992) using the full data set and an Rmax of 45Å. A) P(r) of Ribonuclease A at 5 
mg/ml in 0.3M NaCl, 50mM tris base, pH8. B) P(r) of ribonuclease A at 5 mg/ml in 0.3M NaCl, 50mM tris base, 0.1% 
v/v LDAO, pH8.  
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3.10.5.5. Generating ribonuclease A molecular envelopes 
Output files (.out) from GNOM (Svergun, 1992) were sent to DAMMIF (Franke & Svergun, 2009), 
an ab initio modelling program which was performed twenty times for each data set and the models 
generated are shown in figures 3.41 and 3.42. All modelling was performed as previously described 
for the first control protein lysozyme. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.41. Molecular envelopes for ribonuclease A without LDAO. Data collected from a ribonuclease A sample at 
5 mg/ml in 0.3M NaCl, 50mM tris base, pH8. Molecular envelopes were generated by DAMMIF (Franke & Svergun, 
2009) and the program repeated to produce twenty independent models. 
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Figure 3.42. Molecular envelopes of ribonuclease A in 0.1% LDAO. Data collected from a ribonuclease A sample at 
5 mg/ml in 0.3M NaCl, 50mM tris base, 0.1% v/v LDAO, pH8. Molecular envelopes were generated by DAMMIF 
(Franke & Svergun, 2009) and the program repeated to produce twenty independent models. 
 
 
3.10.5.6. Evaluation and refinement of the ribonuclease A models 
Assessment of the generated models was made using the DAMAVER suite of programs (Volkov & 
Svergun, 2003), the PDB files for the twenty generated models were submitted to DAMSEL (Volkov 
& Svergun, 2003). Following alignment of the models for ribonuclease A without LDAO it was 
determined that envelopes R and T should be discarded as their calculated NSD was beyond two 
points of standard deviation alike that of envelopes K and T for ribonuclease A envelopes with 
LDAO. Following removal of the outliers the remaining models were sent to DAMSUP (Volkov & 
Svergun, 2003) for further alignment and the NSD calculated a second time. All alignment data is 
shown in table 3.10. 
 
Following alignment the remaining models were submitted to DAMAVER (Volkov & Svergun, 
2003) where all models were averaged and a probability map computed, this averaged envelope was 
then taken by DAMFILT (Volkov & Svergun, 2003) for removal of low occupancy regions. The 
resulting final models are shown in figure 3.43. 
S 
B 
H 
N 
F I 
E D C 
K 
G 
M 
R Q P 
J 
O L 
T 
A 
Page | 205  
 
Solution DAMSEL NSD 
average (Standard 
deviation of NSD = 
0.067 without 
LDAO and 0.106 
with LDAO) 
Include/Discard? DAMSUP NSD 
superimposition value 
Indicative fit 
(Chi squared) 
Ribonuclease A (No LDAO)  
A 0.739 Include 0.592 4.829 
B 0.853 Include 0.798 4.834 
C 0.694 Include 0.646 4.783 
D 0.736 Include 0.663 4.841 
E 0.680 Include 0.642 4.804 
F 0.737 Include 0.663 4.834 
G 0.750 Include 0.589 4.803 
H 0.756 Include 0.715 4.821 
I 0.718 Include 0.513 4.809 
J 0.803 Include 0.768 4.824 
K 0.748 Include 0.632 4.822 
L 0.673 Reference 0.000 4.813 
M 0.690 Include 0.606 4.790 
N 0.727 Include 0.619 4.789 
O 0.739 Include 0.593 4.786 
P 0.701 Include 0.564 4.786 
Q 0.714 Include 0.667 4.821 
R 0.916 Discard ----- 4.814 
S 0.705 Include 0.675 4.825 
T 0.890 Discard ----- 4.835 
Ribonuclease A (0.1% LDAO)  
A 0.711 Include 0.535 3.339 
B 0.726 Include 0.603 3.336 
C 0.678 Include 0.506 3.327 
D 0.736 Include 0.598 3.326 
E 0.693 Include 0.615 3.335 
F 0.683 Include 0.505 3.357 
G 0.690 Include 0.528 3.326 
H 0.836 Include 0.934 3.346 
I 0.723 Include 0.563 3.312 
J 0.767 Include 0.654 3.325 
K 1.006 Discard ----- 3.339 
L 0.774 Include 0.731 3.361 
M 0.674 Include 0.536 3.346 
N 0.683 Include 0.528 3.344 
O 0.689 Include 0.547 3.322 
P 0.709 Include 0.553 3.360 
Q 0.839 Include 0.873 3.345 
R 0.664 Reference 0.000 3.332 
S 0.723 Include 0.550 3.324 
T 1.052 Discard ----- 3.348 
 
Table 3.10.A summary of the evaluation and refinement of ribonuclease A models by DAMSEL and DAMSUP. 
DAMSEL (Volkov & Svergun, 2003) determined the mean NSD as 0.748 and 0.753 for models generated with and 
without LDAO respectively. Envelopes R and T generated for ribonuclease A without LDAO and envelope K and T with 
LDAO were calculated as outliers and the data discarded. Data for envelope L and R again with and without LDAO were 
identified as the most probably solutions in each case and this data used as the reference sets for superimposition. 
DAMSUP (Volkov & Svergun, 2003) NSD values were calculated relative to the reference set. The chi squared value 
represents the indicative fit calculated by DAMMIF (Volkov & Svergun, 2003) for each generated model. 
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Figure 3.43. Refined and filtered molecular envelopes of ribonuclease A with and without LDAO detergent. The 
green represents the DAMFILT (Volkov & Svergun, 2003), filtered envelope, the grey as the computed probability map 
generated by DAMAVER (Volkov & Svergun, 2003) and the pink ribbon cartoon is the known crystal structure of 
ribonuclease A (1FS3) taken from the protein data bank A, B, C Final molecular envelopes for ribonuclease A at 7 mg/ml 
in 0.3M NaCl, 50mM tris base, pH8 with front, side and end on views. 1, 2, 3Final molecular envelopes for ribonuclease 
A at 7 mg/ml in 0.3M NaCl, 50mM tris base, 0.1% v/v LDAO, pH8 shown with front, side and end on views. 
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3.10.5.7. Effects of LDAO upon the ribonuclease A molecular envelope 
In order to deduce the effects of LDAO scattering upon the ribonuclease A models a final envelope 
for lysozyme in LDAO and without detergent was created. These DAMFILT (Volkov & Svergun, 
2003) envelopes are shown in figure 3.44. The envelopes were overlaid alongside the surface 
structure from published X-ray diffraction experiments (PDB entry 1RNC – Aguilar et al., 1992). 
The envelopes correlate well and no major changes to the model can be identified upon the addition 
of LDAO to the sample and the blank.  
 
The data analysis of the second control protein ribonuclease A was also promising, the radius of 
gyration was not seen to change between the two data both with and without the detergent LDAO. 
The experimentally determined radius of gyration for ribonuclease A both with and without LDAO 
was 15.7Å, this is larger than literature data of 14.3Å (Wang et al., 2008) however the radius of 
gyration can be effected by experimental conditions including temperature and pH (table 3.11).   
 
Most importantly it was determined that the scattering caused by the detergent LDAO could be 
compensated for by the acquisition of good quality data and appropriate background subtraction. The 
control experiments also identified the need for extra care when preparing blanks with a dialysis 
matched blank being the most desired option. 
 
 
Molecule Radius of gyration (Å) 
Ribonuclease A in 0.3M NaCl, 50mM tris base, pH8 15.71 
Ribonuclease A in 0.1% v/v LDAO, 0.3M NaCl, 50mM tris base, pH8 15.68 
Ribonuclease A literature data (Wang et al. 2008) 14.3 
 
Table 3.11. A summary of the radius of gyration of ribonuclease A. Calculated Rg of ribonuclease A both with and 
without 0.1% v/v LDAO alongside the literature data. The calculated Rg with and without detergent are extremely close 
and both are relative to published literature values. 
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Figure 3.44. Assessment of the final molecular envelope of ribonuclease A by overlaying the models. Overlaid 
models of ribonuclease A generated in Pymol (Schrödinger, 2010) and showing the molecular envelope of ribonuclease 
A with LDAO (orange) and without (green), plus a surface representation of the ribonuclease A crystal structure (purple) 
taken from the protein data bank (1FS3). 1-2. Front and rear view. 3-4. End on views. 5-6. Side view of the overlaid 
envelopes. 
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3.10.6. When detergent scattering is not accounted for 
In order to determine the importance of correct background subtraction, experiments were conducted 
where non-corresponding background scattering was subtracted from the sample scattering. Buffer 
blank scattering data from a sample of 0.3M NaCl, 50mM tris base at pH8 was subtracted from the 
scattering generated by a sample of lysozyme at 7 mg/ml and a sample of ribonuclease A at 5 mg/ml 
reconstituted in the above buffer plus 0.1% v/v LDAO. The resulting data shows that when detergent 
isn’t accounted and isn’t subtracted from the sample, ab inito modelling leads to the creation of 
micelle structures as shown in figure 3.46. 
 
For these test experiments all analysis, modelling and refinement was carried out as previously 
described, the only difference was that LDAO was not accounted for within the background 
subtraction. The full parameters are shown in table 3.12 and the Guinier approximation, Kratky 
analysis and P(r) functions shown in figure 3.45. 
 
Calculated Parameters  Lysozyme Ribonuclease A 
Rmax 44 44 
AutoRg 15.61 +-0.42 sRg limits 0.511-1.288 15.67+-0.67 sRg limits 0.6-1.32 
Guinier Rg 16.2 +-0.161 sRg limits 0.506-1.49 15.6 +-0.271 sRg limits 0.488-1.22 
Reciprocal space Rg 16.01 16.04 
Real space Rg 15.99 16.03 
I (0)  0.4036E+02  
 
Table 3.12. Parameters used for the analysis of the effects caused by poor background subtraction on the control 
protein lysozyme. All analysis was performed as previously described, a gnom output file (Svergun, 1992) was generated 
and used for molecular envelop generation. 
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Figure 3.45. Graphical output from the analysis of lysozyme at 7 mg/ml and ribonuclease at 7 mg/ml with incorrect 
background subtraction. A) Guinier plot showing no obvious signs of problems, the Guinier approximation gave an 
estimated Rg of 16.2. B) A Kratky analysis with a typical bell shape curve indicating a folded protein. C) P(r) analysis of 
the sample suggesting a globular compact molecule. From initial analysis the poor back subtraction cannot be identified. 
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Figure 3.46. Final molecular envelopes for lysozyme and ribonuclease samples at 7 mg/ml with inappropriate 
background subtraction. Following the generation of 20 DAMMIF (Franke & Svergun, 2009) models for both lysozyme 
and ribonuclease A the final envelopes were determined after filtering and refinement as previously described. The green 
represents the DAMFILT (Volkov & Svergun, 2003), filtered envelope and the grey the computed probability map 
generated by DAMAVER (Volkov & Svergun, 2003). The final models for both samples are representative of a LDAO 
micelle. By applying an incorrect background subtraction the contrast between the protein sample and the solvent is poor 
allowing visualisation of the target protein. 
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3.10.7.1. SAXS data collection of BAPKO_0422 
SAXS data for BAPKO_0422 was collected for three different concentrations with the poly-histidine 
tag and for two data sets at different concentrations with the tag removed with the background 
subtracted scattering obtained shown in figure 3.47. Data was collected for 2400 seconds per frame, 
with ten frames for every sample and the blank. Various concentrations were used to ensure there 
was no relationship between an increasing the concentration and changes in the radius of gyration. 
Monodisperse systems from good quality samples devoid of protein aggregation or interpacticle 
interference should give a consistent radius of gyration regardless of the protein concentration. An 
increasing radius of gyration when increasing concentration is a sign of protein aggregation and is 
often seen by an upturn during Guinier analysis, in contrast a decreasing radius of gyration with an 
increase in sample concentration highlights interpacticle interference (Jacques and Trewhella 2009). 
A small upturn was noticed for all samples however this was also observed for the blank sample and 
decided that these first 12 points were due to the beamstop positioning for the NanoStar. Visual 
inspection of all 10 frames showed the level of scattering was consistent throughout the experiment 
and the protein appeared to remain stable for the full exposure with no signs of radiation damage.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.47. Background subtracted scattering data of samples of BAPKO_0422 at various concentrations. BLUE 
– Scattering data for tagged BAPKO_0422 at 2.5 mg/ml. RED – Scattering data for tagged BAPKO_0422 at 4 mg/ml. 
q 
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PINK – Scattering data for tagged BAPKO_0422 at 4.5 mg/ml. GREEN – Scattering data for untagged BAPKO_0422 at 
4 mg/ml. BLACK – Scattering data for untagged BAPKO_0422 at 3 mg/ml. 
3.10.7.2. Calculating the radius of gyration of BAPKO_0422 
All data analysis was carried out as previously described for the control protein lysozyme. The Rg for 
BAPKO_0422 was calculated using the Guinier approximation (figure 3.48) and also calculated in 
real space using GNOM (Svergun, 1992). AutoRg was used where possible and where sRg limits 
permitted. All Rg data for BAPKO_0422 is compiled in table 3.13. From initial analysis of the six 
data sets only three were suitable for modelling and the selection was based upon the quality of the 
data. Three data sets were excluded, two with the tag present and one without, these were discarded 
due to varying levels of aggregation identified from an upturn at low q2 and due to an inconsistent 
Kratky plot indicating a mixture of folded/unfolded protein which is shown in figure 3.49. 
 
 
3.10.7.3. Kratky analysis of BAPKO_0422 
A Kratky plot or I(q)*q2 versus s was produced for all BAPKO_0422 data sets using sasplot within 
the Primus package (Konarev et al., 2003). Kratky plots for all data sets are shown in figure 3.49. 
Two of the data sets for tagged BAPKO_0422 at 2.5 and 4 mg/ml produced a curve with a clear 
maximum but also with an increasing tail, the plots were representative of a partially folded protein 
indicating poor sample quality and the data sets were discarded. The three remaining data sets one 
for the histidine tagged protein and two for generated from untagged protein samples gave rise to the 
typical bell-shaped curve with a clear maximum value and these data sets were used for GNOM 
(Svergun, 1992) analysis and further modelling. Included and excluded data sets with their 
corresponding radius of gyration values are shown in table 3.12. 
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Figure 3.48. Guinier plots of BAPKO_0422. Guinier plots generated using Primus (Konarev et al., 2003) and 
representing data sets used for modelling. The scattering data is plotted as In[I(q)] vs q2. The blue data points represent 
the scattering data, the red line shows the Guinier fit and the green data shows the corresponding residuals. A) Guinier 
analysis of tagged BAPKO_0422 at 2.5 mg/ml. B) Guinier plot of tagged BAPKO_0422 at 4 mg/ml. C) Guinier plot of 
tagged BAPKO_0422 at 4.5 mg/ml. D) Guinier plot of untagged BAPKO_0422 at 4 mg/ml. E) Guinier plot of untagged 
BAPKO_0422 at 3 mg/ml. 
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Figure 3.49. Kratky plot analysis of BAPKO_0422. Kratky plots or I(q)*q2 plots of BAPKO_0422 samples generated 
using Primus (Konarev et al., 2003) A) Kratky plot of the scattering data generated by tagged BAPKO_0422 at 4.5 mg/ml 
in 0.3M NaCl, 50mM tris base, 0.1% v/v LDAO, pH8. B) Kratky plot generated from 3 mg/ml untagged BAPKO_0422 
in 0.3M NaCl, 50mM tris base, 0.1% v/v LDAO, pH8. C) Kratky analysis of untagged BAPKO_0422 at 4 mg/ml. Plots 
A, B and C are representative of a folded globular like protein and these data sets were used for further analysis. D) Kratky 
analysis of the two excluded data sets, the Kratky represents partially folded protein and therefore the data was excluded. 
BLUE – BAPKO_0422 untagged at 4 mg/ml. RED – BAPKO_0422 histidine tagged at 2.5 mg/ml.  
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Sample Auto Rg (Å) Guinier Rg (Å) Reciprocal 
space Rg (Å) 
Real space 
Rg (Å) 
Data used/ 
Discarded? 
BAPKO_0422 tagged 2.5 
mg/ml 
---- 15+-0.361 
sRg 0.916-1.41 
16.78 16.79 Discarded 
BAPKO_0422 tagged 4 
mg.ml 
12.48+-0.39  
SRg 0.959-1.278 
14.1+-0.204 
sRg 0.922-1.5 
16.75 16.77 Discarded 
BAPKO_0422 tagged 4.5 
mg/ml 
13.91+-0.39 
sRg 0.789-1.65 
13+-0.227 
sRg 0.958-1.38 
16.62 16.65 Used 
BAPKO_0422 untagged 
4 mg/ml 
 
---- 
12.2+-0.39 
sRg 0.896-1.50 
14.4 14.47 Used 
BAPKO_0422 untagged 
3 mg/ml 
11.68+-0.16 
sRg 0.482-0.931 
12.4+-0.114 
sRg 0.510-1.11 
14.29 14.28 Used 
 
Table 3.13. Radius of gyration values for all BAPKO_422 data sets. The radius of gyration was calculated for all data 
sets using the Primus (Konarev et al., 2003) AutoRg function and by manual Guinier approximation. The values were 
further calculated using the full experimental data both in reciprocal and real space during GNOM (Svergun, 1992) 
analysis. Following Kratky analysis data sets, 2.5 and 4 mg/ml tagged BAPKO_0422 were discarded due to the presence 
of partially folded protein. 
 
 
3.10.7.4. GNOM analysis and evaluation of the pair-distance distribution function P(r) of 
BAPKO_0422 
Following the initial analysis of the background subtracted scattering data GNOM (Svergun, 1992) 
was used as an indirect transform program for examination of the P(r) function and for preparation 
of a gnom.out file for use in ab initio modelling. The three BAPKO_0422 data sets were submitted 
to GNOM (Svergun, 1992) independently where their radius of gyration was calculated in both 
reciprocal and real space, shown in figure 3.50. The P(r) function for all three data sets was 
representative of a single domain compact protein. 
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Figure 3.50. GNOM analysis of the BAPKO_0422 data sets. GNOM (Svergun, 1992) was used as an indirect transform 
tool, the radius of gyration was calculated for all data sets in both real and reciprocal space. 1-3A – Reciprocal space fit 
for tagged BAPKO_0422 at 3 mg/ml, untagged BAPKO_0422 at 4 mg/ml and tagged BAPKO_0422 at 4.5 mg/ml 
respectively. 1-3B – P(r) function for tagged BAPKO_0422 at 3 mg/ml, untagged BAPKO_0422 at 4 mg/ml and tagged 
BAPKO_0422 at 4.5 mg/ml respectively. 
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3.10.7.5. Generating molecular envelopes for untagged BAPKO_0422 
Using the same methodology as was used for the control protein lysozyme, data for untagged 
BAPKO_0422 was transformed using GNOM (Svergun, 1992) and the output file submitted to 
DAMMIF (Franke & Svergun, 2009) for ab initio modelling. The process was repeated until twenty 
impendent molecular envelopes were produced for each data set giving a total of forty models. The 
initial envelopes for both data sets are shown in figure 3.51. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.51. DAMMIF molecular envelopes of untagged BAPKO_0422. Molecular envelopes were generated by 
DAMMIF (Franke & Svergun, 2009) and the program repeated to produce twenty independent models per data set. 
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Envelopes A-T were generated from scattering data from untagged BAPKO_0422 at 4.5 mg/ml. Envelopes 1-20 generated 
from scattering data from untagged BAPKO_0422 at 3 mg/ml. 
 
3.10.7.6. Evaluation and refinement of untagged BAPKO_0422 
For initial modelling both data sets of untagged BAPKO_422 at 4.5 and 3 mg/ml were refined 
independently from each other. Assessment of the generated envelopes was carried out by DAMSEL 
(Volkov & Svergun, 2003) and DAMSUP (Volkov & Svergun, 2003) as previously described for the 
control proteins. Outliers were identified by two points of standard deviation from the calculated NDS 
mean and were removed. Envelopes P and 20 were chosen by DAMSEL (Volkov & Svergun, 2003) 
as the reference envelopes for superimposition with full DAMSEL (Volkov & Svergun, 2003) and 
DAMSUP (Volkov & Svergun, 2003) data summarised in table 3.14. Assessment by eye of the 
DAMMIF (Franke & Svergun, 2009) envelopes highlighted that model 7 generated for untagged 
BAPKO_0422 at 3 mg/ml was rather different from the other models, DAMSEL (Volkov & Svergun, 
2003) confirmed this and removed the envelope alongside model S for the 4 mg/ml data. 
 
Following refinement DAMAVER (Volkov & Svergun, 2003) was used to produce an averaged 
probability map this map was then filtered by DAMFILT (Volkov & Svergun, 2003) which removed 
regions of low occupancy to give a final molecular envelope for both of the untagged BAPKO_0422 
data sets which are shown in figure 3.52. 
 
E. coli, OmpX was selected as an example OMP to be docked into the experimentally derived 
molecular envelope. This protein was used to make initial assessments of the SAXS model and was 
selected as it represented a well-studied 8-stranded beta barrel. OmpX was selected over OmpA as 
its dimensions were proposed to be most similar to the Borrelia OMPs. The relative order of OmpX 
was hypothesised to represent the Borrelia OMPs. OmpX is composed of an 8-stranded beta barrel 
which has an extensive hydrogen bonding network of conserved residues and resembles an inverse 
micelle. The extracellular loops are much more variable than the barrel region and much larger than 
the intracellular turns. The docked structure is represented as a cartoon of the secondary structure 
elements within the molecular envelope as shown in figure 3.52. 
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Solution DAMSEL NSD 
average (Standard 
deviation of NSD = 
0.010 and 0.048 ) 
Include/Discard? DAMSUP NSD 
superimposition value 
Indicative fit 
(Chi squared) 
Untagged BAPKO_0422 at 4.5 mg/ml  
A 0.517 Include 0.492 4.363 
B 0.515 Include 0.497 4.362 
C 0.528 Include 0.522 4.363 
D 0.500 Include 0.506 4.363 
E 0.503 Include 0.510 4.363 
F 0.502 Include 0.446 4.362 
G 0.513 Include 0.516 4.362 
H 0.505 Include 0.482 4.363 
I 0.511 Include 0.524 4.363 
J 0.508 Include 0.429 4.364 
K 0.515 Include 0.494 4.363 
L 0.502 Include 0.486 4.363 
M 0.521 Include 0.501 4.362 
N 0.530 Include 0.506 4.363 
O 0.515 Include 0.537 4.363 
P 0.497 Reference 0.000 4.363 
Q 0.513 Include 0.457 4.364 
R 0.513 Include 0.527 4.363 
S 0.535 Discard ----- 4.363 
T 0.518 Include 0.520 4.363 
Untagged BAPKO_0422 at 3 mg/ml  
1 0.480 Include 0.487 3.953 
2 0.491 Include 0.479 3.960 
3 0.489 Include 0.472 3.962 
4 0.482 Include 0.489 3.957 
5 0.492 Include 0.489 3.954 
6 0.492 Include 0.494 3.953 
7 0.702 Discard ----- 3.962 
8 0.496 Include 0.496 3.962 
9 0.488 Include 0.498 3.958 
10 0.478 Include 0.256 3.955 
11 0.488 Include 0.492 3.957 
12 0.480 Include 0.442 3.957 
13 0.492 Include 0.476 3.958 
14 0.480 Include 0.438 3.958 
15 0.497 Include 0.485 3.960 
16 0.482 Include 0.428 3.958 
17 0.483 Include 0.488 3.958 
18 0.488 Include 0.471 3.960 
19 0.499 Include 0.494 3.960 
20 0.478 Reference 0.000 3.957 
 
Table 3.14. DAMSEL and DAMSUP scoring for untagged BAPKO_0422. A summary of the evaluation and 
refinement of untagged BAPKO_0422 models by DAMSEL (Volkov & Svergun, 2003) and DAMSUP (Volkov & 
Svergun, 2003). DAMSEL (Volkov & Svergun, 2003) determined the mean NSD as 0.513 and 0.498 for the 4.5 mg/ml 
and 3 mg/ml data sets respectively. Envelope S and 7 were calculated as outliers and the data discarded. Data for envelopes 
P and 20 were identified as the most probably solutions in each case and this data was used as the reference set for 
superimposition. DAMSUP (Volkov & Svergun, 2003) NSD values were calculated relative to the reference set. The chi 
squared value represents the indicative fit calculated by DAMMIF (Volkov & Svergun, 2003) for each generated model. 
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Figure 3.52. Final molecular envelopes for untagged BAPKO_0422. Following the generation of 20 DAMMIF (Franke & Svergun, 2009) models the final envelopes were 
determined after filtering and refinement as previously described. The green represents the DAMFILT (Volkov & Svergun, 2003), filtered envelope, the grey as the computed 
probability map generated by DAMAVER (Volkov & Svergun, 2003) and the pink ribbon cartoon is the known crystal structure of E. coli OmpX (1QJ8 - Vogt & Schulz, 1999) 
taken from the protein data bank. All models were generated using Pymol (Schrödinger, 2010). 1A-D) Final molecular envelope of untagged BAPKO_0422 at 4.5 mg/ml. 2A-D) 
The final model of untagged BAPKO_0422 at 3 mg/ml.
1A 
1C 1D 
1B 2A 2B 
2C 2D 
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3.10.7.7. Generating molecular envelopes for histidine tagged BAPKO_0422 
Molecular envelopes were generated for the final BAPKO_0422 data set which contained a 
polyhistidine tag, the output file generated from GNOM (Svergun, 1992) for the data set was 
submitted to DAMMIF (Franke & Svergun, 2009) for ab initio modelling. DAMMIF (Franke & 
Svergun, 2009) modelling was repeated twenty times to generate 20 independent envelopes for 
further evaluation and refinement. The envelopes for tagged BAPKO_0422 are shown in figure 3.53. 
 
 
 
 
Figure 3.53. DAMMIF molecular envelopes of histidine tagged BAPKO_0422. Twenty envelopes were independently 
generated by DAMMIF (Franke & Svergun, 2009) for tagged BAPKO_0422 at 4 mg/ml which were then evaluated by 
DAMSEL (Volkov & Svergun, 2003). 
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3.10.7.8. Evaluation and refinement of histidine tagged BAPKO_0422 
The envelopes generated by DAMMIF (Franke & Svergun, 2009) for histidine tagged BAPKO_0422 
were assessed by DAMSEL (Volkov & Svergun, 2003) and DAMSUP (Volkov & Svergun, 2003) as 
previously described. The NSD of envelope J was calculated as significantly different from the 
remaining envelopes and was removed before the files were submitted to DAMSUP (Volkov & 
Svergun, 2003). Envelopes D and O were observed to have the lowest NSD values and were 
automatically selected as the reference envelopes for superimposition as shown in table 3.15. 
 
Following the removal of the outliers and the superimposition of all remaining models the coordinate 
and PDB files were submitted to DAMAVER (Volkov & Svergun, 2003) in order to compute a 
probability map which was later filtered by DAMFILT (Volkov & Svergun, 2003). The final 
DAMAVER (Volkov & Svergun, 2003) and DAMFILT (Volkov & Svergun, 2003) envelopes are 
shown in figure 3.54. 
 
 
Solution DAMSEL NSD 
average (Standard 
deviation of NSD = 
0.128) 
Include/Discard? DAMSUP NSD 
superimposition value 
Indicative fit 
(Chi squared) 
Histidine tagged BAPKO_0422  
A 0.514 Include 0.465 4.750 
B 0.519 Include 0.475 4.749 
C 0.520 Include 0.496 4.751 
D 0.491 Reference 0.000 4.750 
E 0.528 Include 0.503 4.749 
F 0.509 Include 0.454 4.751 
G 0.528 Include 0.495 4.749 
H 0.532 Include 0.508 4.750 
I 0.524 Include 0.496 4.750 
J 1.092 Discard ----- 4.750 
K 0.518 Include 0.452 4.749 
L 0.520 Include 0.453 4.750 
M 0.520 Include 0.496 4.750 
N 0.531 Include 0.503 4.750 
O 0.491 Reference 0.000 4.749 
P 0.526 Include 0.484 4.750 
Q 0.516 Include 0.434 4.750 
R 0.538 Include 0.530 4.749 
S 0.530 Include 0.499 4.750 
T 0.521 Include 0.497 4.750 
 
Table 3.15. A summary of the evaluation and refinement of histidine tagged BAPKO_0422 models by DAMSEL 
and DAMSUP. DAMSEL (Volkov & Svergun, 2003) determined the mean NSD as 0.548. Envelope J was calculated 
as an outlier and the data discarded. Data for envelopes D and O were identified as the most probably solutions in each 
case and this data used as the reference set for superimposition. DAMSUP (Volkov & Svergun, 2003) NSD values were 
calculated relative to the reference set. The chi squared value represents the indicative fit calculated by DAMMIF 
(Volkov & Svergun, 2003) for each generated model. 
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Figure 3.54. Refined and filtered molecular envelope for histidine tagged BAPKO_0422 at 4 mg/ml. Following the 
generation of 20 DAMMIF (Franke & Svergun, 2009) models the final envelope was determined after filtering and 
refinement by DAMAVER (Volkov & Svergun, 2003). The green represents the DAMFILT (Volkov & Svergun, 2003), 
filtered envelope and the grey is the computed probability map generated by DAMAVER (Volkov & Svergun, 2003). 
The purple cartoon is OmpX from E. coli, data taken from the protein data bank (1QJ8 - Vogt & Schulz, 1999). 
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3.10.8.1. SAXS data collection for BB_0562 
Scattering data for BB_0562 was collected over three different concentrations both with and without 
the poly-histidine tag. The scattering data following background subtraction is shown in figure 3.55. 
Scattering data was collected for 2400 seconds per frame with ten frames for every sample and for 
the blank.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.55. Background subtracted scattering data for samples of BB_0562 at various concentrations. From top 
curve to bottom. A) BLACK – Scattering data for tagged BB_0562 at 6.5mg/ml. B) DARK BLUE – Scattering data 
for tagged BB_0562 at 6mg/ml. C) GREEN – Scattering data for untagged BB_0562 at 5mg/ml. D) RED – Scattering 
data for tagged BB_0562 at 4mg/ml. E) PURPLE – Scattering data for untagged BB_0562 at 3mg/ml. F) LIGHT 
BLUE – Scattering data for untagged BB_0562 at 2.5mg/ml. 
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3.10.8.2. Calculating the radius of gyration of BB_0562  
All data analysis was carried out as previously described for the control protein lysozyme. The radius 
of gyration for BB_0562 was calculated using the Guinier approximation and also calculated in real 
and reciprocal space using GNOM (Svergun, 1992). AutoRg was used where possible and where sRg 
limits permitted. All radius of gyration values for BB_0562 are compiled in table 3.16 and the Guinier 
analysis shown in figure 3.56. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.56. Manual Guinier plots for BB_0562. Guinier plots generated using Primus (Konarev et al., 2003) and 
representing all data sets. The scattering data is plotted as In[I(q)] vs q2. The blue data points represent the scattering data, 
the red line shows the Guinier fit and the green data shows the corresponding residuals. A) Guinier analysis of tagged 
BB_0562 at 6.5 mg/ml. B) Guinier plot of tagged BB_0562 at 6 mg/ml. C) Guinier plot of untagged BB_0562 at 5 mg/ml. 
D) Guinier plot of tagged BB_0562 at 4 mg/ml. E) Guinier plot of untagged BB_0562 at 3 mg/ml. F) Guinier plot of 
untagged BB_0562 at 2.5 mg/ml. The Guinier region was particularly difficult to determine and the dataset discarded.  
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3.10.8.3. Kratky analysis of BB_0562 
Kratky plots were generated for all six data sets for BB_0562 and are shown in figure 3.57. From 
both the Guinier approximation and the Kratky plots only three of the six data sets were deemed 
suitable for modelling. This selection was based upon the quality of the data with data sets A (tagged 
BB_0562 at 6.5 mg/ml), D (tagged BB_0562 at 4 mg/ml) and F (untagged BB_0562 at 2.5 mg/ml) 
being excluded due to the Kratky analysis which failed to show a bell shaped curve with a clear 
maximum peak which returned towards zero, this was indicative of a sample containing partially 
folded protein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.57. Kratky plot analysis of BB_0562. A) DARK RED Kratky plot or I(q)*q2 plot of the scattering data 
generated by tagged BB_0562 at 6.5 mg/ml in 0.3M NaCl, 50mM tris base, 0.1% v/v LDAO, pH8. B) BLUE -  Kratky 
plot generated from a sample of tagged BB_0562 at 6 mg/ml. C) LIGHT GREEN - Kratky analysis of untagged BB_0562 
at 5 mg/ml. D) RED - Kratky analysis of tagged BB_0562 at 4 mg/ml. E) GREEN – untagged BB_0562 at 3 mg/ml. F) 
DARK BLUE – untagged BB_0562 at 2.5 mg/ml. The Kratky analysis of samples of BB_0562 at 6 mg/ml, 5 mg/ml and 
3 mg/ml, B/C/E respectively show a well behaved bell shape curve with a clear maxima. These samples were selected for 
further modelling.   
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From evaluation of both the Guinier fit and the Kratky analysis it was decided to exclude BB_0562 
data generated for untagged BB_0562 at 2.5 mg/ml, and for tagged BB_0562 at 4 and 6.5 mg/ml. 
This data was discarded due to difficulty when applying the Guinier approximation and due to the 
generated Kratky plots shown in figure 3.57. Kratky analysis of the excluded data sets failed to show 
a bell shaped curve with a clear maximum peak which returned towards zero, this was indicative of 
a sample containing partially folded protein. 
 
 
 
Sample Auto Rg Guinier Rg Rmax Reciprocal 
space Rg 
Real space 
Rg 
Data used/ 
Discarded? 
A. BB_0562 6.5 
mg/ml 
Tagged 
----- 11.02+-0.109 
sRg 0.970-1.57 
45 14.03 14.09 Discarded 
B. BB_0562 6 
mg/ml 
Tagged 
 
---- 
14.3+-0.125 
sRg 0.915-1.61 
45 14.27 14.31 Used 
C. BB_0562 5 
mg/ml 
Untagged 
13.91+-0.39 
sRg 0.789-
1.65 
14.1+-0.158 
sRg 0.882-1.66 
45 14.29 14.34 Used 
D. BB_0562 4 
mg/ml 
Tagged 
38.57+-11.33 
sRg1.152-
1.701 
13.8+-0.213 
sRg 0.861-1.59 
45 14.43 14.50 Discarded 
E. BB_0562 
3 mg/ml 
Untagged 
14.82+-11.15 
sRg 0.946-
1.286 
 
14.6+-0.246 
sRg 0.872-1.64 
45 14.07 14.09 Used 
F. BB_0562 2.5 
mg/ml 
Untagged 
 
---- 
13.5+-0.294 
sRg 0.788-1.6 
45 14.5 14.6 Discarded 
 
Table 3.16. Radius of gyration values for all BB_0562 data sets. The radius of gyration was calculated for all data sets 
using the Primus (Konarev et al., 2003) AutoRg function and by manual Guinier approximation. The values were further 
calculated using the full experimental data both in reciprocal and real space during GNOM (Svergun, 1992) analysis.  
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3.10.8.4. GNOM analysis and evaluation of the pair-distance distribution function of BB_0562 
Following the removal of unsuitable data the two remaining data sets for untagged BB_0562 and the 
single dataset for tagged BB_0562 were processed by GNOM (Svergun, 1992) and the P(r) function 
evaluated. All parameters were kept as standard and an Rmax of 45 selected. The chosen Rmax 
reflected the point in which the P(r) function returned to zero with a steady decline. The radius of 
gyration for each of the samples was calculated both in reciprocal and reals space with the curves 
shown in figure 3.58.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.58. Calculation of reciprocal and real space Rg with P(r) analysis of included BB_0562 data sets. GNOM 
(Svergun, 1992) was used as an indirect transform tool, the radius of gyration was calculated for all data sets in both real 
and reciprocal space. 1-3A – Reciprocal space fit for tagged BB_0562 at 6 mg/ml, untagged BB_0562 at 5 mg/ml and 
untagged BB_0562 at 3 mg/ml respectively. 1-3B – P(r) function for tagged BB_0562 at 6 mg/ml, untagged BB_0562 at 
5 mg/ml and untagged BB_0562 at 3 mg/ml respectively.. 
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3.10.8.5. Generating molecular envelopes for untagged BB_0562 
The two remaining data sets for untagged BB_0562 were used for ab initio modelling as previously 
described. Twenty independent models were generated by DAMMIF (Franke & Svergun, 2009) for 
each data set which are shown in figure 3.59. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.59. Molecular envelopes of untagged BB_0562 generated by DAMMIF. Molecular envelopes were 
generated by DAMMIF (Franke & Svergun, 2009) and the program repeated to produce twenty independent models. 
Models A to T generated from the 5 mg/ml data and models 1-20 generated from BB_0562 at 3 mg/ml. 
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3.10.8.6. Evaluation and refinement of untagged BB_0562 
The generated untagged envelopes for BB_0562 were evaluated by DAMSEL (Volkov & Svergun, 
2003) and DAMSUP (Volkov & Svergun, 2003). Outliers were removed as previously described and 
the envelopes superimposed on top of the reference set. For the 5 mg/ml untagged data set envelope 
S was removed and envelopes H and T selected as the reference. For the 3 mg/ml data set envelope 
2 was removed and models 7 and 20 used as the reference sets. Full DAMSEL (Volkov & Svergun, 
2003) and DAMSUP (Volkov & Svergun, 2003) results are summarised in table 3.17. 
 
Following refinement DAMAVER (Volkov & Svergun, 2003) was used to produce an averaged 
probability map which was later filtered by DAMFILT (Volkov & Svergun, 2003) to give two final 
molecular envelopes which are shown in figure 3.60. 
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Solution DAMSEL NSD 
average (Standard 
deviation of NSD = 
0.086) 
Include/Discard? DAMSUP NSD 
superimposition value 
Indicative fit 
(Chi squared) 
Untagged BB_0562 at 5 mg/ml  
A 0.528 Include 0.452 2.904 
B 0.520 Include 0.468 2.900 
C 0.533 Include 0.471 2.904 
D 0.523 Include 0.517 2.902 
E 0.527 Include 0.506 2.904 
F 0.523 Include 0.489 2.909 
G 0.528 Include 0.514 2.902 
H 0.503 Reference 0.000 2.895 
I 0.519 Include 0.502 2.913 
J 0.528 Include 0.499 2.909 
K 0.520 Include 0.510 2.904 
L 0.514 Include 0.519 2.900 
M 0.530 Include 0.548 2.904 
N 0.580 Include 0.563 2.902 
O 0.519 Include 0.515 2.903 
P 0.534 Include 0.487 2.909 
Q 0.556 Include 0.529 2.902 
R 0.521 Include 0.508 2.894 
S 0.903 Discard ----- 2.912 
T 0.504 Reference 0.000 2.911 
Solution DAMSEL NSD 
average (Standard 
deviation of NSD = 
0.110) 
Include/Discard? DAMSUP NSD 
superimposition value 
Indicative fit 
(Chi squared) 
Untagged BB_0562 at 3 mg/ml  
1 0.585 Include 0.534 4.599 
2 1.036 Discard ----- 4.587 
3 0.547 Include 0.513 4.597 
4 0.546 Include 0.544 4.598 
5 0.550 Include 0.496 4.600 
6 0.547 Include 0.508 4.588 
7 0.516 Reference 0.000 4.606 
8 0.543 Include 0.467 4.597 
9 0.556 Include 0.496 4.588 
10 0.521 Include 0.315 4.599 
11 0.567 Include 0.522 4.581 
12 0.553 Include 0.530 4.598 
13 0.550 Include 0.513 4.597 
14 0.564 Include 0.508 4.585 
15 0.542 Include 0.496 4.604 
16 0.550 Include 0.511 4.612 
17 0.549 Include 0.526 4.612 
18 0.602 Include 0.638 4.590 
19 0.570 Include 0.549 4.592 
20 0.516 Reference 0.000 4.597 
Table 3.17. A summary of the evaluation and refinement of untagged BB_0562 models by DAMSEL and 
DAMSUP. DAMSEL (Volkov & Svergun, 2003) determined the mean NSD as 0.546 and 0.575 for the 3 mg/ml and 6 
mg/ml data sets respectively. Envelope S from the 3 mg/ml data set and B from the 6 mg/ml data set were calculated as 
outliers and the data discarded. Data for envelopes H and T from the 3 mg/ml data set and G and T from the 6 mg/ml data 
set were identified as the most probably solutions for each case and this data used as the reference sets for superimposition. 
DAMSUP (Volkov & Svergun, 2003) NSD values were then calculated relative to the reference set. The chi squared 
value represents the indicative fit calculated by DAMMIF (Volkov & Svergun, 2003) for each generated model. 
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Figure 3.60. Final molecular envelopes for untagged BB_0562. Following the generation of 20 DAMMIF (Franke & Svergun, 2009) models the final envelope was determined 
after filtering and refinement as previously described. The green represents the DAMFILT (Volkov & Svergun, 2003), filtered envelope, the grey as the computed probability map 
generated by DAMAVER (Volkov & Svergun, 2003) and the pink ribbon cartoon is the known crystal structure of E. coli OmpX (1QJ8 - Vogt & Schulz, 1999) taken from the 
protein data bank. All models were generated using Pymol (Schrödinger, 2010). 1A-D) Final molecular envelope of untagged BB_0562 at 5 mg/ml. 2A-D) The final model of 
untagged BB_0562 at 3 mg/ml. 
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3.10.8.7. Generating molecular envelopes for poly-histidine tagged BB_0562 
Using the same methodology as previously described the background reduced scattering data for 
tagged BB_05622 was transformed using GNOM (Svergun, 1992) and the output file submitted to 
DAMMIF (Franke & Svergun, 2009) for ab initio modelling. The process was repeated until twenty 
impendent molecular envelopes were generated. The initial envelopes are shown in figure 3.61. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.61. Molecular envelopes of histidine tagged BB_0562 at 6 mg/ml. Molecular envelopes were generated by 
DAMMIF (Franke & Svergun, 2009) and the program repeated to produce twenty independent models. 
 
 
3.10.8.8. Evaluation and refinement of poly-histidine tagged BB_0562 
Following the generation of twenty independent models for poly-histidine tagged BB_0562 by 
DAMMIF (Franke & Svergun, 2009) the PDB files were submitted to DAMSEL (Volkov & 
Svergun, 2003) and DAMSUP (Volkov & Svergun, 2003) for evaluation. The NSD was calculated 
for each model and outliers removed based upon a standard deviation of two. Envelope B was 
deemed as an outlier and removed before superimposition using envelopes D and L as the reference 
models. Full refinement data is shown in table 3.18. 
 
Following the removal of the outlier and the superimposition of all models the files were used by 
DAMSEL (Volkov & Svergun, 2003) to produce a probability map which was further filtered by 
DAMFILT (Volkov & Svergun, 2003) generating two final models as shown in figure 3.62. 
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Solution DAMSEL NSD 
average (Standard 
deviation of NSD = 
0.091) 
Include/Discard? DAMSUP NSD 
superimposition value 
Indicative fit 
(Chi squared) 
Histidine tagged BB_0562  
A 0.544 Include 0.521 4.042 
B 0.944 Discard ----- 4.042 
C 0.545 Include 0.551 4.040 
D 0.516 Reference 0.000 4.044 
E 0.548 Include 0.505 4.043 
F 0.573 Include 0.576 4.045 
G 0.535 Include 0.530 4.040 
H 0.534 Include 0.521 4.041 
I 0.563 Include 0.532 4.045 
J 0.534 Include 0.538 4.042 
K 0.549 Include 0.516 4.039 
L 0.515 Reference 0.000 4.040 
M 0.527 Include 0.506 4.045 
N 0.578 Include 0.549 4.037 
O 0.549 Include 0.340 4.042 
P 0.528 Include 0.535 4.042 
Q 0.528 Include 0.535 4.043 
R 0.583 Include 0.547 4.042 
S 0.554 Include 0.545 4.040 
T 0.571 Include 0.534 4.041 
 
Table 3.18. A summary of the evaluation and refinement of histidine tagged BB_0562 models by DAMSEL and 
DAMSUP. DAMSEL (Volkov & Svergun, 2003) determined the mean NSD as 0.566. Envelope B was calculated as an 
outlier and the data discarded. Data for envelopes D and L were identified as the most probably solutions in each case 
and this data used as the reference set for superimposition. DAMSUP (Volkov & Svergun, 2003) NSD values were 
calculated relative to the reference set. The chi squared value represents the indicative fit calculated by DAMMIF (Volkov 
& Svergun, 2003) for each generated model. 
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Figure 3.62. Refined and filtered molecular envelope for histidine tagged BB_0562 at 6 mg/ml. Following the 
generation of 20 DAMMIF (Franke & Svergun, 2009) models the final envelope was determined after filtering and 
refinement by DAMAVER (Volkov & Svergun, 2003). The green represents the DAMFILT (Volkov & Svergun, 2003), 
filtered envelope and the grey is the computed probability map generated by DAMAVER (Volkov & Svergun, 2003). 
The purple cartoon is OmpX from E. coli, data taken from the protein data bank (1QJ8 - Vogt & Schulz, 1999). 
 
 
 
 
 
 
 
 
 
 
 
A B 
C D 
Page | 237  
 
3.10.9.1. SAXS data collection for poly-histidine tagged BB_0406 
SAXS data was generated for tagged BB_0406 across three concentrations. Data was collected at 
Diamond Light Source on beamline B21. A total of 18 frames were acquired each lasting three 
seconds, the resulting scattering was averaged and the blank buffer scattering subtracted resulting in 
the scattering data shown in figure 3.63. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.63. Background subtracted scattering data generated for samples of BB_0406 at various concentrations. 
The background subtracted scattering data for three different concentrations of BB_0406. Recorded scattering data 
displayed as log of intensity over the scattering vector q (Ǻ). BB_0406 is in 0.3M NaCl, 50mM tris base, 0.1% v/v LDAO, 
pH8. Background subtraction made with a dialysis matched buffer. Purple data generated from BB_0406 at 3 mg/ml. 
Blue data generated from BB_0406 at 2 mg/ml. Red data generated from BB_0406 at 1 mg/ml. 
 
 
All three concentrations of tagged BB_0406 showed an upturn at low q following background 
subtraction, likely indicative of some level of aggregation within the sample. As preliminary 
evaluation of the radius of gyration was similar to previous OMP proteins the data was kept and used 
for modelling. Full Guinier analysis results are summarised in table 3.19. Kratky analysis shown in  
 
 
 
q 
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figure 3.64 demonstrated that two of the samples (3 and 2 mg/ml) had a defined maxima. However, 
the curves did not rapidly approach zero. The 1 mg/ml sample was clearly indicating a sample 
containing partially folded protein and was discarded.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.64. Kratky analysis generated from samples of poly-histidine tagged BB_0406. Kratky analysis or I(q)*q2 
plot of BB_0406 in 0.3M NaCl, 50mM tris base, 0.1% v/v LDAO, pH8. BLUE – BB_0406 at 3 mg/ml. RED – 
BB_0406 at 2 mg/ml. GREEN – BB_0406 at 1 mg/ml. 
 
 
 
 
 
 
 
 
 
(I)*q2 
q 
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Parameter Calculated Radius of gyration (Å) 
1 mg/ml sample 
Radius of gyration (Å) 
2 mg/ml sample 
Radius of gyration (Å) 
3 mg/ml sample 
Primus Auto Rg 22 +- 0.7 
(sRg 1.1-1.5) 
15.3 +-0.3  
(sRg 0.89-1.3) 
15.5 +-0.49  
(sRg 0.75-1.235) 
Manual Guinier Rg 25 +-3 
(sRg 0.9-1.6) 
15.2 +-0.5 
(sRg 0.9-1.33) 
14.8 +-0.146  
(sRg 0.674-1.50) 
Reciprocal space Rg 
 
--- 14.79 14.90 
Real space Rg 
 
--- 14.8 14.89 
 
Table 3.19. Radius of gyration data for tagged BB_0406. The radius of gyration was calculated for all three 
concentrations of BB_0406 using several methods. The 1 mg/ml data set was discarded due to the large Rg determined 
from the Guinier analysis and was not taken forward to GNOM (Svergun, 1992) for determination of reciprocal and real 
Rg. 
 
 
3.10.9.2. GNOM analysis and evaluation of the pair-distance distribution function of poly-
histidine tagged BB_0406 
Following background subtraction and the initial analysis of the scattering data for BB_0406 the two 
remaining data sets were transformed using GNOM (Svergun, 1992), the one dimensional scattering 
curves were taken and the P(r) function was determined and are shown in figure 3.65. The radius of 
gyration for both samples of BB_0406 at 2 and 3 mg/ml were calculated in both real and reciprocal 
space and were in good agreement as shown in table 3.18. The P(r) function also was indicative of a 
compact single domain structure with a selected dmax of 42 Å. GNOM (Svergun, 1992) was also 
used to produce a .out file in preparation for ab initio modelling later used to generate initial models 
be DAMMIF (Franke & Svergun, 2009). 
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Figure 3.65. GNOM analysis of included BB_0406 data sets. GNOM (Svergun, 1992) was used as an indirect transform 
tool, the radius of gyration was calculated for all data sets in both real and reciprocal space. 1A – Reciprocal space fit for 
tagged BB_0406 at 3 mg/ml. 1B – P(r) function for tagged BB_0406 at 3 mg/ml. 2A - Reciprocal space fit for tagged 
BB_0406 at 2 mg/ml. 2B - P(r) function for tagged BB_0406 at 2 mg/ml. 
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3.10.9.3. Generating molecular envelopes for poly-histidine tagged BB_0406 
Using the same methodology as previously described, the background subtracted scattering data was 
transformed using GNOM (Svergun, 1992) and the output file submitted to DAMMIF (Franke & 
Svergun, 2009) for ab initio modelling. The process was repeated until twenty impendent molecular 
envelopes were produced for each data set resulting in a total of 40 models as shown in figure 3.66. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.66. Molecular envelopes of poly-histidine tagged BB_0406. Molecular envelopes were generated by 
DAMMIF (Franke & Svergun, 2009) and the program repeated to produce twenty independent models for each data set. 
Models A-T generated from tagged BB_0406 at 3 mg/ml. Models 1-20 generated from tagged BB_0406 at 2 mg/ml. 
A B C D E F G 
H I J K L M N 
O P Q R S T 
1 2 3 4 5 6 7 
8 9 10 11 12 13 14 
15 16 17 18 19 20 
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3.10.9.4. Evaluation and refinement of poly-histidine tagged BB_0406 
Assessment of the generated envelopes was carried out by DAMSEL (Volkov & Svergun, 2003) and 
DAMSUP (Volkov & Svergun, 2003) as previously described with full refinement results shown in 
table 3.20. Only one envelope was identified as an outlier across both BG_0408 datasets, envelope K 
from the 3 mg/ml data set gave a NSD on 0.592 which was beyond two standard deviation points and 
was removed prior to DAMSUP (Volkov & Svergun, 2003) analysis. Envelopes K and 18 were 
selected as the reference models and used for superimposition of the remaining solutions. 
 
Following the removal of the outlier and superimposition DAMAVER (Volkov & Svergun, 2003) 
was used to produce an averaged probability map which was filtered by DAMFILT (Volkov & 
Svergun, 2003) to give a final molecular envelope for tagged BG_0408 which is shown in figure 3.67. 
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Solution DAMSEL NSD average 
(Standard deviation of 
NSD = 0.015) 
Include/Discard? DAMSUP NSD 
superimposition 
value 
Indicative fit 
(Chi squared) 
Tagged BB_0406 at 3 mg/ml  
A 0.552 Include 0.525 10.503 
B 0.561 Include 0.515 10.524 
C 0.567 Include 0.544 10.566 
D 0.555 Include 0.531 10.509 
E 0.560 Include 0.536 10.513 
F 0.559 Include 0.568 10.510 
G 0.559 Include 0.531 10.522 
H 0.552 Include 0.527 10.519 
I 0.567 Include 0.581 10.377 
J 0.535 Include 0.539 10.483 
K 0.592 Discard ----- 10.503 
L 0.546 Include 0.492 10.471 
M 0.555 Include 0.517 10.429 
N 0.571 Include 0.566 10.450 
O 0.532 Reference 0.000 10.377 
P 0.543 Include 0.512 10.385 
Q 0.552 Include 0.554 10.508 
R 0.582 Include 0.559 10.497 
S 0.539 Include 0.492 10.510 
T 0.541 Include 0.470 10.483 
Solution DAMSEL NSD average 
(Standard deviation of 
NSD = 0.027) 
Include/Discard? DAMSUP NSD 
superimposition 
value 
Indicative fit 
(Chi squared) 
Tagged BB_0406 at 2 mg/ml  
1 0.612 Include 0.624 19.844 
2 0.622 Include 0.630 19.906 
3 0.539 Include 0.375 19.902 
4 0.562 Include 0.488 19.929 
5 0.576 Include 0.546 19.807 
6 0.555 Include 0.494 19.992 
7 0.549 Include 0.520 19.985 
8 0.554 Include 0.487 19.898 
9 0.537 Include 0.476 19.887 
10 0.603 Include 0.611 19.905 
11 0.584 Include 0.502 19.846 
12 0.561 Include 0.512 19.881 
13 0.587 Include 0.610 19.833 
14 0.543 Include 0.512 19.827 
15 0.551 Include 0.542 19.972 
16 0.615 Include 0.638 19.948 
17 0.584 Include 0.504 19.962 
18 0.532 Reference 0.000 19.828 
19 0.562 Include 0.510 19.879 
20 0.572 Include 0.522 19.943 
 
Table 3.20. A summary of the evaluation and refinement of untagged BB_0406 models by DAMSEL and 
DAMSUP. DAMSEL (Volkov & Svergun, 2003) determined the mean NSD as 0.556 for the 3 mg/ml sample and 0.568 
for the 2 mg/ml sample….. Envelope K was the only model selected as an outlier across both data sets with the data 
removed before analysis by DAMSUP (Volkov & Svergun, 2003). Envelopes O and 18 were identified as the most 
probably solutions for the 3 mg/ml and 2 mg/ml data respectively and used as the reference sets for superimposition by 
DAMSUP (Volkov & Svergun, 2003). The chi squared value represents the indicative fit calculated by DAMMIF (Volkov 
& Svergun, 2003) for each generated model.
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Figure 3.67. Refined and filtered molecular envelopes for poly-histidine tagged BB_0406. Following the generation of 20 DAMMIF (Franke & Svergun, 2009) models for 
each data set the final envelopes were determined after filtering and refinement by DAMAVER (Volkov & Svergun, 2003). The green represents the DAMFILT (Volkov & Svergun, 
2003), filtered envelope and the grey is the computed probability map generated by DAMAVER (Volkov & Svergun, 2003). The purple cartoon is OmpX from E. coli, data taken 
from the protein data bank (1QJ8 - Vogt & Schulz, 1999). Models 1A-D generated from BB_0406 at 3 mg/ml and models 2A-D generated from BB_0406 at 2 mg/ml. 
1A 
1C 1D 
1B 2A 2B 
2C 2D 
Page | 245  
 
3.10.10.1 SAXS data collection for BG_0408 
SAXS data was generated for untagged BG_0408 at a single concentration of 3 mg/ml and the 
background subtracted scattering data is shown in figure 3.68. Data was collected for 2400 seconds 
per frame with ten frames for the sample and blank. Guinier analysis was applied both automatically 
and manually and is summarised in table 3.21.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.68. Background subtracted scattering data and Kratky analysis generated from a sample of BG0408 at 3 
mg/ml. A) The background subtracted scattering data for BG_0408 at 3 mg/ml. Recorded scattering data displayed as log 
of intensity over the scattering vector q (Ǻ). BG_0408 in 0.3M NaCl, 50mM tris base, 0.1% v/v LDAO, pH8. Background 
subtraction made with a dialysis matched buffer. B)  Kratky analysis or I(q)*q2 plot of BG_0408 at 3 mg/ml. The Kratky 
plot shows a Gaussian-like bell shape and is indicative of a folded molecule. 
 
 
Parameter Calculated Rg 
Primus Auto Rg 15.5 +-0.49  (sRg 0.75-1.235) 
Manual Guinier Rg 14.8 +-0.146 (sRg 0.674-1.50) 
Reciprocal space Rg 14.90 
Real space Rg 14.89  
 
Table 3.21. A summary of the calculated Rg for BG0408 at 3 mg/ml. The Rg was calculated throughout analysis of 
the scattering data. The automatically generated Rg using Primus (Konarev et al., 2003) appears to deviate from the other 
values possibly due to poor selection of the Guinier region. 
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q q2 
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3.10.10.2. GNOM analysis and evaluation of the pair-distance distribution function of BG0408 
After the initial analysis of the raw SAXS data, GNOM (Svergun, 1992) from the ATSAS (Svergun, 
1992, Franke & Svergun, 2009, Volkov & Svergun, 2003, Kozin & Svergun, 2001, Svergun, 1999) 
software package is often utilised as an indirect transform program which takes one-dimensional 
scattering curves and calculates a distance distribution function or P(r) it also prepares files for Ab 
initio modelling. The P(r) function and reciprocal space fit for the three included data sets are shown 
in figure 3.69. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.69. GNOM analysis of poly-histidine tagged BG0408. GNOM (Svergun, 1992) was used as an indirect 
transform tool, the radius of gyration was calculated in both real and reciprocal space. A – Reciprocal space fit for tagged 
BG0408 at 3 mg/ml. B – P(r) function for tagged BG0408 at 3 mg/ml. 
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3.10.10.3. Generating molecular envelopes for poly-histidine tagged BG0408 
Using the same methodology as previously described, the raw scattering data was transformed using 
GNOM (Svergun, 1992) and the output file submitted to DAMMIF (Franke & Svergun, 2009) for ab 
initio modelling. The process was repeated until twenty impendent molecular envelopes were 
produced and these initial envelopes are shown in figure 3.70. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.70. Molecular envelopes for poly-histidine tagged BG0408 generated at 3 mg/ml. Initial molecular 
envelopes were generated by DAMMIF (Franke & Svergun, 2009) and the program repeated to produce twenty 
independent models. 
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3.10.10.4. Evaluation and refinement of poly-histidine tagged BG0408 
Assessment of the generated envelopes was carried out by DAMSEL (Volkov & Svergun, 2003) and 
DAMSUP (Volkov & Svergun, 2003) as previously described. No envelopes were deemed as outliers 
with the mean NSD calculated to be 0.559. Envelope P was selected as the reference model as used 
by DAMSUP (Volkov & Svergun, 2003) for superimposition with full evaluation data shown in table 
3.22. 
 
Following refinement of the DAMMIF (Franke & Svergun, 2009) models DAMAVER (Volkov & 
Svergun, 2003) was used to produce an averaged probability map which was filtered by DAMFILT 
(Volkov & Svergun, 2003) to give a final molecular envelope for poly-histidine tagged BG_0408 
which is shown in figure 3.71. 
 
 
Solution DAMSEL NSD 
average (Standard 
deviation of NSD = 
0.019) 
Include/Discard? DAMSUP NSD 
superimposition value 
Indicative fit 
(Chi squared) 
Untagged BG_0408  
A 0.593 Include 0.599 1.759 
B 0.550 Include 0.530 1.756 
C 0.549 Include 0.555 1.757 
D 0.577 Include 0.602 1.757 
E 0.549 Include 0.521 1.760 
F 0.584 Include 0.589 1.758 
G 0.534 Include 0.520 1.758 
H 0.553 Include 0.536 1.758 
I 0.564 Include 0.521 1.757 
J 0.594 Include 0.533 1.757 
K 0.546 Include 0.319 1.755 
L 0.562 Include 0.554 1.757 
M 0.561 Include 0.540 1.759 
N 0.537 Include 0.495 1.756 
O 0.584 Include 0.571 1.760 
P 0.532 Reference 0.000 1.757 
Q 0.534 Include 0.520 1.755 
R 0.550 Include 0.537 1.759 
S 0.571 Include 0.514 1.759 
T 0.557 Include 0.537 1.757 
 
Table 3.22. A summary of the evaluation and refinement of untagged BG_0408 models by DAMSEL and 
DAMSUP. DAMSEL (Volkov & Svergun, 2003) determined the mean NSD as 0.559. No outliers were identified 
based upon the standard deviation of the NSD. Envelope P was identified as the most probably solution and used as the 
reference set for superimposition and from this DAMSUP (Volkov & Svergun, 2003) NSD values calculated relative to 
this reference set. The chi squared value represents the indicative fit calculated by DAMMIF (Volkov & Svergun, 2003) 
for each generated model. 
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Figure 3.71. Refined and filtered molecular envelope for BG0408 at 3 mg/ml. Following the generation of 20 
DAMMIF (Franke & Svergun, 2009) models the final envelope was determined after filtering and refinement by 
DAMAVER (Volkov & Svergun, 2003). The green represents the DAMFILT (Volkov & Svergun, 2003), filtered 
envelope and the grey is the computed probability map generated by DAMAVER (Volkov & Svergun, 2003). The purple 
cartoon is OmpX from E. coli, data taken from the protein data bank (1QJ8 - Vogt & Schulz, 1999). 
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3.10.11 Combining homology modelling and SAXS 
All molecular envelopes generated for the four OMP proteins display a distinctive surface shape 
similar to that of many known 8-stranded β-barrel membrane proteins. Throughout the SAXS analysis 
the crystal structure of E. coli OmpX has been used to show the overall fit of the generated envelope 
and had been manually docked into the molecular envelope using Pymol (Schrödinger, 2010). 
However, the four Borrelia OMPs may not share the same dimensions or overall shape as the 
proposed E. coli homolog. In order to better understand the fit of each Borrelia OMP to the 
constructed envelope, homology models were generated for all four OMP proteins using Chimera 
(Pettersen et al., 2004) and Modeller (UCSF – Webb & Sali, 2014, Martin-Renom et al., 2000, Sali 
& Blundell, 1993, Fiser et al., 2000) with modelling based upon templates listed in table 2.17 of the 
methods section. These models were then superimposed into the experimental molecular envelopes 
as a final assessment of the overall fit with the data shown in figure 3.72. The pdb file coordinates 
were used to manually dock the homology models into the experimentally determined molecular 
envelopes. However, software (Colores – Chacón & Wriggers, 2002) is available to perform an 
exhaustive search of all rigid body degrees of freedom which is useful for multi-domain or multimeric 
proteins. Following the generation of the homology models for all four Borrelia OM proteins the 
constructed structures were used to compute a theoretical SAXS profile shown in figure 3.73 which 
was in turn compared to the experimentally determined SAXS profiles. The Chimera (Pettersen et 
al., 2004) generated homology models for all four Borrelia OM proteins were seen to fit well within 
the experimentally determined molecular envelopes supporting the theory that these possible 8-
stranded β-barrel proteins adopt the typical cylindrical shape with similar diameters of known 8-
stranded β-barrel crystal structures. 
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Figure 3.72. Final molecular envelopes for Borrelia OMPs with corresponding homology models. The molecular 
envelopes were produced from the experimental SAXS data with the grey envelope corresponding to the unfiltered 
DAMAVER (Volkov & Svergun, 2003) model and the green representing the filtered and refined DAMIFILT model. 
The pink superimposed homology models were created in silico using Chimera (Pettersen et al., 2004) and Modeller 
(UCSF – Webb & Sali, 2014, Martin-Renom et al., 2000, Sali & Blundell, 1993, Fiser et al., 2000). 
BAPKO_0422 BB_0562 BG0408 BB_0406 
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Figure 3.73. Computed theoretical SAXS profiles for Borrelia OMP homology models. Theoretical intensity curves generated by Chimera (Pettersen et al., 2004) using the 
constructed homology models. The theoretical profiles are shown as a green solid line with the experimental SAXS data for each recombinant protein shown as blue crosses. Plots 
were generated using Chimera (Pettersen et al., 2004).
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3.10.12. Overall measurements and dimensions of Borrelia OMP molecular envelopes 
Measurements for the experimental molecular envelopes and the homology model computed surface 
were calculated using Pymol (Schrödinger, 2010). Full dimensions are shown in table 3.23. Overall 
dimensions for all four molecular envelopes for the Borrelia OM proteins compare well with the sizes 
of known 8-stranded β-barrel proteins with examples shown in table 3.24. 
 
 
Parameters 
(Å) 
BAPKO_0422 
untagged 
BAPKO_0422 
polyhistidine 
tagged 
BB_0562 
untagged 
BB_0562 
polyhistidine 
tagged 
BG0408 
polyhistidine 
tagged 
BB_0406 
polyhistidine 
tagged 
Radius of 
gyration 
14.38 16.74 14.22 14.31 14.89 14.85 
DMAX 42 44 45 45 42 42 
Estimated 
molecular weight 
(kDa) 
20.2 22.9 17.7 20.4 22.8 22.8 
Average length of 
the molecular 
envelope 
45.1-49.2 44.3-50.1 44.6-48.1 44.6-51.8 51.4-58.6 45.3-56.7 
Average length of 
the homology 
model 
57.8 57.8 57.5 57.5 58.9 59.2 
Average diameter 
of the molecular 
envelope 
20.2-26.2 14.8-19 15.7-21.9 15.3-23.7 23.1-33.7 12.9-20.2 
Average diameter 
of the homology 
model 
22.4 22.4 23.5 23.5 23.6 21.2 
Table 3.23. Comparing the dimensions of the models for Borrelia OM proteins. Estimated molecular weight 
calculated minus the presumed signal sequence 
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Protein PDB entry PDB reference Molecular 
weight (kDa) 
Length 
(Å) 
Diameter 
(Å) 
OmpA (E. coli) 1BXW Pautsch and 
Schulz, 1998 
35 61.4 22.3 
OmpW (E. coli) 2F1T Hong et al., 2006 21 57.6 22.2 
OmpX (E. coli) 1QJ8 Vogt & Schulz, 
1999 
18.6 54.9 24.2 
Ail (Yersinia pestis) 3QRC Yamashita et al., 
2011 
17.5 59.2 19.2 
OPRG (Pseudomonas aeruginosa) 2X27 Touw et al., 2010 25.2 71.8 22 
TT_C0834 (Thermus thermophillus) 3DZM Brosig et al., 2009 23.7 58.6 25.1 
NspA (Neisseria meningitidis) 1P4T Vandeputte-Rutten 
et al., 2003 
18.4 52.6 24.5 
 
Table 3.24. Overall sizes and dimensions of known OMP structures. PDB files for each protein were taken from the 
Protein Data Bank and opened using Pymol (Schrödinger, 2010). Dimensions were calculated using the measurement 
function in Pymol (Schrödinger, 2010) with calculations based upon the surface exposed model. 
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3.10.13. SAXS Discussion 
Following the production of recombinant protein for the four proposed OmpA-like Borrelia proteins, 
SAXS experiments were designed and carried out with the intention to fulfil the below criteria. 
 
a) To determine a low resolution molecular envelope for each of the four proteins. 
b) To compare the low resolution molecular envelopes with surface representations of known 8-
stranded β-barrels. 
c) To determine the radius of gyration. 
d) To calculate the overall dimensions and compare with known 8-stranded β-barrels. 
e) To construct homology models and compute a theoretical SAXS profile to be compared with 
the experimentally obtained data. 
 
Prior to collecting data for the four recombinant proteins the methodology was extensively tested 
using lysozyme and ribonuclease A as control proteins. The objective of this initial testing was to 
ensure that the chosen detergent LDAO could be successfully subtracted from the experimental 
scattering and to explore the issues which surround poor background subtraction. Both lysozyme and 
ribonuclease A were reconstituted in the same buffer which was used for the four OmpA-like proteins 
and contained 0.1% v/v LDAO. Data collected and subtracted with the appropriate blank for both 
proteins produced a molecular envelope in good agreement with models based upon data generated 
without detergent. This confirmed that for these particular proteins the scattering of the detergent 
LDAO could be subtracted successfully from the experimental data on the condition that the blank 
was a good match. When an incorrect blank was subtracted from the same experimental data the 
resulting envelope resembled a detergent micelle underlining the importance of ensuring that the 
buffer blank is a true match to the experimental sample. 
 
Although lysozyme and ribonuclease A were extremely useful for testing the proposed methodology 
the limiting factor was that neither of these are membrane proteins. As membrane proteins contain an 
exposed hydrophobic region there is an expectation that the detergent LDAO will behave differently 
within this environment. Prior to processing the experimental data it was expected that the generated 
molecular envelope may have additional bulking around the proposed hydrophobic girdle. This 
however did not appear to be the case and detergent subtraction did not give rise to any complications 
when extra care was taken preparing buffer blanks used for subtraction. These buffer blanks were 
created by extensive dialysis it was found that a five day dialysis with only one buffer change within 
the first two hours was sufficient to produce a quality buffer blank for SAXS experiments. 
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Aggregation observed in SAXS experiments is often hugely detrimental to the resulting data. It is 
often detected by a sharp upturn at high q or a curvature of the data or residuals in a Guinier analysis.  
Some levels of aggregation can be alleviated on the condition that the Rg is of an expected size and 
that the upturn in the data does not drastically effect the overall curve. With the exclusion of the 
control proteins all experimental samples barring one displayed some levels of aggregation as 
expected with refolded recombinant membrane proteins. Although assessment of aggregation can 
easily be undertaken by eye, aggregation levels can also be estimated using the autoRg function in 
Primus (Konarev et al., 2003). Primus (Konarev et al., 2003) estimated the levels of aggregation of 
1-3% and as the calculated Rg was within the expected range the data was deemed usable. The data 
also matched well with the sample with no aggregation indicating the small amount of aggregation 
in the other samples was minimal enough not to effect contrast and cause sufficient changes to the 
curve.  
 
The two Borrelia proteins BB_0406 and BG0408 were particularly problematic for SAXS 
experiments. Both proteins contain two cysteines eight residues apart at positions 31 and 40. As 
previously discussed in section 3.4.4. Not only was the final yield of protein poor these proteins also 
have the ability to appear as monomeric, dimeric, tetrameric and octameric (as shown demonstrated 
by SDS-PAGE in figure 3.13 of section 3.4.4. The ability of these oligomers to form appears to be 
dynamic and at some kind of equilibrium making separation difficult (Weber, 1983, Chadwick et al., 
1997). Addition of fresh reducing agents including DTT and β-mercaptoethanol at normal 
concentrations failed to produce a monomeric sample. These difficulties resulted in fewer samples 
for data collection however one sample was prepared for BG0408 and three samples for BB_0406 by 
addition of β-mercaptoethanol at 100mM followed by immediate data collection. 
 
Throughout the experiments there was also some discrepancy between the calculated P(r) function 
and the final DAMMIN (Svergun, 1999) bead model. The P(r) distribution function describes the 
paired-set of all distances between points within a molecule. The function is also considered as a 
smooth, non-negative curve when approaching dmax (maximum particle dimensions). As SAXS is a 
low resolution technique, the measurements are limited by the experimental resolution. Therefore, 
the P(r) can be thought of as resolution limited sampling of the P(r) distribution function. In most 
cases the calculated P(r) function was indicative of something between a globule and cylindrical 
molecule. The P(r) curves (Figures 3.50, 3.58, 3.65, 3.69) are not Gaussian curves which would 
represent a perfect sphere but instead tail off towards zero which is a feature of cylindrical molecules. 
In contrast the final bead model was more cylindrical or dumbbell shaped. These differences are due 
Page | 257  
 
to the low resolution limits of SAXS. P(r) functions calculated using synchrotron data were seen to 
be more accurate and represented something between a globular molecule and a cylindrical structure 
which agreed more closely with the final DAMMIN (Svergun, 1999) bead model. This was due to 
the higher level of resolution obtained using synchrotron data over in-house SAXS. The dumbbell 
shape often seen in the final DAMMIN models (Svergun, 1999) is likely an artefact of software 
averaging. As the protein molecules are positioned in no particular orientation the end model is an 
average model over three dimensions. As the loop regions at each end of the Borrelia OMPs are 
considered the most flexible components they may be considered as the most averaged portion 
leading to a rounding or dumbbell shape. 
 
The dmax or the maximum particle dimension was similar for all Borrelia OMPs and was between 
42-45 Å. When the dmax was selected within this range the P(r) function was smooth and non-
negative at dmax. This estimated dmax value was slightly lower than the average length of the 
experimentally generated molecular envelopes which ranged from 44.3-51.4 Å for the filtered model 
(full dimensions and parameters can be reviewed in table 3.22). Homology models were also slightly 
larger with the average length of OMPs at ~57 Å. The differences observed can be explained by the 
way each measurement was deduced. The dmax is an estimate of the maximum protein size prior to 
bead modelling. The DAMFILT (Volkov & Svergun, 2003) envelopes which are the final refined and 
filtered models agreed well with dmax. The DAMAVER (Volkov & Svergun, 2003) envelopes were 
larger than dmax yet this is expected as this is the unrefined and unfiltered model. Measurements 
taken from homology models made in silico are theoretical and have not been experimentally 
obtained. It is likely that the OMPs are more compact than the calculated homology model which 
would explain the increase seen within the average length of the model when compared to the SAXS 
envelope. 
 
The Borrelia OMP homology models were used to generate theoretical SAXS profiles (figure 3.73) 
using FoXS (Schneidman-Duhovny et al., 2010). In order to assess the level of agreement between 
the experimental SAXS curve and the theoretical curve derived from the homology models the chi 
squared fit was calculated. The chi-square value represents the overall agreement between the two 
data sets by measuring the error-weighted score (Rambo & Tainer, 2013). However, this function can 
be unreliable with noisy datasets (Rambo & Tainer, 2013). The chi-squared values are shown in figure 
3.73 and were reasonable at ~3.5 for BAPKO_0422, BB_0406 and BG0408. For the case of BB_0562 
the chi-squared value was 12.9 indicating the agreement between the two curves was lower than that 
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observed for the other Borrelia OMPs. This higher chi-squared value is likely due to low levels of 
aggregation within the sample. 
In summary the molecular envelopes generated for the four Borrelia proteins are consistent with a 
small transmembrane β-barrel structure, the diameter and overall length of the envelopes are close to 
literature values for known 8-stranded β-barrels and generated homology models fit well within the 
generated surface structure. 
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3.11. Crystallisation attempts of B. burgdorferi s.l.OmpA-like proteins 
3.11.1. Vapour diffusion crystallisation of BAPKO_0422 and BB_0562 
Attempts were made to crystallise recombinant BAPKO_0422 and BB_0562 both using traditional 
methods and lipidic cubic phase crystallisation. The remaining Borrelia proteins BB_0406 and 
BG0408 were excluded from these trials due to the difficulty in obtaining enough high quality sample. 
As described in section 2.2.9, BAPKO_0422 and BB_0562 were refolded, purified and concentrated 
prior to crystallisation attempts. Where possible protein samples were fresh and subjected to 
refrigerated centrifugation and the concentration assessed using a Jenway Genova Nano, Micro-
volume spectrophotometer prior to being placed into crystallisation trays. Hanging drop trays were 
set up for both BAPKO_0422 and BB_0562 using concentrations ranging from 6-14 mg/ml using 
seven crystallisation screens described in section 2.2.9 and full formulations can be found within the 
appendix. Hanging drop trays were stored at both 10 and 20oC and checked at regular intervals. Many 
conditions resulted in rapid precipitation often within the first couple of days for these cases 
optimisation was attempted where the precipitant was reduced in concentration however this did not 
result in any protein crystals. Some conditions did give rise to crystal growth, these were however 
confirmed to be salt crystals. 
 
3.11.2 Lipidic cubic phase crystallisation of BAPKO_0422 
Following the lack of success using traditional crystallisation methods lipidic cubic phase 
crystallisation was attempted for BAPKO_0422. Lipidic cubic phase (LCP) or In meso 
crystallography exploits the fact that membrane proteins are most stable within lipid bilayers and uses 
a complex mixture of hydrated lipid often monoolein, protein in solution, detergent and precipitants 
in order to support crystal growth (Aherne et al., 2012). The lipidic cubic phase is composed of a 
single lipid bilayer which creates an infinite periodic minimal surface (IPMS) which acts to divide 
space into two networks of non-intersecting water channels (Landau & Rosenbusch, 1996). 
Bicontinuous lipidic cubic phases can be separated into three types based upon their space group 
symmetry these phases are known as Ia3d, 1m3m and Pn3m which are summarised in figure 3.75. 
 
Although LCP's have been used for many applications from drug delivery to biosensors these phases 
were found particularly useful for the crystallisation membrane proteins (Landau & Rosenbusch, 
1996, Srivastava et al., 2014, Tiefenbrunn et al., 2011, Liao et al., 2012, Rasmussen et al., 2011). The 
first application of LCP for the crystallisation of a membrane protein was achieved in 1996 by Landau 
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& Rosenbusch. The attraction of LCP crystallisation is that it recognises that often membrane proteins 
are manipulated in harsh detergent environments as opposed to the more native lipid environment 
LCP provides.  
 
It has also been suggested that crystals obtained using LCP have better crystal ordering this was 
proposed as crystals grown in this manner have type 1 packing with protein molecules forming 
contacts through both hydrophilic and hydrophobic portions reducing the solvent content. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.74. The three bicontinuous LCP’s and their space groups. The two non-intersecting water channels are 
represented in two different colours. Figure taken from Qiu & Caffrey, 2000. 
 
Although several lipids can be used for LCP crystallisation monoolein is most commonly the lipid of 
choice. When mixed with water it spontaneously swells to form distinctive mesophases as further 
discussed in figure 3.74. At room temperature and at a water concentration of around 40% the Pn3m 
cubic phase is formed, the water concentration is reduced and the phase moves into the further cubic 
phase la3d. Either of these phases can be used when beginning in meso crystallisation but further 
dehydration after experimental set up is believed to be the key driving force of crystallisation as the 
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cubic phase moves to a lamellar phase as further discussed in figure 3.75. It is however important to 
ensure the protein solution is incorporated into the cubic phase and to understand the changes in phase 
behaviour for the supporting detergent, as the cubic phase is easily disrupted by the addition of 
detergents and precipitants inducing transition from the cubic to the lamellar phase during 
experimental set up. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.75. Monoolein/water phase diagram - temperature versus composition. The phase states and their 
corresponding cartoon representations. 1. Lamellar crystalline. 2. Lamellar liquid crystalline. 3. Fluid isotropic. 4. 
Inverted hexagonal. 5. Cubic Pn3m. 6. Cubic la3d.  Diagram taken from Caffrey 2008.  
 
 
Monoolein was selected as the supporting lipid and purchased from Sigma Aldrich and prepared using 
published methods (Caffrey and Cherezov, 2009). The protein of BAPKO_0422 and BB_0562 
samples were reconstituted in Monoolein at 40% w/v using two syringes and a syringe coupler. Using 
a syringe dispensing unit 0.5µl of the lipid/protein mixture was ejected into each well of a 96 well 
LCP screening plate (Swissci) and overlaid with 0.5µl of precipitant solution before being sealed with 
UPV file for storage at 20oC (section 2.2.9.2). In order to prevent evaporation and drying of the 
lipid/protein mixture plates were prepared and sealed in quarters. 
1 
2 
3 
4 
5 
6 
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Figure 3.76. Formation of protein crystals within a lipidic cubic mesophase. A cartoon representation of crystal 
formation within the Pn3m cubic phase. Following reconstitution of the protein into the lipid bilayer environment as 
shown in the bottom left portion of the diagram the addition of precipitants causes a shift in the equilibrium of the cubic 
phase. This disruption leads to a phase separation where by protein molecules move towards a sheet-like or lamellar 
structure as shown in the upper right corner. Once several protein molecules congregate they begin to form regular arrays 
which may include detergent and lipid molecules. This organised crystal continues to grow from the continuous supply 
of protein molecules from the remaining cubic phase (Cherezov et al., 2006). Lipids are shown as light yellow ovals with 
tails, detergent molecules are shown as pink ovals with tail, protein molecules are shown in blue (pdb 2RH1 – Cherezov 
et al., 2007) and remaining native lipids are shown in purple. Figure taken from Caffrey 2008. 
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Alike with vapour diffusion trials plates were checked and photographed everyday for the first week 
and weekly thereafter. Under some conditions BAPKO_0422 appeared to be forming four forms of 
crystals as shown in figure 3.77. These crystals appeared small 3-dimensional facets (figure 3.77A), 
2-dimensional triangular shaped bodies (figure 3.77B), 2-dimensional plate crystals (figure 3.77C) 
and 3-dimensional rods (figure 3.77D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.77. Lipid cubic phase crystallisation trails of Borrelia BAPKO_0422. Photographs taken after 7 days of 
incubation at 20oC. A. 3-dimensional facets which developed in 0.5 µl of lipid/protein mixture overlaid with 0.5µl of 10% 
v/v ethanol and 100mM CHES at pH 9.5. B. 2-dimensional triangular shaped bodies using 160mM ammonium sulphate, 
47% v/v PEG 400 at pH 5.5 as the precipitant. C. 2-dimensional plate crystals using 47% v/v PEG 400, 170mM 
ammonium sulphate as the precipitant (photograph courtesy of Dyer 2013). D. 3-dimension rod crystals using 1M 
ammonium sulphate, 0.1M tris, pH8.5 as the precipitant.  
 
A B 
C D 
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Further investigation of the BAPKO_0422 crystals suggested that the 3-dimensional facets (figure 
3.77A) and the 2-dimensional triangular bodies (figure 3.77B) could have been formed by the lipid 
monoolein due to a shift in the phase. As previously discussed the phase behaviour of the lipid is 
essential in order to promote crystallisation growth. This phase structure can easily be shifted to other 
phase orders by changes in the environment. 3-dimensional facets (figure 3.77A) are often associated 
with the Im3m cubic phase which can be induced by the presence of ethanol. In contrast the small 
triangular bodies (figure 3.77B) are often an indicator of the Pn3m phase. The instability of the lipid 
phase may have been detrimental to the LCP crystal trials and further work was carried out to ensure 
the set up and storage environment was constant and precipitants used were compatible. These facets 
and 2-dimensional triangular bodies were no longer observed suggesting that the phase had been 
stabilised and the changes were likely induced by components of the initial precipitants used. Several 
precipitant conditions during LCP crystallography of BAPKO_0422 gave rise to 2-dimensional rods 
and plates as shown in figure 3.77C. These rods were particularly difficult to manipulate, did not 
make a distinctive noise during crushing and appeared to dissolve when Izit dye was applied. These 
crystal were only observed in the presence of PEG and most often associated with 47% v/v PEG 400. 
It was not thought that these crystals were the result in a lipid phase shift nor did they share any 
characteristics with salt crystals. Attempts to remove them from the lipid phase with loops was 
problematic and their 2-dimensional structure was not suitable for diffraction. Attempts were made 
to optimise these conditions in order to produce smaller 3-dimensional crystals. However, no progress 
was made under the conditions tested.  
 
Other crystals noted within the trials were large 3-dimensional rods as shown in figure 3.77D these 
were particularly suspicious as they were seen in most drops containing ammonium sulphate and 
were confirmed to be salt using Izit dye and crushing. 
 
A number of limitations can be associated with the crystallisation experiments for BAPKO_0422 and 
BB_0562 which may need to be addressed in order to produce crystals suitable for diffraction 
experiments. Firstly, LDAO was used exclusively throughout the crystallisation experiments and may 
be responsible for the lack of success in obtaining suitable protein crystals. The use of different 
detergents can give rise to different crystal forms (Allen & Feher, 1984) and crystals of the highest 
quality may only be obtained from one or a small group of the numerous detergents available. An 
example of this was seen for bovine mitochondrial cytochrome c oxidase whereby diffraction of the 
crystals reduced when the chain length of the detergent was either decreased or increased beyond a 
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10-carbon acyl chain (Tsukihara et al., 1996). Future work should aim to screen a number of other 
stabilising detergents as research suggests this can be a major issue to overcome during crystallisation. 
 
All crystallisation experiments were carried out using polyhistidine tagged BAPKO_0422 and 
BB_0562, this tag along with the amino acid sequence for the HRV3C cleavage site may have led to 
unwanted flexibility. Attempts were made to remove the tag using the HRV3C enzyme. However, 
digests were poor following numerous rounds of optimisation and tag removal was problematic. It is 
likely that the HRV3C cleavage site was no longer fully exposed once the protein was refolded. Future 
work should aim to produce further constructs to produce either untagged recombinant protein and 
purify by ion exchange chromatography or constructs which would express tagged protein with a 
larger span of amino acids between the HRV3C cleavage site and the start of the protein. 
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3.12. Discussion: B. burgdorferi s.l. OmpA-like proteins 
The aims of the research project were to identify and characterise integral β-barrel proteins from the 
spirochaete Borrelia. Previous bioinformatic analysis sought to identify possible OmpA-like proteins 
from B. burgdorferi s.l. This initial work used hidden Markov models, fold prediction and signal 
sequence analysis in order to detect possible OmpA-like homologs which share very low sequence 
similarity. A total number of 12 proteins across B. afzelii, B. burgdorferi and B. garinii were identified 
to contain a possible OmpA-like domain with 9 of these containing a traditional signal sequence 
(Dyer, 2013). To date only around ten OMPs have been identified in B. burgdorferi (Brooks et., 2006, 
Lenhart & Atkins., 2010, Antonara et al., 2007, Bunikis et al., 2008, Coburn & Cugini et al., 2003, 
Cugini et al., 2003, Noppa et al., 2001, Skare et al., 1997, Wood et al., 2013 and Russell & Johnson., 
2013) and none of these proteins fall into the OmpA-like family. 
 
As the OmpA-like membrane spanning domain is well conserved amongst gram-negative bacteria it 
seemed reasonable to presume a homolog would be present within the Borrelia sp. Although 
spirochaetes differ somewhat from many other bacteria of the Gram-negative family they do share a 
number of common characteristics including the double membrane structure, presence of 
peptidoglycan within the periplasmic space and both groups express large numbers of lipoproteins. 
The more recent discovery of β-barrel assembly apparatus (Lenhart and Akins, 2010) and also 
secretion mechanisms within Borrelia highlight that the spirochaete has the ability to express, 
assemble, orientate and export membrane proteins into the outer membrane. Of Borrelia’s known 
beta barrel membrane proteins none can be considered as similar to the well conserved OmpA. The 
presence of other beta barrel proteins within the spirochaetes outer membrane and Borrelia’s ability 
to assemble such structures allows the assumption to be made that Borrelia may indeed express small 
beta barrel proteins such as the common 8-stranded beta barrel. 
Scanning electron microscopy of B. burgdorferi has identified a number of integral transmembrane 
proteins and although the contribution of these to the membrane was much lower than seen in other 
gram negative bacteria such as E. coli it is safe to assume that there are more than those examples 
discussed in section 1.4.4 especially as a number of Borrelia genes have a recognisable signal 
sequence. 
Much work has revolved around B. burgdorferi’s large number of lipoproteins many which confer 
favourable advantages with roles as key virulence factors (Cassatt et al., 1998, Haake. 2000, Schroder 
et al. 2003). Although these are important and often crucial for the spirochaetes long term survival 
within the host they are often non-essential for bacterial function and often encoded on Borrelia’s 
Page | 267  
 
numerous plasmids. In contrast, all of the proposed integral membrane proteins within this study are 
encoded on the chromosome highlighting that they may play essential physiological roles. 
The initial bioinformatics analysis undertaken by Dyer et al, Appendix 4, identified a number of 
potential membrane spanning beta barrel proteins across B. burgdorferi, B. afzelii and B. garinii, these 
proteins were all predicted as 8-stranded beta barrel proteins with signal sequences further supporting 
that this family were indeed integral membrane proteins with possible homology to the OmpA family. 
The subsequent aims for this thesis was to characterise a selection of these proposed OmpA-like 
proteins which are currently annotated either ‘hypothetical’ and ‘conserved hypothetical’ proteins. 
Both BAPKO_0422 and BB_0562 were demonstrated to exist as a monomer in 0.3M NaCl, 50mM 
Tris, 0.1% v/v LDAO at pH8 this was confirmed by native PAGE (figure 3.13), SEC-MALLS (data 
not shown – Dyer, 2013), SEC (figure 3.14) and SAXS (section 3.10). In contrast BB_0406 and 
BG0408 were shown to form higher order oligomers including dimers, tetramers and octamers (figure 
3.13). 
The differences in behaviour observed between the four OmpA-like proteins indicate that although 
they are likely to share some level of homology they may have distinct roles. BB_0406 and BG0408 
show the highest degree of sequence similarity of (90%). Both BB_0406 and BG_0408 contain two 
cysteine residues both of which are at position 31 and 40. Both proteins were seen to form oligomers. 
Species of monomeric, dimeric, tetrameric and octameric protein was found for both proteins during 
both reducing SDS-PAGE (figure 3.13) and native PAGE. These oligomeric species were confirmed 
by western blotting against the polyhistidine tag. However, the importance of these oligomers remains 
poorly understood and it is unknown whether these species are physiologically relevant. Literature 
searching for beta barrel proteins which are known to form octamers includes the staphylococcal γ-
haemolysin toxin which is composed of the two different proteins LukF and Hlg2 and the octameric 
penicillin binding protein which is a homo-octamer of the pab87 protein. However B. burgdorferi is 
not known to encode any toxins nor is there any sequence similarity shared between these proteins. 
Alternatively it could be proposed that BB_0406 and BG0408 are part of the lipocalin family as they 
share a number of lipocalin characteristics. Lipocalins are small proteins with a length of around 200 
residues and molecular masses averaging 20kDa which transport small hydrophobic molecules. These 
proteins carry an N-terminal signal sequence and although sequence similarity within this family is 
low (~20%) their tertiary structures are well conserved. Lipocalins can be described as 8-stranded 
antiparallel β-barrels with both N and C-terminal helices. The barrel is open at one side and the 
structure encloses a binding pocket. They have been identified to form oligomers including dimeric 
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structures as observed in an odorant binding protein (Tegoni et al., 1996) and also complex octamers 
of the crustacyanins (Keen et al., 1991). The sequence similarity between lipocalins is low. However, 
many are seen to share three motifs yet others are observed to share only one yet the tertiary structure 
is still preserved. 
Both BB_0406 and BG0408 contain one lipocalin motif known as the structurally conserved region 
2 (SCR2) this motif is TDY- - I and is observed at the correct positioning (within the end of strand 
six) for both proteins (figure 2.10). Although lipocalins are known to share three SCR’s some are 
known to only share one of these motifs yet retain the preserved lipocalin structure. Furthermore both 
BB_0406 and BG0408 are predicted to form an 8-strand antiparallel β-barrel and on some occasions 
homology modelling has shown the presence of an N-terminal helix. As both these proteins contain 
two cysteine residues and in vitro oligomers were observed for both proteins it was identified that 
these pair of Borrelia proteins could be part of the lipocalin family rather than the originally searched 
for OmpA-like family. As discussed, both proteins shared many of the lipocalin characteristics. 
However, crucially lipocalins are extracellular soluble proteins a characteristic which was not seen in 
either BB_0406 or BG0408 which are particularly hydrophobic and insoluble without the presence 
of harsh denaturants or detergents above CMC. Due to the behaviour of the four Borrelia OMPs it is 
unlikely any of these proteins belong to the lipocalin family and submission of their amino acid 
sequences to the online prediction software LipocalinPred resulted in negative scoring and no 
lipocalin prediction being made. The molecular envelopes for all four also did not support the notion 
that these proteins could be lipocalins with the final surface structures more closely resembling an 
elongated barrel alike those seen in transmembrane beta barrels as opposed to the short barrel 
structure seen in lipocalins. 
The sequence similarity between the twelve Borrelia OmpA-like proteins identified and E. coli 
OmpA is very low and not statistically significant (less than 13%). However, this is not unusual for 
integral β-barrel membrane proteins which are often difficult to identify due to containing short 
membrane spanning strands (<10 amino acids) of alternating hydrophobic residues separated by loop 
regions which are often highly variable (Schulz, 2000). Proteins within the OmpA-like domain family 
(Pfam - PF01389) are made up of eight membrane spanning antiparallel β-strands connected by three 
short periplasmic turns and four large extracellular loops (Schulz, 2000). Existing structural data for 
several OmpA-like proteins suggest that the membrane spanning region is highly conserved and the 
highly variable extracellular loops may be responsible for the functional diversity of this protein 
family. 
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Sequence alignments of OmpA-like proteins with known structures show a high level of conservation 
of alternating hydrophobic residues separated by small side chain residues often glycine within the 
region spanning the membrane. This distinct alternation between these amino acid types is also seen 
within the proposed Borrelia OMPs (figure 2.10). Notably, within structurally characterised OmpA-
like proteins aromatic residues such as tyrosine and phenylalanine can be identified at either end of 
the transmembrane spanning region. These aromatic residues are highly conserved and probably 
involved in the formation of the aromatic girdle (Ulmschneider & Sansom, 2001). 
 
Multiple positively charged amino acids can be identified within the N-terminal region of all four of 
the Borrelia OmpA-like proteins investigated within the project. BAPKO_0422, BB_0406 and 
BG_0408 all contain an alanine in the predicted -1 position and proposed to be processed by a type I 
signal peptidase. However, this isn’t observed for BB_0562. This may be an indication that this 
protein is not an integral transmembrane protein. However, both HMM searching and topology 
predictions (PRED-TMBB) suggest otherwise. As most of the proposed Borrelia OMPs from the 
early bioinformatics studies appear to contain an N-terminal signal sequence it is likely that these 
proteins utilise the Sec dependent secretory pathway in order to translocate across the inner 
membrane. As previously discussed BB_0562 does not contain an alanine in the -1 position, the 
bioinformatics study also identified this missing residue in BA0026 and BG0027. However, the close 
orthologue BB0027 contains the signal sequence. These differences may be unique to Borrelia signal 
sequences and somewhat different from the SignalP reference sets. Alternatively these subtly 
different signal sequences may have arisen, as Borrelia are known to encode three different type-I 
signal peptidases as opposed to the single protein found within E. coli (Paetzel et al., 2000). The 
presence of three such proteins may allow for some deviation from the normally conserved signal.  
Both BB_0406 and BG0408 have two cysteine residues at positions 31 and 40 and would normally 
indicate potential sites for N-terminal lipidation. Inspection of the N-terminal, however, is a poor 
match to other spirochaetal lipobox sequences (Setubal et al., 2006) and as these residues are 
predicted to be within a periplasmic turn they are likely to be disulphide bonded. 
 
The C-terminal region of most integral outer membrane β-barrels appears to follow a signature 
sequence which resembles Z-x-Z-x-Z-x-Y-xF>, where Z represents non-polar residues and x 
represents any amino acid. The terminal residue is predominantly a phenylalanine (Struyvé et al., 
1991) which appears conserved and has been proposed to be essential for the correct assembly of 
bacterial outer membrane proteins (Struyvé et al., 1991). Recent research by Gessmann et al., 2014, 
however, has highlighted that this terminal phenylalanine although acts to enhance processing by the 
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BamA apparatus is not essential and can be substituted by aromatic amino acids and more rarely by 
other non-polar amino acids. Deviations from the typical C-terminal signature and its recognition by 
BamA have been demonstrated to be species specific. An example is seen within Proteobacterial 
OMPs which have a positively charged residue in the penultimate position. However, this is never 
observed in E. coli (Robert et al., 2006). This C-terminal sequence is apparent in the majority of the 
proposed Borrelia OMPs identified in the bioinformatics study (Dyer, 2013) and can be detected in 
all four of the experimental Borrelia OMPs (BAPKO_0422, BB_0562, BB_0406 and BG0408). The 
most prominent deviation from the Proteobacterial C-terminal motif is the absence of phenylalanine 
at the C-terminus (with the exception of BB_0562) within the three experimental Borrelia OMPs this 
residue is replaced by a small non-polar residue such as isoleucine (BAPKO_0422) or the polar 
residue asparagine (BB_0406 and BG0408). This replacement of a terminal phenylalanine was also 
seen in the other 8 orthologues previously identified (Dyer et al., Appendix 4). In some cases the 
terminal residue was replaced by leucine. 
 
In order to further investigate this replacement of the terminal residue an analysis of the C-terminal 
of other known Borrelia OMPs was undertaken (Dyer et al., 2015). The pore forming protein DipA 
contains a C-terminal motif similar to BAPKO_0422 and terminates with K-Y and the large P66 porin 
terminates with a polar sequence of S-G-S. Borellia BamA itself, a transmembrane β-barrel, 
terminates R-Y and the integral membrane protein P13 ends S-Y. It is therefore proposed that integral 
β-barrel membrane proteins found within Borrelia contain a Borrelia-specific C-terminal signature 
sequence which is recognised by the BamA apparatus. This sequence is proposed to resemble Z-x-Z-
x-Z-x-Z-[KR]-[ILNY] again where Z represents a small non polar residue and x can be any amino 
acid. There appears to be a conserved positively charged residue, however, it is not always the 
penultimate residue. Rarely is the terminal residue a phenylalanine (with the exception of BB_0562). 
An investigation of Borrelia C-terminal residues of potential β-barrel proteins found a range of 
possible terminal residues including isoleucine, valine, lysine, asparagine and tyrosine. 
 
Topology prediction and homology modelling of the proposed Borrelia OMPs demonstrate a lack of 
a C-terminal domain and it is expected that the C-terminal portion forms part of the terminal β-barrel 
strand, this region is also expected to contain a conserved C-terminal signal motif (Tommassen, 
2010). As previously described this motif in bacteria is a 10-residue sequence consisting of three 
alternating non-polar residues at positions -9, -7 and -5 from the C-terminus. The side chains of these 
residues are in direct contact with the aliphatic region of the membrane. Within this signature 
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sequence the -3 residue is often a tyrosine and is involved in the aromatic girdle between the polar 
and non-polar environments (Struyvé et al., 1991). 
 
In order to gain an insight into other possible roles of the Borrelia OMPs a literature search for 
homologues was undertaken. To date only two of the proteins identified as possible β-barrels have 
been investigated. One homologue BB_0405 has been demonstrated as surface exposed, present in 
outer membrane vesicles (Yang et al., 2011) and expressed in conditions representing both the tick 
and mammalian environment (Brooks et al., 2006). The second BB_0407 has been identified as a 
human factor H binding protein (Bhide et al., 2009) which initiated the factor H binding investigation. 
 
Traditional cloning methods were utilised throughout the project in order to produce constructs to 
express recombinant B. burgdorferi OmpA-like proteins. The DNA supplied by Dr Volker Fingerle 
(German National Reference Centre for Borrelia) for B. afzelii, B. burgdorferi and B. garinii was of 
a high level of purity and nested PCR was not required in order to successfully amplify the target 
genes (section 3.2). The pET47 vector was selected for use alongside an E. coli expression system 
which allowed the addition of an N-terminal polyhistidine tag and a HRV3C recognition sequence 
between the tag and the start of the proteins. Early attempts to produce constructs resulted in the 
transformation of E. coli cells with empty plasmids. A large amount of pET47 was passing through 
cloning experiments uncut by both restriction enzymes. In order to rectify this, less plasmid was used 
within restriction digests, the amount of restriction enzyme was increased and the digestion time was 
extended. However, this failed to improve transformation yields. This was rectified by adding an 
additional restriction digest after the ligation step. This involved subjecting all ligation reactions to 
the restriction enzyme SalI. The SalI site was not present in any of the target gene inserts and the site 
is lost following the full digestion of pET47 with BamHI and NotI, making the site a desirable target 
for the destruction of any ‘empty’ vectors. Following the extraction and purification of the construct 
from successful clones samples were sequenced by Source Bioscience (Rochdale) using T7 promoter 
and terminator primers both forward and in reverse. The resulting sequences were then translated and 
subjected to protein BLAST (Altschul et al., 1990). 
 
Recombinant protein for all four samples (BAPKO_0422, BB_0562, BB_0406 and BG0408) was 
produced using an E. coli expression system and was expressed as insoluble inclusion bodies. For the 
case of BAPKO_0422 and BB_0562 this protein was solubilised and refolded both by rapid dilution 
and on-column folding methods and gave a fair yield of up to 40%. This ease of refolding observed 
for BAPKO_0422 and BB_0562 reflects what has been reported for E. coli OmpA which readily 
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refolds in detergent. However, this was not shared by BB_0406 and BG0408 which often encountered 
final yields of 1-10%. In order to improve these yields future experiments should aim to refold using 
a better redox system or alternatively return to the cloning stages and mutate the two cysteine residues 
in hope to improve stability. Gel filtration of refolded BAPKO_0422 and BB_0562 normally gave a 
single peak corresponding to approximately 20kDa (section 3.4.5). Fractions preceding the peak were 
normally observed as higher order aggregates but this rarely appeared as a distinctive peak indicating 
the majority of the aggregated proportion was removed by high speed centrifugation. BB_0406 and 
BG0408 often eluted during gel filtration with several peaks which were normally poorly defined. 
The samples were fairly polydisperse with a mixture of high order aggregates, octamers, tetramers, 
dimers and monomers (Figure 3.14). This was often observed but at lower levels when under reducing 
conditions using fresh SEC buffer containing 10mM DTT with similar results occurring during 
reducing SDS-PAGE possibly indicating a fairly strong interaction between each protein unit. 
 
Gel shift experiments demonstrated that all four Borrelia proteins were not modified by heat (section 
3.5). Several membrane spanning β-barrel proteins have been demonstrated to conserve their folded 
state when solubilised in the detergent SDS at room temperature (Fairman et al., 2011). However, 
this is lost when exposed to boiling and the protein denatures. Gel shift assays are therefore useful 
and a shift in the apparent size of the membrane protein is observed when the protein sample is boiled. 
This however, was not seen for any of the four Borrelia proteins. This behaviour is consistent with 
another Borrelia outer membrane protein, P66 which is proposed to be a 24 stranded porin also 
observed to remain unmodified by heat (Kenedy et al., 2014). It has been suggested that this 
characteristic could be a general feature of OMPs from the Borrelia genus. As all four Borrelia 
proteins remained unmodified by heat, phase partitioning experiments were carried out to 
demonstrate that the proteins were amphiphilic. As Triton X-114 has a relatively low cloud point the 
detergents properties could be exploited in order to separate amphiphilic proteins from their soluble 
counterparts at a reasonable temperature (~23oC). All four proteins were found within the detergent 
rich phase supplying evidence that these proteins could indeed be integral membrane components. 
 
Circular dichroism is a powerful technique used to rapidly identify secondary structure, monitor 
unfolding behaviour and can be used to assess the binding properties of proteins. The technique is 
non-destructive providing the sample is not heated and requires only small amounts of often valuable 
samples. Throughout the project, CD was an essential tool to ensure protein samples were folded and 
to assess the percentage of secondary structure using deconvolution algorithms and reference data 
sets. Although powerful, CD has its limitations. Not only is it a low resolution technique but it is 
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sensitive to the composition of buffers and carry-over impurities. Buffer components such as high 
salt, detergents and some denaturants alongside high protein concentrations can cause a rapid increase 
in the H[T] voltage above a set threshold which differs for each piece of equipment. Once this H[T] 
voltage threshold has been met any data collected beyond this point is considered to be unreliable. It 
was therefore important to avoid any non-essential buffer components, keep detergent levels to a 
minimal and test several protein concentrations. The CDSSTR algorithm (Manavalan and Johnson, 
1987) was selected for deconvolution as membrane proteins are underrepresented in all reference sets 
and this method would allow this bias to be over come to some degree. The CDSSTR method 
(Manavalan and Johnson, 1987) is a modification of the original variable selection method known as 
VARSLC which performs all possible calculations using a fixed number of proteins from the given 
reference set. The CDSSTR method (Manavalan and Johnson, 1987) can recognise proteins which 
are dissimilar from the test proteins and excludes them from the reference set. It has been suggested 
that this method produces the most accurate results but often takes the longest due to the number of 
calculations. The reference sets SP175 (Lees et al., 2006) and SMP180 (Abdul-Gader et al., 2011) 
were selected purely as they contained the largest number of proteins the major difference between 
the two is that SMP180 (Abdul-Gader et al., 2011) contains an addition number of proteins often 
useful for the analysis of membrane proteins. The contents of the datasets and their corresponding 
pdb codes can be viewed in the appendix 2. 
 
The CD experiments (section 3.9.2) revealed a classic β-strand spectrum with a maxima at 196 nm 
and the minima reached at 216 nm. The spectra generated agreed well with CD data from other 
structurally characterised 8-stranded β-barrels and secondary structure analysis predicted 
approximately 42% β-sheet, 4% helix, 12% turns and 40% unordered again agreeing well with other 
known integral membrane proteins. 
 
The ab initio modelling from SAXS experiments (section 3.10) for the four Borrelia proteins revealed 
a peanut shaped structure. The structural dimensions of the molecular envelopes differed slightly but 
all four had a diameter close to 20-25 Å and a total length of 45-50Å. These parameters agreed well 
with the length and diameter of the homology models and are similar to other structurally 
characterised 8-stranded β-barrels. All of the structures are consistent with a monomeric barrel 
structure. The molecular envelopes for BB_0406 and BG0408 which both contain two cysteine 
residues were obtained from their reduced state and further work is required in order to elucidate 
whether these proteins are involved in any other high order structures. Participation of BAPKO_0422 
and BB_0562 in a multimeric porin type structure. However, is unlikely and all experiments to date 
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have suggested these proteins exist as monomeric constituents within the outer membrane. This 
independent monomeric existence would not be unusual as B. burgdorferi BB_0405 has been 
identified as a monomeric surface exposed protein which does not make any significant interactions 
with any other major outer membrane proteins (Yang et al., 2011). Although the SAXS experiments 
provided valuable information with regards to the OMPs size and surface shape there are some 
limitations, firstly the deduced molecular envelope and the calculated sizes are likely to reflect some 
contribution from the detergent LDAO. Although extensive steps were taken in order to ensure the 
detergent concentration and the dispersity matched the sample it would be naïve to believe this is 
fully accounted for and it is likely that the final envelopes represent the Borrelia proteins with some 
level of interaction with the detergent LDAO. Secondly, as with many experiments involving 
membrane proteins there is likely to be some level of aggregation within the samples. This was 
normally identified by a small upturn at low q when visualising the scattering data. Monodispersity 
is considered crucial for bioSAXS experiments and large levels of aggregation can cause abnormal 
scattering which is difficult to account for. During this study it was found that low levels of such 
aggregation did not change the final model or calculated size on the condition that the upturn at low 
q did not obscure the overall curve and the estimated Rg agreed with previous samples. As a final 
note although two controls were used throughout the SAXS study (lysozyme and ribonuclease A) it 
would have been beneficial to use a membrane protein with a known structure as a further control in 
order to assess the contribution of detergent interactions. Unfortunately such a sample was not 
available but is being considered for future experiments. Although there are some limitations to the 
SAXS data the experiments provided a valuable insight into the size and shape of the Borrelia proteins 
and the acquired data further supported that BAPKO_0422, BB_0562, BB_0406 and BG0408 could 
indeed be small 8-stranded beta barrel proteins. 
   
Crystallisation attempts were problematic, BB_0406 and BG0408 were considered unsuitable 
crystallisation targets due to their difficulty to refold, poor overall yield and their multiple oligomeric 
states. BAPKO_0422 and BB_0562 were notably stable at room temperature once folded and did not 
appear particularly susceptible to degradation and were selected for crystallisation experiments 
(section 3.11). Traditional vapour diffusion crystallography failed to produce any promising 
environments across a large number of conditions. This, however, was limited to the number of 
detergents screened as only LDAO was used throughout the project. A further influencing factor may 
be the presence of the poly-histidine tag and HRV3C protease recognition site which was not removed 
prior to crystallisation. This area of flexibility may have inhibited crystallisation or reduced protein-
protein contact. However, it is not unusual to crystallise proteins with such tags still remaining 
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(Carson et al., 2007) . Further work should aim to screen other stabilising detergents such as DDM 
(n-Dodecyl-β-D-maltoside), OG (n-Octyl-β-D-maltopyranoside) and C8E4 (Octyltetraoxyethylene) 
which has been identified as particularly useful for the crystallisation of β-barrel outer membrane 
proteins from Gram-negative bacteria (Prive, 2007). 
 
The complement system is a crucial component of innate immunity and it’s activation by the 
alternative pathway is the initial obstacle for invading microbes (Sarma and Ward, 2011). In order to 
regulate complement formation, the regulator, factor H must differentiate between host and non-host 
surfaces. Procurement of factor H by pathogenic microbes is well reported and provides a level of 
protection against complement attack (Lambris et al., 2008). The overall effect of the acquisition of 
factor H to the microbial surface downregulates opsonisation which would normally involve the 
marking of the microbe for ingestion by a phagocyte. Alongside the evasion of phagocyte elimination 
the recruitment of host factor H prevents the amplification of the complement cascade which would 
lead to the formation of membrane attack complexes. The prevention of these processes is beneficial 
to any invading microbe but the evasion of the membrane attack complex is of particular importance 
to Gram-negative bacteria and spirochaetes (Meri et al., 2013). Microbial surface proteins have been 
identified to interact with several domains of the large glycoprotein. Both Neisseria (Madico et al., 
2006) and group A streptococci (Blackmore et al., 1998) interact with factor H within domains 6-7. 
These microbial proteins are also known to bind the factor H like protein-1 (FHL-1) which is an 
alternatively spliced transcript from the FH-gene which contains domains 1 to 7 (Madico et al., 2006, 
Blackmore et al., 1998). 
 
Some microbes including B. burgdorferi sensu stricto appear to interact with factor H at multiple sites 
(Kraiczy et al., 2004, Hellwage et al., 2001). The spirochaete protein CRASP-1 is known to bind to 
factor H via domain 7 (Kraiczy et al., 2004) in contrast to OspE which has been demonstrated to 
interact with domains 19 and 20 (Hellwage et al., 2001). The ability of B. burgdorferi s.s. to interact 
with factor H at multiple locations using a number of outer surface proteins increases the protection 
the spirochaete can mount against complement activation.  
 
The B. afzelii protein BAPKO_0422 was identified as a human factor H binding protein in vitro 
(section 3.7 and Dyer et al., 2014 – Appendix 4). Binding occurred with incubations of human factor 
H at concentrations much lower than what is seen within a human host (<3 fold lower). Although 
BB_0562, BB_0406 and BG_0408 were not observed to bind human factor H they may play roles in 
the acquisition of factor H during the infection of other mammalian hosts. Factor H binding has been 
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observed as species specific and is worthy of further investigation. Further work is required in order 
to assess the interaction between BAPKO_0422 and human factor H possibly using isothermal 
titration calorimetry in order to ascertain a binding affinity and a co-crystal structure would be highly 
desirable. Alternatively mutant studies would be useful and allow some estimation of which 
BAPKO_0422 residues are essential for the interaction. 
 
Proteoglycans are found within the extracellular matrix in all connective tissues and on the surfaces 
of several cell types they are highly glycosylated proteins composed of a core proteins and one or 
more GAG chain. These GAGs are classified into four distinct groups including, heparin, heparan 
sulphate, dermatan sulphate and chondroitin-6-sulphate. It has been understood for over a decade that 
Borrelia strains which can bind heperan sulphate appear to invade endothelial cells and those that can 
bind to the alternative GAG type, dermatan sulphate can attach to glial cells (Leong et al., 1998). Any 
strain that can target both these GAG classes have been demonstrated to invade both cell types. It is 
not unusual for pathogenic bacteria to target any of the four GAG molecules in their strategy to invade 
cells with GAG binding identified across the field of pathogenic bacteria. 
 
Preliminary in vitro data suggests that the B. afzelii protein BAPKO_0422 may have some level of 
affinity for heparin. This feature was somewhat noticed by chance during the early stages of 
recombinant expression. As previously discussed in section 3.4.2 difficulties were encountered during 
the purification of BAPKO_0422. This recombinant protein failed to bind to a His-tag column due to 
an excess amount of DNA present within the sample. This DNA presence was unusual and wasn’t 
seen for any other recombinant Borrelia protein. BAPKO_0422’s affinity for DNA led to question 
whether the protein could bind other highly negatively charged molecules.  
 
Due to time restraints in vitro heparin binding was only assessed using a HiTrap Heparin HP column 
(GE Healthcare) by means of a competitive elution gradient using 1M NaCl. BAPKO_0422 was 
retained on the column suggesting there is some level of interaction between BAPKO_0422 and 
heparin (section 3.8). However, as many proteins are known to bind heparin this interaction remains 
poorly understood and requires further investigation.  Should this interaction be of physiological 
importance it may further our understanding of the mechanisms Borrelia employs to invade and 
disseminate though mammalian tissues. Interestingly biovar-specific differences in GAG binding 
have been observed in Chlamydia (Moelleken and Hegemann, 2007) and may also exist across 
Borrelia strains alike what has been suggested for the spirochetes acquisition of factor H. 
 
Page | 277  
 
The interaction between BAPKO_0422 and DNA could suggest a role in oligonucleotide transport. 
However, it is unlikely that BAPKO_0422 would function as a channel to transport DNA or RNA. If 
the homology model reflects the proteins true structure then the interior of the barrel appears too small 
for such transport. This does not rule out involvement within oligonucleotide transport. 
BAPKO_0422 could act as a smaller component in a more complex system responsible for the 
transport of DNA or RNA across the membrane. 
 
Integral membrane proteins are the gatekeepers of the impermeable lipid bilayer which encases all 
living cells. They have a wide variety of roles including cellular transport (Verma et al., 2009, Oomen 
et al., 2004, Van den Berg et al., 2004, Chimento et al., 2003, Ferguson et al., 1998, Buchanan et al., 
1999, Ferguson et al., 2002.), cell signalling (Srivastava et al., 2014), cellular architecture (Pautsch 
& Schulz, 1998) and enzyme activity (Vandeputte-Rutten et al., 2003, Snijder et al., 1999). The 
medical importance of this protein family cannot be overestimated with 50% of modern medicinal 
drugs targeting these surface exposed molecules (Adams et al., 2011). Although the determination of 
these protein structures has remained challenging it is crucial we push to further our understanding 
of these fascinating and medically important molecules. 
 
In summary the data presented throughout the project suggests that B. burgdorferi sensu lato encode 
a number of proteins which could fall into the OmpA-like family (PF01389) with possible 
orthologues across several strains. As these proteins are encoded on the Borrelia chromosome they 
are likely to be play important roles and may have implications in virulence. The data suggest that 
BAPKO_0422, BB_0562, BB_0406 and BG0408 all form membrane spanning β-barrels and their 
topology prediction matches the domain defined by the Pfam family PF01389 with eight membrane 
spanning β-strands linked with short periplasmic turns and longer extracellular loops. This research 
supports the extension of the species distribution of the PF01389 domain to include bacteria from the 
Spirochete phylum (Dyer et al., Appendix 4). BAPKO_0422 is proposed as another of Borrelia 
numerous virulence factors and has been demonstrated to bind human factor H in vitro with factor H 
incubation levels much lower than what is observed in vivo. This acquisition of host factor H rescinds 
the complement response and possibly reduced antigenicity of BAPKO_0422’s surface exposed 
loops. 
 
Further work is required to investigate the host-specific factor H binding activity of the OmpA-like 
homologues and to determine other physiological functions of these proteins. The relationship 
between BAPKO_0422 and heparin requires further investigation in vivo in order to determine the 
Page | 278  
 
physiological importance of this interaction. On the whole furthering our knowledge of the outer 
membrane of Borrelia and its surface exposed epitopes may lead to the improvement of recombinant 
immunoblots currently used for diagnostic testing and the identification of new vaccine targets. 
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Chapter 4: Results & Discussion: Borrelia Superoxide dismutase A 
4.1 Sequence analysis of B. burgdorferi SodA 
Members of the spirochaete class can be divided into three distinctive families which include 
Brachyspiraceae, Leptospiraceae and Spirochaetaceae and within these families fall a number of 
disease causing members which include B. burgdorferi, the relapsing fever spirochaetes such as B. 
recurrentis, Leptospira which is responsible for leptospirosis or Weil’s disease, Treponema pallidum 
the causative agent of treponematoses including syphilis and finally Brachyspira pilosicoli which can 
cause intestinal spirochaetosis. Prior to the initial sequence analysis it was assumed that most Borrelia 
proteins would share sequence similarity with other proteins expressed by bacteria from the 
Spirochaetaceae family. For example it was believed that B. burgdorferi SodA would be most similar 
to other SODs from Leptospira or Treponema; however, this was not the case. 
 
As with many Borrelia genes the bb0157 SodA gene is AT rich with a GC content of 24.6%. 
Nucleotide BLAST (Altschul et al., 1990) searches with exclusions on the Borrelia taxid returned no 
significant similarity which is not unusual for coding regions from the Borrelia genome. More 
sensitive protein BLAST (Altschul et al., 1990) searches, again excluding the Borrelia taxid identified 
a number of proteins with significant sequence similarity and are summarised in table 4.1 Intriguingly 
the proteins identified were mainly from the Thermus family, multiple sequence alignments of B. 
burgdorferi SodA and other similar proteins from Thermus sp are shown in figure 4.1.  
 
When BLAST (Altschul et al., 1990) searching within the Borrelia taxid only, the B. burgdorferi 
SodA enzyme shared varying levels of sequence similarity to SODs in other Borrelia strains. The 
highest scoring SOD protein was from B. finlandenis with an identity of 99% and then down to a 
much lower identity of 67.3% when compared to B. miyamotoi. Considering how well conserved 
SODs generally are from humans to archaea this shift in sequence similarity from 99% to 67.3% 
between just two Borrelia strains highlights just how different these family members could be. Full 
BLAST (Altschul et al., 1990) search results are shown in table 4.1 and the corresponding multiple 
sequence alignment for Borrelia SODs can be seen in figure 4.2. 
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Description Max 
Score 
Total 
Score 
Query 
Cover 
E-
value 
Ident Accession 
Superoxide dismutase – Thermus sp. 2.9 221 221 97% 5e-69 51% WP_039457669.1 
Superoxide dismutase Mn – Thermus 
thermophilus 
221 221 98% 6e-69 51% WP_011172643.1 
Superoxide dismutase – Thermus aquaticus (EC 
1.15.1.1) Mn 
221 221 98% 8e-69 51% S07147 
Superoxide dismutase – Thermus oshimai 221 221 98% 9e-69 51% WP_016329036.1 
Superoxide dismutase – Thermus islandicus 221 221 98% 1e-68 51% WP_022798718.1 
Superoxide dismutase – Thermus filiformis 220 220 97% 1e-68 51% WP_038062973.1 
Superoxide dismutase – Chthonomonas 
calidriosea 
220 220 99% 2e-68 50% CEK19605.1 
Superoxide dismutase – Thermus sp. CCB US3 
UF1 
220 220 97% 2e-68 52% WP_014515330.1 
Superoxide dismutase – Thermus thermophilus 220 220 98% 2e-68 51% WP_014629993.1 
Superoxide dismutase - Chthonomonas 
calidriosea 
220 220 99% 2e-68 50% CEK19593.1 
Table 4.1. Protein BLAST search results for B. burgdorferi SodA (BB_0157). The top ten hits following submission 
of the B. burgdorferi gene to protein BLAST (Altschul et al., 1990) with the Borrelia taxid excluded. BLAST (Altschul 
et al., 1990) searches were performed using the NCBI website (https://www.ncbi.nlm.nih.gov/) and all default settings. 
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Figure 4.1. Multiple sequence alignment of B. burgdorferi SodA BLAST hits following the exclusion of the Borrelia 
taxid. The multiple sequence alignment was generated by Clustal Omega (Sievers et al., 2011) via the EMBL-EBI web 
service (http://www.ebi.ac.uk/services) using default settings and a text file of FASTA amino acid sequences supplied in 
the electronic supplementary data. All resulting BLAST (Altschul et al., 1990) hits were annotated as superoxide 
dismutases with accession codes shown in table 4.1.  Pink residues are positive, blue are negative, red are non-polar and 
green any other. 
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Description Max 
score 
Total score Query cover E-value Ident Accession 
Superoxide dismutase 
– B. finlandensis 
416 416 100% 7e-149 99% WP_008882325.1 
Superoxide dismutase 
– B. bissettii 
407 407 100% 2e-145 97% WP_014023408.1 
Superoxide dismutase 
– B. garinii 
386 386 100% 4e-137 90% WP_031478289.1 
Superoxide dismutase 
– B. spielmanii 
383 383 100% 6e-136 90% WP_006433450.1 
Superoxide dismutase 
– B. afzelii 
383 383 100% 7e-136 90% WP_044052137.1 
Superoxide dismutase 
– B. valaisiana 
381 381 100% 4e-135 89% WP_006068873.1 
Superoxide dismutase 
– B. bavariensis 
380 380 100% 2e-134 89% WP_011193502.1 
Superoxide dismutase 
– B. chilensis 
376 376 100% 5e-133 88% AJA89990.1 
Superoxide dismutase 
– B. turicatae 
318 318 99% 5e-110 72% WP_041178560.1 
Superoxide dismutase 
– B. hermsii 
317 317 99% 9e-110 74% WP_025406281.1 
Superoxide dismutase 
– B. parkeri 
315 315 99% 3e-109 72% WP_025375195.1 
Superoxide dismutase 
– B. coriaceae 
314 314 99% 1e-108 72% WP_025407831.1 
Superoxide dismutase 
– B. crocidurae 
310 310 99% 3e-107 71% WP_014696049.1 
Superoxide dismutase 
– B. anserina 
301 301 99% 1e-103 69% WP_025419376.1 
Superoxide dismutase 
– B. recurrentis 
308 308 99% 3e-106 70% WP_012538697.1 
Superoxide dismutase 
– B. duttonii 
308 308 99% 5e-106 70% WP_012537922.1 
Superoxide dismutase 
– B. hispanica 
307 307 99% 6e-106 70% WP_024655636.1 
Superoxide dismutase 
– B. persica 
303 303 99% 2e-104 69% WP_024654104.1 
 
Table 4.2. Protein BLAST search results for B. burgdorferi SodA (BB_0157) within the Borrelia taxid. The resulting 
sequence similarity following submission of the B. burgdorferi amino acid sequence to protein BLAST (Altschul et al., 
1990) with the Borrelia taxid included. BLAST (Altschul et al., 1990) searches were performed using the NCBI website 
(https://www.ncbi.nlm.nih.gov/) and all default settings. 
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Figure 4.2. Multiple sequence alignment of B. burgdorferi SodA BLAST hits from within the Borrelia taxid. The 
multiple sequence alignment was generated by Clustal Omega (Sievers et al., 2011) via the EMBL-EBI web service 
(http://www.ebi.ac.uk/services) using default settings and a text file of FASTA amino acid sequences supplied in the 
electronic supplementary data. All of the BLAST (Altschul et al., 1990) hits were annotated as SODs with accession 
codes shown above in table 4.2. The dotted line separates Lyme disease causing strains (top) and relapsing fever strains 
(bottom). Pink residues are positive, blue are negative, red are non-polar and green any other. 
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The B. burgdorferi SodA gene was also analysed for the presence of rare codons, not commonly 
utilised within an E. coli expression system using the Rare Codon Calculator (RaCC), provided by 
the NIH MBI Laboratory for Structural Genomics and Proteomics UCLA 
(www.nihserver.mbi.ucla.edu/RACC/) with results shown in figure 4.3. As numerous rare codons 
were identified the gene was codon optimised and synthetically produced by MWG Operon prior to 
subcloning into the pET47 expression vector. 
 
 
Figure 4.3. Rare codon analysis of the B. burgdorferi SodA gene. The B. burgdorferi SodA gene (bb0157) was analysed 
for rare codons using the Rare Codon Calculator (RaCC) provided by the NIH MBI Laboratory for Structural Genomics 
and Proteomics – UCLA (www.nihserver.mbi.ucla.edu/RACC/). A total of 8 rare codons were identified and are 
highlighted in red for rare Arg-codons, Green for rare Leu-codons and Blue for rare Ile-codons. No rare Pro-codons were 
found within the sequence. 
 
 
 
4.2 Expression, solubility and the recovery of SodA from inclusion bodies 
The B.burgdorferi SodA (bb0157) gene was codon optimised for expression within an E. coli system 
and synthetically produced (Eurofins MWG Operon). Solubility trials using several E. coli expression 
strains at varying conditions failed to yield soluble protein (section 2.2.7). However, high level 
expression as inclusion bodies was obtained and maximal expression levels reached after four hours 
of induction by IPTG at a final concentration of 1mM at 37oC as shown in figure 4.5. Although 
autoinduction was tested for the expression of SodA, high levels of expression were obtained using 
the standard IPTG induced system and this method was carried forward. 
 
In attempt to produce soluble SodA protein the vector was transformed into Rosetta DE3, NEB T7 
and BL21 cells and expression tested using various concentrations of IPTG at temperatures ranging 
from 10 to 37oC. No soluble protein was produced under the conditions tested with an example of the 
B. burgdorferi SodA (bb0157) 
ATG TTT AAG CTG CCA GAA CTT GGT TAT GAT TAT GAT GCT GTT GAG CCT TAT ATT GAT GCT AAA ACT 
ATG GAA ATT CAT CAT AGC AAG CAT CAT AAT GGT TTT GTA ATG AAT TTG AAT TCT ATT TTG GAA AAA 
ATG GGG AAA ATT CAT TTA ACA GAT GTG TCA AAC ATA TTA AAA AAT ATT CAT GAT TTT CCA GAA GAA 
TTT CAA ACT TTA ATA AGA AAT AAT GCT GGT GGT TAT TCT AAC CAT ACT TTA TAT TTT AGA ACT 
TTA AGG CCA GGA AAC AAG GAC AAT CTT TTT GAA AAG TTT AAA GAT GAT ATT AAT GCA GCT TTT GGA 
AGC CTA GAC GTT CTT AAG GCC AAT TTG AAA GAT ACT GCA ATG AAA ATT TTT GGA AGT GGT TGG GCA 
TGG TTA GTA TTG TGT CCT GAG AGT GGC CTT AAA GTG ATT TCA ATG CCT AAT CAG GAT AGT CCT TTG 
ATG AAT TCT TAT AAG CCG ATT TTA GGT ATT GAT GTT TGG GAG CAT GCC TAT TAC CTT AAA TAT CAA 
AAT AGA AGA ATT GAA TAT GTT GAT GCA TTT TTA AAG GCT TTA AAT TGG GAA GAA GTT TCA AAA GTT 
TAC AAT GAA GTG ATT AAT TAG 
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SDS-PAGE analysis following expression at 10oC with 1mM IPTG shown in figure 4.4. In order to 
assess the possibility of obtaining soluble protein the B. burgdorferi SodA amino acid sequence was 
evaluated by PROSO II an online protein solubility evaluator (Smialowski et al., 2006). PROSO II 
categorises proteins (without transmembrane regions) as either soluble or insoluble and scores the 
sequence between 0 (insoluble) to 1 (soluble). The method utilises over 80,000 known proteins in 
order to score the solubility of any given amino acid sequence. Analysis by PROSO II categorised B. 
burgdorferi SodA as insoluble with a score of 0.269 which may explain the difficulties encountered 
when attempting to recover soluble protein. Failure to obtain soluble B. burgdorferi SodA using an 
E. coli expression system led to the development of a refolding protocol as previously described in 
section 2.2.5. As refolding methods were already employed for the proposed Borrelia OMPs the same 
method was trialled for Borrelia SodA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4. SDS-PAGE analysis of B. burgdorferi SodA expression. SDS-PAGE performed using 10% Bis/Tris gels 
and MES running buffer (50mM MES, 50mM Tris base, 0.1% w/v SDS, 1mM EDTA, pH 7.3) A total amount of 20µg 
of protein was mixed with LDS loading buffer (NuPage) and loaded per lane. BL21, NEB T7 and Rosetta E. coli cells 
were transformed with the SodA-pET47 construct and expression tested using 1mM IPTG at 10oC. No soluble protein 
was produced and all of the recombinant protein was found within the insoluble pellet under the conditions tested. From 
left to right – Lane 1 – Novex Protein Standard, Lane 2 – Soluble fraction following expression of SodA using BL21 
cells. Lane 3 - Soluble fraction following expression of SodA using NEB T7 cells. Lane 4 - Soluble fraction following 
expression of SodA using Rosetta cells. Lane 5 – Insoluble fraction following expression of SodA using BL21 cells. Lane 
6 – Insoluble fraction following expression of SodA using NEB T7 cells. Lane 7 – Insoluble fraction following expression 
of SodA using Rosetta cells. 
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Following expression, cells were harvested by centrifugation, resuspended in lysis buffer (0.3M 
NaCl, 50mM tris base, 0.1% v/v triton X-100, 10mM DTT, 1mM EDTA at pH8) and the cell 
suspension separated into 15 ml aliquots. As previously described in section 2.2.4.1 lysis of the E. 
coli cells by pulsed sonication appeared complete following a sonication round of 6 minutes. This 
was tested by plating the lysate onto non selective LB agar and incubating overnight at 37oC. 
Substantial E. coli growth was noted when the volume processed by sonication was greater than 15 
ml indicating that the pulse was not propagating throughout the sample and therefore leading to 
incomplete lysis. Following cell lysis the soluble portion was removed following a round of 
centrifugation by removal of the supernatant which was retained for examination. Western blot 
analysis of the soluble lysate was negative for any his-tagged protein (data not shown) again 
indicating that Borrelia SodA forms insoluble exclusion bodies when using an E. coli expression 
system. 
 
Development of the inclusion body wash method both improved the initial purity and increased the 
refolding yield, perhaps due to the removal of key contaminants which may promote aggregation 
during the refolding process. Following the removal of the soluble portion the remaining insoluble 
pellet was washed 6 times as described in the methods section 2.2.4.2. Unlike the Borrelia OMPs, 
recombinant SodA was not observed to interact with residual DNA and a DNase incubation prior to 
solubilisation was not required. Following the washing procedure the pellet was solubilised in 
denaturant (8M urea, 0.3M NaCl, 50mM tris base, pH8) overnight and the supernatant removed by 
centrifugation. By this point the solubilised recombinant protein was relatively pure considering it 
had not yet been subjected to any type of chromatography purification (figure 4.5B). 
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Figure 4.5. Expression and pellet washing of recombinant B. burgdorferi SodA from E. coli – SDS-PAGE performed 
using 10% Bis/Tris gels and MES running buffer (50mM MES, 50mM Tris base, 0.1% w/v SDS, 1mM EDTA, pH 7.3) 
A. SDS-PAGE analysis stained with coomassie blue. From left to right - Lane 1: Novex pre-stained protein standard, 
Lane 2: Pre-induction whole cell lysate, Lane 3: Soluble lysate, Lane 4: Insoluble fraction showing SodA monomeric 
protein.  B. SDS-PAGE analysis of recombinant B. burgdorferi SodA pre and post wash. Lane 1: Novex pre-stained 
protein standard, Lane 2: recombinant SodA prior to pellet washing, Lane 3: recombinant SodA following pellet washing. 
 
 
 
4.3 On-column refolding and purification of SodA 
The washed recombinant SodA enzyme was efficiently purified and refolded by immobilised metal 
affinity chromatography (adapted from It et al., 2003). Initial attempts of refolding used a gradient 
from 8M urea down to no denaturant using an Akta Prime system. However, after further trials the 
yield improved when the gradient only ran as far 1M urea and the remaining denaturant removed 
during elution (section 2.2.7.4). These changes possibly aided refolding by stabilising hydrophobic 
interactions and suppressing aggregate formation during the final stages of refolding. Overall 
denatured SodA recovered from inclusion bodies and refolded on-column was successful with yields 
around 30-40% and an example chromatogram is shown in figure 4.6. Unlike the Borrelia OMP 
proteins, SodA faced no issues regarding to the binding of the nickel column under the condition that 
the selected buffers were above pH 7 so that the histidine residues were deprotonated and were able 
to bind to the nickel stationary phase. 
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Figure 4.6. Immobilised metal affinity chromatography of B. burgdorferi SodA The blue line represents the changes 
in absorbance at 280 nm and recorded in mAu. Solubilised SodA was purified and refolded by IMAC using a Nickel 
column (GE Healthcare). The column was equilibrated as described in section 2.2.5.8 and solubilised SodA was loaded 
at a flow rate of 1 ml/min as represented by the peak in absorbance between 30 and 60 ml. Bound SodA was refolded by 
the gradient removal of the denaturant over a total volume of 120 ml at a flow rate of 0.5 ml/min prior to a wash step to 
remove non-specifically bound proteins (~200 ml). Refolded SodA was eluted by a gradient increase in the concentration 
of imidazole within the eluent (0.3M NaCl, 50mM tris, 0.3M imidazole, pH8) as shown by the increase in absorbance at 
300 ml. 
 
 
On-column refolding was achieved by the gradual removal of denaturant by means of a buffer 
exchange gradient. Protein yield was seen to increase when the refold gradient was both slower and 
a larger volume was used. However, this reached a maximum using a gradient length of 180 ml and 
a flow rate of 0.5 ml/min, totalling a refold time of 6 hours. Protein yield was also dependent upon 
temperature with the best results seen when refolding took place overnight and the room dropped to 
around 10oC. Refrigerated refolding may have improved final protein yield further. However, this 
was not investigated (Xie & Wetlaufer, 1996). Following IMAC purification and on column refolding 
the recombinant SodA protein was eluted by a gradient increase of imidazole (0.3M NaCl, 50mM tris 
base, 0.3M imidazole, pH8) and fractions subjected to SDS-PAGE as shown in figure 4.7. 
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Figure 4.7. SDS-PAGE analysis of refolded and purified SodA. SDS-PAGE performed using 10% Bis/Tris gels and 
MES running buffer (50mM MES, 50mM Tris base, 0.1% w/v SDS, 1mM EDTA, pH 7.3)  A. SDS-PAGE analysis of 
the SodA eluate from immobilised metal affinity chromatography. From left to right, 1. Novex pre-stained protein 
standard, 2-5 Eluted fractions following purification. B. Reduced and non-reduced SDS-PAGE analysis of purified SodA. 
From left to right, 1. Novex pre-stained protein standard, 2. Purified monomeric SodA from DTT reduction, 3. Purified 
monomeric and dimeric SodA. 
 
 
Purity of the SodA extracted from inclusion bodies remained high from a single step purification 
method as shown by the SDS-PAGE analysis in figure 4.7. Fractions of purified SodA were pooled, 
concentrated and centrifuged to remove large aggregates before further polishing by SEC.  SEC was 
conducted at a flow rate of 0.5 ml/min and 1 ml fractions collected. The molecular weight of each 
fraction was calculated using the calibration curve as shown in figure 2.5 in section 2.2.5.8. 
Monomeric SodA eluted within 12.5 ml giving a molecular mass of 23.5kDa less than the predicted 
molecular weight of 26.2kDa calculated using the online tool, ExPASy. Dimeric SodA as shown in 
the SEC chromatogram in figure 4.7 eluted within 11.2 ml. Using the calibration curve in figure 2.5 
this volume represented a protein of 47kDa double the size of the apparent monomer. Fractions from 
both peaks were confirmed as recombinant Borrelia SodA by detection of the poly-histidine tag by 
western blotting and subsequent enzyme assays. 
 
 
 
kDa 
 
 
 
 
 
 
110 
 
60 
50 
40 
 
30 
 
20 
 
 
15 
kDa 
 
 
110 
 
 
60 
 
50 
40 
 
 
 
 
30 
 
20 
 
 
 
15 
A B 
Monomeric  
SodA 
Dimeric 
SodA  
 Dimeric 
SodA  
 Monomeric 
SodA  
 
Page | 291  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8. Final purification step of recombinant B. burgdorferi SodA by SEC. SEC was performed on a Superdex 
75 10/300 GL column (GE Healthcare). The chromatogram shows three distinct peaks the first peaking at 8.1 ml following 
injection of the sample, this protein fraction fell within the void volume and is likely large aggregates. The second peak 
occurred at 11.2 ml and represents dimeric SodA at approximately 47kDa and the third peak at 12.5 ml corresponding 
with the 23.5kDa monomer. The exclusion volume/void volume was calculated as discussed in section 2.2.5.8 using blue 
dextran which eluted at 8.7 ml. 
 
 
 
4.4 Preparation of Apo-SodA, Fe-SodA and Mn-SodA 
Initial attempts to undertake SOD activity assays using the recombinant SodA protein produced as 
described in section 4.3, gave rise to multiple problems and adaptations to the existing methodology 
were required (section 2.2.7).  
 
In order to determine enzymatic rates for B. burgdorferi SodA with bound Mn or Fe three samples 
were required, one containing no metal ions, the second containing only manganese and the third 
containing iron. Due to the severe implications of simply supplementing reactions with excess metal 
ions prior to the assay (further discussed in section 4.6) it became apparent that each sample would 
need to be produced independently. The first issue was to produce recombinant SodA with no metal 
co-factor (Apo-SodA). The simple use of chelators could not be used as these chemicals were found 
to interfere with the final SOD assay even in modest quantities and their effects could not be removed 
by the use of additional control reactions. 
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In order to produce Apo-SodA, denatured solubilised protein was stripped of its native metal ions by 
passing the sample through a stripped nickel column (GE Healthcare) twice. A third of this Apo-
SodA was refolded as previously described with care taken when preparing buffers to prevent the 
addition of iron or manganese. For the case of Fe-SodA and Mn-SodA, Apo-SodA was supplemented 
with either 1mM MnCl2 or FeCl2 and refolded on-column as previously described.  
 
The refolding of Apo-SodA was particularly problematic and gave a very low yield highlighting the 
possibility that the metal co-factor could be crucial for stability. Addition of FeCl2 was also 
challenging due to its tendency to oxidise and following its addition the sample required filtration and 
rapid purification. All three samples were purified and refolded independently and the eluate pooled 
and centrifuged to remove large aggregates. The samples were not subjected to SEC due to the worry 
of sample loss, especially in the case of Apo-SodA. To ensure all three samples were folded prior to 
undertaking the SOD activity assay, samples were used for circular dichroism experiments further 
discussed in section 4.4. 
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4.5 Secondary structure determination of B. burgdorferi SodA 
Circular dichroism experiments (section 2.2.8.1) were carried out to confirm whether recombinant B. 
burgdorferi SodA was folded. This was of particular importance for Apo-SodA which had proven 
difficult to refold. Secondly, the experiments aimed to estimate the amounts of secondary structure 
elements in order to compare to other known superoxide dismutases. Circular dichroism experiments 
were carried out on a JASCO J-810 spectropolarimeter (University of York) and the resulting data 
analysed using the online server dichroweb (Lobley et al., 2002). 
 
Four samples were used for circular dichroism experiments. These included, B. burgdorferi SodA 
with endogenous metal ion (this sample had no alteration made to the existing metal ion and its co-
factor was unknown and obtained during recombinant expression by E. coli), Apo-SodA, Mn-SodA 
and Fe-SodA with the resulting spectra shown in figure 4.9. Although only one concentration for each 
SodA sample is shown within figure 4.9, several concentrations were used for CD in order to provide 
the clearest spectra within a suitable mdeg range. Data for all concentrations can be seen within the 
appendix. CD data was recorded from 260 nm down to 185 nm and all data excluded once the H[T] 
reached 600V. All experimental data were submitted to the online server DichroWeb (Whitmore and 
Wallace, 2004, Whitmore and Wallace, 2008) using the CDSSTR algorithm (Compton & Johnson, 
1986, Manavalan & Johnson, 1987) with reference sets SP175 (Lees et al., 2006) and SMP180 
(Abdul-Gader et al., 2011). The full deconvolution results are shown in table 4.3 with the 
experimental and predicted fit shown in figure 4.10. As several samples were used for CD and two 
independent reference sets used for deconvolution the final percentages of secondary structure were 
averaged. Mn-SOD was deemed to be composed of around 57% helix, 14% β-strand, 12% turns and 
17% disordered, Fe-SOD was calculated as 60% helix, 16% β-strand, 13% turns and 21% disordered 
and Apo-SOD as 55% helix, 11% β-strand, 13% turns and 21% disordered. The deconvolution for all 
three samples, Mn, Fe and Apo-SOD agreed well and was in line with literature data for T. filiformis 
SOD with 58% helix (Mandelli et al., 2013) and T. thermophilus HB8 SOD (Sato & Nakazawa, 1978) 
with 56% helix, both of which had previously been identified to share significant sequence similarity. 
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Figure 4.9. Circular dichroism of B. burgdorferi SodA at 20oC. The recorded CD profile for four samples of B. 
burgdorferi SodA in 0.3M NaCl, 50mM tris base, pH8 at 0.01mg/ml. Data was acquired over 260-185 nm at 0.5 nm 
increments. For Mn-SodA, Fe-SodA and endogenous SodA the H[T] voltage crossed 600V at 204 nm and for Apo-SodA 
the threshold was reached at 199nm, data exceeding this points was discarded prior to deconvolution. The four profiles 
are all indicative of a folded protein with a large proportion of helix. Apo-SodA is seen to differ from the other three 
samples however the profile does follow the same pattern indicating a high amount of helical structure. The Apo-SodA 
sample was later found to be at a slightly lower concentration than the other samples at 0.008mg/ml explaining the 
deviation. 
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Figure 4.10. CDSSTR analysis of B. burgdorferi SodA samples. CD data for apo, Mn and Fe-SodA were analysed by 
dichroweb using the CDSSTR method (Compton & Johnson, 1986, Manavalan & Johnson, 1987) and data sets SP175 
(Lees et al., 2006) and SMP180 (Abdul-Gader et al., 2011). The green data is the experimental CD values, the blue is the 
reconstructed curve and the purple is the difference between the two. For all samples the difference between the 
experimental and the reconstructed values is minimal with the exception of the data at low nm where the HT voltage 
exceeded 600 in turn reducing the values accuracy. The left spectra were produced using the SP175 (Lees et al., 2006) 
data set and the right spectra were generated from the SMP180 (Abdul-Gader et al., 2011) data set. From top to bottom, 
1A – Apo-SodA  (SP175), 1B – Apo-SodA (SMP180), 2A – Mn-SodA (SP175), 2B – Mn-SodA (SMP180), 3A – Fe-
SodA (SP175), 3B – Fe-SodA (SMP180).
1A 1B 
2A 2B 
3A 3B 
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Protein Sample Method: CDSSTR - Reference set SP175 Method: CDSSTR - Reference set SMP180 
Helix β-strand Turns Unordered NRMSD Helix β-strand Turns Unordered NRMSD 
Apo-SodA (0.2 mg/ml) 0.58 0.13 0.12 0.17 0.003 0.56 0.13 0.1 0.2 0.003 
Apo-SodA (0.1 mg/ml) 0.58 0.10 0.15 0.17 0.036 0.50 0.08 0.14 0.28 0.030 
Mn-SodA (0.2 mg/ml) 0.59 0.15 0.09 0.17 0.002 0.59 0.18 0.08 0.15 0.002 
Mn-SodA (0.1 mg/ml) 0.55 0.13 0.11 0.2 0.003 0.55 0.13 0.13 0.19 0.002 
Fe-SodA (0.2 mg/ml) 0.62 0.14 0.09 0.15 0.002 0.59 0.16 0.09 0.16 0.001 
Fe-SodA (0.1 mg/ml) 0.63 0.13 0.07 0.18 0.002 0.59 0.19 0.08 0.14 0.002 
Native SodA (0.2 mg/ml) 0.63 0.09 0.13 0.15 0.006 0.58 0.14 0.12 0.16 0.002 
Native SodA (0.1 mg/ml) 0.62 0.013 0.07 0.18 0.002 0.59 0.2 0.08 0.13 0.002 
 
Table 4.3. Deconvolution data for B. burgdorferi SodA. CD spectra were obtained for Apo-SodA, Mn-SodA, Fe-SodA and Native SodA across several concentrations. Two 
data sets for each sample were then processed by dichroweb for assessment of the secondary structure components. Deconvolution was undertaken using the CDSSTR method 
(Compton & Johnson, 1986, Manavalan & Johnson, 1987) using both SP175 (Lees et al., 2006) and SMP180 (Abdul-Gader et al., 2011) as independent data sets.
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4.6 Small angle scattering experiments for B. burgdorferi SodA 
Samples of recombinant B. burgdorferi were prepared as explained in section 2.2.8.2 and a dialysis 
matched buffer blank prepared in the same way. Scattering data were recorded both in-house on a 
Bruker NanoStar and at Diamond Light Source B21 (DLS funded – Session ID - SM12308). Data 
from in-house experiments showed a large upturn at low q indicative of sample aggregation although 
the protein sample had behaved well during SEC and had eluted at the expected volume. It was 
postulated that the sample had aggregated during the 2400s data collection period possibly due to the 
slight increase in temperature within the vacuum chamber. All scattering data was deemed unsuitable 
for further analysis due to the high level of aggregation.  
 
Further SEC samples were transported on ice for data acquisition on beamline B21 at DLS. SodA 
samples were centrifuged for 30 mins at 16,000 x g at 4oC to remove large aggregates and sample 
aggregation assessed at 340 nm. At this point the sample was considered suitable for data collection 
and loaded at various concentrations into the automated sample holder. The sample movement was 
monitored using the on-board capillary camera and at first exposure the sample precipitated out of 
solution. As the temperature was stabilised at 20oC it was unlikely that temperature was responsible 
as previously thought and it is likely that the protein responded negatively to X-ray exposure possibly 
due to oxidation of the metal ion. This precipitation/aggregation was also seen with the addition of 
stabilisers such as 10% v/v glycerol and all further SAXS experiments were terminated. 
 
 
4.7 SOD activity and chemical characterisation 
B.burgdorferi SodA was originally characterized as a Fe-SOD based upon its resistance to cyanide 
yet enzymatic sensitivity to H2O2 (Whitehouse et al., 1997). Three years later a study demonstrated 
that this classification for Borrelia was unlikely. Their reasoning included that Borrelia have an 
extremely low intracellular iron concentration with evidence suggesting this could be as low as 10 
atoms per cell (Posey and Gherardini., 2000). Furthermore, Borrelia have no growth requirement for 
iron and there is a distinct lack of cellular machinery for the uptake of iron (Posey and Gherardini., 
2000).  Further studies failed to confirm Whitehouse’s findings that B.burgdorferi’s SOD was 
enzymatically sensitive to H2O2 but resistant to cyanide however instead suggested that the 
B.burgdorferi SOD was resistant to both treatments and was indeed a Mn-SOD (Troxell et al., 2012).  
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SOD activity was assessed by the use of a SOD determination kit  (Sigma 19160) which allows SOD 
activity to be determined based upon Dojindo’s water-soluble tetrazolium salt, WST-1 (2-(4-
Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H tetrazolium, monosodium salt) which 
produces a water soluble formazan dye upon reduction with a superoxide anion. The rate of reduction 
with O2 is linearly related to xanthine oxidase activity which is inhibited by SOD allowing inhibitory 
activity to be determined by use of a simple colorimetric assay alongside appropriate blank controls. 
 
Initial activity testing (section 2.2.7.5) highlighted a number of problems which needed addressing. 
Originally the assay was performed by supplementing recombinant B. burgdorferi with either 1mM 
MnCl2 or 1mM FeCl2. However, excess amounts of these two additives terminated the colorimetric 
reaction. Also the rapid oxidisation of FeCl2 gave rise to other colour changes within the reaction 
which couldn’t be removed simply by a suitable blank or control. 
 
Apo-SodA produced as described within the methods section gave an averaged 3% inhibition shown 
in figure 3B. This indicated that the method used to produce apo-protein was relatively successful 
and the majority of SodA protein was stripped of any native co-factors. Apo-protein supplemented 
with a supply of FeCl2 prior to refolding also failed to inhibit the colorimetric assay to a reasonable 
level, giving an averaged inhibition of 5.9%. Apo-protein supplemented with MnCl2 and refolded 
using the same method as Fe-SodA gave a significantly higher percentage inhibition at 82.9%. 
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Figure 4.11. SOD activity and inhibition curves. Assays were performed under manufacturer’s instructions and SodA 
samples were prepared in 0.3M NaCl, 50mM tris base, pH8. Error bars were calculated as standard error. 
A. Assay inhibition curves for B. burgdorferi SodA samples. The absorbance was monitored at 440 nm and values 
recorded every minute for a total of 20 minutes. Data was averaged from 4 repeats and the background subtracted. 
B. Percentage inhibition of the colorimetric SOD assay. Data is averaged over 4 repeats and the background subtracted. 
Percentage inhibition was calculated from an end point of 20 minutes. Bars from left to right, GREEN – Apo-SodA 
supplemented with a supply of MnCl2 prior to refolding, total percentage inhibition of 82.9%.  BLUE – Apo-SodA 
supplemented with FeCl2 prior to refolding, total percentage inhibition of 5.9%. RED – Apo-SodA, no added co-factor, 
total percentage inhibition of 3%. 
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4.8 Crystallisation trials of B. burgdorferi SodA 
Refolded B. burgdorferi SodA was concentrated to 10 and 15 mg/ml in 0.3M NaCl, 50mM tris at 
pH8 using 10,000K MWCO centrifugal concentrator using manufacturer instructions and centrifuged 
at 13,000rpm in a bench top centrifuge for 20 minutes prior to crystal screening (section 2.2.9). 
Hanging drops trays were set up in duplicate and by hand using 24 well plates at a ratio of 1:1 whereby 
the drop consisted of 1µl of protein solution with the same amount of well solution. All crystal screens 
were made in house from stock solutions and are summarised in table 4.4. 
 
Trays were observed immediately after set up using a light microscope and stored at both 20 and 
10oC. Crystal trays were further checked on day 2, 4, 7 and weekly after this period for any changes. 
 
Crystal Screen  Manufacturer Formulation 
Clear strategy crystal screen 1 (CSSI) Molecular dimensions In house 
Clear strategy crystal screen 2 (CSSII) Molecular dimensions In house 
Wizard Screen 1 Rigaku In house 
Wizard Screen 2 Rigaku In house 
Wizard Screen 3 Rigaku In house 
Wizard Screen 4 Rigaku In house 
Table 4.4. Crystallisation screens used for SOD crystallisation attempts. All crystal screens were made in house using 
formulation recipes from Rigaku. 
 
Screening using recombinant SodA failed to produce any crystals with the exception of some salt 
crystals which were apparent in conditions containing ammonium sulphate and were identified using 
Izit dye and by crushing. 
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4.9 Homology Modelling: Borrelia burgdorferi superoxide dismutase 
Homology models for B. burgdorferi SodA were generated using PHYRE2 (Kelley, 2015). 
Throughout the project two homology modelling methods were utilised these included PHYRE2 
(Kelley, 2015) and Chimera (Pettersen et al., 2004) with Modeller (UCSF – Webb & Sali, 2014, 
Martin-Renom et al., 2000, Sali & Blundell, 1993, Fiser et al., 2000). The program PHYRE2 (Kelley, 
2015) was the preferred method and can be considered the most automated approach. When templates 
with a high degree of sequence similarity can be found PHYRE2 (Kelley, 2015) can rapidly produce 
homology models and predict ligand binding and active site structures. This tool was highly effective 
for SOD modelling as the enzyme is highly conserved in contrast Borrelia OMPs shared no level of 
sequence similarity to other known proteins and Chimera (Pettersen et al., 2004) and Modeller (UCSF 
– Webb & Sali, 2014, Martin-Renom et al., 2000, Sali & Blundell, 1993, Fiser et al., 2000) provided 
a powerful alternative when alignment editing was required. 
 
Protein BLAST (Altschul et al., 1990) searches identified a manganese superoxide dismutase from 
T. thermophilus with the highest sequence similarity of 51%. The structure of this protein (PDB 
3MDS – Ludwig et al., 1991) along with the next four highest scoring proteins were selected by 
PHYRE2 (Kelley, 2015) for homology modelling and the generated structures shown in figure 4.12 
and full template information shown in table 4.5. 
 
Model Template Sequence similarity Confidence Coverage 
1 Mn-SOD - T. thermophilus (3MDS) 51% 100% 99% 
2 Mn-SOD - Nostoc sp. (1GV3) 42% 100% 99% 
3 Mn-SodA-2 – Bacillus anthracis (1XRE) 45% 100% 99% 
4 Mn-SOD – Bacillus subtilis (2RCV) 47% 100% 99% 
5 Fe-SOD – Clostridium difficile (3TJT) 43% 100% 99% 
 Table 4.5. Summary PHYRE2 data for B. burgdorferi SodA homology modelling.  
 
 
The model ranked highest by PHYRE2 (Kelley, 2015) was based upon a known Mn-SOD from T. 
thermophilus which shared a significant level of sequence similarity. As this model was calculated 
with 100% confidence the generated model was submitted to the 3D Ligand Site (Wass et al., 2010) 
with the aim of predicting potential binding sites. Predicted binding sites are shown in figure 4.14 
with the server identifying His26, His81, Asp164 and His168 as possible residues within the binding 
site. This agreed particularly well with previous modelling work undertaken by Aguirre et al., 2013 
previously discussed in figure 1.26 of section 1.6.5. 
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Figure 4.12. PHYRE2 homology models for B. burgdorferi SodA. The top five ranking homology models for B. 
burgdorferi SodA based on five independent templates. 1- B. burgdorferi SodA homology model using a Mn-SOD from 
T. thermophilus (PDB code - 3MDS – Ludwig et al., 1991) as a template. 2- Homology model generated using a Mn-
SOD from Nostoc sp. (PDB code – 1GV3 – Atzenhofer et al., 2002). 3 – Generated using Mn-SodA-2 from Bacillus 
anthracis (PDB code – 1XRE – Boucher et al., 2005) as a template. 4 – Mn-SOD from Bacillus subtilis (PDB code – 
2RCV – Liu et al., 2007) used as a template. 5 – A homology model generated using and Fe-SOD from Clostridium 
difficile (PDB code – 3TJT – Li et al., 2015) as a template. 
 
1. 2. 3. 
4. 5. 
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Figure 4.13. PHYRE2 secondary structure and disorder prediction of B. burgdorferi SodA. Output data generated 
by PHYRE2 (Kelley, 2015) summarising the predicted secondary structure of B. burgdorferi SodA. 
 
 
The PHYRE2 (Kelley, 2015) prediction was further supported following submission of the amino 
acid sequence to RaptorX (Källberg et al., 2012) a web tool for protein structure and function 
prediction. Alike PHYRE2 (Kelley, 2015) a tertiary structure for B. burgdorferi SodA was generated 
using the highest ranking template based upon the B. burgdorferi amino acid sequence. Alike 
PHYRE2 (Kelley, 2015) this was deemed to be a Mn SOD from T. thermophilus (3MDS - Ludwig et 
al., 1991) following generation of a homology model as shown in figure 4.14. This model was used 
for ligand binding prediction. Mn was identified as the ligand with His24, His81, Asp164 and His168 
predicted to be participating within the binding site, full parameters and scoring is shown in table 4.6. 
 
Models built using RaptorX (Källberg et al., 2012) are assessed for their reliability using three major 
parameters. These include the p-value, the score and the uGDT (GDT). The p-value represents the 
likelihood of the generated model being worse than the best set of randomly generated models for the 
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protein or domain in question. Therefore the lower the p-value the higher the quality of the computed 
model. As a general rule the p-value of a good model should close to 10^-3 for alpha proteins and 
less than 10^-4 for beta proteins. The second value is known as the score and is based upon the 
alignment scoring which can fall between 0 and the sequence length with the value of 0 being the 
lowest score. In some cases the score can exceed the sequence length due to error estimations.  
 
The final value in order to assess the model is the uGDT (GDT), the uGDT is the unnormalised global 
distance test which is defined as, 1*N(1)+0.75*N(2)+0.5*N(4)+0.25*N(8)  
where N(x) is the number of residues with estimated modelling error (in Å) smaller than x. From this, 
GDT is calculated as uGDT divided by the protein length and multiplied by a 100.  
 
The uGDT(GDT) measures the absolute model quality. For a protein with >100 residues, uGDT>50 
is a good indicator. For a protein with <100 residues, GDT>50 is a good indicator. If a model has 
good uGDT (>50) but bad GDT (<50), it indicates that only a small portion of the model may be 
good. 
 
To judge the quality of the generated model all three values are used. A model with a good o-value 
and uGDT is likely to be of high quality in contrast a model with a good p-value but poor uGDT may 
be of low quality even though the p-value indicates it is better than the set of randomly generated 
models. Models with a low p-value but a good uGDT value may of fair quality although they may 
not be better than the set of randomly generated models. All three of the values exhibit a bias towards 
sequence or domain length. The longer the amino acid sequence submitted to RaptorX (Källberg et 
al., 2012) the more likely the software can build a better model with a better score, uGDT and p-
value. This is somewhat rectified by taking the GDT into account when evaluating the quality of the 
generated model. However, other values may be useful in order to counteract the sequence length 
bias. 
 
The model generated by RaptorX (Källberg et al., 2012) for B. burgdorferi SodA was based upon the 
same T. thermophilus template (identity 51%) as selected by PHYRE2 (Kelley, 2015) and the model 
scored highly with a score of 216 a p-value of 1.92e-10 and an overall uGDT (GDT) 180 (88). This 
high quality model was used for ligand binding searching with the predicted active site shown in 
figure 4.14.  
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Highest ranking template Mn-SOD from T. thermophilus (3MDS) 
Predicted number of domains 1 
p-value 1.92e-10 
Overall uGDT(GDT) 180 (88) 
uSeqId(SeqId) 101 (50) 
Score 216* 
Number of residues modelled 203 (100%) 
Number of positions predicted as disordered 0 (0%) 
Secondary structure prediction 57% α-helix, 7% β-sheet, 34% loops 
Solvent access prediction 29% exposed, 31% medium, 39% buried 
 
Table 4.6. RaptorX summary of parameters and estimation values. All values were calculated by RaptorX 
(Källberg et al., 2012) structure prediction and Raptor X (Källberg et al., 2012) binding prediction. *The score value 
exceed the total sequence length due to error estimations. 
 
 
 
 
 
Figure 4.14. Predicted active site for B. burgdorferi SodA. Amino acids involved within the active site were 
identified using RaptorX (Källberg et al., 2012) from an initial homology model generated using a Mn-SOD from T. 
thermophilus (1MNG – Lah et al., 1995). LEFT – Cartoon representation of the homology model generated by RaptorX 
(Källberg et al., 2012) with the four predicted amino acids involved within the ligand binding site. RIGHT – A closer 
look at the four predicted amino acids and the Mn co-factor. 
 
 
 
 
 
Page | 306  
 
4.10 Discussion 
As with many Borrelia genes, the B. burgdorferi SodA contains numerous rare codons. In the hope 
of improving expression by E. coli the gene was commercially codon optimised for use within an E. 
coli expression system. High expression levels were achieved under IPTG control and using 
autoinduction methods. However, SodA was observed to form insoluble inclusion bodies under all 
conditions tested (section 4.2). This negatively impacted the final yield as SodA required extraction 
and refolding from these inclusion bodies. A number of SODs from both prokaryotes (Whittaker & 
Whittaker, 2000, Love et al., 2002, Brennan et al., 2015) and eukaryotes (Shi et al., 1999, 
Sujiwattanarat et al., 2016) have been demonstrated to be produced as active soluble proteins 
following expression within E. coli. However, this was not seen for B. burgdorferi SodA suggesting 
an alternative expression system such as Pichia pastoris maybe useful for any future work. 
Interestingly around 30% of native E. coli proteins would also not be expressed as soluble 
polypeptides when overexpressed in E. coli (Vincentelli et al., 2003) highlighting the challenges 
faced when producing Borrelia proteins within this expression system. 
 
Refolding yields were fair with 1L of E. coli expression culture often delivering 10-20 mg of 
recombinant SodA following gel filtration. These yields were not observed during the production of 
apo-SodA where the amount of final product dropped over ten-fold indicating that the metal ion co-
factor plays a major role in stability. Of the small amount of apo-protein that could be obtained this 
sample was confirmed as folded by circular dichroism. It was determined that less apo-SodA would 
precipitate if metal ions were stripped from the sample prior to refolding rather than taking a sample 
of folded SodA and removing bound metal ions either by dialysis or by chromatography. 
 
Both in-house and synchrotron SAXS experiments were problematic (section 4.6). Samples of Mn-
SodA subjected to data collection on a Bruker nanostar exhibited radiation damage and progressive 
aggregation and precipitation during the exposure time. This occurred as early as the first frame of 
2400 seconds making data analysis impossible. Samples of Mn-SodA taken to DLS were of good 
quality and enzymatically active. However, the samples precipitated instantly upon X-ray exposure. 
Literature searches have failed to identify any similar problems for SODs or for any other 
metalloprotein. However, the observed behaviour of SodA in response to X-ray exposure suggests 
that oxidation of the metal ion may have induced instability leading to aggregation.  
 
Previous studies have identified that B. burgdorferi SodA is likely a Mn-SOD in contrast to its initial 
characterisation as a Fe-SOD. However, this is yet to be confirmed using a pure recombinant sample. 
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This study confirms that B. burgdorferi SodA is indeed active in the presence of manganese and has 
limited activity when it is stripped of this ion or when supplemented with iron (section 4.7). The low 
level of activity observed for Apo-SodA and Fe-SodA is likely due to residual Mn ions within the 
sample. For the first time it has been demonstrated that B. burgdorferi SodA does not exhibit 
cambialistic behaviour to any significant degree. The limitations of the enzymatic study is the 
acceptance that each SodA sample contained the desired metal ion. Atomic absorption spectroscopy 
could be useful in order to confirm presence of Fe and Mn within the protein sample (Del Vechhio et 
al., 2009).  
 
Early crystallisation attempts of B. burgdorferi SodA were promising. The protein appeared fairly 
stable and clear drops were observed across a number of conditions with minimal amorphous 
aggregation observed.  However, optimisation of these conditions failed to yield crystals (section 
4.8). Optimisation revolved around increasing the protein concentration and increasing the precipitant 
concentration within each condition. Crystallisation experiments were carried out both under 
reducing and non-reducing conditions and where possible the reducing agents DTT and β-
mercaptoethanol was supplemented with fresh stock every few days to maintain the reducing 
environment. Future work should aim to produce B. burgdorferi SodA mutants devoid of the cysteine 
residue at position 136 in order to improve stability for crystallisation and to conclude whether the 
dimer formation is physiologically relevant and required for enzymatic activity. 
 
As previous discussed B. burgdorferi SodA shares a significant level of sequence similarity to a Mn-
SOD from Thermus sp. (section 4.1) this brought to question whether this would be seen for other 
Borrelia proteins. In order to deduce whether this similarity was an exception or whether the 
similarity between the two species extended further, a selection of housekeeping and other important 
cellular Borrelia proteins were selected and subjected to protein BLAST (Altschul et al., 1990) 
searching. The full list and results can be seen within the appendix 3. This small investigation 
highlighted a number of Borrelia proteins with sequence similarity to other extremophiles rather that 
other spirochaetes such as Leptospira and Treponema. Further work is needed in order to decipher 
this shared identity with the possibility that some Borrelia proteins may be of commercial interest 
should they retain function under extreme conditions. 
 
Unlike many other micro-organisms, B. burgdorferi appears to have evolved without any known 
requirement for iron and several studies have demonstrated that the spirochaete accumulates very 
high levels of cellular manganese when compared to organisms such as E. coli and S. cerevisiae 
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(Aguirre et al., 2013). This high manganese environment may serve an important purpose for this 
unique micro-organism. Firstly the absence of cellular iron and the lack of iron requiring enzymes 
encoded within the Borrelia genome suggests that manganese may be much more widely used as a 
co-factor for the spirochaetes metalloproteins. When B. burgdorferi SodA is expressed within S. 
cerevisiae the enzyme is only activated once cellular manganese levels exceeds the concentration of 
mitochondrial iron. These levels of manganese simulate the normal conditions within Borrelia 
(Aguirre et al., 2013).  
 
The high manganese conditions observed within the spirochaete may also be considered a unique 
adaption which provides the micro-organism with an exceptional response to metal starvation. The 
effects of ROS upon pathogenic bacteria has been of high interest for a number of years. However, 
much of this work has revolved around the study of the effects of ROS upon bacteria that require iron 
and possess a TCA cycle (Shimizu, 2013, Rosato et al., 2014, Thomas et al., 2013). The overall effects 
of ROS are directly related to a micro-organisms cellular iron, due to Fenton chemistry. As Borrelia 
have no need for iron the organism presents an interesting platform to further our understanding of 
the effects of oxidative stress in a system devoid of iron. As the destruction of Fe-metalloproteins or 
damage to DNA (Troxell et al., 2012) does not appear to be the primary target of ROS within Borrelia 
the presence of the spirochaetes SodA enzyme questions its purpose. Recent work has identified that 
the SodA protein may offer protection from ROS mediated damage of membrane polyunsaturated 
fatty acids. However, if this was the primary purpose of the SodA enzyme should we not expect this 
protein to be membrane bound or localised within the periplasm as a result of selective pressure? 
(Troxell et al., 2012). As most Mn-SODs are considered intracellular proteins (Gregory et al., 1973), 
and it is currently accepted that B. burgdorferi SodA is a cytoplasmic enzyme, it is likely that the 
SodA protein does not only have roles within protecting the membrane. Recent work has identified 
that the SodA gene is essential for the spirochaetes resistance to streptonigrin (Troxell et al., 2012) 
which is curious as streptonigrin toxicity is dependent on iron (Yeowell & White, 1982). Streptonigrin 
is naturally produced by Streptomyces flocculus and is considered to exhibit both anti-tumour and 
anti-bacterial activity (Rao & Cullen, 1960). It was observed from as early as the 1980’s that the 
activity of streptonigrin was hindered should a bacterium become unable to uptake iron (Yeowell & 
White, 1982). The overall effect of streptonigrin within the cell is the promotion of ROS (Hassan & 
Fridovich, 1979) and NADH is thought to aid the redox cycling of streptonigrin (White & White, 
1968, Troxell et al., 2012). The sensitivity of B. burgdorferi to this compound remains poorly 
understood and the presence of either manganese or copper could be involved within this reaction 
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(Troxell et al., 2012). More importantly this sensitivity highlights that Borrelia may be susceptible to 
damage by other redox cycling compounds which the SodA enzyme offers protection from. 
 
In conclusion B. burgdorferi SodA appears as an essential and unique protein in a family of normally 
well conserved enzymes. It is likely that SodA plays other roles other than protection to 
polyunsaturated fatty acids within the membrane which will at some point explain its intracellular 
localisation. The Borrelia system also provides an interesting and unique platform for the study of 
ROS damage in a system where iron is not required and may be of importance for improving our 
understanding of redox cycling drugs. 
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Appendix 1. 
Sequencing data and chromatograms for B. burgdorferi OmpA-like proteins 
Sequencing was performed with both forward and reverse using primers for the T7 promoter and 
terminator respectively. All sequencing were performed by Source Bioscience (Rochdale). 
 
Chromatogram 1. BB_0562 forward read 
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Chromatogram 2. BB_0406 forward read 
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Chromatogram 3. BG0408 forward read 
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Raw FASTA sequencing data for B. burgdorferi OmpA-like proteins 
 
BB_0562 – Forward 
NNNNNNNNNCCCTCTANNNNNTTTTGTTNNCTTTAAGAAGGAGATATACATATGGCACATCACCACCACCATCACTCCGC 
GGCTCTTGAAGTCCTCTTTCAGGGACCCGGGTACCAGGATCCGAAAGATTCATATTTAAATAGAGGAATTGGCTTTGGAG 
CAAGCATTGGAAATCCAATTATTAACTTAATAATGTCATTTCCTTTCATTGATTTTGAAATTGGCTATGGTGGTAGTAAT 
GGAATAAATCTATCAGGCCCCAAACTTGAATCAAAATTTTATGATTTTAATTTATTAGCAATAGCAGCACTTGATTTCAT 
TTTTACAATATCTTTGATAAAAAATTTAAATTTAGGAATTGGAATAGGAGGAAATATAAGCATATCGTCTCACACATCTA 
AATTAATAAATGTAGAATTAGGATTTGGAATGAGAATTCCATTGGTTATTTTTTACGACATTACAGAAAATTTAGAAATA 
GGTATGAAAATAGCACCTTCAATAGAATTCATCTCAAATACAAGGTCTCTTGCTCAACATAGAACCTATTCGGGCATAAA 
ATCAAACTTTGCTGGGGGAATATTTGCTAAGTACTATATCTTTTAACACCAATTCATTCTAATTTATTAAATTTATTGCC 
AAGCGCTATGAAAAAATTCGCGGCCGCAGAGCTCGCTCTGGTGCCACGCGGTAGTAAAGAAACCGCTGCTGCTAAATTCG 
AACGCCAGCACATGGACAGCTCTACTTCTGCTGCTCTCGAGGCTTAATTAACCTANGCTGCTAAACAAAGCCCGAAAGGA 
AGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTT 
TGCTGAAAGGAGGAACTATATCCGGATTGGCGAATGGGACGCGCCCTGTAGCGGCGCATTAGCGCGGCGGGNGGNNGGNN 
GNTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTANCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCAC 
GTTCGCCGGCTTTCCCCGTCNNCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTANNGCTTTACGGCNCNCNACCCC 
AAAACTGATTANNNGATGNTNNNCGTANNGGGCNTCNCCCNNNNNNANNGNTTTTNNCCCNTNNNNCNNNGNNTCACNNN 
NTTTANNANNNGNANNCTTNNNCNNACNGGANANNNNNNNNCNNNNNNNNNNNNTNNNNNNNNAANGGNNNTNNNCNANT 
NNNNNNCNNNNGNNNNAAAAANNNNNNNATTNNNNNNTNNNNCNNATTNNNNNNNNNNNNNNNNNNNNNNNTTNNNNNNN 
NNNCGNN 
 
BB_0562 – Reverse 
NNNNNNTCNTTCGGGCTTTGTTTAGCAGCCTAGGTTAATTAAGCCTCGAGAGCAGCAGAAGTAGAGCTGTCCATGTGCTG 
GCGTTCGAATTTAGCAGCAGCGGTTTCTTTACTACCGCGTGGCACCAGAGCGAGCTCTGCGGCCGCGAATTTTTTCATAG 
CGCTTGGCAATAAATTTAATAAATTAGAATGAATTGGTGTTAAAAGATATAGTACTTAGCAAATATTCCCCCAGCAAAGT 
TTGATTTTATGCCCGAATAGGTTCTATGTTGAGCAAGAGACCTTGTATTTGAGATGAATTCTATTGAAGGTGCTATTTTC 
ATACCTATTTCTAAATTTTCTGTAATGTCGTAAAAAATAACCAATGGAATTCTCATTCCAAATCCTAATTCTACATTTAT 
TAATTTAGATGTGTGAGACGATATGCTTATATTTCCTCCTATTCCAATTCCTAAATTTAAATTTTTTATCAAAGATATTG 
TAAAAATGAAATCAAGTGCTGCTATTGCTAATAAATTAAAATCATAAAATTTTGATTCAAGTTTGGGGCCTGATAGATTT 
ATTCCATTACTACCACCATAGCCAATTTCAAAATCAATGAAAGGAAATGACATTATTAAGTTAATAATTGGATTTCCAAT 
GCTTGCTCCAAAGCCAATTCCTCTATTTAAATATGAATCTTTCGGATCCTGGTACCCGGGTCCCTGAAAGAGGACTTCAA 
GAGCCGCGGAGTGATGGTGGNGNGGGNGATGTGCCATATGTATATCTCCTTCTTAAAGTTAAACAAAATTATTTCTAGAG 
GGGGAATTGTTATCCGCTCACAATTCCCCTATAGTGAGTCGTATTAATTTCGCGGGATCGAGATCGATCTCGATCCTCTA 
CGCCGGACGCATCGTGGCCGGCATCACCGGCGCCACAGGTGCGGTTGCTGGCGCCTATATCGCCGACATCACCGATGGGG 
GAAGATCGGGCTCGCCACTTCGGGCTCATGAGCGCTTGTTTCGGCGTGGGTATGGTGGCNNNCCCGNGGNCGGGGGACTG 
TTGGGCGCCATCTNCNTGCATGCACCATTCCTTGNNNNGNNGNGCTNANNNNNNNNACTACTGGCTGNTNCTNNNGCAGN 
NNNCATAGNANNNCGNNNNATCCCGNNNCCNNNNNNGGNNNNANNTTNCGNNGNATGNTNNNNNNNNNNNNNNANTCNGG 
NGNGNANNNNNNNNNACNNNNNANNNNCNAANNNNNGNNNNNNNNNNNNNNNNNNNNNNNNNNNNNTNNNNNNNNNNNNN 
NNNNNNNNNNNNNNTNNTCN 
 
BB_0406 – Forward 
NNNNNNNNNNTCCCTCTNNNNNNNTTTTGTTTAACTTTAAGAAGGAGATATACATATGGCACATCACCACCACCATCACT 
CCGCGGCTCTTGAAGTCCTCTTTCAGGGACCCGGGTACCAGGATCCGTCTGACAATTATATGGTCAGATGCAGCAAGGAA 
GAAGATTCAACCACCTGTATCGCAAAGCTTAAAGAAATAAAAGAAAAGAAAGATTATGACTTATTTTCAATGGGCATTGG 
AATAGGAGATCCTATTGCAAATATTATGATTACAATTCCTTATATAAATATTGATTTTGGATGTGGAGGTTTTATTGGCC 
TTAAGTCAAACAATTTTGAAAATTATCTAAATGGTGGAATAGACGTTATTTTTAAAAAGCAAATTGGACAATATATGAAA 
ATTGGCGGCGGCATTGGAATAGGTGCGGATTGGTCAAAAACATCCCTTATACCCCCTAATGAAGAAGAAGAAACTGATTA 
TGAGAGAATAGGCGCTGTTATAAGAATTCCTTTTATAATGGAATATAATTTTGCAAAAAATTTATCCATAGGATTCAAAA 
TTTATCCTGCAGTAGGGCCAACAATATTACTAACAAAACCCAGCATTTTATTTGAAGGAATTAAATTCAATTTTTTTGGA 
TTTGGATTCATAAAATTTGCATTTAATTAACCAAATAATTAAATTGGTAATTAAAATTAAGCTCGCATAGCGGCCGCAGA 
GCTCGCTCTGGTGCCACGCGGTAGTAAAGAAACCGCTGCTGCTAAATTCGAACGCCAGCACATGGACAGCTCTACTTCTG 
CTGCTCTCGAGGCTTAATTAACCTAGGCTGCTAAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCA 
ATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGATTGG 
CGAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCA 
GCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAAT 
CGGGGGCTCCCTTTAGGGTTCCGATTTNNTGCTTTANNNNCNCGACCCCAAAAACTTGATTAGGGTGATGGNNACGTANN 
GGGNNTCNCCNGATNNANGNTTTCNCCTNNACNNNGNANNCCACNTNCNTTANANNGNNTNTNTCNACTNNNNANNNNNN 
NNNATCTCNGNNNNNTNTTGNNTNNNANGNNTTNNNGANTNNNNNNNNNNNNNAAANNNNNNNNNNNNNNNNNNNNNNNC 
NANTTTNNNNNNN 
 
BB_0406 – Reverse 
NNNNNNTCNTTCGGGCTTTGTTTAGCAGCCTAGGTTAATTAAGCCTCGAGAGCAGCAGAAGTAGAGCTGTCCATGTGCTG 
GCGTTCGAATTTAGCAGCAGCGGTTTCTTTACTACCGCGTGGCACCAGAGCGAGCTCTGCGGCCGCTATGCGAGCTTAAT 
TTTAATTACCAATTTAATTATTTGGTTAATTAAATGCAAATTTTATGAATCCAAATCCAAAAAAATTGAATTTAATTCCT 
TCAAATAAAATGCTGGGTTTTGTTAGTAATATTGTTGGCCCTACTGCAGGATAAATTTTGAATCCTATGGATAAATTTTT 
TGCAAAATTATATTCCATTATAAAAGGAATTCTTATAACAGCGCCTATTCTCTCATAATCAGTTTCTTCTTCTTCATTAG 
GGGGTATAAGGGATGTTTTTGACCAATCCGCACCTATTCCAATGCCGCCGCCAATTTTCATATATTGTCCAATTTGCTTT 
TTAAAAATAACGTCTATTCCACCATTTAGATAATTTTCAAAATTGTTTGACTTAAGGCCAATAAAACCTCCACATCCAAA 
ATCAATATTTATATAAGGAATTGTAATCATAATATTTGCAATAGGATCTCCTATTCCAATGCCCATTGAAAATAAGTCAT 
AATCTTTCTTTTCTTTTATTTCTTTAAGCTTTGCGATACAGGTGGTTGAATCTTCTTCCTTGCTGCATCTGACCATATAA 
TTGTCAGACGGATCCTGGTACCCGGGTCCCTGAAAGAGGACTTCAAGAGCCGCGGAGTGATGGTGGGNGGTGATGTGCCA 
TATGTATATCTCCTTCTTAAAGTTAAACAAAATTATTTCTAGAGGGGAATTGTTATCCGCTCACAATTCCCCTATAGTGA 
GTCGTATTAATTTCGCGGGATCGAGATCGATCTCGATCCTCTACGCCGGACGCATCGTGGCCGGCATCACCGGCGCCACA 
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GGTGCGGTTGCTGGCGCCTATATCGCCGACATCACCGATGGGGAAGATCGGGCTCGCCACTTCGGGCTCATGAGCGCTTG 
TTTCGGCGTGGGTATGGTGGCAGGCCCCGTGGNNGGGGGANTGTTGGGCGCCATCTNCNTGCATGCANCATTCCTTNNNN 
NGNNGGTGNTCANCGGNNTNANCTACTACTGGGCTGCTTCCTAATGCAGNANTCNNATANNANNNCGTCNAGATCCCNGA 
NNNCATCNNNGNNNAAACNTNNNNGNNNNGCATGNTANCNCCNNANNNNNTCATNNGGNNGGNNANNNNANNGTANNTNT 
NNNANNNNCNNNNNNNCNNNNCTTNNNNNACNNNNCNNNNNGNNNNCNNNNNNNNNNNNNNNNNNNAANNNNNNNTGNGA 
NNNNTNNNNNNNNNNNNNNNNNNN 
 
BG0408 – Forward 
NNNNNNNNNNCNNNCTNNNNNNATTTTGTTTAACTTTAAGAAGGAGATATACATATGGCACATCACCACCACCATCACTC 
CGCGGCTCTTGAAGTCCTCTTTCAGGGACCCGGGTACCAGGATCCGTCTGACAATTATATGGTCAGACGCAGCAAGGAAG 
AAGATTCAACAACCTGTATCGCAAAGCTTAAAGGCATAAAAGAAAAAAAAAGTTATGACTTATTTTCAATGGGTATTGGA 
ATAGGCAATCCTATTGCAAACATAATAATTACAATTCCTTATATAAATATTGATTTTGGATATGGGGGTTTTATTGGTCC 
TAAGTCAAATAATTTTGAAAATTATCTAAACGGCGGAATAGATATTGTTTTTAAAAAACAAATTGGACAATACATGAGAA 
TCGGTGGCGGCATTGGAATAGGTGCAGATTGGTCAAAAACATCCCTCATACCTCCTGACGAAGAGAAAGAGACTGATTAT 
GAGAGAATAGGCGCTGTTATAAGAATTCCTTTTGTAATGGAATATAACTTTGCAAAAAATTTGTACATAGGATTCAAACT 
TTACCCTGCACTAGGGCCAACAATATTGCTAACAAAGCCAAAAATTTTATTTGAAGGAATTAAATTCAATTTTTTTGGAT 
TTGGATTCATAAAATTTGCATTTAATTAGCCAAACAATTAAATTGGTGATTAAAATTAAGCTTACTTAAGCGGCCGCAGA 
GCTCGCTCTGGTGCCACGCGGTAGTAAAGAAACCGCTGCTGCTAAATTCGAACGCCAGCACATGGACAGCTCTACTTCTG 
CTGCTCTCGAGGCTTAATTAACCTANGCTGCTAAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCA 
ATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGATTGG 
CGAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCA 
GCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCNGGCTTTCCCCGTCAGCTCTAAATC 
GGGGGCTCCCTTTAGGGNTCCGANTTANNGCTTTANGCACNCGACCCCNAAAACTTGATTAGGNTGATNNNCACGTNNNG 
NNNTCNNCCNNATANANGTTTTCNCCNTNGACNTNNANTCNNNTNNTTANANNGNNTNNNNNNANCNGANNNNNNNNNNN 
TCNNGNNTNNNNTTTGATNNNNNNNNTTTNCNANTTNNNNNNNNTNNANNNNNNTNNNNNNNNNNNNNNNNNNNNTNANN 
NNNTTTNN 
 
BG_0408 – Reverse 
NNNNNNNTNNTTCGGGCTTTGTTTAGCAGCCTAGGTTAATTAAGCCTCGAGAGCAGCAGAAGTAGAGCTGTCCATGTGCT 
GGCGTTCGAATTTAGCAGCAGCGGTTTCTTTACTACCGCGTGGCACCAGAGCGAGCTCTGCGGCCGCTTAAGTAAGCTTA 
ATTTTAATCACCAATTTAATTGTTTGGCTAATTAAATGCAAATTTTATGAATCCAAATCCAAAAAAATTGAATTTAATTC 
CTTCAAATAAAATTTTTGGCTTTGTTAGCAATATTGTTGGCCCTAGTGCAGGGTAAAGTTTGAATCCTATGTACAAATTT 
TTTGCAAAGTTATATTCCATTACAAAAGGAATTCTTATAACAGCGCCTATTCTCTCATAATCAGTCTCTTTCTCTTCGTC 
AGGAGGTATGAGGGATGTTTTTGACCAATCTGCACCTATTCCAATGCCGCCACCGATTCTCATGTATTGTCCAATTTGTT 
TTTTAAAAACAATATCTATTCCGCCGTTTAGATAATTTTCAAAATTATTTGACTTAGGACCAATAAAACCCCCATATCCA 
AAATCAATATTTATATAAGGAATTGTAATTATTATGTTTGCAATAGGATTGCCTATTCCAATACCCATTGAAAATAAGTC 
ATAACTTTTTTTTTCTTTTATGCCTTTAAGCTTTGCGATACAGGTTGTTGAATCTTCTTCCTTGCTGCGTCTGACCATAT 
AATTGTCAGACGGATCCTGGTACCCGGGTCCCTGAAAGAGGACTTCAAGAGCCGCGGAGTGATGGTGGTGGTGATGTGCC 
ATATGTATATCTCCTTCTTAAAGTTAAACAAAATTATTTCTAGAGGGGAATTGTTATCCGCTCACAATTCCCCTATAGTG 
AGTCGTATTAATTTCGCGGGATCGAGATCGATCTCGATCCTCTACGCCGGACGCATCGTGGCCGGCATCACCGGCGCCAC 
AGGTGCGGTTGCTGGCGCCTATATCGCCGACATCACCGATGGGGAAGATCGGGCTCGCCACTTCGGGCTCATGAGCGCTT 
GTTTCGGCGTGGGTATGGTGGCAGGCCCCGNGGNNGGGGGACTGTTGGGCGCCATCTCCTTGCATGCACCATTCCTTGCG 
CGGCGNGCTCANGGNNCAACNACTACTGNNTGNNNNAANGCNGNNTCGCATNNNANANCGNCNANATCCCGNNNCATCNA 
TGNNCAAACNTTNNNNNANGNATGATAGCGCCNNNNNNNANTNNNNNGNNNGNNANNNNAAANNGTANNTNNNNCNANNN 
NNCANANNNNCNNNNNNNNNNNTANNNNANNNTTNCCNNNNNNGNNNNNNNNNNNNCNNCNNTTCTGNNANNNCNGGAAA 
NNNGANNNGNNNNNNNGNNNGNNNNNNNNA 
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Appendix 2. 
Circular dichroism data for B. burgdorferi s.l. OmpA-like proteins 
CD data were generated for Borrelia OMPs across several concentrations the resulting spectra are 
shown below. 
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Figure 7.1. CD spectra of BAPKO_0422 at varying concentrations. CD data was collected on a JASCO J-
810 at 20oC from 260 nm down to 185 nm. Recordings were made at 0.5 nm intervals. Proteins were 
prepared in 0.3M NaCl, 50mM tris base, 0.1% v/v LDAO at pH8. 
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Figure 7.2. CD spectra of BB_0562 at varying concentrations. CD data was collected on a JASCO J-810 at 
20oC from 260 nm down to 185 nm. Recordings were made at 0.5 nm intervals. Proteins were prepared in 
0.3M NaCl, 50mM tris base, 0.1% v/v LDAO at pH8 
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Figure 7.3. CD spectra of BB_0406 at varying concentrations. CD data was collected on a JASCO J-810 
at 20oC from 260 nm down to 185 nm. Recordings were made at 0.5 nm intervals. Proteins were prepared in 
0.3M NaCl, 50mM tris base, 0.1% v/v LDAO at pH8 
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Figure 7.4. CD spectra of BG0408 at varying concentrations. CD data was collected on a JASCO J-810 
at 20oC from 260 nm down to 185 nm. Recordings were made at 0.5 nm intervals. Proteins were prepared in 
0.3M NaCl, 50mM tris base, 0.1% v/v LDAO at pH8 
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Circular dichroism reference sets 
Reference Set: SP175 
 
Protein Organism PDB 
Aldolase Rabbit 1ADO 
Alkaline phosphatase E. coli 1 E D 9 
α-Amylase B. licheniformis 1VJS 
α-bungarotoxin Many-banded krait 1HC9 
α-chymotrypsin Cow 5CHA 
α-chymotrypsinogen Cow 2CGA 
Aprotinin Cow 5PTI 
Avidin Chicken 1RAV 
β-amylase Sweet potato 1FA2 
βB2-Crystalin Cow 2BB2 
β-galactosidase E. coli 1BGL 
β-lactoglobulin Cow 1B8E 
Carbonic anhydrase-I Human 1HCB 
Carbonic anhydrase-II Cow 1CA2 
Carboxypeptidase-A Cow 5CPA 
Calmodulin Cow 1LIN 
Catalase Human 1DFG 
Ceruloplasmin Human 1KEW 
Citrate synthase Pig 2CTS 
Concanavalin A Jack bean 1NLS 
c-Phycocyanin Spirulina platensis 1HA7 
Cytochrome-c Horse 1HRC 
Dehydroquinase-typeI S. typhimurium 1QFE 
DHQase-II M. tuberculosis 2DHQ 
DNase-I Cow 3DNI 
Elastase Pig 3EST 
Ferredoxin C. pasteurinum 1FDN 
γ-B-Crystalin Cow 4GCR 
γ-D-Crystalin Cow 1ELP 
γ-D-Crystalin Human 1HK0 
γ-E-Crystalin Cow 1M8U 
γ-S-Crystalin (C-term) Human 1HA4 
Glucose oxidase Aspergillus niger 1CF3 
Glutamate dehydrogenase Cow 1HWX 
Glycogen phosphorylase-b Rabbit 1GPB 
Haloalkane dehydrogenase R. spheroids 1BN6 
Hemoglobin Cow 1HDA 
IgG Mouse 1IGT 
Insulin Human 1TRZ 
Jacalin Jack fruit 1KU8 
Kap95p Baker’s yeast 2BKU 
Lactoferrin Cow 1BLF 
Latexin Mouse 1WNH 
Lentil lectin Common lentil 1LES 
Leptin Human 1AX8 
Lysozyme Chicken 1 9 3 L 
Monelin Serendipity berry 1M OL 
Myoglobin Horse 1YMB 
Myoglobin Sperm whale 1 A 6 M 
NmrA A. nidulans 1 K 6 J 
Ovalbumin Chicken 1OVA 
Ovotransferrin Duck 1DOT 
Papain Papaya 1PPN 
Pea lectin Garden pea 1OFS 
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Pepsinogen Pig 2PSG 
Peroxidase Horseradish 7ATJ 
Phosphoglucomutase Rabbit 3PMG 
Phoshoglycerate kinase Baker’s yeast 3PGK 
Phospholipase-A2 Cow 1UNE 
PNMT Human 1HMN 
Pyruvate kinase Rabbit 1A49 
Ribonuclease A Cow 3RN3 
Rubredoxin Desulfovibrio vulgaris 1RB9 
Serum Albumin Human 1N5U 
Streptavidin Strep avidinii 1STP 
Subtilisin A B. licheniformis 1SCA 
Superoxide dismutase (Cu, Zn) Cow 1CBJ 
Thaumatin Thaumatococcus daniellii 1THW 
Triose phosphate isomerase Baker’s yeast 7TIM 
Trypsin inhibitor Soybean 1AVU 
Ubiquitin Human 1UBI 
 
 
Reference Set: SMP180 
All of the proteins in SP175 plus, 
 
Protein Organism PDB 
Bacteriorhodopsin Halobacterium salinarum 1QHJ 
E203Q mutant of Cl-/H+ exchanger E. coli 2FED 
Lactose permease E. coli 2CFQ 
C123aT mutant of Succinyl-CoA Synthetase E. coli 2NU9 
Ammonia channel E. coli 2NOP 
Rhodopsin Bos taurus 1HZX 
ABC transporter E. coli 1L7V 
SecY Methanococcus jannaschii 1RH5 
Cytochrome C oxidase Bos taurus 2DYR 
Potassium channel Streptomyces lividans 1J95 
MscL Mycobacterium tuberculosis 2OAR 
AcrB E. coli 2GIF 
Photosynthetic reaction center Rhodobacter sphaeroides 1PCR 
Photosynthetic reaction center Blastochloris viridis 2WJN 
Cytochrome BC1 complex Bos taurus 1BE3 
Ca2+-ATPase Ca2-E1-AMPPCP form Oryctolagus cuniculus 1T5S 
Succinate dehydrogenase E. coli 1NEK 
Potassium channel KirBac3.1 Magnetospirillum magnetotacticum 1XL4 
WZA membrane protein E. coli 2J58 
Outer membrane complex of type IV secretion system E. coli 3JQO 
Translocator domain of NALP autotransporter Neisseria meningitidis 1UYN 
Argininosuccinate lyase Homo sapiens 1AOS 
Ferric hydroxamate uptake receptor E. coli 2FCP 
Ferric enterobactin receptor E. coli 1FEP 
Cobalamin transporter E. coli 1NQH 
OPCA adhesion Neisseria meningitidis 2VDF 
Yajl lipoprotein E. coli 2JWY 
Rhodopsin II-transducer complex Natronomonas pharaonis 1H2S 
Na+/Cl- dependent neurotransmitter transporter Aquifex aeolicus 2A65 
LH2 B800-850 Membrane protein Rhodoblastus acidophilus 1NKZ 
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Appendix 3: BLAST searching key Borrelia proteins 
Protein name NCBI accession Closest Match (organism) Identity 
Aminopeptidase YP_008686584.1 Psychromonas sp. 44% 
L-Lactate dehydrogenase WP_010889680 
 
Thalassobacillus devorans 52% 
Phosphoglycerate kinase WP_002658313 
 
Spirochaeta thermophila 62% 
Ribonuclease III WP_050581418 
 
Salinispira pacifica 49% 
UDP-N-acetylglucosamine--N-
acetylmuramyl-(pentapeptide) 
pyrophosphoryl-undecaprenol N-
acetylglucosamine transferase 
AIU79269 
 
Spirochaeta alkalica 39% 
DNA polymerase I WP_002557136 
 
Spirochaeta thermophile 40% 
Uridine kinase CAA66081 
 
Salinispira pacifica 60% 
NAD kinase WP_002660542 
 
Clostridium sp. 33% 
Glycerol kinase WP_002663811 
 
Leptolyngbya sp. 63% 
Acetate kinase EEH00007 
 
Spirochaeta cellobiosiphila 48% 
Pyridoxal kinase AIU79421 
 
Peptostreptococcus anaerobius 36% 
Telomere resolvase AIU80041 
 
Agrobacterium tumefaciens 27% 
Caax protease WP_002557180 
 
Spirochaeta thermophila 39% 
Clp protease WP_044273071   
 
Sulfurospirillum sp. 32% 
Lon protease AAB72011 
 
Spirochaeta bajacaliforniensis 52% 
Zinc protease WP_010889761 
 
Filimonas lacunae 30% 
Membrane protease AIU78903 
 
Spirochaeta thermophile 42% 
ATP-dependent protease ADQ29063 
 
Thiomicrospira sp. 60% 
Heat shock protein AAB04621 
 
Thiomicrospira sp. 60% 
Cell division protease EEF82543 
 
Spirochaeta alkalica 58% 
Molecular chaperone WP_002557236 
 
Spirochaeta cellobiosiphila 70% 
Nucleoside transport system permease AGS66335 
 
Deferribacter desulfuricans 29% 
Oligopeptide transport system permease AGS66350 
 
Spirochaeta thermophila 53% 
Mg2+ transport protein NP_212514 
 
Fervidicella metallireducens 48% 
Chromate transport protein AGS66461 
 
Atopobacter phocae 40% 
Sensor histidine kinase WP_002661705 
 
Methyloglobulus morosus 33% 
dTMP kinase WP_002664672 
 
E. coli 92% 
Type III pantothenate kinase WP_044273090 
 
Dethiosulfatarculus 
sandiegensis 
35% 
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UMP kinase WP_002661420 Spirochaeta alkalica 42% 
Phosphoglycerate kinase AAB53931 
 
Spirochaeta thermophila 61% 
Cytidylate kinase 2 WP_010889829 
 
Spirochaete thermophila 47% 
Dephospho-CoA kinase AIU79220 
 
Thermotoga sp. 37% 
Adenylate kinase AIU79103 
 
Thermovirga lienii 49% 
Mevalonate kinase WP_038378800 
 
Waddila chondrophila 33% 
FAD-dependent thymidylate synthase AIU79595 
 
Treponema denticola 48% 
Hydroxymethylglutaryl-CoA synthase WP_031542070 
 
Spirochaeta sp. 44% 
Methylglyoxal synthase P_002657078 
 
Psychrilyobacter atlanticus 67% 
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The Borrelia afzelii outer membrane protein
BAPKO_0422 binds human factor-H and is
predicted to form a membrane-spanning β -barrel
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Synopsis
The deep evolutionary history of the Spirochetes places their branch point early in the evolution of the diderms, before
the divergence of the present day Proteobacteria. As a spirochete, the morphology of the Borrelia cell envelope shares
characteristics of both Gram-positive and Gram-negative bacteria. A thin layer of peptidoglycan, tightly associated
with the cytoplasmic membrane, is surrounded by a more labile outer membrane (OM). This OM is rich in lipoproteins
but with few known integral membrane proteins. The outer membrane protein A (OmpA) domain is an eight-stranded
membrane-spanning β -barrel, highly conserved among the Proteobacteria but so far unknown in the Spirochetes. In the
present work, we describe the identification of four novel OmpA-like β -barrels from Borrelia afzelii, the most common
cause of erythema migrans (EM) rash in Europe. Structural characterization of one these proteins (BAPKO_0422) by
SAXS and CD indicate a compact globular structure rich in β -strand consistent with a monomeric β -barrel. Ab initio
molecular envelopes calculated from the scattering profile are consistent with homology models and demonstrate
that BAPKO_0422 adopts a peanut shape with dimensions 25 × 45 A˚ (1 A˚ = 0.1 nm). Deviations from the standard
C-terminal signature sequence are apparent; in particular the C-terminal phenylalanine residue commonly found in
Proteobacterial OM proteins is replaced by isoleucine/leucine or asparagine. BAPKO_0422 is demonstrated to bind
human factor H (fH) and therefore may contribute to immune evasion by inhibition of the complement response.
Encoded by chromosomal genes, these proteins are highly conserved between Borrelia subspecies and may be of
diagnostic or therapeutic value.
Key words: β -barrel, Borrelia, Lyme disease, outer membrane protein A (OmpA), small angle X-ray scattering (SAXS),
spirochete.
Cite this article as: Bioscience Reports (2015) 35, e00240, doi:10.1042/BSR20150095
INTRODUCTION
Various species in the genus Borrelia are capable of zoonotic
infection in humans when transmitted via the saliva of haema-
tophagous ticks resulting in Lyme disease [1]). Considerable re-
search has been directed at Borrelia burgdorferi sensu stricto,
the most prevalent strain in North America but only a minor
contributor to incidence rates in Europe and Asia. The available
data on the natural hosts/vectors present in Europe show that the
most common species present are Borrelia garinii and Borrelia
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Abbreviations: ALBI, affinity ligand-binding immunoblot; AtVDAC1, Arabidopsis thaliana voltage-dependent anion channel 1; BamA, barrel assembly machinery; BB, Borrelia burgdorferi;
BG, Borrelia garinii; BAPKO, Borrelia afzelii strain PKO; DDAO, N,N-dimethyldodecylamine-N-oxide; DipA, dicarboxylate-specific porin A; EM, erythema migrans; fH, factor H; HMM, hidden
Markov model; OM, outer membrane; OmpA, outer membrane protein A; Rg, radius of gyration; TM, transmembrane.
1 These authors contributed equally to the work.
2 To whom correspondence should be addressed (email r.j.bingham@hud.ac.uk).
afzelii, the latter of which is responsible for the vast majority
of observed erythema migrans (EM) rash [2,3]. Although early
treatment with antibiotics can be effective, symptoms may con-
tinue post-treatment probably due to a variety factors including
the presence of immunogenic cell debris, survival of viable spiro-
chetes [4–6] or the presence of persister phenotypes [7]. Borrelia
have evolved numerous strategies to aid survival for extended
periods within the mammalian host. Evasion strategies include
antigenic variation [8,9], variable expression of surface antigens
[10–12], invasion of immune privileged sites [13,14] and spe-
cific binding of immune regulators [15]. As part of the latter, the
c© 2015 Authors. This is an open access article published by Portland Press Limited and distributed under the Creative Commons Attribution Licence 3.0. 1
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ability to bind factor-H (fH) at the bacterial cell surface and
so exploit the host’s own protection against the complement re-
sponse is an essential virulence factor to establish infection and
is thought to determine host specificity [16]. Adhesion, invasion
and immune evasion is mediated primarily by a variety of surface
lipoproteins and membrane spanning β-barrels. Other notable
surface proteins include the integrin-binding BBB07 [17], the
α-helical P13 channel protein [18,19] and the BesABC (Borrelia
efflux system proteins A, B and C) efflux pump [20,21].
Lipoproteins are readily identified by their characteristic sig-
nal sequence, consisting of a positively charged N-region, hydro-
phobic H-region and a lipobox terminating with a single cysteine
amino acid [22]. Genome data [23,24] has shown Borrelia has
∼105 such proteins, many of which have been studied in detail
and have been shown to bind to a wide range of host extracel-
lular matrix proteins [25], immune regulators and cell surface
receptors [15].
β-Barrel membrane-spanning proteins pose a significant chal-
lenge to prediction methods because they are characterized by
short (<10 amino acids) membrane-spanning strands of altern-
ate hydrophobic residues interspersed by highly variable loop
regions [26]. The sequence conservation between orthologues
can also be very low. Consequently and probably also due
to their relative scarcity on the outer membrane (OM), very
few β-barrel membrane-spanning proteins have been identified
in Borrelia. Those that have been identified, BesC (BB0142)
[20], dicarboxylate-specific porin A (DipA) (BB0418) [27], P66
(BB0603, Oms66) [28,29] and BamA (barrel assembly ma-
chinery; BB0795) [30] are all predicted to form 16–24-stranded
porin-type barrels. The smaller barrel-types with 8–10 strands,
commonly found in other Gram-negative bacteria have so far
remained undetected in Borrelia.
Highly conserved among the Proteobacteria, the outer mem-
brane protein A (OmpA)-like transmembrane (TM) domain,
defined by Pfam family PF01389, consists of eight membrane-
spanning antiparallel β-strands with four large extracellular loops
and three short periplasmic turns [26]. High-resolution structural
data are available for several members of this family with a
range of different functions [31–34]. This structural data con-
firmed that the TM region is highly conserved and functional
diversity is mainly due to variations in extracellular loop regions.
The prototypical Escherichia coli OmpA functions as a non-
specific diffusion channel and with the addition of a C-terminal
peptidoglycan-binding domain, contributes to the maintenance
of cell shape and structural integrity of the OM [35].
In addition to these physiological functions, numerous mem-
bers of this family are known virulence factors including E. coli
OmpA [36,37], Cronobacter sakazakii OmpA [38], Salmonella
typhimurium Rck and PagC [39,40] and Yersinia pestis Ail [31].
These proteins contribute to pathogenicity by binding to a range
of host factors mediating adhesion, invasion and resistance to the
complement response.
To date, the OmpA-like TM domain has not been identified
in Borrelia. Considering the similarities between the membrane
structure of Borrelia and that of the Proteobacteria, we con-
sidered it likely that the OmpA-like TM domain would be con-
served in both. To this aim we conducted PSI-BLAST searches
of the NCBI protein database against the available B. burgdorferi
proteomes using a variety of OmpA sequences as search targets.
Although larger β-barrel proteins such as BamA (BB0795) were
found, no proteins matching the criteria of an OmpA-like do-
main could be identified. Consequently, we used a profile hidden
Markov model (HMM) search strategy, which enables sequences
with more remote homology to be detected [41]. Four homo-
logous proteins were identified, all encoded by chromosomal
genes and highly conserved between different species of Borrelia.
Analysis of signal sequences and bioinformatic analysis suggest
that all four proteins adopt similar topology as eight-stranded
membrane-spanning β-barrels. As the most common cause of
EM in Europe, we chose the B. afzelii homologue BAPKO_0422
for further experimental work.
In the following work, we describe the production of a re-
combinant version of BAPKO_0422 consisting of the predicted
membrane-spanning domain (no signal sequence) in the E. coli
expression system. Furthermore an affinity ligand-binding im-
munoblot (ALBI) assay demonstrates that BAPKO_0422 binds
specifically to human fH. Finally, data from SAXS, CD and
phase partitioning demonstrate that BAPKO_0422 adopts a com-
pact peanut-shaped structure rich in β-strand, consistent with a
membrane-spanning β-barrel topology.
MATERIALS AND METHODS
Identification of Borrelia OmpA-like domains
Protein sequences of all available OmpA-like TM domains were
obtained from the Pfam database family PF01389 [42]. Se-
quences with greater than 90 % or 40 % similarity were removed
using the Decrease Redundancy program (ExPASy) to generate
two lists, which were then submitted to JACOP for classifica-
tion [43]. Three families were identified corresponding to OmpA,
OmpX and OmpW. Sequences corresponding to each family were
aligned using ClustalW2 (EBI) and used to build a profile HMM
using HMMER (http://hmmer.janelia.org/). This generated six
profile HMMs, which were then used to search the genomes
of B. afzelii, B. burgdorferi and B. garinii to generate a list of
potential OmpA-like proteins. The top scoring hits were filtered
based on the presence of a signal sequence predicted using Signal
P 4.1 [44] and fold prediction using the Fold and Function As-
signment System server (FFAS03) [45]. The procedure identified
two proteins BB0027 and BAPKO_0422 matching all criteria. A
PSI-BLAST search was then conducted to identify homologous
proteins in B. afzelii, B. burgdorferi and B. garinii. Topology pre-
dictions were conducted using the PRED-TMBB web server [46]
using the mature sequences of all homologues identified above
(minus signal peptide).
Homology modelling
Homology models were generated using Modeller [47] based on
co-ordinates from PDB accession codes 1BXW, 1P4T, 1QJ8,
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1QJP, 1THQ, 2ERV, 2F1T, 2K0L, 2X27, 3DZM, 3GP6 and
3QRA. A structure-based multiple sequence alignment was gen-
erated using the MatchMaker function in the UCSF Chimera
package [48] with default settings. This was manually adjus-
ted to minimize sequence gaps in loop regions. Sequences for
the putative Borrelia OmpA-like TM domains were then added
to this alignment and manually adjusted to match the topology
and β-strand positioning as predicted by PRED-TMBB. Multiple
models were then generated using Modeller. Theoretical radius of
gyration (Rg) values, based on the centre of mass, were calculated
using the UCSF Chimera package [48].
Cloning of BAPKO_042220-201
The coding region for amino acids 20–201 of BAPKO_0422
(European Nucleotide Archive accession number ABH01676.1)
was amplified by PCR using the forward primer 5′-GCA-
TGGATCCGCAATCAAAAAGCAAAACTAT-3′ and reverse
primer 5′-ATCGAAGCTTTCATTTATTCTCCATTATATATA-3′
with the addition of BamH1 and HindIII restriction sites (under-
lined). This was ligated into the pET-47b( + ) expression vector
(Novagen) and confirmed by DNA sequencing. PCR primers
were synthesized by Eurofins MWG Operon.
Recombinant expression and purification of
BAPKO_042220-201
Protein expression in RosettaTM(DE3)pLysS cells (Merck Mil-
lipore) was induced by the addition of 1 mM IPTG to a 3 l of
culture of cells with a D of 0.6. After 3 h, cells were harvested
by centrifugation and lysed on ice by pulsed sonication in 0.3 M
NaCl, 50 mM Tris/HCl, pH 8.0. The lysate was incubated with
DNase before removal of the soluble fraction by centrifugation
(20 000 g for 30 min at 4 ◦C) and the pellet prepared for solu-
bilization by means of several preparative washes (0.3 M NaCl,
50 mM Tris/HCl, 10 mM EDTA, 1 mM DTT, 0.1 % Triton-X-
100, pH 8.0). The washed inclusion body was then solubilized in
8 M urea, 0.3 M NaCl, 50 mM Tris/HCl, pH 8.0, overnight and
clarified by centrifugation at 16 000 g for 30 min.
Protein was loaded on to a HisTrap HP 5 ml column (GE
Healthcare) in 8 M urea, 50 mM Tris/HCl, 0.3 M NaCl at pH 8.
On-column refolding was performed by the use of a linear gradi-
ent into 1 M urea, 50 mM Tris base, 0.3 M NaCl, 0.1 % N,N-
dimethyldodecylamine-N-oxide (DDAO) at pH 8.0 over 60 ml
at a flow rate of 0.5 ml/min. Refolded BAPKO_042220-201 was
then subjected to 10 column volumes of wash buffer, 1 M urea,
50 mM Tris/HCl, 1 M NaCl, 50 mM imidazole, pH 8.0, before
being eluted by a linear gradient of 50 mM Tris/HCl, 0.3 M NaCl,
0.3 M imidazole, 0.1 % DDAO at pH 8.0.
The N-terminal 6× His-tag was removed enzymatically using
the HRV-3 (human rhinovirus-3) protease (Sigma–Aldrich). Pur-
ified BAPKO_042220-201 was incubated at room temperature for
48 h in buffer 0.3 M NaCl, 0.1 % (w/v) DDAO, 50 mM Tris/HCl,
pH 8.0. The reaction mixture then was passed through a HisTrap
HP 5-ml column (GE Healthcare) to remove the 6× His-tagged
HRV-3C and any uncleaved protein.
Protein was concentrated using a 10 NMWL Amicon Ultra-15
centrifugal filter unit (Merck Millipore), centrifuged at 16 000 g
for 20 min at 10 ◦C and the protein concentration measured by
spectroscopy and Bradford analysis.
Size exclusion chromatography of
BAPKO_042220-201
Following initial purification, BAPKO_042220-201 was subjected
to gel filtration and was applied to a Superdex 75 10/300 column at
a flow rate of 0.5 ml/min in 0.3 M NaCl, 50 mM Tris/HCl, 0.1 %
DDAO at pH 8. Peak fractions containing BAPKO_042220-201
were pooled and concentrated. BSA, ovalbumin, ribonuclease A
and vitamin B12 were prepared in the same buffer and used as
size exclusion chromatography (SEC) standards.
Affinity ligand-binding immunoblot assays
ALBI assays were performed to detect specific binding to human
fH. BAPKO_042220-201 (10 μg) was subjected to native-PAGE
alongside human fH (HC2130, Hycult Biotech) (0.5 μg) as a pos-
itive control. Negative controls consisted of BSA (10 μg, Sigma–
Aldrich) and recombinant superoxide dismutase A (SodA; 10 μg)
from B. burgdorferi produced from the same vector and subjec-
ted to the same purification protocol. All incubations were carried
out at 4 ◦C. Proteins were immunoblotted on to PVDF membrane
and blocked in 5 % milk powder made up in TBS. Following
three 5-min washes with TBS-Tween (0.05 %), the membrane
was incubated with human fH at a concentration of 73 μg/ml in
TBS for 14 h with gentle agitation. This concentration is approx-
imately 3-fold lower than the mean concentration of fH in human
blood (233–269 μg/ml) [49]. The membrane was further washed,
as described above, before incubation with the primary antibody
for 1 h (1:1000 of mouse monoclonal anti-Human fH, Abcam).
Following washing as above, the membrane was then subjected to
the secondary antibody for 1 h (1:5000 of Goat Anti-Mouse IgG
H&L, Alexa Fluor®680, Abcam). The blot was then visualized on
a LI-COR Odyssey infrared imaging device by measuring emis-
sion at 700 nm. A negative control blot was carried out alongside
the experimental assay. In the latter case, human fH was replaced
with TBS for the 14-h incubation.
CD spectroscopy
CD data were collected from a solution of 0.33 mg/ml
BAPKO_042220-201 in 0.1 % (w/v) DDAO, 0.3 M NaCl, 30 mM
Tris/HCl, pH 8.0, on a Jasco J-810 Spectropolarimeter. Measure-
ments were taken in duplicate over a wavelength range of 195–
260 nm before background subtraction using a dialysis matched
buffer. Data were processed using the DichroWeb server using
the algorithm CDSSTR and reference sets 4 and 7.
Phase partitioning
Phase partitioning was conducted according to published meth-
ods [50]. Control proteins haemoglobin and lysozyme were
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purchased from Sigma–Aldrich. Arabidopsis thaliana voltage-
dependent anion channel 1 (AtVDAC1) was refolded and purified
according to published methods [51]. All temperature incubations
were for a period of 3 min. Protein solutions were made up to
1 mg/ml in 10 mM Tris/HCl, pH 7.4, 150 mM NaCl, 1 % Triton
X-114 at 0 ◦C. A 200 μl of sucrose cushion was prepared con-
sisting of 6 % (w/v) sucrose, 10 mM Tris/HCl, pH 7.4, 150 mM
NaCl and 0.06 % Triton X-114. Fifty microlitres of protein solu-
tion was overlaid on the sucrose cushion and incubated at 30 ◦C
before centrifugation at 300 g for 3 min. The upper aqueous layer
(70 μl) was removed and additional Triton X-114 was added to
0.5 % concentration. After incubation at 0 ◦C and gentle mixing,
this aqueous phase was overlaid on the same sucrose cushion, in-
cubated at 30 ◦C and then centrifuged at 300 g for 3 min to pellet
the detergent phase. The upper aqueous phase was removed and
received an additional 2 % Triton X-114. This was then cooled to
0 ◦C, mixed, then incubated at 30 ◦C before a final centrifugation
at 300 g for 3 min (pellet discarded). The supernatant (aqueous
phase) was then analysed by SDS/PAGE alongside the previous
detergent phase.
SAXS
SAXS data were acquired using a Bruker Nanostar from solu-
tions of BAPKO_042220-201 in 0.1 % (w/v) DDAO, 0.3 M NaCl,
50 mM Tris/HCl, pH 8.0. Protein samples of ∼100 μl were sealed
in a 1.5 mm bore quartz glass capillary and the sample chamber
was evacuated to minimize background scattering. The sample
to detector distance was 106.85 cm. The s-axis and beam centre
were calibrated using the scattering pattern of silver-behenate
salt (d-spacing = 5.84 nm). The momentum transfer was defined
as s = 4πsin(θ )/λ. Although detergent solutions exhibit scat-
tering similar to that of water, proper background subtraction
is essential to ensure good quality data. In addition, the pres-
ence of protein can sequester detergent from the surrounding
solution and alter the monomer/micelle equilibrium. For this
reason, samples were dialysed against the blank buffer at 4 ◦C
for 5 days prior to data collection. Each scattering data set con-
sisted of 10 × 2400 s exposures. Scattering data were collected
from His-tagged BAPKO_042220-201 at 3.3, 4.5 and 5.5 mg/ml
and from native BAPKO_042220-201 at 2.5, 3.5 and 4.5 mg/ml. For
each sample, the equivalent scattering data collected for dialysis-
matched buffer (10 × 2400 s) was subtracted using Primus soft-
ware. Equivalent scattering data were also acquired for lysozyme
using identical buffers (result not shown).
Rg values were evaluated using both the Guinier approximation
and also in real space from the entire scattering pattern using the
indirect transform program GNOM.
Ab initio molecular envelopes were calculated using the DAM-
AVER program suite, part of the ATSAS package [52,53]. DAM-
MIN generated 20 independent models by simulated annealing
(P1 symmetry) using a bead model, which were then aligned and
outliers removed before averaging (Supplementary Figures S1
and S2, Supplementary Tables S1 and S2). A filtered model was
generated in DAMFILT. Figures were generated in PyMOL (The
PyMOL Molecular Graphics System, Version 1.7.4 Schro¨dinger).
RESULTS
Identification and topology prediction of OmpA-like
TM domains in Borrelia
The sequences of known OmpA-like membrane-spanning
domains, defined by Pfam family PF01389 [42], show high con-
servation in only a small number of key positions, specifically the
various residues involved in forming the two aromatic-girdles,
several glycine residues and residues involved in ion pair interac-
tions. The aliphatic residues orientated towards the membrane-
interior are highly variable between different proteins whereas
the loop-regions are exceptionally variable. Because of this low
sequence conservation, we employed a sensitive HMM-based
search strategy to find potential OmpA-like domains in the genus
Borrelia. The results revealed four chromosomally encoded pro-
teins, consisting of three closely related paralogous sequences,
BAPKO_0422, BAPKO_0423, BAPKO_0591 and the more
distantly related BAPKO_0026. An analysis of whole genome se-
quences of the 35 species in the Lyme-borreliosis group and seven
species in the relapsing fever group [54] revealed conserved or-
thologues of these proteins in all known Borrelia species. Ordered
locus names from the three main strains known to be pathogenic
to humans (B. afzelii, B. burgdorferi and B. garinii) are shown
in Table 1. All the sequences identified are currently annotated
as putative uncharacterized proteins. Fold recognition using the
FFAS03 server [45] suggested that BAPKO_0026 was more
closely related to E. coli OmpW, whereas the BAPKO_0422 para-
logous group (BAPKO_0422, BAPKO_0423, BAPKO_0591)
bore similarities to a range of proteins including the Neisseria
meningitidis protein NspA and the E. coli proteins OmpA and
OmpW (Table 1). However, an analysis of sequence similarity
and turn/loop lengths with comparison to the E. coli homologues
did not reveal any consistent features, suggesting the Borrelial
proteins share the same basic topology as OmpA/OmpW/NspA
but are not closely related to any of these proteins in particular.
Topology predictions (PRED-TMBB) of the proteins listed in
Table 1 match an eight-stranded β-barrel with long extracellular
loops and short periplasmic turns (Figures 1 and 2). Both N- and
C-termini are predicted to be periplasmic. A consensus topology
was generated based on the PRED-TMBB results and manual
inspection of conserved of aliphatic residues (shaded grey, Fig-
ures 2A and 2B). The topology prediction failed for BB0405 and
BG0407 and some manual interpretation was required based on
the sequence similarity to other members of the group. Some
uncertainty remains about the positioning of the first strand (in-
dicated by dashed lines in Figure 2). The sequence alignment
reveals that TM regions are more conserved than loop regions,
which vary in sequence and length between the four homologues.
Side chains predicted to occupy the barrel interior are in general
more conserved than neighbouring residues exposed to the hy-
drophobic lipid-bilayer, as might be expected considering the
constraints imposed by packing inside the barrel.
Signal sequence prediction (Signal P) [44] suggests that nine
out of the 12 homologues listed in Table 1 contain a functional
signal sequence (Figures 2A and 2B). Multiple positively charged
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Table 1 Ordered locus names of potential OmpA-like domains identified by HMM/FFAS03/BLAST searches from
B. afzelii (BAPKO), B. burgdorferi (BB) and B. garinii (BG)
The top hit from FFAS03 searches are all eight-stranded membrane-spanning proteins (either OmpA, OmpW or NspA). All
sequences are currently annotated as putative uncharacterized proteins. Signal sequence prediction results are based on
the no TM neural network. *Present as monomer in OM vesicles [65]. †fH-binding activity [59]. ‡UniProt sequence is 11
amino acids shorter than GenBank sequence, full sequence is shown.
Ordered locus
name
GenBank (UniProtKB)
Accession codes
No. of amino
acids
FFAS03 highest
scoring template
Signal sequence
prediction (SignalP 4.1)
BAPKO_0026 ABH01291.1 (Q0SPD7) 211 OmpW (2X27) N
BB_0027 AAC66429.1 (O51058) 212 OmpW (2X27) Y
BG0027 AAU06886.1 (Q662Y5) 212 OmpW (2X27) N
BAPKO_0422 ABH01676.1 (Q0SNA2) 201 OmpA (2K0L) Y
BB_0405* AAC66795.1 (O51366) 203 OmpW (2X27) Y
BG0407† AAU07257.1 (Q661L4) 203 OmpW (2X27) Y
BAPKO_0423 ABH01677.1 (Q0SNA1) 203 OmpA (2K0L) Y
BB_0406 AAC66794.1 (O51367) 203 OmpA (2K0L) Y
BG0408 AAU07258.1 (Q661L3) 203 OmpA (2K0L) Y
BAPKO_0591 ABH01831.1 (G0IQB2‡) 181 NspA (1P4T) Y
BB_0562 AAC66924.1 (O51510) 180 NspA (1P4T) N
BG0572 AAU07409.1 (Q660W2) 179 NspA (1P4T) Y
Figure 1 Topology prediction (PRED-TMBB) of ordered loci BAPKO_0026, BAPKO_0422, BAPKO_0423 and BAPKO_0591
Colours indicate regions predicted to be extracellular (blue), periplasmic (green) and TM (red). Sequences are numbered
based on the mature protein (no signal sequence).
amino acids are seen in the N-terminal region, a feature consist-
ently found in confirmed signal sequences from both spirochetes
and proteobacteria [55,56]. With the exception of BB0562, all
sequences have an alanine residue in the predicted − 1 position
and so are expected to be processed by a type-I signal peptidase.
Inspection of BAPKO_0423, BB0406 and BG0408 shows two
cysteine amino acids at positions 31 and 40, indicating potential
sites for N-terminal lipidation. However, the potential lipobox
is a poor match with previous analysis of spirochetal lipobox
sequences [22]. The topology prediction presented in the present
study suggest these two cysteine amino acids form part of a
small periplasmic region and are therefore likely to be disulfide
bonded.
Borrelia OmpA-like domains contain a C-terminal
signature sequence
The vast majority of OM β-barrels in Gram-negative bacteria
contain a C-terminal signature sequence resembling Z-x-Z-x-Z-
x-Y-x-F>, where x represents any amino acid and Z-represents
non-polar residues. The terminal residue is invariably a non-polar
residue, usually a phenylalanine [57].
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Figure 2 Multiple sequence alignment and consensus topology of the BAPKO_0026 group (A) and the BAPKO_0422
paralogous gene family (B)
Sequences from the three main Borrelia sub-species known to infect humans are included (BA, B. afzelii; BB, B. burgdorferi;
and BG, B. garinii). Colours indicate predicted topology based on PRED-TMBB results (Figure 1). Non-polar membrane
spanning residues are shaded light grey. Predicted N-terminal signal sequences are shaded dark grey (SignalP 4.1, using
neural network ‘SignalP-noTM’). Sequences were aligned using ClustalW. A consensus topology prediction is shown above
each sequence alignment based on the PRED-TMBB topology and conserved hydrophobic residues. All sequences were
analysed for potential stop-transfer sequences using ProtScale. The potential C-terminal signature sequence is indicated
by Z-Z-Z-Z-Z-ZK. (C) An analysis of C-terminal signature sequences from experimentally confirmed β -barrels BamA (BB0795),
DipA (BB0418) and P66 (BB_0603).
The four alternate non-polar residues are well conserved in
the C-terminal region of the Borrelia OM-proteins (Figures 2A
and 2B); however, some differences in the terminal residues are
apparent. Only BB0562 terminates with a phenylalanine residue,
almost all other sequences terminate with the small non-polar
amino acids isoleucine or valine. The putative OM β-barrels
identified in the present study contain an invariant lysine residue
within four residues of the C-terminus. Following this lysine
residue, the C-terminal sequence of the BAPKO_0422 group is
rich tyrosine and small non-polar-residues. A comparison was
made with the C-terminal regions of other experimentally con-
firmed Borrelia β-barrel proteins BamA, DipA and P66 (Fig-
ure 2C). The sequences reveal four alternate non-polar residues
followed by a conserved positively charged residue (lysine or
arginine).
Homology model of BAPKO_0422
To allow a more detailed analysis of residue packing within the
barrel interior and positioning in the membrane, homology mod-
els were generated using Modeller [47] (Figure 3). This mod-
elling benefited from the availability of several high-resolution
structures of TM β-barrels from an evolutionary diverse range of
bacteria including E. coli, N. meningitidis, Y. pestis, Pseudomo-
nas aeruginosa and Thermus thermophilus. The four B. afzelii
homologues shown in Figure 1 were used as target sequences.
The models suggest that all four proteins have a vertical height
45–62 ˚A in the membrane with a width of ∼25 ˚A (Figure 3). Rg
values based on centre of mass were also calculated and ranged
between 17.0 and 19 ˚A. The modelled β-barrels resemble an
inverse micelle, with numerous polar residues and ion-pair inter-
actions forming a tightly packed interior. This is surrounded by an
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Figure 3 Homology models of BAPKO_0026, BAPKO_0422, BAPKO_0423 and BAPKO_0591 generated using Modeller
The predicted secondary structure shows an eight-stranded antiparallel β -barrel (blue). Loops and turns are shown in
yellow, α-helices are shown in green. Aromatic-girdle residues are shown as sticks representation. The approximate limits
of the aliphatic region are indicated by dashed lines. Rg values calculated in Chimera: BAPKO_0026 18.9 A˚, BAPKO_0422
16.8 A˚, BAPKO_0423 18.1 A˚, BAPKO_0591 18.4 A˚.
exterior band of aliphatic residues predicted to interact with the
non-polar acyl chains of Borrelia glycolipids. Aromatic residues
are frequently observed at the lipid-water interface in membrane
spanning β-barrels of Gram-negative bacteria [26]. Two aromatic
girdles are present in the Borrelia proteins, allowing the vertical
positioning in the membrane to be estimated (dashed line, Fig-
ure 3). The distance between the two aromatic girdles (24–27 ˚A)
is consistent with the hydrophobic distance (∼26 ˚A) of β-barrels
from other Gram-negative bacteria [58].
Expression, purification and characterization of
recombinant BAPKO_0422
The predicted mature form of BAPKO_0422
(BAPKO_042220-201) was produced in the E. coli expres-
sion system with a cleavable N-terminal 6× His-tag and
purified to homogeneity as described in ‘Materials and Meth-
ods’ (Figure 4A). The resultant protein lacked a functional
N-terminal signal sequence and so was produced as inclusion
bodies, facilitating separation from native E. coli membrane
proteins. Purified BAPKO_042220-201 readily refolded using a
variety of methods including dilution and on-column refolding
protocols (see Materials and Methods). Numerous studies have
demonstrated that eight-stranded β-barrel membrane proteins
can spontaneously refold in lipid bilayers or detergent micelles
following either heat- or chemically-induced unfolding [58].
The size exclusion chromatogram (Figure 4B) revealed a
single peak. The elution volume corresponds to a molecular mass
of 23 kDa indicating that BAPKO_0422 forms a monomer un-
der the conditions tested. Protein folding was confirmed by CD,
which revealed a classic β-strand-type spectrum with maxima
at 196 nm and minima at 216 nm (Figure 5A). The secondary
structure analysis predicts 40 % β-sheet, 20 % turn and 35 % un-
ordered.
The relatively low cloud point of Triton X-114 (∼23 ◦C) allows
the separation of amphiphilic integral membrane proteins from
water-soluble proteins at physiological temperatures. Above the
cloud point, aggregation of detergent micelles results in a two-
phase system consisting of an aqueous phase and a detergent-rich
phase. This detergent phase can be readily isolated by low speed
centrifugation. BAPKO_0422 was shown to be amphiphilic, par-
titioning to the detergent phase (Figure 5B).
Structural characterization of BAPKO_0422 by
SAXS
SAXS data from a solution of a monodisperse protein can provide
a measure of the Rg and overall molecular shape. SAXS data were
recorded from both untagged BAPKO_042220-201 (Figure 6A)
and His-tagged protein (6His-BAPKO_0422). Inspection of the
Guinier region and residuals from linear fitting (Figure 6B) re-
vealed linearity an indication of good quality data with minimal
aggregation.
Radiation damage may result in sample aggregation or protein
misfolding through the course of an experiment. Scattering data
were compared from initial and final images with no signific-
ant changes observed in either scattering form or calculated Rg
values. Samples were analysed by SDS/PAGE both before and
after X-ray exposure and were unchanged. To test for the pos-
sibility of concentration dependent effects such as aggregation
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Figure 4 Production and purification of recombinant BAPKO_042220-201
(A) SDS/PAGE of purified BAPKO_042220-201 with a single band at ∼23 kDa. (B) Size exclusion trace for BAPKO_042220-201.
Purified protein was applied on to a Superdex 75 10/300 column at a flow rate of 1 ml/min resulting in a single sharp
peak corresponding to an approximate molecular mass of 23 kDa.
Figure 5 CD (A) and phase partitioning (B) of BAPKO_042220-201
CD data were acquired at 20 ◦C in duplicate at a protein concentration of 0.33 mg/ml in 0.1 % (w/v) DDAO, 0.3 M NaCl,
30 mM Tris/HCl, pH 8, between wavelengths of 195–260 nm. Maxima at 196 nm and minima at 216 nm indicate a
structure rich in β -strand. Phase partition experiments were conducted using the non-ionic detergent Triton X-114, allowing
separation of hydrophilic proteins (Aq) from amphiphillic detergent-soluble proteins (Det). Haemoglobin (1) was used as
an aqueous phase negative control. BAPKO_042220-201(2) partitions to the detergent phase. AtVDAC1 (3) was used as a
known detergent-phase positive control.
or inter-particle interference, Rg values were determined at three
concentrations for both His-tagged and native protein (Table 2).
Rg values calculated by both Guinier analysis and Real Space
analysis (Table 2) are comparable to the Rg calculated from
the homology model (Figure 3) indicating that BAPKO_0422 is
monomeric under the conditions tested. The pair-distance distri-
bution function [P(r) function] gives information on the shape of
a molecule by describing the paired-set of all distances between
points in an object (Figure 6C). The single peak is indicative
of a single-domain globular protein. The distribution of longest
dimensions approaches zero with a concave slope and a Dmax
of 43 ˚A.
A Kratky plot [q2I(q) versus q] can be used to distinguish
between compact folded structures and unfolded flexible systems.
The data show a parabolic curve indicative of a compact globular
structure (Figure 6D).
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Figure 6 SAXS data of BAPKO_042220-201
Analysis of the scattering data generated from a sample of untagged BAPKO_042220-201 at 3.5 mg/ml in 0.3 M NaCl,
50 mM Tris-base, 0.1 % DDAO, pH 8.0. (A) The raw scattering data shown as a log of intensity over the scattering vec-
tor (A˚− 1) and generated in Primus following background subtraction. (B) Guinier analysis of the background subtracted
scattering data. A Guinier approximation was applied manually using Primus as In[I(s)] versus s2. The blue data points
represent the scattering data, the red line shows the selected Guinier region and the green data illustrates the corres-
ponding residuals. (C) The distance distribution function P(r) of BAPKO_042220-201 generated using GNOM with a Dmax of
43 A˚. (D) Kratky plot [s2 × I(s) versus s] generated using Primus. The momentum transfer was defined as s = 4π sin(θ )/λ.
Table 2 Calculated Rg values for BAPKO_042220-201
A summary of Rg values for untagged and His-tagged BAPKO_042220-201 calculated using various methods. The Rg was
calculated for both samples manually by Gunier approximation and then by Gnom in reciprocal and real space using the
full curve.
Untagged BAPKO_042220-201
2.5 mg/ml 3.5 mg/ml 4.5 mg/ml
Guinier Rg (A˚) 13.5 +− 0.15 14.6 +− 0.11 12.5 +− 0.39
Reciprocal space Rg (A˚) 15.7 14.3 14.4
Real space Rg (A˚) 15.7 14.3 14.5
His-tagged BAPKO_042220-201
3.0 mg/ml 4.5 mg/ml 6.0 mg/ml
Guinier Rg (A˚) 14.2 +− 0.13 14.1 +− 0.12 14.0 +− 0.10
Reciprocal space Rg (A˚) 16.8 16.8 16.6
Real space Rg (A˚) 16.8 16.8 16.7
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Figure 7 Low-resolution molecular envelopes of
BAPKO_042220-201 (A and B) and His-tagged BAPKO_042220-201 (C
and D) determined by SAXS
Refined and filtered molecular envelopes were generated from 20 in-
dependent DAMMIN models (Supplementary Figures S1 and S2). The
green surface represents the filtered envelope generated by DAMFILT,
the grey envelope is the computed probability map generated by DAM-
AVER. The homology model of BAPKO_042220-201 is shown as purple
cartoon.
Ab initio molecular envelopes of native and His-tagged
BAPKO_0422 calculated by simulated annealing reveal similar
structures with some minor additional density in the latter (Fig-
ure 7). The SAXS envelope is consistent with the dimensions
of a β-barrel and the homology model of BAPKO_0422 docked
within the envelope shows close agreement (Figure 7).
BAPKO_0422 is an fH-binding protein
Numerous studies have revealed the complex differential bind-
ing of both human and animal fH by various strains of Borrelia,
contributing significantly to pathogenicity and host-competence
[59,60]. A broad screen of whole cell sonicate from B. garinii
against human sera followed by de novo sequencing identified the
hypothetical protein BG0407 (Genbank AAU07257) as a novel
fH-binding protein [59]. To test the possibility that the close
homologue BAPKO_0422 may also be an fH-binding protein we
used a far western blot (ALBI assay). Briefly, immunoblots of
BAPKO_0422 along with positive and negative controls were
Figure 8 ALBI assay
Non-reducing 1D immunoblots of 0.5 μg of human fH as a positive con-
trol (lanes A and C) and 10 μg of recombinant BAPKO_042220-201 (lanes
B and D). Blot 1 (A and B) was incubated with human fH (73 μg/ml),
whereas blot 2 (C and D) was incubated with TBS buffer. Human fH was
detected by a mouse monoclonal anti-human fH primary, followed by
a fluorescent goat anti-mouse IgG secondary antibody, as described in
‘Materials and Methods’.
incubated with human fH. Bound fH was detected by a mono-
clonal Anti-human fH primary antibody, followed by a fluores-
cent secondary antibody (see Materials and Methods). The results
demonstrated that recombinant BAPKO_0422 formed a specific
interaction with human fH at a concentration 3-fold lower than
that found in human blood (Figure 8).
DISCUSSION
Although the OM of Borrelia is distinct from Gram-negative
bacteria, the central components of the Sec-dependent secretion
pathway and the barrel assembly apparatus involved in localiza-
tion and insertion of proteins into the OM (BamA, BamB, BamD,
Skp), appear to be conserved [30,61]. Genome data are now
available for numerous strains of Borrelia; however, it remains a
significant challenge to identify all potential OM β-barrels due
to the inherent difficulties in theoretical prediction. With the ex-
ception of the lipoproteins, very few surface exposed proteins
have been identified in Borrelia. In the present study, we have
identified a paralogous group of four Borrelia proteins which we
predict are eight-stranded membrane-spanning β-barrels. As the
most common cause of EM rash in Europe, we chose to study the
four B. afzelii homologues in more detail. Bioinformatic analyses
using a range of prediction methods indicate a topology similar
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to the well-studied E. coli proteins OmpA, OmpX and OmpW.
Experimental evidence from CD and a low-resolution SAXS
structure of recombinant BAPKO_0422 support this hypothesis.
As recombinant protein was produced from the E. coli expres-
sion system and purified from inclusion bodies, confirmation of
protein refolding is required. The CD data indicate recombinant
BAPKO_042220-201 forms extensive secondary structure rich in
β-strand. The results are directly comparable to a range of other
β-barrels such as OmpW [62], OmpA and OprF [63]. In addi-
tion, Kratky plots generated from SAXS data indicate a compact,
folded structure. The formation of tertiary structure of many β-
barrels proteins can be monitored by the difference in apparent
molecular mass between the folded and the unfolded states, as
determined by SDS/PAGE. Numerous membrane-spanning β-
barrels have been shown to maintain a folded state when solubil-
ized in SDS at room temperature, but once denatured by boiling
will remain in an unfolded state [64]. Therefore, gel-shift assays
are conducted by comparing boiled and unboiled samples. Gel-
shift assays were conducted using recombinant BAPKO_0422;
however, the protein remained unmodified by heat (results not
shown). This result is consistent with studies on the 24-stranded
P66, which was also not modified by heat [28] and is perhaps
indicative of a general feature of OMPs in Borrelia.
The ab initio molecular envelope of BAPKO_0422 determined
by SAXS reveals a peanut shaped structure with dimensions
25 × 45 ˚A. This structure is consistent with a monomeric eight-
stranded β-barrel and suggests a multimeric porin-type structure
is unlikely. This is consistent with data on the orthologous protein
from B. burgdorferi BB0405, which was shown to be monomeric
while not making significant interactions with other major OM-
proteins [65].
An analysis of N-terminal signal sequences of the
BAPKO_0422 family of proteins revealed that the majority are
predicted to have a functional signal sequence and so may enter
the Sec-dependent secretory pathway for translocation across the
inner membrane. In common with OM-proteins from other Gram-
negative bacteria the Borrelia proteins identified in Table 1 are
devoid of long hydrophobic stretches, precluding lateral transfer
from the translocase to the inner membrane [66]. Some differ-
ences in N-terminal sequence between the three sub-species of
Borrelia are seen. The N-terminal sequence of the B. burgdorferi
protein BB0562 may not be recognized by signal peptidase I as
it lacks a small non-polar residue normally present at the − 1
position. Additionally BA0026 and BG0027 are not predicted
to have functional signal sequences, whereas the close ortho-
logue BB0027 does (Figure 2). These differences in predicted
signal sequence may be due to subtle differences between the
spirochetal signal peptides compared with those of the signal P
training set. Alternatively, Borrelia is known to have three type-I
signal peptidases compared with the single protein in E. coli [67].
This allows for the possibility of concerted divergence of signal
peptides along with their corresponding peptidase resulting in a
wider range of functional signal sequences in Borrelia compared
with E. coli.
The homology models and topology predictions clearly show
that the Borrelia OmpA-like domains listed in Table 1 are devoid
of any C-terminal domains. The C-terminal residues are therefore
predicted to form the terminal strand of the β-barrel and as such
are expected to contain the highly conserved C-terminal signature
sequence motif [68]. This 10-residue signature sequence consists
of three alternating non-polar residues at positions − 9, − 7 and
− 5 from the C-terminus. These side chains make contact with
the aliphatic region of the membrane. The − 3 residue is usually
a tyrosine residue that forms part of the aromatic girdle occupy-
ing the interface between polar and non-polar environments [57].
The C-terminal residue is usually a phenylalanine but may occa-
sionally be substituted with other aromatic amino acids or more
rarely other non-polar amino acids. Although not essential for
proper processing, the aromatic nature of the C-terminal residue
enhances processing by the BamA apparatus, facilitating barrel
assembly in the OM [57,69]. Variations in the C-terminal signa-
ture sequence and their recognition by BamA have been shown
to be species specific, in particular, many Proteobacterial OMPs
have a positively charged residue in the penultimate position,
whereas this is never observed in E. coli [70]. A C-terminal
signature sequence is apparent among the BAPKO_0422 fam-
ily and BA0026, both consisting of a series of six alternative
non-polar residues, a single lysine residue and a small polar ter-
minal motif (Figure 2). With the exception of BB0562, the most
notable exception to the standard proteobacterial C-terminal se-
quence is the absence of a C-terminal phenylalanine residue.
Instead the sequences terminate with either the small non-polar
residues leucine, isoleucine or the polar asparagine. In addition,
a number of tyrosine residues are also present in the final three
residues. The differences observed in the present study may be
suggestive of a Borrelia-specific C-terminal signature sequence.
In order to confirm this, we analysed the C-terminal strands of
the small number of experimentally confirmed β-barrels in Bor-
relia. DipA has a C-terminal signature sequence reminiscent of
the BAKPO_0422 family, terminating with K-Y. In addition, the
barrel assembly apparatus BamA, is itself a β-barrel and the last
membrane-spanning strand terminates with R-Y. The terminal
strand of the OM porin P66 also contains the conserved positive
lysine residue and terminates with the polar sequence S-G-S. We
therefore propose that these membrane-spanning β-barrels con-
tain a Borrelia-specific C-terminal signature sequence and this
is recognized efficiently by the Borrelia BamA apparatus. This
sequence resembles Z-x-Z-x-Z-x-Z-[KR]-[ILNY], where Z rep-
resents a small non-polar residue, x can be any amino acid. A
conserved positively charged residue is present, but is not neces-
sarily the penultimate residue. The terminal residue appears to
be variable and is rarely a phenylalanine residue. An analysis of
Borrelia proteins identified as potential β-barrels by the TMBB-
DataBase [71] reveals a range of C-terminal residues including
isoleucine, valine, lysine, asparagine and tyrosine.
A literature search for homologues of BAPKO_0422 from
other Borrelia subspecies revealed insights into possible func-
tions and cellular localization. The B. burgdorferi homologue
BB0405 was shown to be surface exposed, present in OM ves-
icles [65] and expressed in conditions representative of both tick
and host environments [72]. Another homologue, BB0407 (Gen-
bank AAU07257) was identified from a screen of proteins with
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fH-binding activity suggesting a possible role in virulence [59].
This fH-binding activity led us to investigate the fH binding of
BAPKO_0422, which we confirmed using an ALBI assay. These
results and the high sequence similarity suggest that the ortho-
logous group BAPKO_0422, BG0407 and BB0405 are expressed
in the mammalian host, exposed at the cell surface and bind to
human fH.
In summary, the data presented suggest that BAPKO_0422
forms a membrane-spanning β-barrel. The topology prediction
matches the OmpA-membrane spanning domain defined by Pfam
family PF01389, consisting of eight membrane-spanning β-
strands linked by short periplasmic turns and longer extracellular
loops. For the first time, this extends the species distribution of the
PF01389 domain to include members of the Spirochete phylum.
The orthologous group consisting of BAPKO_0422, BB0405 and
BG0407 are proposed to play a role in virulence by binding to
host fH, therefore abrogating the host complement response and
reducing antigenicity of surface exposed loops. Further work is
required to establish the host-specific fH-binding activity of the
remaining homologues and to determine any other physiological
functions of these proteins in Borrelia. Surface exposed epitopes
may enhance recombinant immunoblots currently used in dia-
gnostic tests for Lyme disease.
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